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Charles S. Robertson
February 13, 1905-May 2, 1981
Charles Sammis Robertson, through his several
gifts to this Laboratory, changed radically our
nature, giving us the capacity again to do science
at a level with the best and allowing us to escape
out of a long cycle of physical decay that had been
badly accentuated in the early 1960s upon the
decision of the Carnegie Institution of Washing-
ton to discontinue support for its Genetics Pro-
gram at Cold Spring Harbor.
We met first in the summer of 1972, soon after
the death of his beloved wife, Marie. They had
married in 1936, quickly assembling a large parcel
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of land in Lloyd Harbor that overlooked the waters
of Cold Spring Harbor and that had for almost 200
years been farmed by members of his mother's
family, the Sammises. On this land, they built a
marvelous Georgian-style home that they had
designed by the noted architect Mott Schmidt. In
it and its surrounding fields and outbuildings they
quietly raised their family of five children, Mimi,
Anne, John, William and Kate. During the war
years they also served as foster parents for two
children evacuated from an England then at risk
from the terror of German bombs and rockets.
Though always known as generous benefactors
to local causes, with Mr. Robertson serving many
years on the Board of Huntington Hospital and for
several years as its president, the extraordinary
nature of their private philanthropy remained a
closely guarded secret for twelve years. To Prince-
ton University, from which Charles Robertson
graduated magna cum laude in 1926, the Robert-
sons, in 1961, donated 35 million dollars to be used
to greatly expand and generously endow the
Woodrow Wilson School of Public and Interna-
tional Affairs. Except for a privileged few, no one
knew the identity of the benefactors until after
Marie's death. Then the President of Princeton
obtained Charles Robertson's permission to reveal
their role. Princeton, like many other universities,
was going through the travails occasioned by the
Vietnamese War, and many students were under
the illusion that only the CIA could be so generous
and wish for anonymity.
Upon his wife's death, Charles Robertson be-
came concerned over the long-term future of his
house and property, worrying that upon his death,
the Sammis lands that he had reassembled would
again be dispersed. He came to us with the hope
that, as an academic institution, we might utilize
well his land and buildings, were he to properly
endow them so they would not soon be regarded
as a white elephant from which we should quietly
disentangle ourselves. And wisely, perceiving that
unless we were inherently stable, we could not
give an intelligent, loving use to his estate, he also
offered to provide several million dollars to create
an endowment fund, the income of which was to
be used to support research at the Laboratory
itself.
It was an offer too wonderful to believe, or to
consider even momentarily turning down, and we
eagerly joined with the Robertson family to set up
a separate corporate entity to be called the
Robertson Research Fund. It came into legal
existence in early June of 1973, accompanied by a
gift of 8 million dollars from the Banbury Founda-
tion. This was the Robertson family foundation
created as a vehicle for the philanthropy made
possible by the sale in the 1950s of their share of
the stock in the Great Atlantic and Pacific Tea
Company, which had been founded by Marie
Robertson's family, the Hartfords.
Among the first uses of the Robertson Research
Fund was the purchase of a Phillips 201 Electron
Microscope to be placed in the newly renovated
Davenport Lab. Soon after, this fund allowed us to
totally renovate and equip Jones Lab as a center for
Neurobiology and then to go on to complete the
renovation of McClintock Lab, creating the new
labs that allowed our Cell Biology Group to come
into existence. Robertson monies also proved
invaluable in allowing our summer research
program for undergraduates to carry on when the
NSF cut back on this program and in maintaining
several key summer courses when the federal
funds on which we had counted were lost due to
last-minute recisions demanded by the OMB.
Equally important, it has provided key monies to
allow new staff members to start up their research
at full blast, as well as funds for many of the
Postdoctoral Fellows who have worked here over
the past eight years.
In 1976, three years after the creation of the
Robertson Research Fund, Mr. Robertson trans-
ferred to us his lovely estate of some 45 acres on
Banbury Lane. The main house, which we now call
Robertson House, came to us tastefully furnished
with reproductions of the fine, antique, family
furniture, which Mr. Robertson had moved to his
winter home in Delray Beach, Florida, upon his
retirement from the investment banking firm of
Smith Barney. A second endowment fund, the
Robertson Maintenance Fund, of $1.5 million
dollars was then created to provide for the
perpetual upkeep of the estate, along with a
special gift of $100,000 to be used in preparing the
estate for our special needs. We thus had the
means to transform the elegant seven-car Geor-
gian-style garage into a meeting complex and so
create the Banbury Educational Center, a facility
uniquely designed for the holding of small
conferences and the teaching of summer courses.
On June 10,1977, the Banbury Meeting House was
formally dedicated, with Francis Crick giving the
first lecture. It was a very happy occasion, with Mr.
Robertson and many of his family being in
attendance. To complete the Banbury complex, a
second residence, containing 16 bedrooms, was
added in 1980 to supplement the housing for 20
visitors provided by Robertson House. Designed
in the post-modern classical idiom by the cele-
brated American architect Charles Moore, it has
been named Sammis Hall.
From the beginning of his formal association
with us, Charles Robertson displayed an active
interest in our Neurobiology Programs and early
expressed the desire to help us further expand
studies on the biological basis of behavior. Toward
that objective, in 1977 he set aside further income
from the Banbury Foundation to create the Marie
H. Robertson Fund for Neurobiology. With these
monies, we have been able not only to further
increase the scope of our summer programs, but
also to initiate a year-round research program.
Though still very modest in size, our experimental
effort in Jones Lab has already created new
immunological tools that may radically alter the
approaches taken by neurobiologists to under-
stand how nerve cells become functionally inter-
connected into brain-like structures.
In all his dealings with me and other members of
the Laboratory, Charles Robertson was the perfect
benefactor, modest, yet highly intelligent and
desirous of further learning, graciously serious,
but always with a sense of humor, and deeply
loving and loyal to those individuals and institu-
tions that he admired. His coming into our lives
was a marvelous, unexpected gift, his delight and
interest in the programs he helped make possible
was a joy, and his passing this spring an occasion of
deep sadness and reverence.
May 20, 1981 J. D. Watson
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D IR E C T O R ’S  R E P O R T
doing it in a properly frugal manner. Are we still all 
too casually writing purchase orders to consume 
the vast sums that are popularly thought to have 
been flowing in our direction ever since Sidney 
Farber, Mary Laker, and Benno Schmidt coopted 
first Senator Yarborough, then Teddy Kennedy, 
and finally Richard Nixon to declare war on 
cancer. This was to be a campaign fought on many 
fronts, ranging from the curing of cancer to its 
prevention. Research as to its nature was to be 
somewhere in the middle, but not in any real way 
neglected. Soon we were to have at least a billion 
per year to spend, and so no one with even the 
chance of a sound idea need go wanting.
Here I will only comment on the ways we have 
gone about finding the origin and nature of 
cancer, since this is the area in which our 
laboratory has been directly involved. The popular 
perception now is that we put our money on the 
wrong horse by not worrying enough about the 
many chemicals that can cause cancer and instead 
mounting a large crash program to discover 
putative human tumor viruses. If viruses were the 
cause of much cancer and we could develop 
effective vaccines against the relevant ones, then 
within a decade or two the incidence of cancer 
should radically drop. But, after ten years of big 
funding, not one virus has yet to be implicated as 
the cause of a major human cancer. Moreover, 
many experts now increasingly believe that at least 
90% of human cancer is due to lifestyle (e.g., 
smoking, the eating of fat, etc.) and environmental 
factors. Thus, with ever-increasing hostile scepti- 
cism about viruses being significant cancer-caus- 
ing agents, shouldn't we now, better late than 
never, deemphasize the various tumor virus 
efforts. By so doing, the money that now supports 
them could go, instead, toward mounting a first- 
rate program on chemical carcinogenesis, a field 
still badly in need of intellectual feeding.
The truth, however, is not that simple, and, in 
fact, we are actually way ahead of the game by 
having directed so much early effort toward the 
understanding of tumor viruses. Jt is not that a 
decade ago chemical carcinogenesis was not 
inherently important. More relevant was the fact 
that there was no way this field could efficiently 
absorb vast sums of new money. It was intel- 
lectually in its infancy, and large numbers of new
The “War on Cancer" is now a decade old. As with 
most battles that go on too long, the hoopla and 
bravado are now muted, and the charismatic 
generals who were to lead us to certain victory 
have been rotated to less conspicuous commands. 
Today we are led by the better staff colonels of the 
immediate past, seasoned enough not to openly 
criticize the tactics of yesteryear, knowing well 
that if their former bosses are perceived not to 
have been equal to their charges, such lack of 
confidence may soon be transferred to them as 
well.
All too clearly the press is testy, and even 
Congress, old enough to be immediately at risk, 
cannot be counted on for still another generation 
of new recruits to march into battle against an 
enemy that still has not yet revealed its exact 
shape. Blind bombing for bombing's sake, al- 
though emotionally satisfying, was the wrong way 
to proceed against the Nazi beasts and might well 
be an equally inappropriate way to bring the 
cancer cells to their knees. Might it not now be 
better to tactically retreat to regroup our forces 
until we can strike with the precision of final 
victory?
If so, conceivably it could be no catastrophe, 
but, in fact, a blessing, for our official slasher, Mr. 
Stockman, to cut back the funding of a NCI that in 
growing so fast on the public purse, may have put 
on fat at the expense of muscle, and by possibly 
being so prematurely superfunded, has never 
acquired the intellectual confidence that comes 
from the making of real decisions. There was, in 
fact, an initial OM B thrust to cut away a billion 
dollars from the NIH (NCI), but it came to naught, 
and the money instead came from the poor and 
socially unfortunate. We thus must be aware that 
given the present national semi-consensus to 
spend more money on defense, we might only be 
able to retain our current ways of doing science by 
taking still more from the unblessed, hoping that 
the benefits of our research will trickle back to 
society either through the development of more- 
efficient medical practices or through the creation 
of the biotechnologic industries in which our 
nation has a competitive edge.
The questions thus must be faced of not only 
whether the medically oriented science we now 
do is really that good, but also whether we are
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scientists could have been brought into this field
only to discover that they had no real working
tools. The answers the public wanted could not
have been obtained in a reasonable period of
time. Now, however, thanks to the new pro-
cedures of recombinant DNA, it is at last possible
to seek the exact genetic changes brought about
by chemical carcinogenesis. Though this will not
be an inexpensive endeavor, it is at last the time to
back a big intellectual push for the nature of the
genes that have become altered through the
action of chemical agents.
This, however, should not be accomplished by
wide-scale cutbacks in the tumor virus area. To be
sure, we do not seem finally about to demonstrate
that tumor viruses are, in fact, responsible for
major killers like cancers of the lung or colon.
Nonetheless, tumor viruses increasingly hold the
center stage in cancer research. Through studies
on the molecular level of both those tumor viruses
that contain DNA and those that have RNA
chromosomes, we are now on the verge of
understanding the fundamental chemical features
of cancer cells. This happy situation, which a
decade ago we thought only marginally possible,
is not the result of the work of a few talented
scientists. Instead, it is the end product of the
moving into tumor virology some ten years ago of
a large number of our best younger molecular
biologists. Then, recombinant DNA was not even a
dream, and the smaller tumor viruses possessed
the only eukaryotic DNA (RNA) that seemed
simple enough to one day master. Given the bribe
of massive funds from the War on Cancer, there
really was no other career choice to make. So,
within several years, a perceptible increase in the
intellectual quality of cancer research was already
apparent, and now the snickers that invariably
once followed the description of a project as
cancer research are gone. By transforming so
much of cancer research into an intellectually
respectable discipline, the War on Cancer has
produced a most-needed victory.
Equally important have been the key research
facts that have already come out of our virus
efforts. Already the onocogenic segments of a
number of tumor viruses, of both the DNA and the
RNA classes, have been precisely defined, and we
are in the process of clearly establishing the
biological function of their protein products. SV40
DNA, for example, codes for two onocogenic
proteins, one of which helps to initiate DNA
synthesis, the other of still unknown cytoplasmic
function. The Rous virus produces sarcomas
because it has picked up accidentally a cellular
gene (sarc) that codes for an enzyme (kinase) that
phosphorylates key cellular proteins. When pre-
sent on the viral chromosome, the gene is not
subject to normal cellular control and over-
produces its kinase products. The overphosphory-
lation leads, in ways that we have yet to discover,
to the sarcoma phenotype.
Initially, the pace at which we could work on
these viral cancer (onco) genes was of necessity
both slow and expensive, with much luck being
necessary just to obtain the mutant virus strains
needed. Now, however, with recombinant DNA,
the pace of tumor virus research has quickened
almost frighteningly, and the normal cellular roles
of the "cancer genes" carried by many more
tumor viruses are likely soon to be known. With
them in hand, we shall have an extraordinarily
powerful set of tools to firmly establish the basic
biochemistry of cancer.
The last stages of this victory, however, will not
be a walkover. In moving our prime molecular
attention from the tumor viruses to the cancer
cells themselves, we face an extraordinary increase
in complexity. The simplest human cells contain at
a minimum some 2000 different proteins, the
interactions of many of which must be dissected
before we can be sure we have the right answers.
The equipment we shall have to use will of
necessity be more sophisticated than that em-
ployed in the past and, unless we are much luckier
than we deserve, will not be cheap.
So, I don't foresee any way that we can maintain
our momentum, much less increase it to the extent
now technologically possible, if the NCI monies
available for these fundamental studies are even
mildly slashed. In a real sense, we are victims of our
enormous success. Until recombinant DNA came
along, we accepted the fact that all the prime
parameters of cancer cells might not be in for
many decades to come. Now with the smell of
victory in the air, we see every reason to push
ahead as fast as possible. This pursuit will take
more, not less, money at a time when even the
maintenance of our status quo is bound to strike
many outsiders as basically indecent.
Moreover, soon we may be approaching the
time when it actually makes sense to spend
substantial monies looking for human tumor
viruses. As we finally begin to master the basic
molecular biology of the RNA tumor viruses
(retroviruses), the more obvious it becomes that
those scientists who, at the beginning of the War
on Cancer, staked their careers on implicating
retroviruses as human carcinogens never had a
reasonable chance of success. They did not know
enough or have the technological handles to
proceed sensibly. Now that we appreciate the
transposonlike qualities of retroviruses, we at last
have a philosophy, admittedly incomplete, for
analyzing the various retroviruslike entities that
will be found over the next few years in a variety of
human cells. By cloning them in bacteria, we can
easily test whether or not they contain cellular
(onc?) insertions into the basic retroviral genome.
Even if we find "onc-like" segments, however, and
then through transfection experiments show that
they are real "oncs," we shall not yet have our
"smoking guns."
To find them, we might best concentrate less
effort on the isolation of new retroviruses and
more on directly testing the DNA from primary
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human tumors to see whether it can transform the
appropriate normal cells into their cancerous
equivalents. Preliminary attempts have already
given positive results, and we have every reason to
expect that a number of human "cancer genes"
will soon be cloned in bacteria. Then, through
DNA sequencing studies, we can find out whether
any of the cancer genes are closely associated with
retroviruslike transposons. If any such putative
retrovirus sequences are identified, it should be
relatively simple to look next for their expression
in various human tissues as the first step to seeing
whether in their RNA form they are horizontally
transmitted from one cell to another as infectious
retroviruses. Those experiments, at long last within
our techological capability, will not be cheap. So
unless there is the prospect of ample long-term
funding for such efforts, we shall remain ignorant
longer than necessary as to the role of retroviruses
in human cancer.
The time may also soon be ripe for looking
much more closely at the various papilloma (wart)
viruses, about which there is no doubt as to their
proliferative potential. Because they still have not
yet been successfully grown in cultured cells, they
were of necessity refractory to molecular analysis
until recombinant DNA came along. Now we have
the potential to routinely screen hundreds of
human tumors for the presence of papilloma
DNA. Definitive answers should also now be
possible as to the oncogenic role, if any, of the
various herpes viruses and in particular of EB,
which has long been identified with the prolifera-
tive aspect of mononucleosis and so always a
tantalizing candidate as the causative agent of one
or more of the Hodgkin's-disease-like syndromes.
Even if it turns out that viruses cause only a
minor fraction of human cancer, it still makes great
sense to try to obtain the respective vaccines. The
doing away with any minor cancer by such
procedures would in a decade or so more than pay
for all the monies so far spent on tumor virus
research. So, given the availability of funds, we
would be most remiss still to be held in check by
our lingering embarrassment over the premature
excesses of past human tumor virus searches.
Instead, we should confidently take advantage of
the fact that soon we shall have the appropriate
base of DNA science to let us proceed in a logical,
sensible manner.
Here we must not lose sight of the fact that a
main reason why we are excited about the next
decade in cancer research is that at last it has
attracted many of the best younger scientists. If,
however, the cancer money targeted toward the
molecular genetics approach noticeably decreases,
the better young Postdocs will see the writing on
the walls and move elsewhere. It would thus be a
tragic mistake now to rebalance money away from
the virus area in order to help protect less-strong
facets of the NCI program from the ravages of
inflation and mounting entitlements. The effect
on NCI could easily be that of a partial lobotomy.
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We are now out of the pre-recombinant DNA
days when tumor virus nucleic acids provided the
best way to get at the eukaryotic genome. Tumor
virology no longer seems the only place to go,
independent of whether or not you are interested
in cancer. It is only one of many fields in the
process of intellectual explosion. Merely attend-
ing our annual RNA Tumor Virus meeting with 450
other highly competent retrovirologists has to
bring up internal doubts as to whether today's
intense competitive hassel is worth the obligatory
psychic strain. For in today's fiscal stringency, your
grant could have a priority score of 185 and not
with certainity be funded.
If, however, you are on the other side of the
fence with the consumer desire to at last cut back
the ravages of cancer, then the more clever
intellects that we can hold in cancer research the
better. Only dismal would be the prospect of a
drift back to the deserved second-rate reputation
that all too long shackled cancer research.
Even, however, if federal cancer money con-
tinues to flow, we must face the increased compe-
tition for bright young brains that is already here
from the creation of the many new recombinant
DNA companies as well as from the major
chemical giants that now privately proclaim that
they may only have a long-term future if they not
only embrace, but also succeed, in biotechnology.
No longer do we worry that academia may not
provide enough slots for our Postdocs. Instead,
our concern is that the ever-descending level of
academic pay will prove inadequate to attract and
hold the superior faculties in molecular biology
that will be required to turn out the students that
industry says it will devour. It is thus by no means
certain that cancer research can maintain its
present upward intellectual spiral even if we
maintain its funding at an inflationary corrected
steady level.
I thus see no choice now but for the NCI and its
NIH parent to look much more closely at its
various divisions to see which programs really are
effective and which are really there only because
no one wants to blow the whistle on good
intentions gone astray. Do we, for example, really
need an ever-growing super National Library of
Medicine, or would medical science be effectively
the same were the striking new NIH edifice never
built? And how much does the clinical research
done by doctors playing part-time medical scien-
tist, using NIH grants for the technicians who do
their lab work, actually advance the pace of
medicine? Were we overly ambitious in trying to
turn virtually all medical schools into high-quality
centers of medical research? To cut off the less-
productive schools from most of their NIH life-
lines, however, would cause havoc with countless
careers. But do we have a choice if we are to
provide our best scientists with the funds that will
permit them to remain capable of deep, as
opposed to play, science?
It is important here to emphasize that, except
for the NCI, we have been painfully shedding the
fat from our individual NIH grants ever since the
last days of Lyndon Johnson; and for the last
several years, the same has been true for the NCI.
Significant further retrenchments will most cer-
tainly be at the expense of future quality. The
average salary paid academic scientists has not
kept pace with inflation, and we have reached the
state where either two bread winners per family or
some moonlighting has become a prerequisite for
a modestly adequate living. We are, furthermore,
not only suffering from the use of equipment past
its prime, but also from having to live with falling
supply budgets, which soon must lead to a cutback
in the number of good experiments. At least in this
laboratory, I don't see much room for additional
supply savings that will not compromise our
productivity, and my impression is that a similar
situation exists in most other leading institutions.
Almost everywhere the general picture seems to
be of overruns in supply budgets that soon must
lead to actual lab shutdowns until the deficits are
paid back.
Thus, with the nature of science getting more
sophisticated and inherently more expensive per
scientist, there is no way we can live with even an
inflationary corrected level of supply funds with-
out cutting back the number of scientists in our
labs. Only with a steadily increasing real budget
can we remain the same, and that we shall be lucky
to get from Congress. It thus seems almost
inevitable that the number of scientists doing
federally sponsored cancer research will steadily
fall, with many of the better younger scientists
leaving pure research to do industrial research. In
a real sense, we may soon be witnessing the
replacement of competent scientists by micro-
processor-enlightened machines that can do their
jobs cheaper, if not better. Of course, if we had
more money, we could have even more scientists
as well as high technology. At some funding level,
however, society has to say it can give its scientists
no more, and that is the message that we now hear
everywhere.
The fostering of high-quality research on cancer
thus may now require the serious pruning away of
the not quite best. How to distinguish the best
from the almost best will never be easy, and in
doing so we are bound to make wrong choices
and cut individuals out of scientific careers that
they have been given every indication to expect.
Wielding this particular axe will be a most
unpleasant task, but it is a job that the NIH (NCI)
directors can no longer avoid. As long as we were
living on growing budgets, the hard choices could
be avoided. Now, either reaffirming the impor-
tance of tumor virus research and keeping up its
magnificent upward crescendo or upgrading the
equally important area of chemical carcinogenesis
research cannot be passive deeds. Such acts can
only be done by deciding that other aspects of
cancer research have lower chances of making
home runs, and such pronouncements would be
bound to offend many long-time, powerful sup-
porters of cancer research. But, as I already know
too well, the function of a director is to lead, not
follow, and we can only hope that the leaders of
NCI (NIH) and their counselors will do their jobs
well.
Highlights of the Year
An Extraordinary Set of
Monoclonal Antibodies Directed against
the Nerve Cells of the Leech
Often characterized as the ultimate biological
challenge and of key interest to virtually all
scientists . is the way in which nerve cells are
specifically linked together to form the neural
networks that underlie the phenomena of per-
ception, memory, and learning. That a problem is
intrinsically interesting, however, does not mean
that the time is at hand for its solution. Witness the
difficulties embryologists have had in making any
fundamental conceptual advances over the last
fifty years. Good intentions by themselves get us
nowhere, and the most savvy of the scientists who
work on nerve cells have been careful not to ask
now for the ultimate of answers, knowing that
until the circuitries of the brains that intrigue them
are known, speculation on their functioning will
be a hopeless pursuit.
That being so, there are many reasons to seek
out the simplest of brains that control demon-
strable behavioral traits and to study them with
every conceivable neuroanatomical trick. Here we
have chosen to work on the interconnected nerve
cells of the medicinal leech. We were first
introduced to it seriously in 1974, when John
Nicholls began teaching a suirmer course on its
neurobiology and had among his first group of
students Birgit Zipser. Excited by what she learned,
Birgit soon after took up the leech as her main
research tool and brought this system to Jones Lab
when she joined our staff two years ago. Each
leech nerve cord contains some 12,000 nerve cells,
organized into some 30 segmentally compart-
mentalized groups that are called ganglia. Each
ganglion, like the leech itself, has bilateral sym-
metry, and the some 400 nerve cells of each
ganglion are organized into identical, equally
sized, left and right groups. All the ganglia are not
exactly the same: those at the head and tail are
more complex and function in brainlike capaci-
ties, and two of the ganglia, called five and six,
have special cells that control sexual behavior. We
also now semi-know the roles played by several
other morphologically distinct cell types, aswell as
the locations of a number of the synapses that
connect together functionally related cells. Totally
lacking yet, however, are any general ideas about
how the nerve cells make their connections to
each other during embryological development or
detailed knowledge about the many intercon-
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necting nerve circuits that must exist to generate
the complex behavioral responses of the leech.
Until recently, even dreaming about collecting
such information was out of the question. Except
for a few cells that have easily distinguishable
morphologies, most of the nerve cells look
roughly alike, and knowing with which specific
cells we are actually dealing is often beyond our
capability.
To generate better ways of tagging nerve cells,
Birgit joined forces here with Ron McKay, who
had just arrived from England, where he had been
introduced to monoclonal antibodies in Walter
Bodmer's Laboratory in Oxford. There he had
already attempted to generate monoclonal anti-
bodies to mammalian nerve cells, but no interest-
ing specificities had come out. Upon coming here
and learning about the leech, Ron first injected
leech nerve cords into mice. Then, after the mice
began to generate specific antibodies to the leech
nerve cells, he fused the respective antibody-
producing spleen cells with mouse myeloma cells
to generate a large number of hybridoma cell
lines. Most excitingly, Ron and Birgit already have
identified some 40 different hybridomas, each of
which produces a specific monoclonal antibody
that binds to one or more specific nerve cells in
each ganglia.
This finding of so many different specific
antibodies surprised us, for until the experiment
was done, we thought we would be very lucky to
generate even one or two. The prospect of coming
up with 40 different specificities at one blow was
much too good to have as a serious objective. Still
unknown are the nerve cell antigens to which our
antibodies bind. As a first step to solve their
identity, we have been fortunate in persuading
Susan Hockfield to join us to use immunoelectron
microscopic techniques to see to which cellular
component(s) the various monoclonal antibodies
bind. Before coming here, Susan was at UCSF, in
Alan Bassbaum's Lab, studying pain receptors and
came to learn of Birgit and Ron's monoclonal
antibodies through her participation in our Pain
Workshop held this past summer.
Now we are very excited by the possibility that
many of our monoclonal antibodies are directed
against those components of nerve cells that
provide the biological specificities used in telling
nerve cells how to link up with each other. Before
we found them, we had no idea as to how to even
begin looking for such linker molecules. Hope-
fully, monoclonal antibodies will provide the
means to find the molecules that determine the
high specificity of neural connections. Clearly, we
are at the beginning of a very exciting chapter in
Neurobiology, and we are most pleased that we
may have almost immediately been thrust into a
vanguard role.
Most crucial for our ability to push the mono-
clonal antibody approach in a big way has been
the help provided by the Marie H. Robertson
Fund for Neurobiology. Not only did it let us act
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swiftly in adding Susan Hockfield to our staff, but it
also provided funds for a most useful small
meeting in November on Monoclonal Antibodies
to Neural Antigens. This was the second of two
meetings on the nervous system held this year at
the Banbury Conference Center. Like the first
such meeting, on Molluscan Nerve Cells, the
proceedings will be published by the laboratory as
a Cold Spring Harbor Report in the Neuro-
sciences. We plan relatively short volumes of some
200 pages each for this new series, which will arise
exclusively out of the Neurobiology programs at
the laboratory.
Our Summer Neurobiology Program
Also Continues to Grow
Again this summer we put on a most impressive
collection of courses and workshops in Neuro-
biology. Most had been successfully held in
previous years. We did, however, add a new
workshop on Perfusion Techniques. It brought
together individuals from different home labs who
had independently devised techniques to perfuse
nerve cells. The merits of their respective metho-
dologies could thus be directly compared. We also
included as participants an equal number of
experienced neurobiologists who wished to ex-
tend their repertoires to include perfusion. Every-
one agreed that this workshop went very well,and
we were most fortunate that the Marie H.
Robertson Fund for Neurobiology could provide
the funds that made it possible.
This summer marked the tenth consecutive year
during this modern era that we have offered
courses in Neurobiology. This program has con-
sistently attracted very high level students and is an
effort that we and its many instructors can be most
proud of. From its inception, we have thought
about rotating instructors and course topics to give
us the renewed vigor that comes from new ideas
and new faces. In fact, our program now bears
little resemblance to our initial offerings. We
should point out, however, that our course in
Experimental Techniques has been most ably run
by JacSue Kehoe since its beginning ten years ago,
and this coming summer JacSue will again be in
charge. Year after year it receives nothing but
strong praise, and we see no point in replacing it
for reasons of theory. Equally successful has been
our Leech Course, led for the seventh consecutive
time last year by John Nicholls and again to be
offered this coming summer.
Most happily, Sir Bernard Katz, from University
College London, was able to participate in our
Synapse Course. Virtually no other neurobiologist
has equalled his many contributions to the biology
of synapses, and our program was indeed honored
by his presence. While here, he and Lady Katz
enjoyed the gracious hospitality that we can
provide at Robertson House. The nature of our
summer program was also most pleasantly en-
livened by having our Trustee from Yale Uni-
versity, Chuck Stevens, and his family in residence
at Osterhout Cottage all summer.
Unfortunately, the ever-growing success of our
Neurobiology summer program has not yet gen-
erated the prospect of long-term financial stability
that we need for the successful planning of its
future. Except for the first several years, when we
had our initial Sloan Foundation Grant, we have
had to use significant internal funds in order to
keep its momentum growing, as well as spend
weeks, if not months, of each year attempting to
find private monies to supplement the never quite
dependable federal funds, which in the last
analysis must carry the main burden for a program
now as large as ours. Here I would like to express
our thanks to the Klingenstein Family, to Milton
Cassel and the Rita Allen Foundation that he helps
direct, and to the Volkswagon and Grass Founda-
tions for giving us much essential last-minute
assistance. Their inability to help would have
meant the cancellation of one to several specific
courses and workshops.
Now given the prospect of even less federal
money for conferences, workshops, and advance
training, we must undertake even more serious
efforts to find support from the few major
foundations that have the potential to help us in a
big way during what clearly will be a rough time
for so much of science. Our program has now
gone on long enough to erase any doubts as to
whether we do our job well. It thus becomes a
question of whether the outside private world will
give us the vote of confidence that will allow us to
maintain a major national asset whose objectives
are not likely to be taken up elsewhere if we were
to pull back. Hopefully, such help will be forth-
coming, since the financial burden we have had to
carry internally for so many years may soon be
more than we can bear.
Isolation of Viral Cancer Genes
Remains a Prime Objective
When we initiated our research on the DNA
tumor viruses we did so with the hope that our
experiments, together with parallel work in other
labs, would show that tumor virus DNAs contained
regions that coded for proteins that could make
cells cancerous. This expectation has been more
than fulfilled, and cancer genes are no longer
speculative dreams, but crisp molecular entities
whose biochemical role we now seek to work out
precisely. Having first determined their existence,
our next task has been to obtain their respective
protein products in amounts sufficient to do
serious biochemistry. At first, we had to rely
heavily on chance events like the finding here of
an adeno-SV40 hybrid virus that overproduces the
SV40 T (tumor) antigen. This allowed Bob Tjian,
then a member of our staff, to show clearly that the
T antigen specifically bound to several sites on
SV40 DNA around its origin of DNA replication.
Now our best guess is that T antigen plays a key
role in the initiation of DNA synthesis, an hypo-
thesis that some years earlier had already seemed
likely from properties of temperature-sensitive
mutants within the T-antigen gene. To go further
and show exactly how the T antigen functions
most likely will require the setting up of the
appropriate in vitro systems for eukaryotic DNA
synthesis. This is a field that still has not caught real
fire, and if we are to succeed here, we as a
laboratory must return to a major commitment in
the field of DNA synthesis. Toward this end, we
have recently appointed to our staff Fuyuhiko
Tamanoi, originally a student of Reiji and Tuneko
Okazaki in Nagoya and most recently a Postdoc of
Charles Richardson at Harvard Medical School,
where he did important work on the in vitro
synthesis of T7 DNA.
At this moment, most of our work on DNA
synthesis involves adenoviral DNA, whose ter-
minal "Bellet" protein has recently been shown,
through the collective work of many of our
scientists, to be encoded by the adenoviral DNA.
As far as we can tell, the Bellet protein is not
involved in adenoviral oncogenesis, with that role
being played by several of the early proteins
encoded by genes at the extreme left end of
adenoviral DNA. As yet, we still have not obtained
these proteins in sufficient amounts to let us test
directly whether they play a role in DNA synthesis.
A prime objective at this moment is to genetically
engineer the adenoviral early genes so that their
respective protein products are overproduced in
quantities that will let us do real biochemistry.
Most helpful here will be the obtaining of
monoclonal antibodies that will facilitate their
purification. Already a monoclonal antibody spe-
cific for the early-1B-region 55K protein has been
obtained, and we anticipate that soon there will be
a stable of others, many of which should prove to
be indispensable tools for our long-term efforts to
establish the fundamental chemical features of
cancer cells.
Our Symposium Focuses on Movable Genes
Experiments showing that some genetic elements
do not have fixed locations, but can move from
one chromosomal site to another, were first done
here by Barbara McClintock in the early 1950s
using the corn plant. Now "movable genes" are
cropping up everywhere in biology, and it seemed
most appropriate for us to use the format of our
45th Annual Symposium to hold a major meeting
on this topic. Ahmad Bukhari and Jim Hicks
worked hard and most effectively as our main
organizers, almost miraculously keeping the for-
mal program within bounds. It attracted some 280
leading genetics-oriented biologists, happily in-
cluding many of our best friends of past years. A
splendid opening lecture was given by Allan
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Campbell, and Michael Yarmolinsky gave what
was generally regarded as the most intelligently
polished summary of at least the past decade.
Only slightly more than one-half the attendees
were able to listen to the lecture in Bush
Auditorium, with the rest watching in other rooms
on our closed-circuit TV system, again most ably
presided over by Herb Parsons. This is far from a
perfect situation, and we have now realistically
accepted the need to build a major new audi-
torium. This past year we committed funds to
commission our architects, Moore, Grover, and
Harper, to come up with a schematic design for a
building to seat 360 and to be located across
Bungtown Road from Bush Lecture Hall. At the
current value of the dollar, we project a cost of
around 1.5 million dollars, a sum that now seems
too large to be raised by a conventional fund drive.
So we are in active pursuit of a suitably en-
lightened single philanthropist, who by giving us
the new auditorium that we must have if our
symposium is to retain its premier rank also will be
providing our community with a building we are
already sure will be a visual delight.
The Pace of Recombinant DNA
Research Quickens
By now so many scientists here are doing recom-
binant DNA experiments that it is hard to remem-
ber back to even three years ago when the then-
effective NIH Guidelines still virtually blocked any
such experimentation with tumor virus DNA as
well as greatly slowed down most experiments
with higher eukaryotic DNA. Now the guidelines
are almost gone and the P3 facilities we once
briefly almost uniquely possessed have little
statutory use and soon may be totally unnecessary.
Because we already possessed containment areas
for tumor virus research, we luckily did not need
to spend vast sums, unlike many other institutions,
to bring ourselves into the recombinant DNA
game. Now our need to prepare the occasional
"memorandum of understanding" continues to
waste valuable hours, but hopefully even that
requirement will soon be gone. What a pleasant
contrast with those bleak days, just five years ago,
when many in the general public feared that DNA
might be a major environmental hazard and so
need the most stringent regulation.
Major Program Project Support for Our
Studies on Vertebrate Gene Structure
and Expression
Through the successive additions of Mike Wig ler,
Dave Kurtz, Steve Hughes, and John Fiddes to our
staff, we now possess a very powerful group of
younger scientists collectively interested in the
structure and expression of vertebrate genes. All
utilize as their main experimental tools the various
recombinant DNA procedures, and each should
benefit from maximum intellectual interaction
with each other. To help facilitate such cohesive
efforts, last May we applied to NCI for a moder-
ately large program project grant to cover key
salary support, major items of shared equipment,
and necessary supplies such as the never inex-
pensive restriction enzymes. I assumed the task of
program director and, like the others, anxiously
awaited the site visit that came in October.
Happily, we were judged well, with formal grant
support starting April 1, 1981.
Among the most attractive features of the grant
are the key-staff salary support that it guarantees
for five years, thereby giving us a most-needed
source of semi-long-term financial stability. Now
every two weeks we hold Vertebrate Gene Group
Advanced Bacterial Genetics course participants ano instructors
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seminars in which current research is discussed,
and a happy future for this new scientific division
seems assured.
To help provide the new research facilities
needed for this program, an extensive remodel-
ling of James Lab has occurred. In effect, a new lab
was provided for John Fiddes, Steve Hughes, and
their collaborators, and much totally modernized
working space became available both for our
tumor virus group and for the courses that are
taught each summer on the second floor. Now,
perhaps for the first time in its history, James Lab
lacks that stale smell that necessarily accompanies
the improverished makeshift.
Unparalleled Interest in Our Summer DNA
Courses on Genetics and Cancer
This past summer the number of students applying
for our courses on genetics and cancer reached a
new high. Our new Cell Culture Course, empha-
sizing the employment of hormones as growth
factors and taught by Gordon Sato and David
Barnes, was very well received, as was our
Transformed Cell Course, to which was added a
section on teratomas and teratocarcinomas taught
by Gail Martin. Over the past several years, we had
watched a perceptible falling off of interest in our
Animal (Tumor) Virus Course that we had been
presenting for over a decade, reflecting the fact
that this material is now taught well in most major
academic centers. To replace it, we started up a
brand new course on Molecular Cloning, with
Tom Maniatis, Ed Fritsch, and Nancy Hopkins as
instructors. It quickly proved to be the most
popular course we have ever offered, with 172
applicants for its 16 places. Also still very popular
was our course on Advanced Bacterial Genetics,
which has been taught for the past four years by
the never-quiet trio of David Botstein, Ron Davis,
and John Roth. Unfortunately, we have not been
able to tempt them to return again this coming
summer, but we remain much in their debt for the
intellectual esprit they have so long conveyed.
Teaching the Yeast Course this year were Brian
Cox and Cal McLaughlin, substituting well for
Jerry Fink and Fred Sherman, who, after ten years,
had a summer sabbatical during which they taught
a parallel course in Brazil. Happily, Jerry and Fred
have consented to return as instructors this
coming summer. Because of its popularity in 1979,
we offered for a second time a course on the
Molecular Biology and Developmental Genetics
of Drosophila. It was again most ably taught by
Mary Lou Pardue and Bill Gelbart. This coming
summer we shall be offering in its time slot a new
course on the Molecular Biology of Plants to
introduce molecular biologists to the many op-
portunities to revolutionize plant breeding that
recombinant DNA techniques may bring.
The Transformation of Davenport
into Delbrtick Laboratory
With the growing use of biochemical procedures
in our genetics courses, the necessarily cramped
quarters provided by Davenport Lab have proven
increasingly inadequate from the point of view of
both students and instructors alike. Equally trou-
blesome has been the strain placed on our Yeast
Group by having to give up their research space
during the summer months. New laboratory space
was clearly demanded, and toward this end we
began construction in October of a major addition
to Davenport that will effectively double the space
available for research and summer teaching.
Designed to fit in harmoniously with Davenport's
Colonial Revival style, the new addition converts
this building into a complex that can function on
its own and not be dependent upon the availa-
bility of facilities in nearby buildings. Thus, it
seemed appropriate to give the complex a new
Delbreick Laboratory under construction
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name. So, beginning last fall, we began to call it
Delbriick, to honor Max Debt- Cick and the Phage
Course that he initiated there in the summer of
1945. The harshness of this past winter slowed
down the early construction phase, but work on it
is now almost back on schedule. The Yeast Group
can thus occupy its new labs before the start of the
summer season, with the formal dedication to
occur at the end of August during the Phage
Meeting.
The Carnegie Dorm Becomes
Davenport House
By November we finished the renovation of the
interior of the large Victorian building on the
corner of 25A and Bungtown Road that was
constructed between 1882 and 1884 by John D.
Jones, the founder of this Laboratory. Long the
residence of Dr. Charles B. Davenport, who
directed the lab between 1898 and 1934, it later was
turned into a dormitory for use by the Department
of Genetics of the Carnegie Institution of Wash-
ington and gradually became known as the
Carnegie Dormitory. With time, its physical shape
gradually fell into greater and greater disrepair.
Now, thanks to the super remodelling effort
presided over jointly by our Superintendent Jack
Richards and by my wife Liz, it has been brought
back to its original Victorian flavor. Particularly
pleasing are the stencilling and wood graining that
we luckily were able to have done by the talented
English artist and craftsman Tony Greengrow. Now
at last it has become a very functional home for
eight of our scientists. To celebrate its refinished
state and the formal change of its name to
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Davenport House, in late November a special
Sunday dinner was prepared in its new kitchen for
the several descendents of Mr. Jones who still live
in our midst and who so long provided support for
us through their Wawapex Society.
A key feature of the renovation effort was the
redoing of the main parlor room into a Music
Room, to which we have just added a marvelous
new Baldwin piano. Its acquisition was made
possible by gifts specifically targeted for this
purpose. We now possess a room appropriate for
music at its finest, and we look forward to the
cultural enrichment that it shall bring to our
village, scientific style.
The Naming of Our New Cancer Research
Facility after Reginald G. Harris
Construction finally started in November on the
major new cancer-research-oriented building that
we shall use to house small animals and to provide
more suitable space for the generation of large
numbers of monoclonal antibodies. It will be
called the Reginald G. Harris Building, to honor
the far-sighted director (1924-1936) of the Long
Island Biological Research Laboratories, then di-
rectly operated on our lab grounds. Particularly
important was the initiation by Harris in 1933 of
our Annual Symposium as an occasion for the
quantitative thinking that would help bring into
Biology the then newly discovered concepts of
modern Physics and Chemistry. Without his
Symposia and the worldwide reputation that they
brought to Cold Spring Harbor, serious science
might have long vanished from this scene. It is only
appropriate, therefore, that the Harris name be
Liz and Jim Watson in Music Room of renovated Davenport House
indelibly fixed onto one of our major research
facilities. After many delays due to bad weather,
the Harris Building is now rapidly assuming its final
shape, and we hope to begin using it late this
coming fall.
Indispensable Help from the
Robertson Research Fund
From the moment of its inception, the Robertson
Research Fund has given us the flexibility to start
up new projects. Particularly important during
1980 was the help it provided in letting us totally
renovate and equip major new labs for John
Fiddes and for Fred Hefferon and Maggie So. It
also proved invaluable in letting us attract two
talented young scientists who already have had
several postdoctoral years of research. Coming
this year as our first Robertson Research Fellows
have been Kenji Shimizu to work on cancer genes
in Mike Wigler's lab and Kim Nasmyth to join the
Yeast Group and its work on the mating-type gene
complex. In addition, through Robertson funds
we had at our disposal adequate funds for a
number of projects for which federal funding
could not cover true costs.
Major New Additions to Our Scientific Staff
This past summer we lost from our scientific staff
two of its most invaluable members: Jim Lewis left
to join the staff of the Fred Hutchinson Cancer
Center in Seattle, and Dan Klessig moved on to Salt
Lake City to become an Assistant Professor of
Microbiology at the University of Utah Medical
School. Both played key roles in the discovery of
RNA splicing and we shall long miss them. Leaving
here following their postdoctoral work have been
Mike Dubow to move to McGill University, Bill
Kilpatrick to go to Wake Forest University, Leah
Lipsich to return to SUNY, at Stony Brook, and
Nigel Stow to take up a staff position at the
Institute of Virology in Glasgow.
Appointed to Staff Investigator slots at the
completion of postdoctoral periods here have
been Manuel Perucho, Ron McKay, Bruce Still-
man, Jim Stringer, and Jim Lin. Coming here in
November, also at the Staff Investigator level, was
Fuyuhiko Tamanoi. And arriving in Jones Lab as a
Staff Investigator just before the year ended was
Susan Hockfield. Promoted from Staff Investigator
positions to Senior Staff Investigators were Jim
Feramisco, Amar Klar, Dave Kurtz, Jeff Strathern,
and Yakov Gluzman. Newly appointed to our staff
as a Senior Staff Investigator in James Lab to begin
January 1, 1981, is Lee Silver, formally a postdoc
with Dorothea Bennett at Sloan Kettering, who
brings to us detailed knowledge of mouse genetics
and embryology.
Promotion to the Senior Scientist Position
Our rank of Senior Scientist carries with it a
continuous rolling commitment of five years of
salary support. Given our inherent dependence
on "soft" federal funds, this commitment repre-
sents our closest approximation to a tenure
position and signifies that we believe the scientists
concerned have the capability for sustained, self-
motivated, high-level research. Acting at their late
spring meeting, our Board of Trustees approved
the well-deserved promotion to Senior Scientist of
Mike Mathews, bringing to seven the number of
such positions on our scientific staff.
We Continue to Have Very High Level
Support and Administrative Staff
That the doing of science here seems such a
natural activity owes much to the dedicated efforts
of our highly talented support and administrative
staff. Here I should point out our great indebted-
ness to Agnes Meyer, who retired this January
after 15 years of cheerful, efficient service as our
switchboard operator; Winifred Modzekeski, who,
following her remarriage, left our Meetings Office
where for 3 years she personified helpful con-
sideration; Eileen Oates, who for 11 years worked
so successfully in our Accounting Office; and Jim
Stanley, who retired from our Buildings and
Grounds Department where he had assisted our
Superintendent Jack Richards so faithfully for the
past 11 years. I must also mention the abrupt and
tragically premature death of Robert Anderson in
February, 1981. Coming to Long Island from
Scotland some 20 years ago, Bob, in his capacity as
head of our Housekeeping Division, was a loyal
friend to all and we continue to mourn his loss.
Robert Anderson
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Our List of Superior Books
Continues to Grow
Again we report another year of high-level
publishing. Three new books in our Monograph
series were published this year. Two concerned
Transfer RNA, one on its structure and physical
properties, the other on its biological aspects. Both
were edited well by Dieter Sall, Paul Schimmel,
and John Abelson. DNA Tumor Viruses, edited by
John Tooze, represients an almost total revision of
material publishedlin much less complete fashion
our earlier volume The Molecular Biology of
Tumor Viruses, which also was edited by John. We
anticipated that DNA Tumor Viruses would sell
better than the average monograph and so priced
it lower than if we had based its price upon the
number of pages. Already the first printing is sold
out, and we are in the process of bringing out an
even lower priced revised paperback edition,
which we hope will further increase its readership.
This practice of going into paperback after we
have covered our publishing costs was most
effectively employed with The Operon, edited by
Miller and Reznikoff. In less than a year, we have
almost doubled its sales.
The publishing of our annual Symposium (Viral
Oncogenes) was as expected again a major task.
Because of delays in getting type set in Dublin, we
did not have finished volumes until mid-July. So
this year we have returned the typesetting process
to this side of the Atlantic with the hope that it will
be out before the start of the next year's
Symposium. Also published this year was a two-
volume set on Viruses in Naturally Occurring
Cancers, which represents the proceedings of our
intellectually most valuable Conferences on Cell
Proliferation.
Appearing late this year to be sent to more than
1000 advance orders was the first of our lab
Manuals for Genetic Engineering. Arising out of
our Advanced Bacterial Genetics Course, it was
prepared by the course instructors, Botstein,
Davis, and Roth, and it already seems destined to
become a minor best seller.
Our total sale of books, abstracts, and manuals
for 1980 totalled 16,041 in comparison to the very
similar figure of 16,300 for 1979.
Another Summer of Talented
Undergraduate Research Students
Beginning in 1958 we started to bring here, on a
formal basis, a group of ten college undergradu-
ates to do research for periods of 10 to 12 weeks
under the supervision of members of our scientific
staff. For many years, this Undergraduate Research
Program was supported by the NSF, but in early
1973 the NSF changed its rules to preclude awards
to non-degree-granting institutions. To continue
this program, we then had to dip into our always
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scarce internal funds designated for research. So
we have greatly welcomed the support given to
this program over the past two years by the
Camille and Henry Dreyfus Foundation. Most
fortunately, they will again support us this coming
summer. So we again await the arrival of a student
group that we find increasingly motivated toward
future careers in pure molecular and cell biology
as opposed to medicine.
I also wish to acknowledge the funds provided
by our own Robert Olney Memorial Fund, which
now supports one additional student per summer.
Unlike those students supported by Dreyfus
Funds, who afterward return to college, generally
for their senior year, the Olney Fellowship is
usually given to a student who has just completed
his undergraduate years.
Increasing Use of
Our Banbury Lane Facilities
A number of high-level small conferences were
held at our Banbury Center during the spring and
fall, in addition to the use of this site for our
summer lecture courses in Neurobiology and for
the housing of guests during our major meetings
on the main laboratory grounds. Three key
meetings related to biological risk assessment
were organized by Victor McElheny. One was
devoted to labeling dangers, another to the role of
diet in gastrointestinal cancer, and the third to
hormones and breast cancer. We also used the
Banbury Meeting House for two specialized
Neurobiology Meetings supported by the Marie
H. Robertson Fund for Neurobiology. Both of
these meetings were so organized as to give rise to
short books consisting of reports prepared by
advanced students in attendance and vetted
afterwards by the meeting organizers. The first
such book, Molluscan Nerve Cells, has appeared,
already with most favorable reviews, giving us
hope that we may have found the right formula for
reporting these meetings to the much larger
audience that books can reach. We also brought to
the Banbury Center some 50 scientists in early
December to discuss their recent work on Cloning
Vectors for Mammalian Cells, now a very hot topic
in the world of recombinant DNA.
Almost completely finished and about to be
dedicated this coming July is our new residence
hall, Sammis Hall. It provides us with 16 additional
bedrooms, bringing to 36 the number of guests
that can simultaneously be housed at Banbury.
Until its completion, we happily had at our
disposal Fort Hill, the magnificent home of the
Mrs. Willis D. Woods that overlooks Center Island
and the entrance to Oyster Bay Harbor. Late this
year, at the age of 98, Mrs. Woods passed away
after several years of impaired health that unfortu-
nately followed more than 90 years of vigorous,
inspired living.
LIBA Successfully Completes Its Fund
Drive for the Carnegie Land Purchase
An institution that has consistent, strong, and loyal
backing from its local neighbors is indeed lucky,
and this has been our situation for all of our 90
years. This support is now most effectively chan-
neled through the Long Island Biological Associa-
tion (LIBA). Mr. Edward Pulling, its chairman, and
its Board of Directors are always on the lookout for
new projects that they can help bring to fruition
through one of their customary low-keyed fund
drives. Over the past two years they have mounted
a $200,000 campaign to cover the costs of the land
that we purchased from the Carnegie Institution
of Washington. This was a most-necessary acquisi-
tion, for we needed part of this land to site our new
Harris Building. Completion of this drive came
ahead of schedule, allowing Ed Pulling to an-
nounce its success at our Annual Meeting held
early this January.
We are most fortunate to have such wonderful
friends.
Major Changes in Our Board of Trustees
The running of this lab has never been a simple
matter, and as the Director I need many sources of
advice and encouragement. I have been very
fortunate in that I have always served under a
Board of Trustees who have been unstinting in
their ability to do real work on our behalf and
whose long-term affection for us has never been
in doubt. During these years no Trustee has been
more invaluable than Harry Eagle, who for the last
six years has served as Chairman of the Board.
Harry became a Trustee, representing the Albert
Einstein College of Medicine, in 1962, following
the reorganization events made necessary by the
withdrawal of support by the Carnegie Institution
of Washington. Quickly he proved invaluable to
the weak, fledgling organization and helped John
Cairns to make the many improvements present
when I took over as the Director early in 1968.
Because our by-laws limit consecutive service on
the Board of Trustees, Harry went off the board in
1967, happily to return in 1973. A year later, in 1974,
he became our Chairman, functioning thereafter
very closely with me and the other members of
our Executive Committee. Always optimistic in an
intelligent fashion and with a firm, no-nonsense
command of his Board, he has helped lead us to
heights unimaginable without his presence. Thus,
his obligatory retirement this fall after six years as
our Chairman is a deep loss, though we know we
can still count on his help in potential moments of
crisis in his capacity as an Honorary Member of our
Board.
In his replacement as Chairman, Walter H. Page,
we shall continue to be led by a person of the
highest experience and integrity, and we have no
reasons to fear our future. Bayard Clarkson, also of
long past experience on the Board, became Vice
Dr. Harry Eagle
Chairman; Robert Cummings is our new Treas-
urer, and Norton Zinder our Secretary.
Also retiring from our Board at our Annual
Meeting were Clarence Galston, who has served
with much faithful dedication as our Treasurer;
Vittorio Defendi, on whom we could always count
for invaluable council while on our Executive
Committee; and Walter Guild. Newly elected to
represent NYU was Claudio Basilico; Bob Webster
returns after a three-year absence to again repre-
sent Duke University; and Matthew Scharff be-
comes the Trustee representing the Albert Ein-
stein College of Medicine. Elected as a private
Trustee was our Lloyd Harbor neighbor John Carr,
a major figure at the Grumman Corporation,
where he is now Vice Chairman of the Board.
Our Currently Sound Financial Picture
Must Be Monitored Closely
This year, like those of the immediate past, we
have operated under a conservative budget. In
preparing for each coming year we try to project
income on the low side and expenses on the high
side, so balanced that our cash position at the end
of the year will be equal to that at the start. We do
this almost automatically by being very cautious
about the sales of our books while projecting on
the low side the interest income from the cash
balances we hold in reserve to cover construction
projects that we are already committed to start.
Until now, this way of proceeding has generally
led to positive cash flows that more than account
for the increasingly large sums that we automati-
cally set aside to cover the depreciation on our
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buildings and our equipment going out of date. As
soon as we know that we are again going in the
black, we commit the newly added cash for still
further improvements to our physical plant. It is
through such procedures that we have been able
to return so much of our formerly dilapidated
physical plant to its now pleasingly effective state.
I worry now, however, that the next several
years will not be so fiscally rosy. In the last analysis,
the sales of our books depend upon the receipt of
government grants by their purchasers, and if
individual grants are squeezed much further, the
choice to buy our books won't even exist. We may
be particularly vulnerable because the massive
lengths of so many of our volumes demand
correspondingly high prices just to cover our
expenses, much less to produce a minor profit
with which we can further upgrade ourselves. We
should thus be prepared to produce more short
books, aimed at the rapid, clear appearance of the
newest facts, as opposed to the highly compre-
hensive monographs that have so characterized
our lists from the past decade. Already we think we
see an increasing preference for our less compre-
hensive books, but it will take several years before
the nature of our list can appreciably change.
Further clouding our fiscal health are the rapidly
escalating oil, gas, and electric bills from which we
try to escape but cannot. And for too many years
we have skimped more than makes long-term
sense on the maintenance of our newly restored
buildings. Our best guess thus is that our current
way of proceeding will soon no longer produce
the substantial infusion of free money that has
been at the heart of our physical revival and that
must continue to be available if we are to remain
truly innovative.
We thus have given serious consideration to the
upgrading of our efforts to raise funds from the
national, as opposed to our local, community.
Over the past decade we have probably devoted
less resources to "developmental activities" than
any equivalent institution of our size. Now my
occasional letter or visit to a major foundation
office is our only such thrust. Over the next few
years, however, we probably have no choice but
to abandon our anomalous ways and seek more
professional help. I must confess, however, that
the biting of this bullet will not be easy.
We May Need to Immerse Ourselves
Increasingly in the Outside World
Because of the high quality of our science and the
prominent role that our courses and meetings
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now play in American science, we shall probably
only be moderately hurt, not badly mangled, by
the initial thrust of the current administration
effort to take the government off the back of its
people. Obviously, we have fared very well
recently with federal support, much better than
we ever did when private benefactors made or
broke us. So we do not in any way mourn for the
supposedly good old days of unrestrained private
initiatives like those existing in 1932. Then our
director Reginald Harris in his Annual Report
listed suicide as one of the alternatives open to his
lab as our nation sank deeper and deeper into the
great depression that filled our streets with able
men out of work. Now, wounded in our discovery
that we cannot remain the best while resting, we
nevertheless remain a nation with the capacity to
promote science for all its worth, and it is my belief
that we have no other choice but to so act. The
withdrawal of our government from the support
of science, as now suggested by the high priest of
monetarism, Mr. Milton Friedman, would be an
act of national hari-kari, and his recent Newsweek
articles only prove that intellectuals of the left do
not have a monopoly on silliness.
Even assuming, however, that sizable sums of
federal monies continue to flow our way, our next
decade is unlikely to follow closely the pattern set
in the 1960s and 1970s. Then we still operated
effectively as pure academics, indifferent to the
possibility that the marvelous edifice of modern
Biology that we were creating was putting us in the
same big league as the Chemistry and Physics that
first produced the industrial, and more recently
the electronic, revolutions.
Now, through recombinant DNA and mono-
clonal antibodies, we may have the capacity to
help change the course of much of our industry
and agriculture as well as of medicine. Thus, even
if we should want to remain aloof, the outside
world needs badly to buy into our lives, and the
real question is not whether we make our forays
out of our ivory towers, but how. These adven-
tures will not come naturally. Yet, if we hesitate too
long, proclaiming the sanctity of the pure mind,
we may easily find that we are not among those
institutions with the financial clout necessary for
the promotion of truly innovative science.
If, however, we can continue to be intelligently
nimble, employing our wits to seek out the best of
the industrial as well as of the academicworlds, we
may be able to leave this decade as happily as we
now somewhat apprehensively enter it.
May 29, 1981 J. D. Watson
M. Delbriick and W. M. Stanley at 1941 Symposium
Max Delbriick
1906-1981
With great sorrow, I must report the passing of
Max Delbrilick on March 9,1981 in Pasadena in his
75th year. Through his great intelligence and clar-
ity of expression, his extraordinary integrity, and
his affection for the many friends whose lives he
helped to form, he cast an indelible mark on the
development of Molecular Biology. His love for
Cold Spring Harbor was manifested in many ways,
and our future summers will never be the same
without him.
Vernon Bryson, Max Delbruck, and Rollin
Hotchkiss at "Graduation Exercises" of the
1950 Phage Course
Frank Stahl, Al Hershey, Max Delbruck, and Salvador Luria
at 1980 dedication of Hershey Building
Delbriick with wife, Manny, and daughters, Nicola
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First row: M. Perucho, M. Wig ler, D. Kurtz, D, Levy, C. Lama, D. Bishop, K. Shimizu; J. Stringer, A. Barros,
C. Stephens, W. Boorstein, J. Fiddes
Second row: M. So; F. Heffron, R. Bialt; B. Parsons, R. Roberts
Third row: G. McGuiness, G. Chaconas, M. George; C. Adler, B. D. Jiang; L. Rodgers, L. Smith, D. Zipser
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TUMOR VIRUSES
As can be seen from the research reports that follow, work on the molecular biology of
adenoviruses and SV40 continues to comprise a major portion of the research effort at the
laboratory. The several autonomous groups, whose work is described below, although
located in different buildings, continue to collaborate in various ways. A major advantage
of this form of organization is that different groups are able to attack the same problem
from different directions.
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MOLECULAR BIOLOGY OF TUMOR VIRUSES
J. Sambrook, C. Adler, B. Ahrens, B. Anderson, M. Anderson, J. Bier, R. Frisque, L. Garbarini, Y.
Gluzman, R. Greene, T. Grodzicker, C. Grzywacz, D. Hanahan, D. Holtzman, S.-L. Hu, R. Kelch, D.
Klessig, R. McGuirk, R. McKay, C. Paul, P. Pope, M. Quinlan, M. Ramundo, P. Rosman, D. Smith, D.
So Inick, C. Stephens, N. Stow, J. Stringer, W. Topp, J. Wiggins, K. Willison
During the past year the Tumor Virus section has
continued its efforts to understand how the
genomes of viruses that malignantly transform
cells are organized and expressed. The topics
investigated fall into six major categories: (1) the
organization of viral DNA sequences in malig-
nantly transformed cells, (2) the mechanism of
RNA transcription and splicing, (3) the properties
of proteins associated with transformation, (4) the
genetics of the transforming viruses simian virus 40
(SV40) and adenovirus 2 (Ad2), (5) the properties of
malignantly transformed cells grown in culture,
and (6) the interaction of SV40 with early mouse
embryos.
The Organization of Viral DNA
Sequences Integrated in the
Genomes of Cells Transformed
by Adenoviruses or SV40
Adenovirus-transformed Cells
J. Sambrook
Semipermissive cells transformed by adenoviruses
(e.g., rat cells transformed by Ad2) often carry
multiple sets of partial copies of viral DNA that are
not colinear with the viral genome. The best-
studied example is the cell line F4, where the
integrated viral DNA, isolated by molecular clon-
ing, has been analyzed by a variety of hybrid-
ization techniques and direct DNA sequencing.
The general structure of the integrated sequences
is shown in Figure 1. Starting from a Hindi!l site on
the left, there occur, in order, a tract of highly
repetitive cellular DNA about 1 kb in length and a
tract of viral sequences 1543 nucleotides long,
which begins 2 nucleotides from the right-hand
end of the viral genome and extends through part
of early region 4 (E4) to nucleotide 1545. These
right-end sequences are then joined directly to se-
quences from the left end of the viral DNA by a
blunt-end joint. There then follows a tract of
sequences approximately 22 kb in length that are
colinear with the viral genome as far as map
position 63. They therefore include not only the
transforming region (early regions 1A [E1A] and 1B
[E1B]), but also a sizable chunk of late genes.
Finally, there is another blunt-ended joint be-
tween the viral and host DNAs (which consists of
unique or nearly unique sequences).
This arrangement, where sequences from the
right end of the viral DNA are joined to those from
the left, is not uncommon in adenovirus-trans-
formed cells; similar configurations have been
detected, by Southern hybridization, in several
other lines of rat cells transformed by adenovirus
type 5 (Ad5) (Visser et al., Cold Spring Harbor
Symp. Quant. Biol. 44: 541 [1980]; J. Sambrook and
R. Greene, unpubl.).
Several lines of transformed cells contain sets of
viral DNA sequences that are amplified together
with their flanking cellular sequences into tan-
demly repetitious structures. For example, F4 cells
contain 16 copies of the arrangement shown in
Figure 1. All 16 copies are identical. In theory, this
situation could arise in three ways. First, integra-
tion may have originally occurred at only one
chromosomal site, but F4 cells, which are known
to be aneuploid, may have since accumulated 16
copies of that chromosome or a fragment of it.
Although not conclusive, the available cytogene-
tic data argue strongly against this hypothesis.
Second, integration may have occurred indepen-
dently in 16 sites that lie at separate places in the rat
genome but are identical to one another with
regard to sequence. Although there is no formal
evidence to exclude this possibility, such a series of
events would run counter to virtually everything
that has been established about the mechanism of
integration of DNA viruses. Comparative analyses
of a large number of cell lines transformed by SV40
or adenoviruses continue to indicate that integra-
tion is a random or quasi-random event. Yet, if the
hypothesis set out above were correct, we would
need to postulate that in the original cells that gave
rise to the F4 line, a bizarre, inverted form of
adenoviral DNA was created that managed to find
and to recombine with a particular cellular
sequence no less than 16 times. It seems much
more likely that the set of viral sequences in F4
cells is the product of a single integration event. At
some subsequent time the viral DNA, together
with its flanking host sequences, was amplified 16-
fold to generate a tandem array. The pressure to
amplify could conceivably be generated by a need
for large quantities of those viral products that are
needed to achieve full expression of the trans-
formed phenotype. How such amplifications might
occur is obscure, but the two most likely mech-
anisms are either successive rounds of unequal
crossover or saltatory replications followed by
recombination. In either case, the final tandem
array is probably genetically unstable and is likely
to be expanding and contracting by unequal
crossover. Presumably, the average of 16 copies
per F4 cell is then a compromise between the
constant selection for fast-growing cells that
contain more copies of viral DNA and the
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The organization of the integrated adenoviral DNA in the cell line F4. The viral insertion consists of two tracts of
adenoviral DNA from the right- and left-hand ends of the viral genome. Also shown are transcription products
found in F4 cells.
increased genetic instability that such expanded
sets would bring.
Although all this is plausible, little direct evi-
dence so far exists to support the idea of an
interspersed tandem array of host and viral
sequences. Cast-iron proof of this arrangement
will come only when two adjacent viral inserts
have been cloned in prokaryotic vectors together
with the host sequences that connect them.
Not all lines of adenovirus-transformed cells
contain such complex arrays of viral DNA se-
quences as those of F4 cells. For example, the cell
lines F17 and F18 contain only two to three copies
of a segment stretching from the left-hand end of
the viral genome to map position 17, just down-
stream from the late promoter. These sequences
have been cloned in prokaryotic vectors, and
preliminary analysis indicates that they are co-
linear with the viral genome. The junctions
between cellular and viral DNA sequences have
not yet been analyzed in detail.
SV40-transformed Cells
J. Stringer
Transformation of cells by SV40 is stabilized by
integration of all or part of the viral genome into
that of the cell. Previous studies using restriction
endonuclease mapping have shown that SV40
DNA can be linked to cellular DNA at many points
on the viral genome and that there are multiple
sites for SV40 integration in the cellular genome.
During the past year we have used molecular
cloning to examine directly the nucleotide se-
quences at cell-SV40 recombinant junctions and
have shown that SV40 integrative recombination is
nonspecific at the level of nucleotide sequence.
DNA fragments containing the integrated viral
DNA present in two SV40-transformed rat cell
24
lines, SVRE9 and SVRE17, were cloned in prokary-
otic vectors, and the DNA sequences linking SV40
and cellular DNAs were determined. Comparison
of the DNA sequences at the SV40-cell junctions in
SVRE9 and SVRE17 cells with those of a previously
characterized viral insertion from SV14B cells
shows that no specific viral or cellular sequences
occur at SV40-cell junctions. In addition, the
sequences at SV40-cell junctions differ from those
present in other DNA insertions (such as bacterial
transposons, Ty1 of yeast, copia elements in
Drosophila, and retrovirus proviruses) in that the
cellular sequences that flank SV40 insertions are
not arranged as direct repeats. It can be concluded
from the structure of SV40-cell recombinant
junctions that the recombination system responsi-
ble for SV40 integration is not site-directed and
that it operates via a mechanism different from




The Late Promoter of Adenovirus 2
S.-L. Hu, M. Anderson
In collaboration with I. L. Manley (MIT), we have
identified a region of the viral genome required
for the initiation of transcription in vitro from the
major late promoter of Ad2. A fragment of the
adenoviral genome containing the cap site of the
major late transcripts was cloned in pBR322.
Deletions were then generated in vitro in and
around the TATAAAA sequence located at posi-
tion -25 to -31 nucleotides upstream from the cap
site (Fig. 2). DNAs with these deletions were tested
by the method of Manley et al. (Proc. Natl. Acad.
Sri. 77: 3855 [1980]) for their ability to initiate










DNA sequence of deletion mutants around the cap site of the Ad2 major late promoter. Ad2 sequences deleted
and substituted by pBR322 sequences are indicated by the open boxes. The upstream boundary of the Ad2
sequences in these clones is located at position -430, or coordinate 15.4, on the Ad2 genomic map.
upstream from position -47 or downstream from
position -12 did not abolish transcription, but
deletions extending into or beyond the TATAAAA
sequence reduced transcription to less than one-
tenth. Removal of the normal cap site slightly
reduced, but did not abolish, transcription. These
results indicate that the region of the genome
upstream of the cap site, with boundaries within
15-17 nucleotides to either side of the TATAAAA
sequence, is required for the initiation of tran-
scription in vitro from the major late promoter of
Ad2. Recently, we have constructed plasmids
containing the T-antigen-coding region of SV40
inserted downstream of both wild-type and de-
leted derivatives of the Ad2 major late promoter
(Fig. 3). We have assayed the expression of T
antigen under the control of the Ad2 promoter by
indirect immunofluorescence after microinjecting
these plasmids into simian cells. Results obtained
substantiate the conclusion drawn from in vitro
studies.
RNA Synthesis and Splicing in
Constructed Variants of Adenovirus
D. Solnick
A region-specific mutagenesis technique has been
used to generate a series of mutants mapping in a
portion of the adenoviral transforming region,
E1A. One of the mutants was characterized in
considerable detail. Using RNA mapping tech-
niques, the mutant was shown to be defective in
one of the splicing events normally responsible for
producing the multiple RNA species from E1A.
The defect acts in cis, and DNA sequence analysis
indicates that it is the consequence of two
nucleotide changes within a splice-site consensus





Structure of pT6 plasmid. The thin line on the circle represents the pBR322 sequence, the filled bar representsAd2
DNA, and the open bar represents SV40 DNA. Numbers next to the filled bar and the open bar indicate the
coordinates of Ad2 and 5V40DNAs in respective map units. The sequence at the junction of Ad2 and SV40 DNAs is
presented at the top, with the cap site and the direction oftranscription as indicated. The Ad2 major late promoter
lies upstream of the cap site and the 5V40 sequence lies downstream of the cap site, with the initiation codon of T
antigen indicated by the box.
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sequence. This is the first direct demonstration
that the splice-site consensus sequence is required
for normal processing of RNA.
Other insights into the control of adenoviral
RNA syntheses have come from analysis of the
specialized recombinants I have constructed.
Viral recombinants were constructed in which a
copy of the adenoviral major late promoter was
inserted at an ectopic site in the viral genome and
used to express downstream genes. The fragment
harboring the late promoter extends from -400 to
+33 nucleotides relative to the RNA start site,
thereby excluding the downstream splice site (at
+41) normally used in the formation of the
tripartite leader. In the first such recombinant (Ad
SVR101), the late promoter was inserted 270
nucleotides upstream from the early promoter for
E1A. Both promoters retained transcriptional ac-
tivity. Transcripts initiated at the inserted late
promoter contained additional 5' sequences but
were spliced and polyadenylated at the sites
normally used for the processing of E1A RNA.
Consistent with recent results from several groups,
transcription from the ectopic late promoter did
not require viral DNA replication.
During a wild-type infection, the two largest
mRNAs (0.9 and 1.0 kb) from E1A are synthesized
prior to the onset of DNA replication, whereas the
smallest mRNA (0.5 kb) requires DNA replication
for its synthesis. The 0.5-kb mRNA generally is
present after replication in an amount roughly
equal to that of the 1.0-kb mRNA and somewhat
greater than that of the 0.9-kb mRNA. During
infection with R101, these ratios are essentially
unperturbed. However, the 5' extended deriva-
tives of these RNAs are present in quite different
amounts. Production of the analog of the 0.5-kb
mRNA is enhanced roughly tenfold relative to that
of the other extended mRNAs, which themselves
are overproduced tenfold in comparison with
their unextended forms. Thus, insertion of a late
promoter in front of a region that primarily (but
not exclusively) synthesizes early products shifts
the emphasis in the expression of that region such
that synthesis of a late product predominates.
A second recombinant (R102) was constructed
in which the late promoter was inserted closer (80
nucleotides) to E1A. Again, both early and late
promoters are used, and splicing and polyadenyla-
tion occur at the usual positions. For unknown
reasons, however, the 5' extended RNAs from
both R101 and R102 are translated quite inef-
ficiently both in vivo and in vitro.
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Another type of recombinant (R105) was there-
fore constructed in which the late promoter was
inserted upstream of a second insert, the SV40
early region (see Fig. 4). The SV40 sequence
contains the coding, intervening, and 3' untrans-
lated regions for large and small T antigens but does
not contain the early promoter. R105 produces
RNAs analogous to the SV40 16S and 19S mRNAs,
but which contain 33 nucleotides of adenoviral
sequence at their 5' ends. These RNAs are transla-
tionally active, producing both large and small T
antigens, the former in particularly large amounts.
R105 is therefore being used (by Ron McKay) in
studies of the protein's DNA-binding functions.
Moreover, the construction of R105 uncovered a
number of unexpected phenomena related to
the biogenesis of adenoviral late mRNA, among
which is the fact that most of the tripartite leader
sequences normally found on such RNA are
expendable.
Using this adeno-SV40 hybrid as a prototype,
recombinants are being constructed that will
allow the insertion and expression of either
cloned cDNAs or genomic DNAs up to 10 kb in
length. A long-term goal is to use adenovirus as a
vector for preparing DNA libraries, and then,
using an immunoassay developed with the help of
Ron McKay, to screen such libraries for recom-
binants expressing the gene of interest. The ability
to obtain a gene given only an antibody to its
product would be an immensely powerful tool.
Proteins of Transformed Cells
Transforming Proteins of SV40
R. McKay
One of thd early gene products of SV40, large T
antigen, remains the only example in higher
organisms of a protein that controls gene expres-
sion by binding to Specific regulatory DNA
sequence& Large T antigen interacts with a specific
DNA sequence and through this interaction
both controls the expression of viral genes and
initiates viral DNA replication. During the past
year we have continued our studies of the
interaction of T antigen with the regulatory DNA
sequences in the viral genome. Using an immuno-
assay, we have shown that one of the three
previously identified binding sites in the viral
genome is a strong, independent binding site and
that in the absence of this site, the other binding
Figure 4











sites do not exhibit marked preferential binding.
In collaboration with D. Di Maio (Johns Hopkins
University), we have shown that SV40 variants
carrying altered sequences in this region that
binds strongly in wild-type SV40 DNA have a much
lower affinity for SV40 T antigen. These observa-
tions provide direct evidence for the hypothesis
that the altered phenotype of the mutant viruses is
a consequence of diminished T-antigen binding.
We have continued to develop the technology
of probing DNA-protein interactions with specific
antibodies by devising an immuno-footprinting
procedure. Using such a procedure, we hope to
be able to screen mutant forms of T antigen rapidly
for alterations in their ability to contact specific
sites in the regulatory region of the viral DNA.
5V40 T antigen is a multifunctional protein, and
in addition to binding DNA, it binds to a cellular
protein of 53,000 daltons, has an ATPase activity,
and is a tumor-specific transplantation antigen. A
number of different experiments show that the
early region of SV40 DNA coding for large T
antigen induces the specific immune response
when animals are challenged with SV40-trans-
formed cells. Recently, a number of groups have
used antisera against large T antigen to show that
there is a large-T-antigen-like molecule on the
surfaces of SV40-transformed cells. With L. Good-
ing (Emory University), we have used a number of
monoclonal antibodies that bind to different sites
on T antigen to show that surface T antigen shares
all the antigenic determinants we have tested. We
conclude that surface T antigen must be very
similar to the much more abundant nuclear form
of the protein. The very low background obtained
when staining cells with monoclonal antibodies
has allowed us to quantitate the expression of
surface T antigen. We hope to be able to use the
knowledge we gain about the structure of surface
T antigen, to ask directly how this tumor-specific
protein functions as a target for the immune
system.
Cellular Proteins Induced in
Transformed Cells
B. Anderson
Previous studies initiated by David Lane (Lane and
Crawford, Nature 278: 261 [1979]) indicated that
the large T antigen of SV40 was bound to a host
protein in a variety of SV40-transformed cell lines.
The host proteins, denoted middle T antigens,
coprecipitate when the large T antigen is immuno-
precipitated from cell extracts reacted with various
sera from animals bearing SV40-induced tumors.
Using this approach, several additional SV40-
transformed cell lines have now been screened for
the presence of middle T antigens. Furthermore,
methods now exist by which it is possible to
determine whether anti-SV40 tumor sera contain
antibodies directed against the middle T antigens,
and these methods have been used to identify
tumor sera containing anti-middle-T-antigen anti-
bodies.
mRNA has been isolated from SV40-transformed
rat cells producing middle T antigen and has been
translated into polypeptides in a reticulocyte
lysate cell-free translation system. Sera containing
anti-middle-T-antigen-specific antibodies have
been used to immunoprecipitate middle-T-anti-
gen-related polypeptides from the mixture of
total cell-free translation products. The cellular
mRNA has been fractionated by sedimentation
through a sucrose gradient, and a fraction rela-
tively enriched in mRNA that can direct the cell-
free translation of middle-T-antigen-related poly-
peptides has been identified.
The mRNAs contained in the sucrose gradient
fraction rich in middle-T-antigen mRNA are to be
used as templates for the synthesis of double-
stranded cDNA molecules, which will be cloned in
plasmids and propagated in bacteria. After identi-
fication and suitable characterization, the resul-
tant middle-T-antigen cDNA clones will be used as
probes in the isolation of the genomic copies of
the middle-T-antigen genes.
Coincidentally, a human melanoma cell line
under study because of its ability to secrete large
amounts of plasminogen activator (see below) has
been found to contain readily detectable levels of
middle T antigen. This represents the first clear
demonstration of the presence of stable middle T
antigen in a human cell in which SV40 was not
involved in the induction of the transformed state.
Induction of plasminogen activators is a classical
characteristic of transformed cells. We are at-
tempting to clone a plasminogen activator gene
from human cells. The ultimate goal is to achieve
expression of the cloned gene in a bacterial host,
which would enable the preparation and purifica-
tion of large amounts of plasminogen activator. In
addition to their potential significance in trans-
formation, Highly purified plasminogen activators
hold promise in the clinical management of
thrombosis conditions.
The project is being undertaken in collabora-
tion with D. Rifkin (New York University) who has
provided both a human melanoma cell line that
¢ecretes the plasminogen activator of interest and
an antiserum raised in rabbits by immunization
with plasminogen activator purified from the
tissue-culture fluid of growing melanoma cells.
Polyadenylated mRNA has been isolated from the
melanoma cells and translated into polypeptides
in the cell-free reticulocyte lysate system. The
anti-plasminogen-activator serum has been used to
identify a plasminogen-activator-related polypep-
tide among the cell-free translation products. The
mRNA has been fractionated by sedimentation
through a sucrose gradient, and of the fractions
collected, two adjacent fractions contained mRNA
that has directed the synthesis of plasminogen-
activator-related polypeptides in the cell-free
translation system.
The next stage in this project will be to clone
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cDNA copies of the plasminogen activator mRNA
and to screen the clones obtained for those
containing a copy of the entire coding sequence
for plasminogen activator. Conventional genetic
engineering techniques will then be used to
achieve the production of the plasminogen activa-
tor polypeptide by linking the coding sequence, in
the appropriate codon reading frame, to a bac-
terial gene promoter.
The Genetics of the Transforming
Viruses SV40 and Adenovirus
Origin-defective Mutants of SV40
Y. Gluzman, R. Frisque
Replication of SV40 DNA begins at a unique site
on the viral chromosome, coinciding with the
Bgll restriction site, and proceeds bidirectionally
around the circular molecule. The viral promoter
responsible for initiation of early transcription is
also located near this site. We have isolated origin-
defective mutants of SV40 (Gluzman et al., Cold
Spring Harbor Symp. Quant. Biol. 44: 293 [1980])
and have determined the nucleotide sequences of
five of them. All of the mutants are Bgll-resistant
and have suffered deletions that range in size from
4 to 241 nucleotides. Mutants with deletions of 4,6,
9, and 58 nucleotides induce the synthesis of wild-
type T antigen, even though the major portion of
the untranslated 5' end of early mRNA is removed
in the case of the mutant with a 58-nucleotide
deletion. These mutants transform rat cells with an
efficiency comparable to that of wild-type SV40
DNA. The mutant with a deletion of 241 nucleo-
tides does not produce any detectable T antigen
and does not transform cells. This deletion extends
to nucleotide 220 (see pp. 799-833, Tooze, The
Molecular Biology of Tumor Viruses, 2nd Edition,
Part 2, Cold Spring Harbor Laboratory [1980]), and
from comparisons with mutants that produce T
antigen, the early viral promoter can be localized
between nucleotides 5 and 220.
Deletions in the mutants producing T antigen
are located between the AT-rich region at nucleo-
tides 15 to 31 and the AUG codon for large-T-
antigen and small-T-antigen proteins. The posi-
tions of the 5' termini of the principal early mRNAs
produced in rat cells transformed by wild-type or
mutant DNAs were determined by a method
involving synthesis, separation, and sequencing of
DNAs complementary to the 5' ends of early viral
messages (in collaboration with P. Ghosh and P.
Lebowitz, Yale Medical School). As previously
reported (Reddy et al., J. Virol. 30: 279 [1979]), the
5' termini of wild-type mRNAs were found to lie
21-28 nucleotides downstream from the AT-rich
sequence on the DNA template. The origin-
defective mutants produced mRNAs with princi-
pal 5' termini that had been shifted downstream
from the positions of the wild-type 5' termini. The
size of this shift corresponded to the length of the
deleted DNA segment (see Fig. 5).
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We have also analyzed the mRNAs isolated from
cells transformed by the viable mutant c11892
(Subramanian and Shenk, Nucleic Acids Res.
5: 3635 [1978]). This mutant has lost 19 nucleotides
beginning 15 nucleotides upstream from the AT-
rich sequence and produces the same principal 5'
termini as does wild-type SV40 (see Fig. 5). These
data suggest that a DNA sequence of 29 nucleo-
tides, which includes the AT-rich sequence,
contains a component(s) of a promoter for early
transcription. This component functions in posi-
tioning the 5' ends of the principal early mRNAs
21-25 nucleotides downstream from the AT-rich
sequence and acts independently of these down-
stream sequences.
From nuclease-S1 analysis of the early viral
messages, we have observed that the quantity of
viral RNA in cells transformed by the origin-
defective mutants is greater than that found in
wild-type transformants. The mutant DNAs have
altered T-antigen-binding sites, and decreased
binding of large-T-antigen protein to these sites
may be responsible for the increased amount of
viral mRNA. However, we have not detected a
corresponding increase in the early viral proteins
in the mutant transformants.
Transformation of Permissive Cells by SV40
Y. Gluzman
Three new lines of transformed monkey cells
(COS-1, COS-3 and COS-7) have been isolated
through transformation of CV-1 cells with an
origin-defective mutant of SV40. The transformed
cell lines obtained are permissive for infection
with SV40 and express a functional viral T antigen.
Thus, these cells support the growth of SV40 tsA
mutants at the nonpermissive temperature and
allow the propagation of pure populations of
other early mutants of SV40. This is in contrast to
the previously isolated SV40-transformed CV-1
cells (C2, C6, and C11), which were made by
infection of CV-1 cells with UV-irradiated SV40.
C2, C6, and C11 cells do not support the replica-
tion of early mutants of SV40. It is probable that
these cells express a mutated T antigen that is able
to transform cells but is defective in a viral
replicative function (Gluzman et al., J. Virol.
22: 256 [1977]).
SV40 Mutants That Differentiate the Lytle
and Transforming Functions of T antigen
Y. Gluzman, J. Stringer
The mutant SV40 DNA insertion in C6 cells has
been rescued through fusion of C6 and COS-1
cells. Fusion to COS-1 cells provides a functional T
antigen in trans that allows the C6 SV40 insertion to
excise and replicate in C6-COS-1 heterokaryons.
The rescued C6 insertion was cloned in pBR322.
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Figure 5
Schematic diagram of the region of SV40 DNA coding for the 5' termini of the early viral mRNAs. Transcription occurs on the lower strand in a left-to-
right direction. On the upper strand, a Goldberg-Hogness sequence and the AUG sequence for initiation of translation of large T antigen are indicated.
In the lower portion of the figure are shown the deletions in the five origin-defective and dl892 mutants used in the present study and the RNA
sequences within which the 5' termini of the early viral mRNAs fall. Heavy and light lines under certain sequences indicate major termini and principal
minor termini, respectively; nonunderlined sequences indicate sites of relatively scarce 5' termini. Numbers in parentheses indicate number of cDNA 3'
termini and probably number of mRNA 5' termini identified within the given stretches of nucleotides; where no numbers are given under sequences,
only one mRNA 5' terminus has been identified to date. Lines with terminal arrowheads indicate number of nucleotides from Goldberg-Hogness
sequence to templates for principal 5' termini of each virus. An A residue has been found at position 5177 in the DNA of the origin-defective mutants;
however, a G residue has been found in this position in mutant 8-4 and 1-11 early mRNAs. The boundaries of deletions are 5190-4 for mutants 1-11
and 3-20, 5239-5242 for 8-4, 5237-5242 for 6-1, 5238-3 for 6-17, and 35-53 for d1892 (inclusive).
0defective for lytic growth but still capable of
transforming rat and monkey cells. The mutation
responsible for the lytic defect has been localized
by marker rescue to the HindIIIB fragment
(0.42-0.65 map units).
A second mutant of SV40 that is competent for
transformation but defective for lytic growth was
discovered during the analysis of the integrated
SV40 DNA present in the rat line SVRE9. The SV40
insertion in these cells contains a mutation in
the viral large-T-antigen gene that renders the
protein incompetent for the synthesis of SV40
DNA. SVRE9 cells, however, are transformed by
the criteria of morphology, growth rate in low
serum, and anchorage-independent growth. In
addition, the cloned viral insertion retains the
ability to transform rat cells in culture to density-
independent growth. The mutation responsible
for this new phenotype has been mapped both
genetically and physically. Marker-rescue experi-
ments localized the mutation between nucleo-
tides 3187 and 3459. DNA sequence analysis of this
region shows a single-base change at position 3342.
This change generates a new Pstl site in the viral
insertion and predicts an amino acid change of a
serine to an alanine in the large-T-antigen protein.
Apparently, this change abolishes the DNA syn-
thesis function of the protein without affecting its
transforming activity.
Cloning of DNA Fragments from the Left-
hand Terminus of the Adenovirus-2 Genome
and Their Use in Site-directed Mutagenesis
P. Rosman, R. Frisque, N. Stow
The left-hand 11% of the genomes of Ad2 and Ad5
contain genes that play important roles both in
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cellular transformation and in the early stages of
lytic viral infection. This early region (El) contains
two separate transcription units, E1A (map coordi-
nates 1.4-4.4) and E1B (map coordinates 4.5-11.2).
Several overlapping spliced mRNAs are specified
by both E1A and E1B, and a number of polypep-
tides encoded by these regions have been identi-
fied (see Fig. 6). The presence of overlapping
genes considerably complicates the investigation
of the roles of individual El polypeptide products
during the lytic cycle and in transformation. To
overcome this problem, we have used molecular
cloning to introduce genetic lesions specifically
within E1A and E1B.
Viral DNA fragments cloned in plasmid vectors
provided convenient sources of substrate for
mutagenesis. A variety of procedures were used to
introduce mutations at either general sites or
specific sites, and the altered viral sequences were
then cloned and amplified. Using a dG-dC tailing
procedure, we have cloned the Ad2 HpaI E
fragment (0-4.5 map units) and the Bel E
fragment (0-9.0 map units) into the Pstl site of the
plasmid vector pBR322. Pst sites regenerated at the
ends of the insert enabled part or all of the insert to
be excised. Cleavage of the plasmid with Pstl plus
Xbal generated a 0-3.8-map-unit fragment, which
was then ligated to the Ad5 mutant dI309A (3.8-100
map units) to generate unit-length genomes.
Transfection with the ligation products resulted in
the production of progeny virus that was able to
replicate on both HeLa cells and line 293 cells,
demonstrating the biological activity of the se-
quences rescued from the plasmid. Small dele-
tions of about 10 by were introduced around the
Smal site (map position 2.9) within the cloned viral
insert, and the altered DNA sequences were












Location of the Smal site in relation to the EM mRNAs.
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XbaI HpaI
above. The mutant viruses grew well on line 293
cells (a line of human embryo kidney cells
transformed by sheared Ads DNA) but plagued
with greatly reduced efficiency on He La cells,
exhibiting a host-range phenotype similar to
previously described mutants with lesions located
within this region of the genome. Mutant-virus
growth appears to be complemented (in at least
some instances) by El products expressed by the
line 293 cells.
Small deletions were also introduced at a variety
of other sites in a plasmid (BE5) containing Bglll E
fragment; specifically, at the sites for Xba I at map
position 3.8, Hpal at map position 4.5, Sstl at map
position 5.0, and Kpn I at map position 6.1. Several
mutations at these sites, which lie at or to the right
of map position 3.8, have been transferred to virus
using an alternative technique. The plasmids were
linearized within the pBR322 sequences with
BamHl and cotransfected with dI309A into line 293
cells. Infectious virus was produced as a result of
homologous recombination within the DNA se-
quences shared by the viral insert and d/309A.
Depending on the site at which the crossover
occurred, wild-type or mutant virus carrying the
deletion was generated. The mutant viruses are
currently being studied in detail with regard to the




The terminal fragment clones of adenoviral DNA
have also proved useful in the study of viral DNA
replication. Surprisingly, when long sequences of
pBR322 DNA are left attached to the left end of an
adenoviral genome, the viral DNA retains its
infectivity and the progeny virus has normal left-
end DNA. Whether the additional pBR322 se-
quences are excised before replication of the
ligated molecules or are lost as a consequence of
the replication of these molecules is not yet
known. If the latter situation is correct, it suggests
that new viral DNA strands can be initiated at a
specific sequence (corresponding to the terminal
sequence) that can be recognized even when
located within a viral DNA molecule. Alternative-
ly, for DNA strands initiated at the right end of the
viral DNA, a sequence-specific mechanism might
determine the position at which the synthesis of
the strand is terminated (corresponding to the
normal left-hand terminus). Genomes construc-
ted with deletions of about 50 by at their left-hand
termini were also infectious, and in this case the
missing DNA sequences were restored in progeny
virus DNAs. This experiment provides evidence
that the inverted repeats at the two ends of the
viral genome interact with each other during DNA
replication. Preliminary evidence indicates that
adenoviral DNA replication can occur even when
both ends of the molecule are linked to foreign
DNA. A plasmid containing two copies of the left
end of Ad2 arranged head to head was constructed.
When cells were coinfected with this plasmid and
Ad2 helper DNA, the viral insert replicated and
accumulated in the infected cells. This type of
plasmid has considerable potential as a cloning
vector for eukaryotic cells because it should be
possible to introduce foreign DNA sequences
within the viral insert and to study their replication
and expression in cells coinfected with helper-
virus DNA.
Construction and Analysis of Cell Lines
That Express Unselected Adenoviral Genes
by Cotransformation of the HSV-1 tk Gene
and Adenovirus-2 DNA
T. Grodzicker, D. Klessig
We have started to obtain sets of human cell lines
that express adenoviral genes and can be used as
permissive hosts for the isolation and propagation
of conditional mutants. The 293 line of human cells,
which carries and expresses the transforming re-
gion of Ad5, was isolated by morphologically
transforming human embryonic kidney cells with
sheared viral DNA. This line has been extremely
useful as a host for propagating transformation-
defective mutants in El. However, all attempts to
make more cell lines using the same procedure
have failed. We adapted the procedure of cotrans-
formation that had been developed for mouse L
Tk- cells to introduce unselected Ad2 genes into
permissive, thymidine-kinase (TK)-deficient hu-
man 143 cells.
Line 143 cells were cotransfected with fragments
of Ad2 DNA (EcoRI A: 0-59; Baml B: 0-29) and a
cloned Barn fragment that carries the HSV-1 tk
gene. TV cells were isolated after selection and
growth in HAT medium. Several cotransformed
lines were obtained that complement the growth
of Ad5 d/312 (M.2-3.7) and Ad5 (11434 (A2.6-8.7)
deletion mutants that lack sequences from the left
end of the viral genome. Mutant-virus growth was
always due to complementation and not to
recombination with viral DNA present in the cell
lines. The amount and arrangement of viral
sequences in the cotransformed cell lines have
been analyzed by restriction endonuclease diges-
tion and Southern hybridization. Most of the cell
lines contain a single insertion of the HSV-1 tk
fragment and a single insertion of adenoviral
DNA. However, one line (B1) contains at least four
different insertions, two of which are present in
multiple copies. The adenoviral DNA in all cell
lines is composed of sequences from the left end
of the genome that extend for varying lengths in
different lines. For example, two lines, A2 and A5,
contain adenoviral sequences that extend from at
least position 0.7 on the left to somewhere
between positions 11 and 14.7 (A5) and 18.5 and 22
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(A2) on the right. These lines, which complement
E1A and E1B mutants, efficiently synthesize both
E1A and E1B mRNAs. The A2 line does not
synthesize viral RNA that lies beyond E1A and E1B.
The B1 line contains multiple and amplified
adenoviral insertions and synthesizes very low
levels of E1A mRNA, higher levels of E1B mRNA,
and a unique mRNA that maps to the right of the
E1B family and extends to at least position 16.7.
Although the B line contains DNA corresponding
to El, none of the insertions contain upstream left-
end sequences because B1 cellular DNA does not
release a Bal fragment (map position 0.7-5.8) upon
restriction enzyme digestion. It seems likely,
therefore, that the El As integrated in B1 lack
sequences needed for efficient transcription and
are, in effect, promoter mutants. Some Tk' sub-
clones support the growth of viral mutants as
efficiently as the original parental line; others give
reduced levels of complementation. For all Tk'
subclones examined, the alteration or reduction
in viral gene expression is independent of changes
in the pattern of integration of viral DNA. To
examine in detail amplification of viral sequences
and the defective E1A promoter, we are attempt-
ing to clone the viral insertions in the B1 cell line.
In attempting to construct cell lines that carry
and express adenoviral genes that lie beyond El A
and E1B, one must take into account the observa-
tion that in lytically infected human cells, expres-
sion of El A is necessary for expression of many
other adenoviral early genes. Thus, in cotransfor-
mation experiments using the HSV-1 tk gene and
adenoviral DNA, it may be necessary to include
left-end DNA sequences. As a plentiful source of
E1A, we have used a plasmid, F4/41, that carries
Ad2 DNA isolated from the rat transformed cell
line F4. This clone contains left-end sequences that
extend from a position 62 nucleotides from the left
end of the genome to the HindlIl site at position
7.9. It thus contains all of the coding sequences of
E1A and part of El B as well.
We transfected line 143 cells with a plasmid
containing both the F4/41 insertion and the HSV-1
tk gene and have obtained five Tk' cell lines that
carry approximately one copy of the F4/41 adeno-
viral sequences (D. Klessig and T. Grodzicker,
unpubl.). They not only fully support the growth
of E1A deletion mutants, but also partially com-
plement the growth of an E1B mutant Ad5 d1313
(A3.6-10.1) and an E1A-E1B mutant Ad5 d1434.
Thus, the truncated E1B in these cell lines (D10,
D16, D21, D27, and D28) must be expressed to
yield proteins that are biologically active and can
carry out some of the E1B lytic functions.
Analysis of adenoviral mRNA from the D cell
lines by the nuclease-51 technique shows that all
of the E1B sequences in these lines are present in
poly(A)' cytoplasmic RNA. It has also been shown
that rat cells transformed by F4/41 also make "El B"
transcripts (R. Frisque, S.-L. Hu, and J. Sambrook,
unpubl.). It is striking that these cell lines make El B
mRNA because (1) the E1B transcription termina-
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tion and poly(A)' addition sites are missing from
the F4/41 clones, and (2) the splice acceptor site for
one of the major E1B mRNAs and both the splice
donor and acceptor sites for the other major E1B
transcript are also missing from the F4/41 clone.
How the El B mRNAs in the D lines are transcribed
and processed remains to be determined: whether
they annex control signals from the plasmid, the tk
insertion, or flanking cellular DNA. It should be
noted that the adenoviral genes were unselected
markers in construction of the D lines, which were
selected to be Tk' only; yet all of them express,
and are partially able to complement, El B mutants.
We are presently constructing cell lines that
contain the left end of the viral genome as well as
other internal adenoviral genes. We have ob-
tained one cell line that contains the gene for the
adenoviral early, 72K, single-stranded-DNA-bind-
ing protein. This line does not contain left-end
sequences and expresses 72K sequences in poly(A)'
RNA at very low levels.
Adeno -SV4O Hybrids That Express SV40
Large and Small T Antigens Under the
Control of Conventional Adenoviral
Promoters
T. Grodzicker, D. Solnick
Adeno-SV40 hybrid viruses have proved to be
invaluable tools in the study of animal virus gene
expression. We are now constructing new hybrid
viruses to define further genetic regulatory mech-
anisms and to obtain viral genomes that are
suitable for use as animal cell cloning vectors.
One of us (Terri Grodzicker), in collaboration
with R. Tjian and C. Thummel (University of
California, Berkeley), has obtained several novel
adeno-SV40 recombinant viruses that express
wild-type SV40 large and small T antigens under
control of different adenoviral promoters.
To place the SV40 early region under adenoviral
transcriptional control, the structural sequences
that code for SV40 large and small T antigens were
separated from the viral early promoter, purified
and amplified in E. coli (Fig. 7A). As recipients for
the SV40 early region, we used two Ad2/Ad5
hybrid viruses that each contain only two of the
three Barn sites present in the Ad2 genome. These
interserotypic viruses, designated lx5li and 4x22Sb,
were formed in vivo as wild-type recombinants
from crosses between temperature-sensitive mu-
tants of Ad5 and the nondefective Ad2-SV40
hybrid virus Ad2+ND1. Neither of these viruses
contains SV40 DNA. The SV40 early region was
inserted at the Barn sites of adenoviruses to
generate a population of defective recombinant
viruses that contain SV40 insertion(s) replacing
essential internal adenoviral genes. These were
propagated in monkey cells in the presence of
helper adenovirus. Expression of SV40 large T
antigen by the recombinants provides a helper
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cells, and this provides a selection for recombin-
ants that express SV40 T antigen. Analysis of four
hybrids indicates that they contain the SV40 early
region inserted in different positions and orienta-
tions within the adenoviral genome (Fig. 7B). (1)
Ad-SVR5 has a tandem insertion of SV40 inserted
between the Barn sites at positions 42 and 60. The
SV40 DNA is oriented with its 5' end at position 42
and is transcribed from the same strand as the
adenoviral major late transcripts. (2) Ad-SVR15 has
one copy of the SV40 early region inserted be-
tween positions 29 and 60 and oriented so that
the A gene is transcribed in the same direction as
the E2 and E4 that lie upstream from it. (3) Ad-SVR1
and R6, which were made by insertion of SV40 into
an Ad2/5 recombinant virus known as 1 x51i, have
grossly rearranged genomes, although the SV40
coding region is intact. No viruses with the 5' end
of the SV40 insert positioned at 29 have been
found. The Barn site at position 29 bisects the VA
RNA gene, leaving its promoter intact. It is
possible that hybrid transcripts originating from
this promoter cannot be properly processed or
that this arrangement of genes interferes with
transcription and/or processing from the major
late promoter. Recent experiments using analyses
of heteroduplexes of Ad-SVR1 (or R6) and adeno-
virus helper DNA by electron microscopy (in
collaboration with Louise Chow, Electron Micro-
scopy section) suggest that the SV40 early region is
inserted in the adenovirus left-end lb transcrip-
tion unit.
Regardless of the arrangement and orientation
of the SV40 insertions in the different hybrids, all
produce wild-type SV40 early proteins. However,
the hybrid viruses produce different amounts of
large and small T antigens with different kinetics
of synthesis. Ad-SVR15-infected cells yield low
amounts of T antigen. Ad-SVR5 produces high
amounts of T antigen as a late viral protein, as do
Ad-SVR1 and R6, which make 3 to 5 times more T
antigen than is found in SV40-infected cells.
Large and small T antigens produced by all
viruses have the same mobility as the wild-type
SV40 proteins, as judged by immunoprecipitation
with various T antisera and analysis of antigens on
SDS-polyacrylamide gels. The Ad-SVR6 T antigen
has been shown to be identical to SV40 T antigen
by partial proteolysis with Staphylococcus aureus
V8 protease and analysis of tryptic peptides. Using
Ad-SVR6-infected cells, it has been possible to
purify about 200 ,ug of T antigen from 8 liters of
infected cells.
The SV40-containing RNAs made by the dif-
ferent recombinants are transcribed from different
positions on the genome, although in all cases
they contain intact SV40 early sequences and
display normal splice patterns. However, the ratio
of small-T-antigen mRNA to large-T-antigen mRNA
in cells infected with hybrid viruses is reduced
relative to the ratio found in mRNA extracted from
lytically infected cells. Some hybrid mRNAs ap-
pear to be transcribed from the adenoviral late
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promoter and to contain the tripartite leader
sequence (Ad-SVR5). Others (Ad-SVR15) are pro-
bably transcribed from I-strand early promoters.
Thus, there seem to be several sites in the
adenoviral genome into which the SV40 early
region can be stably integrated to allow ,the
synthesis of active mRNA. We are presently
attempting to insert a variety of viral and human
cellular genes into the adenoviral recombinants to
see whether they can be expressed.
Using a different approach, David Solnick has
also constructed a new adeno-SV40 hybrid virus
that holds promise as a vehicle for the expression
of cloned DNAs. This recombinant is shown in
Figure 4 and is described above in Transcription
and Processing of Viral RNA.
Transformation and Tumor Induction
by SV40 and Adenovirus
This year has been one of transition for our group.
We have finished the studies on SV40 early mu-
tants, particularly mutants defective in the viral
small-T-antigen protein, and SV40-transformed
cells, which have occupied our group for the past
several years. In addition, we have begun a
number of new projects involving transformation
and tumor induction by the human adenoviruses.
Characterization of Small-T-Antigen
Mutants of SV40
W. Topp, M. Anderson, C. Paul
Christine Paul has sequenced a number of so-
called viable deletion mutants of the small-T-
antigen gene of SV40, which were isolated in our
lab three years ago by Merilyn Sleigh. She has also
examined, by immunoprecipitation, the small-T-
antigen proteins that are encoded by these
viruses. Although it has been reported that the
levels of small-T-antigen mRNA and protein that
are produced by a similar set of mutants correlates
well with the location of the deletion, we find no
such correlation. In fact, one mutant, d12004,
which in reality carries only a base-change muta-
tion at the Taql cleavage site, produces only very
low levels of a normal-size small-T-antigen pro-
tein, suggesting that the picture might be consi-
derably more complex than originally thought.
Another surprising result is that the mutants d1883,
d1884, and d12005, all of which have deleted
sequences around the splice point for small-T-
antigen mRNA production, synthesize low levels
of a small-T-antigen protein of the proper size for
the corresponding deletion. Either these proteins
are being translated off an unspliced message or
there is a second, perhaps aberrant, splice that can
be made elsewhere in the primary transcript.
Marilyn Anderson has studied the uptake of
glucose in rat cells transformed by SV40 and by
SV40 variants defective in either the small-T-
antigen or large-T-antigen proteins.
SV40-transformed rat embryo fibroblasts char-
acteristically exhibit an enhanced 2-deoxyglucose
transport rate relative to the untransformed parent
cell. To investigate the role of small and large T
antigens in this process, 2-deoxyglucose transport
was studied using a number of cell lines derived
from rat embryo fibroblasts transformed by wild-
type SV40, tsA209, and the small-T-antigen de-
letion mutant d1884. The presence or absence of
small-T-antigen protein was found to have no
effect on 2-deoxyglucose transport in subcon-
fluent cultures of the transformants. The transport
rate of all transformants was 3 to 5 times higher
than that of the normal rat embryo fibroblasts
when measured over a 10-minute period at 37°C.
Large T antigen was shown to be required for
maintenance of the elevated glucose transport.
Unlike the wild-type transformants, when tsA
transformants were maintained for at least two
generations at 40°C, glucose transport declined
dramatically.
Isolation of a Thymidine-kinasedeficient
Rat Cell Line
W. Topp
Transformation by the human adenoviruses is, in
general, several hundredfold less efficient than
that by SV40. Although many explanations for this
effect are plausible, there is as yet no experimental
evidence that bears on the problem. It is our belief
that this may be so because the integration and
expression of the transforming region of these
viruses is by itself insufficient to bring about
cellular behavior sufficiently altered that it could
be detected as commonly assayed. Some un-
defined second event, perhaps amplification of
the viral genes or a second site mutation, must
then occur that results in the development of a
fully transformed phenotype. To study this hypo-
thetical stepwise progression, it is necessary to
have a means of selecting infected cells solely for
the expression of adenoviral transforming pro-
teins. The means by which we intend to do this is
through cotransfection of the adenoviral trans-
forming region, either as viral DNA or as cloned
fragments of viral DNA, with a second selectable
gene. It is known that cotransfected genes fre-
quently are both integrated and expressed even
though only one has been selected for. To this
end, we have isolated three cell lines, derived by
serial passage in sequentially increasing concen-
trations of BrdU of the 3T3-like rat fibroblastoid
cell line Rat-1, which are lacking in nuclear
thymidine kinase (TK). These lines are easily
transfectable by cloned HSV TK and other DNAs
and are "normal" by all criteria tested, save that
they are both established as cell lines and clonable.
Marilyn Anderson, Dick Frisque, and Mary Ramundo
are now using these cells to establish cell lines
carrying and expressing the genes from E1A and
E1B of human Ad2. Once isolated, these lines will
be characterized and contrasted to lines similarly
isolated expressing the SV40 transforming pro-
teins.
Oncogenesis by Group-D Adenoviruses
W. Topp, D. Smith
The human adenoviruses can be divided into five
groups on the basis of a variety of criteria. Of the 36
identifiable human adenovirus serotypes, only
three, Ad12, 18, and 31 (group A), are highly
tumorigenic in newborn hamsters. The substantial
majority (groups B and D) are only weakly
oncogenic, tumors appearing after 12 months in
only 5-10% of the animals infected. All these
tumors are almost invariably undifferentiated
fibrosarcomas arising at the site of injection. The
C-group and E-group adenoviruses have no
detectable oncogenic potential. Similar results are
obtained when groups A, B, C, and E are injected
into newborn rats. However, it has been reported
that the group-D adenoviruses behave differently
in rats. One member of this group, human Ad9,
induces, with nearly 100% efficiency, benign
breast fibroadenomas within 3 to 4 months of
injection into newborn female rats. The same
result is obtained with adult rats. Diane Smith, in
collaboration with Tom Broker and Louise Chow
(Electromicroscopy Section) and C. Shellabarger
and B. Lane (State University of New York, Stony
Brook), has begun a series of studies first to repeat
this unusual result and then to identify what
feature of the little-studied group-D adenoviruses
is responsible for this unique behavior.
Transformation of Culture Cells
by Mutants of Adenovirus 2
R. Frisque, M. Anderson, N. Stow, P. Rosman,
M. Ramundo
We have now cloned most of El of Ad2 in pBR322.
In addition, two clones representing E1A and ElB
have been made. A large number of deletion
mutants have been constructed at specific sites in
these clones, and we are now testing their
transforming capabilities in an effort to determine
which Ad2 proteins are involved in the initiation
and maintenance of the transformed state. Be-
cause the transformation efficiencies are low
when using DNA transfection techniques, we have
attempted to increase the efficiency in several
ways: by microinjecting the DNA into cells, by
cotransfecting Tk- cells with the tk gene and
mutant DNAs, and by using reconstructed viruses
containing the various deletions.
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Molecular Biology of a Human
PapOvavirus
R. Fnsque
JCV is a human papovavirus associated with the
disease progressive multifocal leukoencephalo-
pathy (PML). It is highly tumorigenic, causing a
wide variety of tumors in hamsters and primates.
Little is known about the molecular biology of
JCV, in part due to the inability to obtain
satisfactory yields of the virus. By cloning the viral
DNA, we should be able to overcome this
problem and begin a more thorough investigation
of JCV. I have constructed several clones that
contain either full-length or deleted species of the
genome. In addition, DNA isolated directly from
PML brains has been cloned. This will allow the
study of the viral DNA without having to pass the
virus in tissue culture, a step that appears to
generate a large number of rearrangements in the
DNA. The biological activity of these recombinant
molecules is now being tested, and an extensive
physical map is being produced. Initial experi-
ments indicate that these clones transform pri-
mary hamster brain cells.
Interaction of SV40 with
Preimpiantation Mouse Embryos
K. Willison
Last year we described experiments that involved
the introduction of SV40 DNA into adult mice by
microinjection of 3.5-day blastocysts with a few
tenths of a picogram of DNA. When total cellular
DNA extracted from animals derived from in-
jected embryos was analyzed by Southern analysis
for the presence of SV40 sequences, we found very
small amounts (approximately 1 copy per genome
equivalent) of SV40 circular DNA in some of the
samples. We were worried about problems of
contamination, and therefore a collaboration was
set up with F. Kelly and C. Babinet at the Institut
Pasteur, Paris, France. In Paris, they produced 50
129Sv inbred mice that had been infected with
SV40 on day 2.5 of development. We received a
travel grant from the International Union against
Cancer, Geneva, and Dr. Kelly spent 2 months
here during the winter. We analyzed DNA ex-
tracted from the head portion of these newborn
mice and found that 15 animals again had very
small quantities of SV40 supercoiled DNA; the
control experiments showed that accidental con-
tamination could not be the explanation. By
Southern analysis, these free genomes appeared
to be identical to wild-type SV40. However, we
could not isolate virus from the tail parts of the
same 5V40-DNA-positive newborn mice, nor
could we rescue virus by transfection of their total
cellular DNA onto permissive CV-1 monkey cells.
Consequently, a bacteriophage X library was
prepared from a pool of DNA from various of the
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5V40-positive mice. The DNA was banded on a
CsCI gradient to isolate supercoiled molecules
that would include the SV40 DNA molecules. This
fraction was cut with EcoRl and inserted into
AWES B. The resultant library was screened by
probing with 32P-labeled SV40 DNA, and a single
recombinant phage was isolated. This phage,
XSV1, had a single insertion of SV40. Detailed
restriction mapping shows that it is altered, as
compared with wild-type SV40. There is rear-
rangement on the late side of the origin of
replication as well as elsewhere.
Virus stocks have been made by transfecting
CV-1 cells with this DNA. This virus grows nor-
mally on CV-1 cells. At present, we are examining
its growth and properties on various primary and
established mouse cell lines. This is because we
believe that there may be particular differentiated
mouse cell type(s) that can support the replication
of this virus. This is in contrast to wild-type SV40
infections of mouse cells, which only result in the
establishment of the transformed state of the virus.
We hope that we may learn more about the
differentiated state of cells during embryogenesis
with this sort of approach. The examination of
alterations in the controlling regions of SV40 genes
required for growth on certain cell types may help
us understand the control of the normal, endo-
genous genes in these cells.
Analysis of Surface Antigens Shared by
Normal Embryos and Tumor Cells
It has long been known that embryonic and tumor
cells often express some of the same antigens on
their surfaces. These antigens may be involved in
morphogenetic processes during normal devel-
opment but, when they are expressed on tumor
cells, are responsible for the uncontrolled growth
and invasiveness of tumors. These antigens are
generally detected by immunological techniques,
and much effort has been expended in raising
conventional antisera against one or the other
type of cell and searching for cross-reactive
antibody activities. The powerful monoclonal
antibody technique has disclosed many new cross
reactions as well. Indeed, one of the first mono-
clonal antibodies made by C. Milstein and co-
workers (MRC Laboratory of Molecular Biology,
Cambridge, England) was found to bind to early
mouse embryos and embryonal carcinoma cells
(ecc) the stem cells of teratoma and teratocar-
cinoma tumors. The antibody, M1 . 22 . 25 . 8, was
shown to recognize a Forssman antigen deter-
minant on sheep red blood cells (SRBC). Forssman
antigen is a neutral glycolipid, and indirect data
suggested that the M1 . 22 . 25 8- binding mole-
cule on embryonal ecc was also a glycolipid.
Several years ago, Hakamori (Proc. Natl. Acad. Sci.
59: 245 [1968]) had shown that Forssman antigen
expression on the surface of hamster cells changed
dramatically upon transformation with polyoma
virus.
Interestingly, the monoclonal technology has
generated many anti-glycolipid antibodies in the
mouse embryo/ecc system as well as in other
systems, such as the rat retina. We wondered
whether they acted as immunodominant deter-
minants and constituted a background problem in
the dissection of complex biological systems by
means of the monoclonal procedure. In collabor-
ation with D. Marcus and his group (Albert
Einstein College of Medicine, Bronx, New York),
we decided to screen a series of conventional
antisera (which were already known to react with
different glycolipids) against ecc in order to
determine which glycolipids were present in these
cells. Immediately, we found that anti-globoside
antisera bound very strongly to ecc in a double-
layer indirect immunofluorescence assay using a
fluorescence-activated cell sorter for analysis of
the samples. We then screened preimplantation
embryos for reaction with this anti-globoside
antisera. It first appears on the surface of two cell
embryos and reaches a maximum level on early
morulae and then declines. This is different from
the monoclonal anti-Forssman antibody, M1 22
25.8, which is only first expressed on early
morulae and increases over the next 24 hours of
development. Figure 8 is a fluorescence micro-
graph of two 10-14-cell embryos showing the
strong reaction with anti-globoside antiserum.
This antiserum can now be used as another
differentiation marker for early embryogenesis. A.
Figure 8
Fluorescence micrograph of two 10-14-cell mouse
embryos showing the strong reaction with anti-globo-
side antiserum.
Suzuki (University of Tokyo) is examining the
chemical nature of the neutral glycolipids on ecc
and has found that the Forssman-carrying deter-
minant of ecc is a different glycolipid from that
found on SRBC. He is presently engaged in
working out the detailed structure of the sugars.
This observation of differences in the molecules
carrying these glycolipid determinants on differ-
ent cell types is important because it raises
questions about the whole approach of looking
for cross-reactive antibody specificities. If one
wishes to make a connection between two cell
types on this basis, it will be necessary to show
biochemical and functional equivalences of the
molecules carrying the antigenic determinants or
the determinants them-selves if they are carried
on different molecules. For the time being, the
antibodies are useful for isolating live cells and for
probing the structure of the cell surface in
developing embryos.
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NUCLEIC ACID CHEMISTRY
R. J. Roberts, I. Battle, R. M. Blumenthal, J. E. Brooks, T. R. Gingeras, B. Jiang, M. Kelly, M. Moschitta,
P. A. Myers, D. O'Loane, K. O'Neill, B. Parsons, P. Rice, M. Wallace, C. Yen
During the past year the Nucleic Acid Chemistry but it will also establish an M13 clone bank,
group has continued to accumulate data toward consisting of single-stranded segments from both
the elucidation of the adenovirus-2 (Ad2) DNA I and r strands of the genome. These clones will
sequence and the mapping of expressed regions be of great use in the future for the purification
of that sequence. Many computer programs and characterization of specific Ad2 mRNAs.
have been written to aid both in the assembly Analysis of the sequence presently available
and in the analysis of the growing body of and its correlation with data gathered elsewhere
sequence data now available. Our long-standing (see, e.g., Baker and Ziff, Cold Spring Harbor
interest in restriction endonucleases has been Symp. Quant. Biol. 44: 415 [1980]; Perricaudet et
maintained and expanded to include their cog- al., Proc. Natl. Acad. ScL 77: 3778 [1980]; Alestrom
nate site-specific methylases. Efforts to clone the et al., Cell 19: 671 [1980]) gives a reasonably corn-
genes for restriction endonucleases have con- plete picture of the organization of information
centrated upon the prior cloning of methylases, at the left end (coordinates 0-17) of the genome,
and substantial progress has been made in including early regions 1A (E1A) and 1B (E1B) and
cloning and characterizing the dam (DNA ade- polypeptides IX and IVa2. Between coordinates
nine methylase) gene of E. coli. 17 and 41 we have located the coding regions for
the segments of the tripartite leader and the
genes for VA, and VAH. We have also identified aAdenovirus-2 Genome Sequence number of significant stretches of open reading
T. R. Gingeras, C. Yen, R.J. Roberts, M. Kelly frames, although detailed assignments in this area
must await the resolution of ambiguities in our se-
The determination of the nucleotide sequence quence and more detailed sequence information
of the Ad2 genome has been one of the about the splicing of mRNAs encoded there. In
principal efforts of this group. On the basis of addition to the expected open reading frames
the nucleotide sequences thus far examined, the present in the I strand, which are presumably
length of the entire genome is estimated to be associated with the newly discovered early region
approximately 36,500 nucleotides. At the pres- 2B (E2B), there are also open reading frames
ent time, two main blocks of sequence have wit
la
hin the intervening sequences that separate
been collected. The first segment consists of the l te leaders.
13,500 nucleotides located between 0% and 41% The most intriguing example of an unassigned
on the genome. The second segment is located open reading frame within an intervening se-
at the right end of the genome (89-100%) and quence is found in early region 4 (E4) at the
consists of 4000 nucleotides of contiguous se- right end of the genome. This region displays a
quence. The remainder of the sequence from complex splicing pattern, as judged by electron
the internal portion of the genome consists of microscopy (Chow et al., J. Mol. Biol. 134: 265
several unconnected blocks of sequence that [1979]). This complexity can now be understood
are frequently clustered about previously map- in terms of the sequence, as there are no less
ped restriction sites. These unconnected seg- than four distinct stretches of open reading
ments total an additional 8000 nucleotides. In frames present. It appears that the observed
addition, two other sources exist for nucleotide spliced mRNAs have been designed to gain
sequence information concerning this internal access to three of the four open reading frames.
portion of the Ad2 genome. F. Galibert and his The fourth open reading frame contains the
colleagues have deduced the sequences from largest coding capacity (a polypeptide of about
coordinates 70% to 89% on the Ad2 genome 28K is predicted), and yet this reading frame is
(Gene 6: 1 [1979]; Nucleic Acids Res. 8: 2173 inaccessible because it lies within an intron.
[1980] and unpubl.), and B. S. Zain (University of Experiments are under way to ascertain whether
Rochester) and her colleagues have in excess of this or any of the other intervening sequences
4000 nucleotides from this same internal region are utilized.
(unpubl.).
Over the course of the past year, the strategy Computer Program Developmentemployed for sequencing the Ad2 genome has
been expanded to include the collection of data R. M. Blumenthal, T. R. Gingeras, P. Rice,
using the M13 cloning and sequencing system. R. J. Roberts
This approach not only provides a simplified
means for obtaining second-strand sequence From the start of the Ad2 sequencing project,
information within segments already sequenced we have been developing software designed to
and allows us to resolve persistent ambiguities, aid in both the DNA sequencing itself and the
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subsequent analysis of that data. Such programs
have elicited considerable interest because of
the huge volume of sequence data being gener-
ated worldwide and because they are written in a
language (FORTRAN) that is relatively "trans-
portable" to other computers.
Several new programs have been written in
the last year to facilitate the generation and
storage of nucleotide sequence data. One such
program, PRIMER, provides the user with strate-
gies for sequencing the gaps in a partially
complete sequence. PRIMER finds appropriate-
sized restriction fragments close to the gap for
use as primers in the Sanger-Coulson dideoxy
sequencing procedure. A major improvement in
the data-entry stage of sequencing resulted from
completion of the program DIGITPAD (see Fig.
1). This program makes use of a digitizing tablet
on which autoradiographs can be placed and
allows the user to enter data directly from the
autoradiograph using a pressure-sensitive posi-
tion pen. The program also contains editing
functions: A gel may be "read in" rapidly several
times, and the entries are compared automati-
cally. Recently, a "voicebox" has been added to
this system so that the user can be sure of proper
data entry without looking up from the auto-
radiograph. The program DRIVER was written 2
years ago and has been used to find overlaps in
different blocks of sequence data and to place
such data both in working files and into a master
archive. DRIVER has recently been revised by the
addition of several subroutines designed to
handle larger amounts of data and to edit the
archive files by removing duplicate entries and
cross-checking these data with the final se-
quence.
A second area of program development has
been in generating restriction maps for sequenced
DNA. These programs have been used in de-
veloping cloning strategies, in sequencing stra-
tegies, and simply to check the accuracy of new
sequence data. The program CUTTER, written
in collaboration with J. Milazzo (Computing
Center, State University of New York at Stony








A semiautomated gel-reading system. Such a system consists of an autoradiograph mounted on a translucent
digitizing tablet that is connected to a computer and cathode-ray-tube terminal. The sequence is read from the
autoradiograph (using the signal pen) directly into memory. The nucleotide sequence is stored and displayed on
the terminal screen. The limit of resolution of the tablet is 0.1 mm. A menu of other functions (editing, homology
searches) is encoded on the surface of the tablet in an area not covered by the autoradiograph. These functions
can be activated by touching the designated areas with the signal pen.
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for every known restriction enzyme activity. This
master list is then used by a variety of other
programs. FRAGOS groups all sites for a given
enzyme together and displays them both in
order of occurrence and in order of size, letter-
ing the fragments in the process. This program
also allows multiple digests, accepting an indi-
cation of end-labeling between the digests, and
indicates which final fragments are unlabeled or
symmetrically or asymmetrically labeled. This is
of considerable use in the Maxam-Gilbert chem-
ical sequencing procedure. Currently, we are
exploring the use of computer graphics in dis-
playing these data more rapidly and clearly.
A third area of program development has
been in the definition of open translational
reading frames, both to localize gene boundaries
and, again, to check the quality of new sequence
data. Two such programs have been written.
One, RFRAME, displays all occurrences of initia-
tion and termination codons in all six reading
frames (three in each direction). The second,
DISPLAY, provides similar information graphical-
ly, showing all open reading frames longer than a
user-defined minimum and allowing regions of
interest to be shown in greater detail.
Finally, a number of programs to assist in
designing gene cloning strategies are under
development. One, REVCUT, is complete. This
program is used when one wishes to clone a
gene coding for a given protein of known
sequence. The amino acid sequence of the
protein is entered, and the program determines
which restriction enzyme sites should not occur
within that gene (barring their occurrence in
intervening sequences). This information is used
in selecting the enzyme with which to digest the
chromosomal DNA and allows an in vitro selec-
tion against undesired genes by judicious redi-
gestion of the clone bank.
At present, we are incorporating graphics
capability into many of these programs and
consolidating the programs into a limited num-
ber of multi-use sequence processing packages.
Restriction Endonucleases and Methylases
J. E. Brooks, B. Jiang, P. A. Myers
The list of restriction enzymes continues to
grow, and of the 258 such enzymes now known,
there are at least 69 different specificities. Of the
nine new enzymes characterized by this group,
eight have proved to be isoschizomers of pre-
viously described enzymes. The ninth, from
Moraxella bovis (ATCC 17947), is still under
investigation. In addition, we have shown that
BstEIII is an isoschizomer of Mbol. One interest-
ing observation concerns PaeR7, from Pseudo-
monas aeruginosa, which, under conditions of
mild digestion, selectively cleaves certain Xhol
sites. However, when gross overdigestion is
employed, all Xhol sites can be cleaved.
Studies of the methylases that serve to protect
the host DNA from the effects of the cognate
restriction enzymes have also continued. The
methylase from Arthrobacter luteus, which pro-
tects against Alul (AGCT), also protects against
Pvull (CAGCTG), Sstl (GAGCTC), and Hindi!'
(AAGCTT). The latter case is particularly inter-
esting because the residue normally methylated
in Haemophilus influenzae Rd is the first A
residue in the sequence, whereas the Alu meth-
ylase must modify one of the four internal
residues. This means that Hindi!l is sensitive to
methylation at more than one position, a phe-
nomenon that has not previously been shown to
occur. Another interesting observation concerns
an isoschizomer of Hhal (GCGIC) that has been
found in Spiroplasma citri. This new enzyme,
Scil, cleaves at a different site within the recog-
nition sequence (G1CGC). However, both en-
zymes are unable to cleave when the first C
residue (GCGC) is methylated. This is unusual,
as most restriction enzyme pairs that recognize
the same sequence but cut at different bases are
blocked by methylation at different bases.
dam Methylase
J. E. Brooks, T. R. Gingeras, R. M. Blumenthal
We are continuing efforts to clone the structural
genes for a number of type-II restriction and
modification enzymes. Our efforts are now di-
rected to two-step clonings, first of the protect-
ing methylase and then of the restriction endo-
nuclease, as attempts to clone both simultane-
ously have met with very limited success both
here and elsewhere. Accordingly, we have de-
veloped methods for the transfer and selection
of methylase genes, starting with the dam gene
of E. coll. The dam methylase modifies the
sequence GATC, and E. colt strains overproduc-
ing the dam methylase should be good hosts for
the cloning of restriction enzymes such as Mbol
(GATC) and several of its isoschizomers, as well
as Bc II (TGATCA) and Cpel (TGATCA).
The dam gene was originally cloned as a 23-kb
piece by selection for the adjacent trpS gene.
This clone, made by G. Herman and P. Modrich
(Duke University), has been subcloned here to
a 1.14-kb piece by using screening and selection
procedures that monitor the methylase itself.
The screening procedure makes use of the
increased sensitivity of dam strains to the mu-
tagen 2-aminopurine; dam" strains transformed
with a dam' plasmid grow much better. The
selection procedure makes use of the fact that
dam' plasmid DNA will itself be methylated and
resistant to the enzyme Mbol; the subcloned
plasmids are passaged through dam- cells, reiso-
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lated, and cleaved in vitro with Mbol to select for
dam+ plasmids.
In addition to using the dam clones as hosts for
cloning certain restriction endonucleases, they
are being used to study the dam methylase itself.
The nucleotide sequence of the dam gene (cod-
ing for a 31,000-m.w. protein) has been deter-
mined. This, together with in vitro transcription
and Northern blot analysis, has allowed the
tentative identification of transcription and trans
lation initiation and termination sites for the dam
gene. These are currently being confirmed. In
addition, in vitro mutagenesis studies of the dam
gene have been started that may lead to identifi-
cation of those regions of the protein and DNA
important to the site-specific action of the dam
methylase. The dam clone has also been used as a
hybridization probe to Southern blots of digested
DNA from the chromosomes of other bacteria.
Thus far, two species, Proteus vulgaris and En-
terobacter cloacae, both known to contain dam-
type methylase activity, have been found to
contain dam-hybridizing sequences. By hybridi-
zation selection of the DNA, it should be possible
to clone these sequences to see whether they are
actually dam genes and, if so, to compare them
with the E. coli dam gene.
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ELECTRON MICROSCOPY
T.R. Broker, L.T. Chow, J.A. Engler, M. Hallaran, B.A. Kilpatrick, M. Rossini, D.M. Smith, B. Urso,
M.P. van Bree
The Electron Microscopy section has continued its
study of the DNA organization, RNA transcription
and splicing patterns, and genetic regulation of
human adenoviruses. Electron microscopic he-
teroduplex analyses, DNA cloning and sequenc-
ing, and microinjection of specific segments of
viral DNA into the nuclei of cells in culture have
been used. Representatives of rather distantly
related adenovirus serotype classes A (Ad12), B
(Ad3 and Ad7), C (Ad2 and Ad5), and D (Ad9) are
being studied.
Other systems have also been examined. The
DNA sequence of bacterial insertion element 155
was determined. In collaborative projects, the
structures of eukaryotic genes, including chicken
/3-actin and rat az globulin, have been analyzed.
Identification of Adenovirus Early Region 2B
RNAs and Proteins
L.T. Chow
To identify minor mRNAs specified by human
adenovirus serotype 2 (Ad2), infected He La cells
were treated with the antibiotic anisomycin. This
drug inhibits protein synthesis and stabilizes
mRNAs, resulting in their accumulation (Lewis and
Mathews, Cell 21: 303 [19801). In collaboration
with Jim Lewis (Protein Synthesis section), Ad2
RNAs were extracted 3 hours and 6 hours after
infection in the presence of 10 bon anisomycin and
were characterized by cell-free translation and by
electron microscopic heteroduplex analysis. Sev-
eral rare early RNAs complementary to the viral I
(leftward-transcribed) strand between coordinates
30 and 11 were detected (Fig. 1). The RNAs are
derived from the early region 2 (E2) promoter at
coordinate 75.1 and utilize the IVa2 mRNA ter-
minator and polyadenylation site at coordinate
11.1. Their map coordinates are 751± 68.5/39/26-11
(major species) and 75/39/30-11 (minor species).
Another infrequently observed species has a main
body between coordinates 23 and 11. Thus, the
transcripts are an alternative product of the E2
promoter previously ascribed only to the message
for DNA-binding protein (DBP). The leader seg-
ments at coordinates 75 and 68.5 are the same as
those found on the DBP message. We propose that
the DBP gene be renamed "early region 2A (E2A)"
and that the new transcripts be described as being
,
: _ . .
.., ',...
Figure 1
Ad2 DNA:early RNA heteroduplex revealing the structure of the predominant E2B RNA: (5') 75.1-75.0/68.5-68.3/
39.3-39.0/26.0-11.1 (3'). The adenoviral DNA strand has circularized by virtue of its terminal inverted duplications.
Arrows indicate the 5' and 3' ends of the RNA. Large arrowheads point to the three DNA deletion loops
corresponding to the intervening sequences of the spliced RNA.
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from "early region 2B (E2B)." The short internal
leader from coordinate 39 is in close proximity to
the 3' end of the major r-strand family-1 transcript
synthesized at immediate-early times through
intermediate and late times (coordinates 16.6/
19.6/ ± 22.0-23.2/26.6/30.5-39.0). It is also close to
the downstream splice point for joining the
tripartite leader to the main body of the late r-
strand family-2 RNAs (16.6/19.6/26.6/39.0-49.5)
(Fig. 2). The 5' ends of the three different main
bodies on the I strand are near the 5' ends of a
minor member of late r-strand family-1 RNAs
(30.5-39.0), the third r-strand RNA leader segment
(26.5-26.8), and the 3' end of the r-strand "i" leader
(22.0-23.2). Thus, as we have reported for many
other regions of the adenoviral genome (/CN-
UCLA Symp. 14: 611 [1979]), there is a clustering of
transcriptional control sequences and RNA splice
sites of transcripts both from the same strand and
from complementary strands. No mRNAs were
found with 5' ends (and, by inference, promoters)
between coordinates 20 and 30 or with 3' ends near
coordinate 20, such as those described on the basis


































The human Ad2 cytoplasmic RNA transcripts characterized by electron microscopy of RNA:DNA heteroduplexes.
The 36,500-bp chromosome is divided into 100 map units. Arrows indicate the direction of transcription along the r
strand or the I strand of DNA. The 5' ends of the cytoplasmic RNA5 fall within the boundaries of those of the primary
nuclear transcripts (Evans et al., Cell 12: 733 [1977]; Berk and Sharp, Cell 12: 45 [1977]) and therefore refine the
locations of transcription promoters (indicated by vertical brackets). The conserved segments constituting early
RNAs (Chow et al., I. Mol. Biol. 134: 265 [1979]; Stillman et al., Cell 23: 49711981pare depicted by thin arrows and
those in late RNAs (Chow et al., Cell 12: 1; Chow and Broker, Cell 15: 497 [1978]; L.T. Chow and 1.8. Lewis, in prep.)
by thick arrows. The promoter for the late RNAs at coordinate 16.5 is also active at early times, but transcription
terminates primarily at coordinate 39 (Chow et al., 1979 see above; Chow et al., Cold Spring Harbor Symp. Quant.
Biol. 44: 401 [1980]). Gaps in arrows represent intervening sequences removed from the cytoplasmic RNAs by
splicing. The marks optional splices. E1A, FIB, E2A, E2B, E3, and E4 are labeled. At intermediate and late times, E2
is expressed from several additional promoters and E3 RNA can be made under the direction of the major r-strand
late promoter (Chow et al., 1979 see above). All derivatives of the late r-strand transcript have the same tripartite
leader, the segments of which are labeled 1, 2, and 3. They form a number of 3'-coterminal families (Chow et al.,
Cell 11: 819 [1977]; Chow and Broker, 1978 see above). All late r-strand messages from the major promoter can
have the i leader segment, but it is most commonly associated with the 55K,52K message, as shown, especially at
early and intermediate times after infection or in cells infected in the presence of cytosinearabinoside (Chow et al.,
1979 see above). Some of the RNA5 for protein IV (fiber) can also contain some combination of ancillary leader
segments x, y, z (Chow and Broker, Cell 15: 497 [1978]). The correlations of mRNAS with encoded proteins were
based on cell-free translations of RNA selected by hybridization to DNA restriction fragments (Green et al.,
Virology 97: 275 [1979]; Harter and Lewis, J. Virol. 26: 736 [1978]; Lewis et al., Proc. Natl. Acad. Sci. 72: 1344 [1975],
Cell 12: 37 [1977]; Cold Spring Harbor Symp. Quant. Biol. 44: 493 [1980]; Lewis and Mathews, Cell 21: 303 [1980];
Pettersson and Mathews, Cell 12: 741 [1977]; Spector et al., Cold Spring Harbor Symp. Quant. Biol. 44: 437 [1980];
van der Eb et al., Cold Spring Harbor Symp. Quant. Biol. 44: 383 [1980]; Stillman et al.,1981). Proteins are designated
by K (1000 daltons)or by Roman numerals (virion components). Alternatively spliced RNAs complementary to E1A,
E1B, E2B, E3, and E4 give rise to multiple proteins, some of which share common peptides (J.E. Smart, J.B. Lewis, and
M.B. Mathews, pers. comm.).
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et al. (J. Mol. Biol. 101: 497 [1976]) and by Galos et
al. (Cell 17: 945 [1979]) in late and early RNAs,
respectively.
These new RNAs have been correlated with
proteins, with molecular weights of 105,000, 87,000,
and 75,000, translated in cell-free systems pro-
grammed with fractions of the same RNA prepa-
rations that have been selected by hybridization to
Hindi!! fragment B (coordinates 17.0-31.5). The
sum of the molecular weights of these three
proteins exceeds the coding capacity of the region
between coordinates 11 and 30. Therefore, at least
two of the proteins must have overlapping coding
sequences. It has been demonstrated that the 87K
protein is the precursor to the 55K protein linked
to the 5' terminus of each DNA strand and is
necessary for DNA replication (see Protein Syn-
thesis section; Stillman et al., [1981]). It is note-
worthy that the relative amounts of the mRNAs
from E2A and E2B (100:1) seem to reflect the
amounts of DBP and terminal protein synthesized,
which is possibly another reason they are ex-
pressed (and presumably coordinated) in the same
transcription unit. The functions of the other two
proteins of 105K and 75K are yet to be determined.
We suspect that they also are involved in DNA
replication.
Identification of Additional Early and Late
RNA Transcripts
L.T. Chow
In collaboration with Jim Lewis (Protein Synthesis
section), we previously characterized early adeno-
viral RNAs made in the absence of drugs or in the
presence of cytosine arabinoside and cyclohexi-
mide (J. MoL Biol. 134: 265 [1979]). In the course of
the analyses of adenoviral transcripts from aniso-
mycin-treated cells, an additional spliced product
of E1B (coordinates 5' 4.6-6.1/9.0-9.6/9.8-11.1 3')
and "fused" products of E1A and E1B and of E4
and E2A were characterized. The fused messages
arise when termination and polyadenylation at the
normal sites fail to occur and transcription extends
into the downstream transcription unit and utilizes
its termination signals. Because splicing of primary
transcripts always conserves the 5' end and 3'
poly(A), the products are new, hybrid messages
composed of spliced segments derived from both
the upstream and downstream transcription units.
Electron microscopic searches for new mes-
sages have also revealed two previously undes-
cribed products of the major late r-strand tran-
scription unit in late RNA preparations (Fig. 2).
Both have the consanguinous tripartite leader or
the tripartite leader plus i leader segment (coordi-
nates 22.0-23.2) found on all products of the
primary transcript. The main bodies of the RNAs
are short and extend from coordinate 48.6 to
coordinate 49.5 (at the 3' end of late family 2) or
from coordinate 59.7 to coordinate 61.8 (at the 3'
end of late family 3). The latter RNA is coincidental
with an open translation frame found by DNA
sequence analysis downstream from the hexon
gene (Kruijer et al., Nucleic Acids Res. 8: 6033
[1980]; Akusjarvi and Pettersson, Nucleic Acids
Res. 9: 1 [1981]) and therefore is inferred to be
message for a virus-encoded endopeptidase iden-
tified by the phenotype of mutant ts1 mapped in
that region. The ts1 mutant virus fails to process
several virion precursor proteins to their mature
forms (Bhatti and Weber, J. Biol. Chem. 254:
12265 [1979]) and in particular does not efficiently
cleave the 87K precursor to the 55K DNA terminal
protein (Challberg and Kelly, J. Virol. [1981], in
press; Stillman et al., 1981.
Studies of Ad9 and Ad12
L.T. Chow
Ad9, a representative of class D, has been
reported to cause tumors specifically in female rat
breast tissue, unlike all other human adenoviruses
tested (An kerst et al., Int. J. Cancer 13: 286 [1974]).
Male rats are unaffected. Bill Topp and Diane
Smith (Tumor Virus section) are in the process of
retesting these results and are constructing re-
striction enzyme cleavage maps and cloning Ad9
and related viruses. We are using electron micro-
scopic heteroduplex techniques to (1) determine
the regions of homology and divergence of the
Ad9 chromosome with respect to the chro-
mosomes of other adenoviruses; (2) map the RNA
transcripts, which we have shown to have tri-
partite leaders and main-body coding regions
quite analogous to those of Ad2, 3, and 7; and (3)
align the transcription and restriction maps. In the
future, we will examine the RNAs produced by
Ad9 in various male and female rat cells or in cell
cultures to attempt to define this unusual sex and
tissue specificity of transformation.
Ashley Dunn (formerly of CSH Laboratory and
now at the EMBO Laboratory in Heidelberg) has
provided us with an Ad12 EcoRI-D clone (16.5-
28.5) of Ad12 DNA. By electron microscopy, we
have found that it encodes all the components of
the tripartite leader. Jeff Engler is currently
sequencing this segment for comparison with the
leader regions and E2B regions of Ad2, Ad3, and
Ad7.
Both Ad9 and Ad12 also specify i leader seg-
ments present in r-strand transcripts analogous to
those of Ad2, Ad3, and Ad7, which we previously
discovered. This reinforces our conviction that
the i leader is essential for the virus and is
consistent with our results in a collaborative study
with Bill Kilpatrick and Jim Lewis (Protein Synthe-
sis section) that the Ad2 i leader segment is
actually an mRNA for a 13,600-dalton protein.
Sequencing of Ad3, Ad7, and Ad12 DNAs
J. A. Engler, M. P. van Bree, B. Urso, T. R. Broker
Previous electron microscopic studies by Kil-
patrick et al. (J. Virol. 30: 899 [1979]) suggested that
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the leader segments encoded by DNAs of class-B
Ad3 and Ad7 were not homologous to those of the
class-C Ad2. Although sufficient divergence in
sequence was found to explain the lack of cross-
annealing, the DNA sequence analysis of cloned
segments of Ad7 and Ad3 DNAs between genome
coordinates 15.9 and 17.0 showed an unexpectedly
high degree of homology with the comparable
region of Ad2, as reported last year. This homology
with Ad2 has now been found to extend from
genome coordinate 11 to at least coordinate 19 in
Ad7 (and, where sequenced, in Ad3 and in the
class-A Ad12). The majority of the divergences are
nucleotide transitions and transversions. The few
deletions and insertions in this region are mul-
tiples of three nucleotides. Also, most transitions
and transversions are found to be separated by
multiples of three nucleotides. On the reasonable
assumption that these divergences occur primarily
in third codon positions, the protein-coding frame
can be assigned. In the case of the IVa2 gene, 90%
of the inferred amino acid sequence is conserved
in all the serotypes studied. Furthermore, many of
the changes in the amino acid sequence involve
substitution of functionally similar amino acids.
Another long open translation frame, with sero-
type divergences in the third coding position,
starts to the right of genome coordinate 19 and
extends leftward to a stop codon near coordinate
15 in the intervening sequence of the IVa2 gene.
One or more of the I-strand transcripts from E2B,
described above, may encode this anticipated
polypeptide.
The DNA sequence of the protein-coding
region for the Ad3 peptide IX gene (genome
coordinates 9.5-11) has also been determined (Fig.
3). Although the aminoterminal halves of the
nucleotide and amino acid sequences are highly
conserved when compared with those of Ad2 and
Ad5, the carboxyterminal halves are much more
diverged. These two domains are separated by an
alanine-rich chain about 10 residues long in all
serotypes studied, sufficient to make an alpha-
helical linker. Many deletions and insertions are
apparent, but except for one near the carboxyl
terminus, which changes the utilized protein
termination codon, all occur as multiples of three
nucleotides within the protein-coding region.
There are a large number of divergences
between class-B viruses Ad3 and Ad7 and class-C
viruses Ad2 and Ad5 near the 5' and the 3' termini
of peptide IX RNA (Fig. 3). These divergences
are located near or at the splice sites of El B RNAs,
the "TATA" box of gene IX, the cap site (5' end) and
ribosomal RNA-binding site of gene-IX RNA, and
the protein termination and polyadenylation sig-
nals at the 3' end. Such extensive variations in
transcription regulatory regions and RNA-splicing
sites emphasize the utility of comparative se-
quence analysis in the study of eukaryotic gene
expression, since the natural variants effectively
provide a collection of viable mutations.
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Regulation of Ad2 E2 by Products of El
M. Rossini
Studies initiated at Temple University with R.
Baserga concerned the induction of cellular DNA
synthesis in Ad2-infected tsAF8 cells (Rossini,
Weinmann, and Baserga, Proc. Natl. Acad. Sci.
76: 4441 [1979]), a G.-specific, temperature-sen-
sitive mutant derived from BHK-21 cells. Ad2 El
and E2A were identified as the minimal require-
ment for the induction of cellular DNA synthesis in
tsAF8 cells at the permissive temperature (Rossini,
Jonak, and Baserga, ICN-UCLA Symp. Mol. Cell.
Biol. 18: 317 [1980]; M. Rossini, G. Jonak, and R.
Baserga, J. Virol., in press). By direct infection and
by microinjection of different combinations of
adenoviral DNA fragments into quiescent (serum-
depleted) cells, it was found that the expression of
E2A is activated by the presence of E1A. This is
analogous to the regulatory effect observed using
adenoviruses deficient in expression of E1A, which
fail to turn on E2A (Jones and Shenk, Proc. Natl.
Acad. Sci. 76: 3365 [1979]; Berk et al., Cell 17: 935
[1979]). These results demonstrate the possibility
for dissecting the eukaryotic genome and placing
into cells noncontiguous segments of DNA for the
study pf the regulatory effects of certain genes on
the expression of others.
At present, microinjection techniques are being
used to introduce into cell nuclei various plasmids
containing adenoviral DNA segments correspond-
ing to those of wild-type or mutagenized E1A
(from Nigel Stow and David Solnick of the Tumor
Virus section, and T. Shenk of SUNY, Stony Brook)
and E2A, in different combinations. In particular,
one such variant, mutated at coordinate 2.8 to
resistance to Sma restriction endonuclease, be-
haves like the wild-type E1A plasmid in activating
E2. In contrast, another mutant, which has a
deletion at the Xba restriction site at coordinate
3.8, is unable to induce a detectable amount of the
DNA-binding protein. More detailed character-
izations of these and other E1A mutants are under
way. Experiments using E2A clones containing
only the early or the late promoter, or no
promoter, are also in progress. These studies
should localize the sequences in the E1A respon-
sible for the activation of E2A and should ultimate-
ly define the target operator sequences and the
roles of the early and late promoters for E2.
Mapping of Eukaryotic Genes
L.T. Chow
/3 -Actin gene from whole chicken embryo
In collaboration with Paul Thomas (Protein Syn-
thesis section), Jim Feramisco (Cell Biochemistry
section), and Steve Hughes (Eukaryotic Genes
section), electron microscopy was used to map the
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Ad2 sequence from AlestrOm et al., Cell 19, 671-681 (1980).
Figure 3
The nucleotide sequences of Ad2 (Alestrom et al., Cell 19: 671 119801) and Ad3 DNA5 near coordinates 9.8 and 11.1.
Divergences in sequence between Ad2 and Ad3 are shaded. To achieve the maximal degree of homology in
sequence alignment, gaps have been introduced into the sequences to denote inferred deletions or insertions of
nucleotides in one serotype relative to the other. Each position, filled or unfilled, has been given a number, starting
The positions of splice points, 5' ends of mRNA, and initiation and
termination codons of proteins encoded by Ad3 are assigned by analogy to Ad2. The deduced amino acid
sequences of the carboxyl terminus of the large E1B protein (terminating at position -85 to -83) and of the amino
acid and carboxyl termini of polypeptide IX of both serotypes are shown below the nucleotide sequence. The 15K
protein specified by E1B is primarily encoded between Ad2 map coordinates 4.7 and 6.1, but the carboxyl terminus
is encoded by the triplet at positions 23-25, downstream of the splice site at position 14. The termination codons
(TGA) (26-28) for the Ad3 and Ad2 15K proteins overlap the ATG initiation codon (25-27) for peptide IX (see Maat
and van Ormondt, Gene 6: 75 11979]; Perricaudet et al., Proc. Natl. Acad. Sri. 77: 3778 119801). At positions where
the same amino acid is encoded in both serotypes, it is written only once. Dashed lines indicate the absence of an
amino acid due to deletion of nucleotides. The nucleotide sequence of Ad7 is virtually identical with that of Ad3;
the positions of the differences are denoted with asterisks. (a) The 3' end of E1B gene and the 5'end of polypeptide
IX gene. The positions of the donor and the acceptor splice points of the E1B RNA are marked by arrowheads at
positions -82 and 13, respectively. The 5' end of polypeptide IX mRNA is located at +1. The first amino acid of
polypeptide IX in Ad2 is serine (Anderson and Lewis, Virology 104: 2711980]). (b) The 3' ends of the polypeptide-IX
and IVa2 genes. An apparent tandem duplication of 20 nucleotides (from position 464 to position 483) containing
two overlapping RNA termination signals AATAAA found between positions 485 and 504. The RNA termination
signal, containing the protein termination codon for the IVa2 gene, is located at position 553-548 in the
complementary strand.
genomic clone of the /3-actin gene. The mRNA
and cDNA had identical structures, with four
splices evident (Fig. 4). In addition, the orientation
of the mRNA was established by the presence of
polyadenylate at the 3' end. Similar to most
eukaryotic mRNAs, the longest uninterrupted
sequence of the segmented RNA is located at the
3' end.
az. Globulin gene from rat liver
In collaboration with David Kurtz (Eukaryotic
Genes section), the mRNA of rat an globulin, a
liver protein under complex hormonal control,
was visualized by heteroduplex formation with its
genomic DNA. The short mRNA contains six
splices, with the longest uninterrupted segment at
its 3' end (Fig. 5). Two segments of the cloned
genomic DNA were found to be flanked by short
inverted duplications, and the single-stranded
DNA formed stem-loop structures. Part of the 02a
mRNA is located within one of the stem loops, and
one of the repetitious sequences is situated within
one of the intervening sequences.
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Figure 4
The structure of chicken f3 -actin mRNA. (a) A hetero-
duplex between cDNA cloned in pBR322 and the
genomic DNA cloned in a A Charon vector. (b) An R loop
between poly(A)-selected mRNA and the genomic
DNA clone. The Sand 3' ends of the message sequences
are indicated. Arrowheads point to the four DNA
deletion loops corresponding to the sequences deleted
in the spliced RNA.
Sequencing of the Insertion Sequence IS5
I. A. Engler, M. P. van Bree
Insertion sequences are short DNA segments
found in the chromosomes of prokaryotes and
which can translocate to other positions in the
chromosome at low frequency. Insertion se-
quences can mediate inversion, deletion, and
fusion of DNA segments, as well as disrupt normal
expression of nearby genes. At least seven dif-
ferent insertion sequences are known. Each ele-
ment consists of a unique region flanked by a short
inverted repetition; they generate a duplication of
up to 11 by upon integration into a new DNA site.
In an earlier paper from this laboratory, Chow
and Broker (I. Bacteriol. 113: 1427 [1978]) identi-
fied several examples of insertion sequence 1S5.
They concluded that 155 was approximately 1.2 kb
long and contained a short inverted duplication at
its ends. These observations have now been
confirmed in the nucleotide sequence. 155 is 1195
by long and has an inverted duplication of 16
nucleotides (with one mismatch) at each end (Fig.
6). IS5 has the shortest terminal inverted duplica-
tion of any of the seven insertion sequences. The
largest potential region for encoding a polypep-
tide extends through approximately 90% of IS5
and could encode 338 amino acids. Upon insertion
into the chromosome, 155 makes a 4-bp duplica-
tion of the host DNA.
Publications
Broker, T.R. and L.T. Chow. 1980. Patterns and
consequences of adenoviral RNA splicing. Ex
pluribus unum-Ex uno plura. Trends Biochem.
Sci. 5: 174.
Cowan, N.J., C.D. Wilde, L.T. Chow, and F.C.
Figure 5
Heteroduplexes formed between genomic rat DNA cloned in a A Charon vector and as, mRNA. The RNA
preparation was total rat liver RNA. The 5' and 3' ends of the RNA are indicated. Arrowheads point to the six DNA
deletion loops corresponding to the sequences deleted in the spliced RNA.
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a. Sites of Insertion of !SS
pGP31 S. CCAGGT CTAA TTCACG 3'
pGP33 S. TGATTT CAAG AATCGG 3'
b. Left End Junction Sequences
pGP31 CCAGGT CTAA G'
pGP33 TGATTT CAAG
c. Right End Junction Sequences
1176 1.'.) 1195
pGP31 5' GGGA 1-l'"







The nucleotide sequences of the sites of integration and of the ends of bacterial insertion element 155. All
sequences are shown in the 5'-3' direction. The four nucleotide pairs of host DNA duplicated upon insertion of155
are marked by light shading. The termini of the 155 element that are inverted duplications of one another are
indicated by dark shading. (a) The nucleotide sequences of two bacteriophage Mu sites prior to IS5 insertion. (b)
The left-end junctions of two 1S5 insertions cloned in plasmids pGP31 and pGP33 (van de Putte et al., Cold Spring
Harbor Symp. Quant. Biol. 45: 347 [1981]). (c) The right-end junctions of three 155 insertions in pGP31, pGP33,
and pGM1 (Kamp et al., Cold Spring Harbor Symp. Quant. Biol. 43: 1159 [1979]). The first nucleotide of 155 is
labeled number 1, and the major open translation frame runs from smaller numbers to higher numbers. The
single EcoRl cleavage site in 155 is near the left end.
Wefald. The structure of a human /3- tubulin
gene and related /3-tubulin-like sequences.
(Submitted.)
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PROTEIN SYNTHESIS
M. B. Mathews, J. B. Lewis, F. A. M. Asselbergs, L. L. Cascio, E. Cilibrasi, A. M. Francoeur, P. LaMar,
P. A. Reichel, B. W. Stillman, F. Tamanoi, G. P. Thomas, L. Woodruff
During the last year the Protein Synthesis section
has continued to focus its attention on the
expression of adenoviral genes, with an increas-
ing concentration on regulatory aspects. The
adenoviruses are DNA viruses that can indulge in
two types of interactions with human and other
mammalian cells: They can multiply in permis-
sive cells, giving rise to a new generation of
progeny viruses; alternatively, they can form a
more lasting liaison with nonpermissive cells,
which then become transformed or tumorous. In
the latter case, only a fraction of the genetic
potential of the virus is expressed and no
progeny virus results. The adenoviruses, there-
fore, pose questions in the areas of eukaryotic
gene structure and regulation and of viral car-
cinogenesis. The topics to be addressed here fall
under five headings: (1) control of gene expres-
sion during productive infection, (2) viral prod-
ucts in transformed cells, (3) viral DNA replica-
tion, (4) expression of adenoviral genes injected
into frog oocytes, and (5) small viral RNAs.
The Early/Late Switch
The life cycle of DNA viruses has customarily
been viewed as biphasic, with an early phase
during which the stage is set for replication of
the viral chromosome followed by a late phase in
which DNA replication is achieved and the
structural proteins of the virus particle are elab-
orated. Using a superinfection protocol, we
have established, both for adenoviruses and for
the monkey virus SV40, that the transition be-
tween the two phases is contingent upon DNA
synthesis. Templates that have not undergone
replication do not express their late genes (with
the exception discussed below), even when
present in cells containing genomes actively
engaged in late gene expression. The cis-acting
nature of this control renders it most probable
that it takes place at the level of transcription,
rather than at some subsequent stage such as
processing, transport, or stabilization of the
mRNA. Since the late promoter is active at early
times (see below), we believe that it is transcrip-
tional termination, rather than initiation, that is
the point of regulation. What remains elusive,
however, is the nature of the coupling between
the processes of replication and transcription:
We, and others, have looked for differences of
various kinds between the early and late forms of
the template, but as yet without success. The
mechanism is likely to be important in regulatory
switching elsewhere (during differentiation, for
example), but all we can say at present is that
some structural change in the template that is
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associated with DNA replication is required to
permit RNA polymerase to read beyond a par-
ticular point.
Regulation in the Early Phase
Work from this and other laboratories in the last
few years has led to a recognition of the
complexities of interactions between the prod-
ucts of individual viral genes during the early
phase. The 72K DNA-binding protein appears to
act as a repressor during later stages of the early
phase, turning off expression of other early
genes. In contrast, the early region 1A (E1A)
gene, which is part of the transforming region,
seems to function as an inducer, and under some
circumstances it is absolutely required for tran-
scription from the other early genes. In the
course of experiments designed to identify the
E1A products involved, we discovered that pro-
found inhibition of protein synthesis interferes
with the production of E1A mRNA. This unex-
pected result implies that E1A-gene activity is
dependent on the synthesis of protein(s) of
either host or viral origin. Hitherto, the E1A
products were supposed to be the first to be
expressed by the virus, which would seem to rule
out the possibility that viral proteins are required
for E1A expression. However, it transpired that
the production of at least two viral mRNAs is
immune to profound inhibition of protein syn-
thesis; these RNAs encode the closely related
polypeptide pair 52K,55K (polypeptides of 52,000
and 55,000 daltons) and another protein of 13,500
daltons (13.5K). We had previously shown that
the former are, in fact, products of the first
portion of the late gene block; the mRNA for the
13.5K protein has not been fully characterized,
but its map position and strand orientation are
consistent with an origin in the major late
transcription unit (Fig. 1). Thus, we have the
paradox that the only autonomous viral gene
products stem from the late gene block. Whether
these so-called "immediate-early" genes exert
control over the E1A gene or other viral genes is
presently under consideration.
Regulation of Late Genes
The mRNA for the 52K,55K protein appears to
be the first (leftmost) member of the late gene
family. Together with the mRNA for virion
polypeptide Illa, which overlaps its 3' portion, it
constitutes the L1 block of late mRNAs (Figs. 1 and
2). Polypeptide Illa, however, is a bona fide late
protein, and neither it nor its mRNA is found
prior to DNA replication. Thus, the late region
Figure 1
The locations and regulation of adeno-
viral gene blocks. The early regions,
E1-E4, are transcribed prior to viral
DNA replication. The newly described
E2B region contains the gene for the
terminal protein precursor. Products
of the E1A gene seem to be involved
in activating the other early genes. For
the most part, the late gene families,
L1 -L5, are not expressed until DNA
synthesis has commenced. An excep-
tion is the L1 mRNA encoding the
52K,55K protein pair, which, like that
for the 13.5K protein, is "immediate-
early"-requiring no prior viral pro-
tein synthesis. Polypeptides IX and
lVa2 and the 16.5K and 17K proteins
are "intermediate" in that they are
produced to some extent both before
and after replication. (Based on results
from this and other laboratories.)
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appears to be subject to two types of regulatory
phenomena: (1) transcriptional and (2) process-
ing. The transcriptional control, discussed above
in relation to the early/late switch, now must be
viewed in terms of attenuation of RNA chain
elongation at or shortly after the 3' end of the L1
block, such that at early times precursors to L2-L5
mRNA5 are not made (Fig. 2). Processing control
must be invoked to explain how it is that all of
the sequences of the polypeptide-Illa mRNA are
contained within the mRNA for the 52K,55K
polypeptide pair, and they presumably stem
from the same precursor, yet only the former
species is produced at early times.
One prediction of this scheme is that the
Figure 2
Regulation of late gene expression.
Contrary to earlier views, the late
promoter is active before DNA repli-
cation commences. Under these con-
ditions, only one member of the L1
family of mRNA5 (encoding the 52K,55K
protein pair) appears. However, both
this and the L1 mRNA for polypeptide
Illa are made from an unreplicated
DNA template if it is introduced by
superinfection into a cell that is al-
ready in the late phase and producing
the full set of late species. (Data from
Lewis and Mathews 1980; Thomas and
Mathews 1980.)
polypeptide-Illa mRNA, alone among the late
species, should be made from unreplicated
templates if, and only if, they are present in the
milieu of a "late" nucleus. This hypothesis has
been verified by superinfecting cells already in
the late stage of an initial infection with an
adenovirus that produces a distinguishable Illa
protein. Even when the replication of the second
virus is blocked, its characteristic polypeptide-Illa
mRNA is detected, and at levels proportional to
the superinfection multiplicity. No other late
mRNAs of this virus are made-apart, of course,
from that encoding the immediate-early 52K,55K
protein.


































adenovirus-specific factor(s) replaces. or modu-
lates the preexisting splicing activity of the host
cell, thereby providing the apparatus necessary
for the fabrication of the many late mRNAs from
their common precursor. This change could well
explain other phenomena in adenovirus-infected
cells-the changing ratios of differently spliced
versions of early mRNAs and the shut off of
host protein synthesis, for example, which both
seem to be linked to DNA replication in as
yet undefined ways. Current experiments-are di-
rected toward identifying the viral products
responsible for these alterations.
Viral Products in Transformed Cells
We have nearly completed a survey of some of
the standard adenovirus-transformed cell lines,
employing the hybridization-selection/cell-free
translation technique, to catalog the mRNAs that
they contain. The survey concentrated on ade-
novirus-type-2 (Ad2)-transformed rat cell lines,
although we also included one adenovirus-type-
5 (Ad5)--transformed human cell line (293 cells)
that is in widespread laboratory use as a per-
missive host for viruses defective in regions E1A
and E1B. The E1A and E1B genes give rise to six to
eight early proteins in infected cells and repre-
sent the transforming region of the virus invariably
expressed in tumor cells. The four largest E1A
proteins (42K-58K) are made in all cell lines, but
the smallest species (28K), which in infected cells
makes a relatively late appearance, is not found.
Both of the major E1B proteins (57K and 15K) are
produced; again, the late species (22K) is not
seen, and polypeptide IX, an "intermediate"
product (Fig. 1), has only been observed in one
cell line (F4). Some of the cells also contain and
express other early regions-late regions, if pres-
ent in the cells' DNA, are quiescent-and there
are few surprises. One curiosity is that analysis of
the structure of the integrated viral DNA and of
the mRNAs in the F4 line, by Joe Sambrook and
Lok Hu (Tumor Virus section), had shown
that some E1A mRNAs were fusions between E4
and E1A, Accordingly, some of the mRNA for the
E4 11K protein hybridizes to E1A DNA (and, to a
lesser extent, vice versa); however, the polypep-
tides translated from these chimeras appear to be
authentic proteins. Some cell lines contain novel
rnRhlA species in addition to the expected
complement: The T2C4 line, for example, pro-
duces mRNAs from the newly discovered E2B
region described below.
DNA Replication
One motive for the analysis of transformed-cell
RNAs and proteins is to seek alternative sources
of quantities of early proteins for functional
studies, many of the most interesting proteins
being rather scarce in productively infected cells.
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As part of a long-term goal to define the proteins
involved in adenoviral DNA replication, we have
begun to screen for monoclonal antibodies that
are capable of inhibiting DNA replication in
vitro. Starting with mice challenged with extracts
of adenovirus-infected HeLa cells (and other
preparations), we hope to obtain monoclonal
antibody that directly inhibits the function of a
replication protein, thus enabling identification
of that protein and eventually of its function.
Results obtained so far show that medium from
wells containing hybridoma cells does not, in
general, affect in vitro replication. Furthermore,
monoclonal antibody against SV40 T antigen is
without effect, whereas monoclonal antibody
against the adenovirus 72K single-stranded-DNA-
binding protein (provided by Dan Klessig and
Ron McKay, Tumor Virus section) effectively
blocks replication. We are currently screening
hybridomas for inhibition of DNA replication as
well as by immunofluorescence against infected
and mock-infected HeLa cells.
An important advance in eukaryotic DNA
replication is the development, by T. J. Kelly and
his coworkers (Johns Hopkins University), of a
soluble nuclear extract from adenovirus-infected
HeLa cells that is able to initiate and complete
one round of semiconservative synthesis (Proc.
Natl. Acad. Sci. 76: 655 [1979]; Proc. Natl. Acad.
Sci. 77: 5105 [1980]). The system uses exogenous
adenoviral DNA as template and requires the
presence of the covalently attached (55K) termi-
nal protein on the 5' termini of the template
strands. Surprisingly, newly made DNA strands
synthesized in vitro bear a covalently linked 80K
protein that is probably a precursor to the virion
55K terminal protein.
During the past year we have improved the
system to obtain more consistent results and
enhanced synthesis and have demonstrated that
nascent DNA strands synthesized in vitro also
contain a protein covalently attached to the 5'
end of the DNA. Nuclear extracts prepared from
cells infected with Ad2 also support the replica-
tion of DNA-protein complex prepared from the
unrelated adenovirus type 7 (Ad7). Ad7 DNA has
a longer inverted terminal repetition than does
Ad2, and the replication origins of these dif-
ferent serotypes have only limited base-sequence
homology. Complementation of this kind could
be used to identify the regions of adenoviral
DNA that are important for initiation of DNA
replication.
The Terminal Protein Precursor
The gene encoding the terminal protein pre-
cursor, 87,000 daltons in our hands, has been
identified by exploiting a virus mutant that
specifies a conditionally defective protease. J.
Weber and his colleagues (Virology 76: 709 [1977];
Virology 80: 83 [1979]) showed that under restric-
tive conditions Ad2ts1 fails to process the pre-
cursors of several virion structural proteins to
their mature forms. At the same time, the virus
contains the 87K form of the terminal protein.
We have shown by peptide analysis, performed
in collaboration with John Smart (Protein Chem-
istry section), that this protein is indistinguish-
able from the 87K protein translated in vitro from
purified viral mRNA. The mRNA was mapped by
molecular hybridization and found to anneal to a
large tract of the genome between coordinates
11 and 29 and, in addition, to sequences between
positions 37 and 41. The mRNAs encoding two
other large proteins, 105K and 75K, also map in
this region of the genome. All of these species
are transcribed in a leftward direction, and they
correspond in structure to a family of RNAs that
has been observed by electron microscopy (in
conjunction with Louise Chow, Electron Micro-
scopy section). The RNA5 have long "bodies,"
extending from coordinate 30, 26, or 23 to
coordinate 11, linked to "leaders" mapped to
positions 75, 68.5, and 39. The location of the
third leader explains the selection of the mRNAs
by hybridization to the DNA sequences between
coordinates 37 and 41, and the first two leaders
are also found in the early form of the mRNA
encoding the E2 72K protein (Fig. 3). It is most
likely, therefore, that they use the same promo-
ter, and we propose the term "region E2B" for
the gene encoding the 87K protein. It is a striking
fact that two proteins that are intimately involved
in DNA replication should also be closely related
in their mode of expression.
The current view of adenoviral DNA replica-
tion is shown in Figure 4. Synthesis is initiated
from either end of the linear DNA duplex by a
complex between the terminal protein and dCTP.
The reaction also requires the presence of
terminal protein on the template molecule: Both
the 87K form and the 55K form of the protein are
effective here. DNA polymerase and the 72K
DNA-binding protein permit growth of the new
chain, displacing its parental counterpart, which
is then free to act as template for second-strand
synthesis. The cleavage of the 87K protein to the
normal mature 55K form seems to occur in the
Figure 3
Region-E2 products. At least three
proteins have been assigned to the
E213 region. One or both of the RNA
species illustrated probably encodes
the 87K terminal protein precursor.
There is an additional E28 RNA with a
messenger body extending between
coordinates 23 and 11 (not shown).
The E28 RNA5 share leaders with E2A
RNA5, encoding the 72K DNA-binding
protein, and they are likely to be
regulated coordinately. (Reprinted,
with permission, from Stillman et al.
1981.)
virus particle, passing through a 62K intermedi-
ate stage, under the direction of the virus-
specified proteolytic enzyme that is defective in
Ad2ts1.
Expression of Adenoviral Genes
in Frog Oocytes
Xenopus oocytes (immature and unfertilized eggs)
afford singular advantages for studies of gene
activity. Their large size makes it possible to
inject DNA or RNA into either nucleus or
cytoplasm and to detect the products of tran-
scription or translation by standard biochemical
techniques. When oocytes are injected intra-
nuclearly with adenoviral DNA and labeled
proteins are examined by immunoprecipitation
with antisera against viral proteins, the activity of
two viral genes can be detected: the genes for
the E2 72K protein and for polypeptide IX.
The E2 gene is distinguished by the possession
of two separate promoters, used differentially at
early and late times, neither of which has been
shown to function efficiently in vitro. In the
oocyte, the 72K protein is the main immuno-
precipitable virus-specific product, amounting to
1-3% of the labeled oocyte protein. Viral DNA
cleaved within the structural gene, or between
the gene and the late promoter, is inactive in 72K
protein synthesis. On the other hand, DNA
cleaved between the early (distal) and late
(proximal) promoters is fully active, implying that
the early promoter is dispensable (and possibly
inactive) in oocytes and that the late E2 promoter
is probably functioning. An isolated fragment of
adenoviral DNA containing the E2 region, cloned
in pBR322, is also capable of efficient synthesis of
normal 72K protein. Two other polypeptides,
with molecular weights of 48,000 and 43,500,
are immunoprecipitated from oocytes injected
with adenoviral DNA or the cloned E2 region.
Tryptic peptide maps of these proteins have
been constructed in collaboration with John
Smart (Protein Chemistry section). The 48K poly-
peptide contains all the internal methionine-
























and it is probably the proteolytic degradation
product of the 72K protein. The 43.5K polypep-
tide lacks one of the internal methionine-con-
taining peptides. Its production in oocytes is
independent of the promoter that directs the
synthesis of the 72K and 48K polypeptides,
suggesting that it is the product of a different
region-E2 mRNA. The observation that it is also
produced by translation of adenoviral mRNA
from infected HeLa cells indicates that it is not an
anomaly caused by the transcription of adeno-
viral DNA in a foreign environment.
The synthesis of polypeptide IX, an inter-
mediate product in infected cells, occurs much
less efficiently than does 72K protein synthesis,
despite the fact that its mRNA is unspliced and
therefore might be less demanding to produce.
It is also made when cloned viral DNA fragments
are injected. We are presently analyzing a series
of deletion derivatives of the polypeptide -IX and
region-E2 plasmids for their activity in oocytes,
with a view to examining several of the stages in
the pathway of gene expression: the initiation
and termination of mRNA synthesis, polyadenyl-
ation of the 3' end and splicing of the mRNA,
and its transport to the cytoplasm and its transla-
tion there. An analysis of the subcellular locali-
zation and structure of the mRNA synthesized by
non-protein-synthesizing mutant plasmids should
provide insights into the interrelationships be-
tween the various steps in mRNA processing and
translation.
Small Viral RNAs
Adenovirus specifies the production of two small
(160 nucleotide) RNAs, the VA RNAs, which are
synthesized in copious amounts during infection
but do not code for proteins. Both species of VA
RNA, VA RNA, and VA RNA,,, bind to late
adenoviral mRNA or to DNA clones thereof,
apparently across splice junctions. This may
imply that these RNAs play a role during the
splicing process, bringing together the two arms
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Figure 4
Model of adenoviral DNA synthesis. The upper line
represents the adenoviral chromosome, showing the
genes for the terminal protein precursor and the
protease (Hassel and Weber, I. Virol. 28:671 119781).
The precursor (stippled circles) seems to function in
the initiation of new DNA strands (dashed lines) and is
normally cleaved by the protease in a later matura-
tional event. A resident terminal protein, either the 87K
precursor or the 55K mature form (kidney-bean-
shaped), is also needed at the DNA terminus for
faithful replication to occur. (Modified from Stillman et
al. 1981; Rekosh et al., Cell 11: 283 [1977]; Challberg et
al., Proc. Natl. Acad. Sci. 77:5105 119801)
of an impending splice point in a precursor
molecule, as has also been suggested for the
small nuclear U1 RNA of uninfected cells (Lerner
et al., Nature 283: 220 [1980]; Rogers and Wall,
Proc. Natl. Acad. Sci. 77: 1877 [1980]). Detailed
analysis of the mRNA:VA RNA interactions is
in progress.
To assess the range of variability permissible in
the VA RNAs of the group-C adenoviruses
(serotypes 1, 2, 5, and 6), we have compared
them by RNA fingerprinting. In addition, we
have attempted to generate variant forms by
selecting versions of the Ad2 VA RNA, gene that
lack the BamHI restriction site which it contains
(in collaboration with Terri Grodzicker of the
Tumor Virus section). The naturally occurring
strains contain VA RNA, in one of two forms (one
found in Ad2 and Ad6 and the other in Ad1 and
Ad5) that differ by two nucleotides. There are
three sites of variation in VA RNA,,, the Ad1, Ad2,
and Ad5 forms, each differing from Ad6 VA
RNA', at one of the positions. Of the selected
variants, one possesses a 4-base duplication
within the BamHI cleavage site, whereas the
other two have acquired sequence changes
rendering their VA RNA, genes indistinguishable
from those of Ad5. Not only are these changes
relatively minor in themselves, but also their
impact on the probable secondary structure of
the RNAs is slight. Both the VA RNAs can adopt
very stable base-paired hairpinlike conforma-
tions with some unpaired loops; the sequence
alterations almost all lie within unpaired regions
and so would not be expected to disrupt the
structures significantly. Thus, the range of varia-
tion among the VA RNAs of the group-C adeno-
viruses is rather slight and certainly far less than
the differences between the VA RNA, and VA
RNA,, species.
Sequences from other serotype groups are not
yet available, but fingerprints suggest that they
are not very closely related. Among the group-C
adenoviruses, the VA RNA data would indicate
that Ad6 is closer to a prototype strain than are
the other serotypes. Taking into account infor-
mation from M. Sleigh and Joe Sambrook (Tumor
Virus section) on the distribution of restriction
enzyme sites in the four canonical group-C
strains, we have been able to make numerical
estimates of the relationships. These show that
Ad1, Ad2, and Ad5 are almost equally removed
from the "average" group-C virus, whereas Ad6
is much closer to the generalized prototype and
also to Ad2.
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PROTEIN CHEMISTRY
j. Smart, G. Binns, P. Chow, K. Drickamer, H. Engeser, M. Hallaran
The Protein Chemistry section came into exist-
ence at the beginning of 1980. During January,
February, and March the laboratory was com-
pletely renovated and equipped for protein-
sequence work. The work in this laboratory is
divided into two main areas: (1) studies on the
structure and function of the transforming pro-
teins of tumor viruses (adenovirus type 2 [Ad2],
simian virus 40 [SV40], and the avian sarcoma




Removal of terminal carbohydrate residues from
serum glycoproteins results in the rapid clearance
of the glycoproteins from the circulation. The
effect is mediated by liver cells, which specifically
recognize the partially degraded glycoproteins
via a receptor at their surfaces. The receptor, by
virtue of its carbohydrate-binding ability, is known
as an hepatic lectin. The receptor is the first
component in the cellular mechanism for endo-
cytosis of the glycoproteins; after binding to the
receptor, the ligand moves to the lysosomes via
coated pits and vesicles. This process is thus an
example of the phenomenon of receptor-medi-
ated endocytosis. Our work is aimed at elucidat-
ing the structure and function of the hepatic
lectins in this process. The specific areas currently
being studied are (1) the sequence of hepatic
lectins (to form the basis for studying their
function), (2) the essential residues in the glyco-
protein-binding site, (3) the arrangement of the
lectins in the membrane, and (4) the mechanism
of synthesis of the lectins.
Sequence of chicken hepatic lectin
Most of the past year has been devOted to
sequence analysis; this involved establishing a
working protein-sequencing facility, which is
now in operation. The major accomplishment has
been the determination of the complete amino
acid sequence of the chicken hepatic, lectin
(CHL). The results are shown in Figure 1. The
sequence reveals several interesting features. Of
particular interest is the stretch of uncharged,
mostly hydrophobic residues in positions 24 to 48.
The location of carbohydrate attachment is at
position 67; this indicates that sequences in this
region are probably exposed at the cell surface,
which is in accord with the general finding that
carbohydrate in plasma membranes faces the cell
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exterior. The hydrophobic nature of the amino
acids in positions 24 to 48 is highly reminiscent of
hydrophobic stretches in other cellular and viral
proteins that span membranes. If CHL does, in fact,
span the hepatocyte plasma membrane, the
amino terming would be on the cytoplasm side if
the carbohydrate-attachment site is on the extra-
cellular side. It is interesting to note that this
proposed orientation of CHL would be the
opposite of the orientation of some other mem-
brane proteins, such as erythrocyte glycophorin
and lymphocyte histocompatibility antigens. Cur-
rent suggestions, based on the "signal hypothe-
sis," about the synthesis of transmembrane pro-
teins would not appear to provide any ready
explanation for how a CHL polypeptide becomes
inserted in the membrane.
Carbohydrate-binding site
Two approaches are being used to study the
carbohydrate-binding site of CHL. In the first,
various affinity labeling reagents analogous to the
normal binding substrate (N-acetylglucosamine)
are being tested for their ability to compete with
glycoprotein ligands for binding to CHL. The
most promising results so far are with the reagent
N -(3- nitro- 4- azidophenyl)- glucosamine, which
competes with agalactoorosomucoid at concen-
trations very similar to free N-acetylglucosamine
(KD approximately 1.5 mm). This reagent can be
photoactivated to generate a very reactive nitrene
that may serve to label the binding site specifi-
cally. A second approach to study the essential
residues of CHL employs group-specific reagents
to modify certain amino acid side groups. To
date, the most interesting results involve sulf-
hydryl groups. With the alkylating reagent N-
ethylmaleimide, rapid inactivation of binding
activity occurs only under conditions that result in
decreased ligand binding (no divalent cation).
We are now studying this conformation-sensitive
reaction to determine the effect of various alkyl-
ating reagents and to identify the responsible
cysteine residue(s).
Vectorial labeling studies
Vectorial labeling techniques adapted from eryth-
rocyte membrane studies are being used to
identify which portions of CHL are on each side of
the membrane. Two membrane systems seem
most amenable to these experiments. The first is
the outer surface of intact hepatocytes, and the
second is the outer surface of isolated coated
vesicles. These two labeling schemes should
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Complete amino acid sequence of CHL. Various fragments used to establish the amino acid sequence are
indicated; leftward arrows indicate residues established by carboxypeptidase digestion, and rightward arrows
indicate residues determined by automated sequential Edman degradations. Hydrophobic stretch discussed in
text is indicated by bold line.
identify portions of CHL on either side of the
membrane. The experiments have progressed to
the point of identifying CHL in cells suitable for
surface-labeling experiments (11-day-old embry-
onic liver cells) and in coated vesicles prepared
from adult chicken liver.
Liver cells from 11-day-old chicken embryos
have been cultured for 1 to 2 days and then labeled
with lactoperoxidase and radioactive iodine. La-
beled CHL can be extracted from these cells,
indicating that the protein is indeed expressed at
the cell surface. Current work is aimed at identify-
ing the portions of CHL that have been labeled.
Synthesis of CHL
As indicated above, the proposed orientation of
CHL raises questions about how this protein is
inserted into the hepatocyte membrane. Our
current hypothesis is that many membrane pro-
teins, such as CHL, are probably not synthesized
with "signal sequences." This is being tested by in
vitro translation of chicken liver mRNA; the
necessary antibody has also been prepared, and
translations are now being undertaken. This
experiment is analogous to one that we have
recently performed to demonstrate that synthesis
of the rat serum protein az. globulin does involve
a signal sequence.
SV40 Small T Antigen
H. Engeser
SV40 small T antigen is a tumor antigen that has
been implicated in some of the transforming
properties of the virus. SV40-infected cells pro-
duce the protein in only limited quantities, and
thus, even though possible in principle, bio-
chemical studies on the protein have been sparce.
Recent advances in genetic engineering tech-
niques have made it possible to construct bacterial
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plasmids that contain the genetic information for
this protein, and strains of Escherichia coil carrying
such plasmids have been found to express the
protein in reasonable quantities (Roberts et al.,
Proc. Natl. Acad. Sci. 76: 5596 [1979]). Therefore,
we are purifying SV40 small T antigen from this
bacterial source in order to obtain quantities
sufficient for subsequent biochemical and cell
biological studies. In this regard, production of
monoclonal antibodies against small T antigen is
considered a primary research interest.
Ad2 Early Proteins
J. E. Smart
Early during lytic infection by Ad2, four regions of
the viral genome are transcribed into RNA. These
RNAs encode proteins known to be involved in
the initiation and maintenance of transformation,
as well as other proteins that directly or indirectly
affect DNA replication and the regulatory pro-
cesses necessary for the switch from early to late
gene expression. Although a great deal of infor-
mation now exists about the structures and
nucleotide sequences of many of these RNAs (see
Electron Microscopy and Nucleic Acid Chemistry
sections), relatively little is known about the
polypeptides that are derived from these regions.
Because the synthesis of these early region mRNAs
often involves complex splicing events, it is not
trivial to identify which of the observed poly-
peptides is translated from a given mRNA. In vitro
studies (see report of Protein Synthesis section)
have helped considerably, but it has proved
essential to obtain additional data by the further
analysis of the polypeptides themselves in order to
establish the detailed relationships. The main
initial objective of the Protein Chemistry section
during its first year has been to establish which of
the theoretically possible polypeptides are actu-
ally present during the early phase of Ad2
infection and to assign these polypeptides to their
respective mRNAs. The main approach that we
have used to analyze the Ad2 early proteins has
involved the characterization of peptides pro-
duced by selective proteolysis and/or chemical
cleavages of the polypeptides labeled both in vivo
and in vitro with various amino acids ([35S]methi-
onine, [35S]cysteine, PHIleucine, etc.). The result-
ing peptides are then separated by high-per-
formance liquid chromatography (HPLC) on re-
verse-phase or cation-exchange columns and
analyzed individually by sequential Edman degra-
dation to locate the positions of the individual
labeled amino acids. By correlating this partial
amino acid sequence information with the DNA
sequence data and mRNA splicing data, the
coding location of these polypeptides can be
assigned unambiguously. This approach also per-
mits deduction and confirmation of the complete
amino acid sequence of these proteins.
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Region E1A: Detailed example
Several lines of evidence suggest that the left end
of the Ad2 genome (early region 1 [El]) codes for
the functions that are responsible for the initiation
and maintenance of transformation. This region is
divided into regions E1A and E1B, and at least a
portion of each is required for complete trans-
formation. Previous work has shown that six
metabolically labeled E1A proteins are obtained
from Ad2-infected HeLa cells (Harter and Lewis,
J. Virol. 26: 736 [1978]). Three of the six proteins
focus at about pH 6.0 and exhibit apparent
molecular weights of about 50,000, 46,000, and
42,000, whereas the remaining three proteins
focus at about pH 5.9 and exhibit molecular
weights of about 46,000, 42,000, and 38,000. In a
recent study (Smart et al. 1981), we have shown
that the three E1A proteins that focus at about pH
6.0 contain two major [35S]methionine- containing
tryptic peptides that do not occur in the three E1A
proteins focusing at about pH 5.9. Sequential
Edman degradation of these peptides shows that
one of them contains methionine at residue
numbers 8 and 14, and the other contains a
methionine at residue number 4. Comparison
with the amino acid sequence predicted from the
DNA sequence from the leftmost 4.5% of the
genomes of Ad5 and Ad2 shows that these
peptides are derived from genetic information
between 2.6 and 3.0 map units, which is contained
in the 1.1-kb E1A mRNA but which is spliced out of
the 0.9-kb E1A mRNA. Similarly, we have shown
that the E1A 58,000- and 48,000-dalton in vitro
translation products contain the peptides en-
coded between 2.6 and 3.0 map units and thus are
derived from the 1.1-kb E1A mRNA. The 54,000-,
42,000-, and 28,000-dalton E1A in vitro translation
products do not include these two methionine-
containing peptides, confirming that they, as well
as the three in vivo E1A proteins that focus at about
pH 5.9, are encoded by shorter E1A mRNAs from
which this information has been removed. The
conclusions from this work are summarized in
Figure 2.
Similar analyses have been completed for re-
gion E2A and are at various stages of completion
for regions E1B, E3, and E4. Recently, a new early
region, designated E2B, has been found to be
transcribed from the I strand and includes se-
quences between coordinates 30.0 and 11.0, with
leaders mapping further to the right (see Protein
Synthesis section for further details). We have
shown that the 55K terminal protein, which is
covalently attached to the 5' termini of Ad2 DNA,
is encoded by this region (Stillman et al. 1981).
Three distinct spliced E2B mRNAs have been
identified, and we are presently analyzing the
tryptic peptides of the terminal protein and its 87K
precursor to establish their precise coding lo-
cations.
One important outcome of these studies will be
a growing catalog of the tryptic (and other)
DNA (map units)
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Region EIA: DNA, mRNAs, and proteins. Predicted locations and amino acid sequences of the methionine-




peptides of the various Ad2 early proteins, which
can be used diagnostically for the unambiguous
identification of the proteins or subfragments of
them. This will allow fragments of the proteins to
be mapped easily and should prove of value in
defining (1) the antigenic domains recognized by
monoclonal antibodies against the Ad2 early
proteins, (2) domains of intra- and intermolecular
interactions within and among viral and host-cell
components, and (3) domains of ligand binding
(e.g., ATP, NADP, and cAMP).
Transformation-specific Gene Products of
Distinct Avian Sarcoma Viruses Have
Homologous Protein Kinase Target Sites
J. E. Smart
Transformation of cells by Rous sarcoma virus
(RSV) is initiated and maintained by the produc-
tion of a virus-encoded 60,000-dalton transform-
ing protein, pp60s ". One of the functions of pp6Os"
is to catalyze the transfer of phosphate from ATP
to acceptor tyrosine(s) of various polypeptides.
Furthermore, when ATP is added to the immuno-
precipitated transformation-specific proteins of all
three classes of avian sarcoma viruses (classified on
the basis of homology between the transfor-
mation-specific nucleotide sequences and their
polypeptide products), some of the phosphate is
transferred to the transformation-specific proteins
themselves. The transforming activity of these
proteins implies that they may play an important
role in metabolic regulation. In fact, by analogy
with other protein kinases, the modification of a
number of different enzymes and/or nonenzymic
proteins via phosphorylation provides an attrac-
tive model for the pleotropic effects of the
transformation event. In the case of cAMP-
dependent protein kinase, it has been shown that
the amino acid sequences at the phosphorylation
sites in physiologically significant protein sub-
strates fall into two categories: (1) -Lys-Arg-X-X-
Ser-X- and (2) -Arg-Arg-X-Ser-X-, in which X
stands for any amino acid (except it should be
noted that the amino acid residues immediately
adjacent on either side of the serine to be
phosphorylated usually have hydrophobic side
chains). Accordingly, it is of interest to inquire into
the unique structural features that enable certain
proteins to serve as substrates for tyrosine kinases.
Czernilofsky et al. (Nature 287: 198 [1980]) have
determined the nucleotide sequence of RSV src
and have used these data to deduce a possible
amino acid sequence for pp60s ". We have con-
firmed that the predicted reading frame is one that
is employed for pp6Os" over most, if not all, of its
length by showing that the positions of the
methionine residues in the tryptic peptides of
[35S]methionine-labeled pp60s" correspond to
those predicted from the DNA sequence (J. Smart,
H. Oppermann, A. Czernilofsky, and J. M. Bishop,
in prep.). Using the same approach on in vivo 32P-
labeled pp60s ", we have shown that the phospho-
tyrosine-containing tryptic peptide has the follow-
59
ing sequence: -Leu-Ile-Glu-Asp-Asn-Glu-Tyr(P)-
Thr-Ala-Arg- (J. Smart, H. Oppermann, J. M.
Bishop, A. Purchio, and R. Erikson, unpubl.). The
same phosphotyrosine-containing tryptic peptide
is observed when immunoprecipitated pp6Os' is
phosphorylated in vitro by incubation with [7-
32P]ATP.
Avian sarcoma viruses rarely occur in nature.
One school of thought as to their evolution has
recently been reviewed by Weinberg (Cell 22: 643
[1980]). He points out that in an animal acutely
infected with a replication-competent virus, it is
likely that a large number of viral replication cycles
lead to a variety of chimeric viral genomes, each
carrying a different cellular gene that has been
expropriated from the host genome by a recom-
bination event. We know only about the rare
recombinant carrying a useful (from the point of
view of the virus) cellular sequence and expressing
an advantageous phenotype-in the present case,
tumorigenicity. This trait allows preferential am-
plification of this virus (since the cells that it has
infected grow better) and creates a macroscopic-
ally scorable phenotype (a tumor). Thus, it has
been shown that normal cells contain and express
(in much lower amounts) a gene that is homo-
logous to the transforming gene of RSV. We have
recently shown that the immunoprecipitated
normal cellular homolog of RSV pp60,' is phos-
phorylated in vitro at a tyrosine that is contained in
a tryptic peptide that is identical to the phospho-
tyrosine-containing tryptic peptide of RSV pp60'`.
Although the class-Ill avian sarcoma viruses
contain transformation-specific genes that are
apparently different from that of RSV src (class I),
their immunoprecipitated transformation-specific
gene products still show an associated tyrosine
kinase activity. In spite of the fact that the class-III
viruses transform cells by a mechanism that is
presumably different (at least initially) from that
employed by the class-I viruses, we have found
that their transformation-specific gene products
are phosphorylated in vitro at a tyrosine that is
contained in a tryptic peptide that is again
identical to the phosphotyrosine-containing tryp-
tic peptide of RSV ppar. These data, as well as
preliminary data on the substrates of other
tyrosine kinases, suggest that the occurrence of
acidic amino acids adjacent to the phospho-
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acceptor tyrosine may be a general property of the
target sites for tyrosine-specific protein kinases.
The observation of the apparent total conserva-
tion of these target sites in the otherwise distinct
class-I and class-III avian sarcoma viruses supports
the hypothesis that such sites may play a central
role in regulating the function(s) of the viral
transforming proteins, as well as their normal
cellular homologs.
Publications
Drickamer, K. 1980. Arrangement of the red cell
anion transport protein in the red cell mem-
brane: Investigation by chemical labeling
methods. Ann. N.Y. Acad. Sci. 341: 419.
.
Complete amino acid sequence of a
membrane receptor for glycoproteins: Se-
quence of the chicken hepatic lectin. J. Biol.
Chem. (Submitted.)
Drickamer, K., T.J. Kwoh, and D.T. Kurtz. Amino
acid sequence of the precursor of rat serum oe,
globulin. J. Biol. Chem. (Submitted.)
Hogg, N., D. Wallace, and J. E. Smart. 1980.
Antibody response to Moloney type C virus-
induced tumors. Nature 283: 304.
Lewis, J.B., H. Esche, J.E. Smart, B.W. Stillman, M.L.
Harter, and M.B. Mathews. 1980. Organization
and expression of the left third of the genome of
adenovirus. Cold Spring Harbor Symp. Quant.
Biol. 44: 493.
Neil, P.K. Vogt, and J.E. Smart.
1981. Transformation-specific gene products of
distinct avian sarcoma viruses have homologous
protein kinase target sites. (Submitted.)
Neil, J.C., I.E. Smart, M.J. Hayman, and O. Jarrett.
1980. Polypeptides of feline leukemia virus-A
glycosylated gag-related protein is released into
culture fluids. Virology 105: 250.
Smart, J.E., J.B. Lewis, M.B. Mathews, M.L. Harter,
and C.W. Anderson. 1981. Adenovirus type 2
early proteins-Assignment of the early region
1A proteins synthesized in vivo and in vitro to
specific mRNAs. Virology (in press).
Stillman, B.W., J.B. Lewis, L.T. Chow, M.B.
Mathews, and J.E. Smart. 1981. Identification of
the gene, mRNA, and precursor for the adeno-
virus terminal protein. Cell (in press).
Movable Genetic Elements
Unstable phenotypes and variegated phenotypes, ascribed to "unstable genes," have
intrigued geneticists for more than half a century. A meticulous study of "variegation" in
maize by Barbara McClintock at Cold Spring Harbor led her to propose many interesting
ideas relating gene expression to DNA rearrangements. Her work has shown remarkable
intellectual durability. It seems that in many cases unstable phenotypes result from high-
frequency DNA rearrangements. Perhaps within the next few years many of these
interesting genetic mysteries will be explained in molecular terms. We hope that the work
done by various groups in our section will contribute to a general understanding of the
principles underlying genetic flexibility.
A highlight of the year was the 45th Cold Spring Harbor Symposium entitled Movable
Genetic Elements. A myriad of DNA rearrangements in bacteria, fungi, protozoa, plants,
and animals came under discussion, resulting in a very exciting Symposium volume, which
has recently been published.
As can be seen from the progress reports that follow, our studies on DNA
rearrangements span prokaryotes, lower eukaryotes, and higher eukaryotes. Our section
received a boost with the arrival of the groups of Fred Heffron and Maggie So. These
groups are examining in great detail the structure and function of Tn3 and some other
bacterial transposons. Other groups in our section continue to study the transposition of
the mating-type genes in yeast, transposition of bacteriophage Mu DNA and flip-flop of
the G segment of Mu, and the functional organization of the herpesvirus thymidine
kinase gene. Our general focus is on the mechanisms by which DNA rearrangements
occur and may affect gene expression.
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INSERTION ELEMENTS AND PLASMIDS
A. I. Bukhari, G. Chaconas, M. S. DuBow, D. Evans, M. F. George, R. M. Harshey,
G. McGuinness, L. Mintz, N. Sarvetnick
Transposition of bacteriophage Mu DNA, inver-
sion of the G segment of Mu, and Mu-induced
modification of host DNA are highly interesting
biological phenomena and they continue to
arouse the curiosity of molecular geneticists. We
understand many things about these phenomena,
and yet there are many intriguing questions left
unanswered. Our focus during the past year was
on the mechanism of Mu DNA transposition. Mu
rearranges the host DNA during its lytic cycle;
thus, the Escherichia coil genome appears to
undergo cataclysmic changes within 30 minutes
after Mu transposition-replication functions are
induced. These changes are evidently related to
the process of Mu transposition. We have sought
to dissect this process by examining the interac-
tion of plasmids containing Mu or "mini-Mu's"
with the host chromosome (see Annual Report
1979). We have also tried to find intermediates
involved in Mu transposition using electron
microscopy techniques. It now seems clear that
Mu DNA and host DNA intimately interact during
transposition and that one consequence of such
interaction is the replication of the Mu genome.
Two questions arise logically: (1) What prepares
Mu DNA and host DNA for such an interaction?
and (2) How does Mu integrate in molecular
terms? A third question, "Is this process mono-
lithic or can it take different forms?" has arisen
from observations discussed below.
Mu DNA Transposition Can Occur by
More Than One Pathway
For many years Mu biologists have assumed that
transposition of bacteriophage Mu DNA occurs
by a single mechanism and that this process could
be activated by infection with phage Mu or by
induction of a Mu prophage. Our recent findings
indicate that this assumption may be incorrect;
the end products of Mu DNA transposition
events occurring during lysogenization are dif-
ferent from those found as a result of lytic
induction of a Mu prophage. Previous studies
from our laboratory, as well as those by others,
have indicated that during lysogenization a single
copy of Mu DNA is inserted at the host target site.
Deletions in the host DNA do not usually occur,
and a duplication of 5 by of the host DNA is
found at the insertion site, as has been reported
for a number of other transposons. We have
probed the transposition process during the lytic
cycle using Mu or mini-Mu prophages. We did
not recover any simple Mu insertions emanating
from the prophages; instead, replicon fusions
were found as the end products of transposition.
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The types of experiments that have led us to these
conclusions are as follows:
1. The fate of a 9-kb plasmid, pSC101, carrying a
Mu prophage was monitored biochemically
following prophage induction. It was found
that by 33 minutes after temperature shift-up
all free forms of the plasmid disappeared and
were found associated with the host DNA.
Analysis of plasmid-host DNA association by
restriction endonuclease cleavage revealed
that the pSC101 and E. coil chromosomal DNA
had been fused. At the junctions of these
fused replicons were copies of Mu DNA
oriented as direct repeats, as shown in Figure
1. This type of structure, also known as a
"cointegrate," has been observed with a vari-
ety of different transposons and apparently
represents the end products of Mu DNA
transposition from a Mu prophage carried on
a plasmid.
2. Using genetically marked mini-Mu prophages
carried on pSC101, we monitored the trans-
position of these mini-Mu molecules into an F'
episome and found that virtually every mini-
Mu insertion carried the plasmid DNA se-
quences along, as judged by the persistence
of the tetracycline-resistance (TO phenotype
that is encoded by pSC101. Further analysis
of these transposition end products also de-
monstrated that they were cointegrate struc-
tures as described above.
3. Attempts were made to recover simple Mu
insertions in an F' episome following induction
of a Mu prophage in the host chromosome. At
least 95% of the Mu insertions into F' generated
this way carried extensive deletions or insert-
tions of host DNA. Insertion of Mu DNA in the
F' factor during lysogenization, however, re-




Transposition of p5C101::Mu to generate a replicon
fusion or " cointegrate."
Our findings show, therefore, that Mu DNA
transposition can give two different types of end
products and that the transposition pathway uti-
lized is dependent on the Mu developmental
cycle. During lysogenization, simple Mu insertions
are formed; following prophage induction, repli-
con fusions predominate.
A Model of Mu DNA Transposition
A characteristic DNA structure found during Mu
growth is a circle with a tail. Both the circles and
their tails vary in length. It seems compelling that
these structures arise as a result of a Mu prophage
trying to insert itself at another site on the host
DNA. One way to visualize this process is as shown
in Figure 2.
Protein-mediated Changes in Mu DNA
Conformation
Several years ago we found, upon infection of Mu
lysogenic cells, a form of Mu DNA distinct from
the linear form. We have examined this form
electron microscopically and have found that it
consists of "open" circles and a "supercoiled"
form of Mu DNA. These forms are not covalently
closed circles, because phenol extraction converts
both forms to linear DNA. Thus, a protein appears
to mediate supercoiling of a linear Mu DNA
molecule. The nature of this protein-DNA inter-
action is not clear.
Maturation of Mu DNA
During the lytic cycle, Mu DNA undergoes
transposition to many different sites on host DNA.
Near the end of the growth cycle, Mu DNA is cut
and packaged into phage heads in such a manner
that heterogeneous host sequences are attached
to both ends. Examination of 22 amber mutants of
Mu has revealed that genes E and I are responsible
for the maturation of Mu DNA.
We have also examined the lengths of the host
sequences attached to the left end of Mu DNA by
labeling the 5' end with 32P, cutting the DNA at a
site 7 by away from the left end, and then running
the DNA on a sequencing gel to size the
fragments. The minimum size of the host se-
quences attached to the left end of the mature
bacteriophage Mu DNA is 56 bp; host sequences
longer than 144 by are rare. The host sequences do
not show a continuum from 56 by to 144 by but,
rather, are packaged in discrete blocks. The first
such block is 56-61 bp, the second block is 67-72
bp, and so on. Thus, in each block the length can
vary from 5 by to 6 bp, and there is a space of 5 by
between each block. It seems that Mu DNA is












A model of transposition (within the same replicon).
The transposable element is shown by jagged lines. The
arrowheads indicate free 3'-hydroxyl ends of DNA, and
the dots indicate 5'-phosphate ends. The initial cleavage
points are shown by arrows. The newly replicated
strands are shown by broken lines. Polarities indicated
are completely arbitrary and may well be reversed. The
DNA ends are presumed to be held together by
proteins. Upon disruption of the protein complex, a
circular structure with a tail would be generated (4a).
The length of the circle would depend on the
distance of the target site from the initial location of the
element, and so also the length of the tail attached to
the circle. Upon completion of replication, when the
distal end of the element arrives at the replication fork,
the 3' end of the parental strand is nicked and ligated to
the free 5' phosphate of the target DNA. Upon sealing
of all the relevant strands, a transposition accompanied
by inversion (of C and D markers in the figure) would
result (4b).
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MOLECULAR GENETICS
D. Zipser, D. Kwoh, L. Lipsich, L. Rodgers
If the work of our section in 1980 were to be given
a title, we would call it "the use of genetics in a test
tube to study control of gene expression." This is
because virtually all of our projects have de-
pended very heavily on the use of in vitro
recombinant DNA technology to generate muta-
tions within precisely defined areas of various
cloned DNAs, followed by the use of restriction
endonucleases and DNA ligase to rearrange these
mutations in fashions appropriate for the studies
we are conducting. These techniques, which have
now become quite standard in the molecular
genetics laboratory, are formally equivalent to
classical genetic manipulations. They are, how-
ever, much more powerful because they are rapid
and enable us to focus attention on the sequences
of interest. In addition, the mutations that we
create are of precisely identified kinds at carefully
chosen locations. What is more, the products can
be analyzed down to the nucleotide sequence
level. Although most of this could be accom-
plished in bacteriophages and bacteria by classical
genetic techniques, it was virtually impossible to
do similar things with animal cells by classical
genetics. The improvements in speed and effici-
ency by going from in vivo to in vitro genetic
technology are at least as great as the improve-
ments in speed and efficiency gained from going
from animals such as
like A and T4.
The two gene-control systems on which we have
been working are those that we have been
interested in for several years. One comes from
bacteriophage Mu and is called the G-inversion
system. The other is the induction of cell-resistant
herpes thymidine kinase (TK) by infecting herpes-
virus. In the G-loop system, we have long known
that the arrangement of DNA is responsible for
gene control. As a result of manipulations per-
formed this year, we now have good reason to
hypothesize that control at the DNA level is also at
least partially responsible for TK induction.
Identification of the gin Protein
of Bacteriophage Mu
D. Kwoh, D. Zipser
The gin-gene product of bacteriophage Mu
catalyzes a specific intramolecular recombination
event leading to the inversion of a 3000bp segment
of Mu DNA. In addition to the inversion of this
segment, called G, gin also inverts a segment in P1
that is similar to the G segment of Mu and a region
of the Salmonella chromosome controlling fla-
gella formation. The G segment of Mu codes for
proteins that determine the host-range specificity.
Different proteins are produced depending on
the orientation of the G segment. The gin gene
maps outside and to the right of the G segment on
the Mu genome. Previously, we had cloned the G
segment and gin region of Mu into a multicopy
plasmid. These plasmids express gin, but the
amount of gin produced is too low to allow
identification of the gin protein in the presence of
the other proteins made. This year we subcloned
into a plasmid, with a strong promoter, a small
fragment containing the gin gene and constructed
gin mutations by in vitro linker insertion. Using
these mutations, we have identified the gin
protein on SDS-polyacrylamide gels.
Studies on G inversion have shown that the rate
of G inversion in both the lytic and lysogenic life
cycles of phage Mu is extremely low. We have
shown that the level of gin protein affects the rate
of G inversion. One reason for the low levels of gin
could be a weak promoter. To overcome this, we
decided to subclone gin next to a strong promoter
contained on a multicopy plasmid.
To obtain a plasmid vector, we started with a
derivative of pBR322 carrying 95 by of the lac
operator-promoter (lacO-P) region and deleted
the DNA segment containing the genes encoding
tetracycline, as shown in Figure 1. As a source of
gin, we used an EcoRI linker insertion mutant of a
previously constructed G gin plasmid. As shown in
Figure 1, this entire G segment
as well as the gin gene. The G segment of this
plasmid inverts, so DNA preparations of it contain
equal amounts of both the G(+) and G(-) forms.
Fragments containing the gin gene were obtained
from this DNA by first cleaving the plasmid with
Hpa I, which cuts near the right end (the end
closest to gin) of the G segment, and then with
EcoRl, which cuts to the other side of gin. Two gin-
containing fragments and several others are
produced. The gin fragments contain opposite
ends of the G segment but they are otherwise
identical. By addition of EcoRl linkers, four
fragments (labeled I-IV in Fig. 1) are obtained that
can be inserted at the EcoRl site of the vector and
produce viable plasmids. We eventually isolated
four plasmids differing in gin orientation with
respect to the lac promoter and the end of G
attached (Fig. 1). All four subclones retain the
IacO -P region, as determined by their ability to
induce f3-galactosidase in transformants. Also, all
four subclones are Gin', as determined by their
ability to invert the G segment of a Mu Gin-
prophage, a very sensitive, but not quantitative,
biological assay for gin.
To analyze the proteins produced, minicells
containing the vector plasmid and the four Gin'
recombinant plasmids were prepared. Two pro-
teins with molecular weights of 27,000 and 21,500
are seen in minicells carrying plasmids that have
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Figure 1
Scheme for subcloning the Mu gin gene next to the lac promoter of pKB430.
the G end adjacent to the lacO-P. These proteins
are not present when the gin fragments are
present in the opposite orientation, and they differ
in size from proteins detected previously in
minicells containing Gin' plasmids. These two
proteins were considered candidates for the gin
protein.
To determine whether either the 21.5K or 27K
protein was gin, we inserted Xhol linkers into a
Hindi site within gin. We isolated three Xhol Gin-
insertion mutants of both the G( +) gin plasmid and
the G(-) gin plasmid. The proteins produced in
minicells carrying the G(-) mutant plasmids were
compared with those produced by their Gin'
parents. The 21.5K protein is missing in minicells of
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the Gin- derivatives, and in each case a protein
with a different mobility is detected. From these
results, we concluded that the 21.5K protein
produced by the G(+) and G(-) plasmids is the
product of the Mu gin gene.
Proteins within the G Loop
of Bacteriophage Mu
D. Kwoh, D. Zipser
Bacteriophage Mu has two distinct bacterial host
ranges. Which of these two sets of bacteria will be
infected depends on the orientation of the G-
loop region on the phage during the time phage
growth is occurring within a bacteria. For example,
if a Mu phage is Gin- so that it cannot invert its G
loop, then when Escherichia coil lysogens carrying
phage with the G loop in the minus configuration
are induced, they produce so-called G(-) phage
that can no longer infect E. coli. These G(-)
phage, however, can infect bacteria from the
alternate host range. G(+) phage can infect E. coli
but not the other host range. By the use of
bacterial strains carrying plasmids in which the G
loop has been cloned in one or the other of the
two possible orientations, we have been able to
demonstrate that phage that are genetically G(-)
can be wrapped in G(+) coats which enable them
to infect E. coli at high efficiency. Thus, for exam-
ple, when a bacteria lysogenic for a Gin- G(-)
Mu and carrying a Gin- G(+) plasmid is induced,
the progeny page will plate efficiently and form
plaques on host bacteria carrying a Gin G(+)
plasmid but not on bacteria carrying a Gin- G(-)
plasmid. This result is consistent with the long-
held view that the proteins produced by the G
loop determine host range largely by determining
the ability of Mu to properly adsorb or inject its
DNA into one or another host. It is in fact known
that one of the genes mapping in the G region, the
5 gene, is responsible for producing a protein that
is part of the virion, almost certainly a tail-fiber-
type protein, called S, that is responsible for
proper phage adsorption and injection. It has
been hypothesized by several people that an
alternate of S, called S', would be produced
G(-) configuration and would be the protein
required for adsorption to the alternate host
range. This year we took plasmids that we had
constructed previously, containing the G loop
frozen in each of the two possible orientations, and
generated a series of restriction enzyme linker
insertion mutations at known restriction sites in
order to help in the identification of this set of
proteins that is altered when the G loop is
inverted. When these linker insertion mutations
were examined for the proteins they make, using
the extracts of labeled minicells that carry the
respective plasmids, we were able to identify the
two alternate forms of the S protein, S and 5',
together with alternate forms of at least one other
protein, probably the product of the U gene,
known to map within G. This result confirms the
conjectures postulating different sets of adsorp-
tion proteins made by the different orientations of
the G loop.
Induction of Cell-resident Herpesvirus TK
by Infecting HSV-1
L. Lipsich, D. Zipser
When L cells carrying a herpes simplex virus type 1
(HSV-1) tk gene that has been introduced by DNA-
mediated cell transformation are infected with Tk-
HSV-1 virus, there is a significant increase in the
level of herpes-specific TK activity. This contrasts
with a drop in the level of cellular TK activity seen
following HSV-1 infection of cells that carry the
normal cellular tk gene. It is known from extensive
work with herpesvirus that expression of herpes
TK requires prior expression of certain viral
functions. Our working hypothesis about the
induction phenomena has been that these herpes-
virus functions recognize some feature of the cell-
resident herpes tk gene or its products to allow
induction to occur after herpesvirus infection. The
fact that herpesvirus TK is expressed in L cells
without herpes infection indicates that the cellular
RNA polymerase and other cellular expression
systems can also recognize herpes tk. To study the
mechanism of expression of herpes TK by both the
cellular and the viral systems, we have constructed
a library of various kinds of mutations in a pBR322-
cloned version of herpes TK. Then by transforming
Tk- L cells with members of this library, we have
been able to determine the effect of various
mutations on the expression of herpes TK either
by the cellular or by the herpes system. One set of
mutations involved deleting sequences from the 5'
untranscribed region of the cloned herpes tk
gene. This work was greatly facilitated by know-
ledge of the sequence of the herpes tk gene and
by much work on its expression that has been
done in other laboratories. We found a deletion
that removed most of the 5' untranscribed region,
which was no longer able to transform LTk-to LTV
under conditions where a single copy of DNA
entered the cells. However, where many copies
could be incorporated, TV L cells could be
isolated. These cells had 10 to 30 copies of the
cloned herpes tk gene. Their level of TK ex-
pression was from 5 to 20 times lower than
would normally be expected from a single copy of
the clone but was sufficient to allow the cells to
grow in HAT medium. Our interpretation of this
result is that these clones use a residual promoter,
probably located in the cloning vehicle, to eke out
a very low level of TK expression. When L cells
carrying this deletion plasmid in multiple copies
were challenged by infection with Tk- HSV-1, they
were not inducible; i.e., the level of TK activity did
not go up. This indicated to us that, in addition to
removing the normal promoter sequences, the
deletion also removed sequences required for
recognition of the herpes tk gene by superinfect-
ing virus. Since a deletion about 200 by shorter
than that previously discussed had little or no
effect on induction, we conclude that a sequence
required for the recognition of cell-resident
herpes TK by superinfecting HSV-1 is located in
the 5' untranslated region of the herpesvirus
clone. Sequence analysis indicated that the
deletion that inactivated induction terminated 8
nucleotides before the cap site of herpes TK
mRNA. This experiment is of extreme importance
in our study because it indicates that induction is
due, at least in part, to interaction between some
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herpes function or herpes-modified function and
the chromosomal DNA of fhe mouse L cell
carrying the herpes tk gene.
To refine these results and more closely map
the regions involved in herpes TK induction, we
have enlarged our mutation library in two ways.
First, we have generated a series of ten additional
deletions all ending in the 200-nucleotide 5'
untranslated sequence between the end of the
shortest deletion that had an effect on induction
and the longest deletion that did not. These
deletions could be concentrated in the region of
interest by opening the cloned herpes tk-gene
plasmid at an appropriate restriction enzyme site
and then chewing back the DNA with the
nuclease Ba131 for very short periods of time. This
enzyme cuts DNA in both the 3' and 5' directions.
After Ba/31 treatment, ragged ends were filled in
with DNA polymerase, an appropriate restriction
enzyme linker piece of DNA was ligated on, and
the treated tk gene was recloned in a different
vehicle plasmid. The endpoints of these deletions
have been mapped, and we are in the process of
determining their effect on induction.
The second approach to the creation of muta-
tions involved making a library of restriction
enzyme linker insertion mutations in the control
regions of herpes tk. The hope here is to be able
to find insertions that affect induction without
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destroying the promoter sequences required for
expression. Such an insertion mutation library has
been made and has produced eight insertions in
the 5' untranscribed region and the 5' untrans-
lated region of the herpes gene sequences. We
are in the process of identifying the exact site of
each insertion and of analyzing their effects on
TK levels and TK induction in L cells transformed
with each of the insertion mutations.
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YEAST GENETICS
J. Hicks, A. Mar, J. Strathern, J. Abraham, D. Barczik, S. Ismail, J. Ivy, C. McGill, J. Mclndoo, K. Nasmyth,
J. Wood
For the Yeast Genetics section, this past year
marked the beginning of several new aspects of
our research on the mechanism of gene regulation
and cell differentiation. The cloning and structural
analysis in 1979 of the mating-type genes, which
verified the cassette model for gene switching,
have added a more biochemical emphasis to our
genetic work. It is now theoretically possible to
isolate the chemical components that cause
"jumping genes" to jump, and it has become the
job of the molecular geneticist to purify these
components and reconstruct the system in the test
tube. It is appropriate, then, that in the summer of
1980 construction began on an addition to Daven-
port Laboratory that will contain a new bio-
chemistry laboratory and associated facilities plus
much-needed office space. The combined com-
plex has been renamed Delbriick Laboratory in
honor of Professor Max Delbriick, who first taught
the bacteriophage course in the main building and
whose Nobel-prize-winning work in phage gene-
tics was performed there. The Yeast Genetics
section will reside in the new complex on a year-
round basis and will share the old laboratory with
the genetics courses in the summer. The complex
is due to be completed in June 1981. Thus, in
addition to a number of firsts, 1980 marked a very
significant "last" for us-the last time we will move
out of the building to make room for the summer
courses.
The year 1980 also saw the arrival of the first
additions to our scientific staff since the section
W X Yo( ZI Z2
HMLoc
was formed. Dr. Kim Nasmyth, who previously
worked on the yeast mating-type genes at the
University of Washington, came as the first
Robertson Research Fellow at Cold Spring Harbor.
Also arriving at the end of the year were two
postdoctoral fellows from the University of Cali-
fornia, Dr. Judy Abraham from Berkeley and Dr.
John Ivy from the San Diego campus.
Another highlight of 1980 was the winter
meeting on Plant Molecular Biology held at the
Banbury Center. This meeting marked the initia-
tion of efforts to explore research in molecular
genetics in plants. The enthusiasm generated at the
meeting led to our first attempts to culture plant
cell lines in the laboratory, and we hope this will
lead to an active plant research group at Cold
Spring Harbor.
Research Summary
As described in last year's report, we were able
to isolate the mating-type cassettes using molec-
ular cloning techniques. Physical analysis showed
that cassettes at each of two cryptic loci (HML and
HMR) and the expressed locus (MAT) contain
regions of sequence homology flanking a se-
quence that determines the "sex" of the cassette (a
or a). This physical structure and the arrangement
of the genes on chromosome III are shown in
Figure 1.
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Schematic diagram of the structures of the mating-type cassettes on chromosome III. Boxes represent regions of
homology at more than one site. Hatched regions are homologous to other regions with the same pattern. Wavy
lines represent RNA transcripts. Homothallic switching results in the replacement of the Y sequences at MAT with Ya
or Ya sequences from HMR or HML.
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of gene regulation in the expressed and un-
expressed cassettes and has led to the notion
that the position of the cassette in the chromo-
some determines its expression and its role in
switching. Several examples of this "position
effect" are described below.
Control of Transcription
Although most yeast strains maintain either a ora
cassettes at three loci (HML, HMR, and MAT), only
the cassette at the MAT locus is normally ex-
pressed. The genetic information at the HML and
HMR loci apparently is kept silent by the com-
bined action of several unlinked genes known
collectively as the MAR/SIR functions. We infer
from this arrangement that some site of negative
control exists near the HML and HMR 'cassettes
but not at MAT. Since the DNA sequence of an a
or a cassette is constant whether it resides at MAT,
HML, or HMR, it follows that the site that
determines expression must lie outside of the
cassette itself.
That HML and HMR might maintain a control
site distinct from that of MAT would not in itself be
surprising were it not for the peculiar arrangement
of the transcription units within the cassette.
Electron microscopy of RNA-DNA hybrids, along
with gel blotting analysis of mRNAs isolated from
a, a, and a/a strains, has shown that each cassette
can give rise to two classes of RNAs transcribed
divergently from the interior of the cassette
outward (Klar et al., 1981; Nasmyth et al., Nature
289 [1981]). These transcription patterns for the
three cell types are shown in Figure 2. In normal
(MAR') cells, only the cassette at MAT is tran-
scribed. In mar mutants, however, all three
cassettes are transcribed at about the same level.
Thus, as in most bacterial regulatory systems
previously studied, gene regulation of the mating-
type cassettes is at the level of mRNA transcription.
Contrary to the lessons learned in bacteria,
however, the initiation of transcription in this case
appears to be far away (between 700 and 1400 bp)
from the possible sites of control outside of the
cassette. Control sites are not likely to be found
inside the cassettes because they have identical
DNA sequences whether expressed at MAT or
silent at the HM loci. This paradox is illustrated in
Figure 1 and has led us to propose that long-range
forces must be available for regulation of eukary-
otic genes that can act over thousands of base
pairs.
Chromatin Structure and Nucleosomal Phasing
Even though a cassette contains all of the machin-
ery and genetic information necessary for full
expression, the position of that cassette on the
chromosome can dictate whether or not it is
actually expressed. A possible source of this
"position effect" may reside in the complex DNA-
70
protein configuration of eukaryotic genes known
as chromatin. Eukaryotic DNA in chromosomes is
packaged along with proteins into units called
nucleosomes. A number of nucleosome units are
necessary for the packaging of a single gene. It is
possible that regulatory molecules binding to a
DNA-protein complex in a chromosome could
stabilize a particular three-dimensional structure
of the DNA sequences that is necessary for
efficient gene expression and implies that we must
not think of a gene simply as a linear array of
genetic information. If a particular DNA sequence
(a control site) caused a singularity in the nucleo-
some series so that flanking nucleosomes were
forced into a specific arrangement, then control
could be exerted at some distance from that site.
That is, DNA sequences responsible for initiation
of transcription might be more or less accessible to
RNA polymerase, depending on their position in
the nucleosome. Alternatively, in a particular
arrangement of nucleosomes, two or more non-
adjacent sequences might be brought into juxta-
position, thus allowing a control protein to
interact with both simultaneously. Any other
arrangement of nucleosomes would put the se-
quences out of register and prevent the inter-
action.
The existence of nucleosomal phasing at spe-
cific genetic loci has recently been demonstrated
in other organisms. Using similar methods, Kim
Nasmyth has shown that nucleosomal phasing
exists at both silent and active mating-type genes.
The phasing pattern is affected by defects in
the MAR/SIR genes that are known to affect
transcription of the silent genes. It is still unclear
whether the change in phasing pattern reflects the
cause or the effect of changes in transcriptional
activity; however, the possibility that chromatin
structure might provide the basis for eukaryotic
gene regulation is a tantalizing prospect.
Control of Direction of Transposition:
A Second Positional Effect
MAT interconversion occurs by transposition of
copies of the silent cassettes at HML and HMR to
MAT. The silent loci remain unaltered; i.e., they
themselves do not switch. In light of the fact that
the DNA sequences of the HM loci and the
corresponding MAT alleles are identical, an im-
portant question is raised: Why is the cassette
switched when situated at MAT but not when
situated at the HM loci?
There is an important difference between MAT
and the HM loci. The cassette at MAT is expressed,
whereas those situated at HM loci are silent. We
wondered whether the HM loci could switch in
strains where they are allowed to express. We
imagine that the mechanism that keeps the HM
loci silent may also be operative for determining
switchability of a particular cassette.



















Schematic diagram of the transcription patterns (wavy arrows) of the MAT locus in normal MATa MAT« and
MATa/MATei cells and the roles of the gene products in the regulation of cell type. Arrows represent putative
positive control functions. Flat lines represent negative control. (Data from Strathern et al., 1981.)
pedigree of a homothallic cell can be established
because the original cell (mother) can be distin-
guished and physically separated from the bud
cell, and the mating type of a cell can be reliably
assayed by its response to a factor. The patterns are
strikingly nonrandom (Fig. 3A) in MAR' cells.
Three "rules" are required to describe the pat-
terns observed (Hicks and Herskowitz, Genetics
83: 245 [1976]; Strathern and Herskowitz, Cell
17: 371 [1979]): (1) Both cells produced by a given
division are always the same mating type. (2) Cells
that have not previously divided (buds and spores)
rarely or never switch mating type in the next
division. (3) Cells that have previously divided
(mothers) give rise to a pair of cells that have
switched mating type in 70-90% of the divisions.
The asymmetric division of the ability to switch
between the mother and the bud can be concep-
tually related to restriction of developmental
potential with the early divisions of embryogenesis
in higher eukaryotes.
Now, let us compare the pattern of switching in
a cell lineage in marl strains. Figure 3 shows a
switching pedigree of a marl cell in which changes
from the a to the a phenotype reflect changes at
HML from the a to an a cassette. Whereas such
switches are extremely rare in MAR' cells, this
marl pedigree demonstrates efficient switching.
In addition, the rules for switching are frequently
violated. Consider Figure 3b in which a daughter
cell at the four-cell stage produced one switched
cell and one unswitched cell. Figure 3c shows an
example where the daughter, but not the mother,
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Pedigree analysis of switching from MATa to MATa. A
pedigree of a zygotic cell constructed by mating HMLa
mata hmra marl ho to hmla mata hmra marl HO.
Daughter cells are drawn to the right, and mother cells
to the left, at each cell division. (S) Spore cell; (01) the
spore's first daughter; (D2) the spore's second daugh-
ter; (D1-1) the first daughter of cell D1, and so on. «and a
cells were distinguished by resistance and sensitivity,
respectively, to a factor as described in the text.
Thus, three rules for switching are violated in mar
cells: both mothers and buds can switch, silent loci
can be switched, and cells are not restrained to
switch in pairs. Similar results were obtained for
the switching of HMR. At present, we cannot
determine whether the MAR function(s) controls
the ability of switching of the HM loci by
controlling their state of expression or whether
MAR itself dictates the direction of transposition.
The equally challenging question remains un-
answered as to why the rules for switching are
violated in mar/ strains. It is clear, however, that
the mechanism that controls transcription at the
silent loci appears also to provide discrimination
between donor and recipient cassettes and dic-
tates the pattern of cassette switching.
Directedness of Mating-type Switching:
The Type-I, Type -ti Experiment
Strains with the common cassette arrangement,
which places a on the left (HMLa) and a on the
right (HMRa), called type-II strains, switch at a high
frequency of up to 86%. In contrast, we have
determined that so-called type-I strains, which
have the HM alleles reversed (HMLa and HMRa),
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switch at a frequency of less than 10%. What is the
basis of this disparity between type-I and type-II
strains in switching efficiency?
One hypothesis is that the mechanism that
directs, for example, a MATa cell to switch to
MATa in fact only directs the MATa cell to
preferentially use HML regardless of the latter's
genetic content. Likewise, MATe cells might
preferentially transport copies of the HMR infor-
mation into MAT. By this hypothesis, the type-I
(HMLa HMRa) strains would predominantly switch
a to a and a to a, events that would go unnoticed.
The 10% switching that does occur could reflect
the error limits of the system and could represent
cases where the a cells choose HML and the a cells
choose HMR as donors. In contrast, the type-II
(HMLa HMRa) cells switch efficiently because
each (or most) of the switches should occur to the
opposite mating type.
We tested the left-donor and right-donor
positional effect by studying the switching of a
strain HMLa MATa HMRa, which contains differ-
ent a information at left and right cassettes. a's can
be genetically distinguished after substitution into
MAT. We observed that over 90% of the switches
of MATa to MATa result from transporting genetic
information from HML, with the balance appa-
rently resulting from transport from HMR. We are
presently investigating whether in type-I strains
the homologous, i.e., a-a and a to a, switches
occur and also what is the molecular explanation
for this bias.
Switching Intermediates
Yet another manifestation of positional control has
appeared in experiments designed to identify
molecular forms representing intermediate steps
in the switching process. Because the conse-
quence of switching is the formation of a/a
diploid cells in which switching is shut off, normal
homothallic strains cannot be grown preparatively
in an actively switching state. However, certain
genetic arrangements can be constructed in which
mating is prevented and switching occurs con-
tinuously. For example, if all three loci are
occupied by a cassettes, switching occurs, but the
cells remain a and mating does not occur.
Using these continuously switching strains, we
have observed that a substantial portion of the
DNA at MAT (up to 5%) is cleaved at a unique site,
as shown in Figure 4. This cleavage is not observed
in nonswitching strains. Interestingly, this site has
been mapped to a region of MAT, 71, that is
identical with HML and HMR. Yet, we do not
observe this cleavage at the HM loci. We have not
yet determined whether the MAR/SIR functions
play a role in this example of positional effect.
The presence of a cut at MAT that is not found in
HML or HMR may be functionally related to
MAT's role as a recipient during the switching
reaction. Such a cut could generate a recombina-









Southern blots of restriction digests of DNA isolated
from HO HMLa MATa HMRa (track 2) and HO hmla
MATa HMRa (track 4) strains showing an extra cleavage
site not found in strains that are not switching (tracks 1,
3, and 5).
process during switching. Alternatively, this switch-
ing-associated cut in the Z1 region of MAT could
reflect an activity required to resolve a switching
intermediate composed of the exiting MAT DNA
and the incoming cassette. The existence of this
cut suggests that particular sites within the regions
of homology between MAT and the HM loci have
defined roles in initiating and completing the
process. Furthermore, this cut defines a candidate
for such a site.
Perspectives
We have recently demonstrated that the MAR/SIR
products will regulate the expression of HML or
HMR when these loci are on replicating plasmids
in yeast. Furthermore, MAT on a yeast plasmid is a
recipient for switching, and HML or HMR on a
yeast plasmid acts as a donor. These observations
allow us to mutagenize the HM cloned DNAs and
identify sites involved in the positional effect and
sites required for donating cassettes. Mutagenesis
of the MAT clones will allow both the identifica-
tion of sites required as a recipient for switching
and the analysis of sites required for the proper
transcription of MAT. Finally, the observation that
these cloned DNA fragments perform their various
normal biological functions suggests that they are
appropriate substrates for the in vitro analysis of
the components involved in MAR/SIR control and
the mechanics of the cassette mechanism.
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Plant Molecular Biology Workshop, February 29-March 2
ORGANIZER: J.B. Hicks
The Cold Spring Harbor staff was brought up to
date on the current state of molecular research in
plants at a workshop at Banbury Center. This
meeting brought together the leaders in the field
of plant genetics and molecular biology and
promoted the interaction of these scientists with
members of the Cold Spring Harbor Laboratory
staff. Research presentations were made by the
visiting plant biologists, and group discussions
were held that focused on possible methods of
further exploiting molecular approaches in the
study of plant genetics and development. Addi-
tional discussions centered on the state of funding
for plant research in the United States and the
ways in which expanded funding might be
directed toward increased scientific participation
in this area. Representatives of the major Federal
agencies funding plant research (National Science
Foundation; Department of Energy; Department
of Agriculture) described the funding programs
now available and those that will be expanded in
the future. The workshop was funded jointly by
the National Science Foundation programs in
Developmental Biology and Genetics and by the
Department of Energy.
PARTICIPANTS/PRESENTATIONS
Day, Peter, Plant Breeding Institute, Cambridge,
England: Plant breeding and pathology.
Walbot, Virginia, Washington University, St. Louis,
Missouri: Plant morphogenesis.
Free ling, Michael, University of California, Ber-
keley: Induction of alcohol dehydrogenase and
other anaerobic proteins in maize; Accessibility
of plant genetic markers for molecular cloning.
Dixon, Elizabeth, Rockefeller University, New
York, New York: Molecular biology of viroids.
Sheperd, James, Kansas State University, Manhat-
ten: Genetic variation in potato plants regen-
erated from cultured protoplasts and its utility
for plant breeding.
Meins, Frederick, University of Illinois, Chicago:
Directed, heritable changes in tobacco cell
culture and regenerated plants.
Levings, CS., North Carolina State University,
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Greensboro: The maize mitochondria! ge-
nome-Plasmids associated with male sterility.
Flavell, Richard, Plant Breeding Institute, Cam-
bridge, England: Genome organization in cer-
eals; Evolutionary consequences of movable
genetic elements; DNA cloning in plants.
Fedoroff, Nina, Carnegie Institution of Washing-
ton, Baltimore, Maryland: Controlling elements
in maize.
Burr, Ben, Brookhaven Laboratory, Upton, New
York: The shrunken locus in maize; Cloning a
gene which responds to controlling elements.
Burr, Frances, Brookhaven Laboratory, Upton,
New York: Zein-Maize storage protein.
Bogorad, L., Harvard University, Cambridge, Mass-
achusetts: Genetic organization and cloning of
chloroplast DNA.
Ausubel, Fred, Harvard University, Cambridge,
Massachusetts: Genetic studies of nitrogen
fixation.
van Montagu, Marc, Laboratory for Genetics,
Ghent, Belgium: Interaction of bacterial plas-
mids and plant DNA in A. tumifaciens (crown
gall).
Giles, Kenneth, Worcester Polytechnic Institute,
Massachusetts: Introduction of plasmid DNA
into plant protoplasts by liposome fusion.
McClintock, Barbara, Cold Spring Harbor Labora-
tory, New York: Summary remarks-Untapped
phenomena in plants.
OTHER PARTICIPANTS
Waldron, Clive, University of Utah, Salt Lake City
Davis, Ronald W., Stanford University, California
To lin, Sue, USDA Competitive Grants Program,
Washington, DC
Clutter, Mary, National Science Foundation, Wash-
ington, DC
Nasser, Delill, National Science Foundation, Wash-
ington, DC
Clark, Betsy, National Science Foundation, Wash-
ington, DC
Rabson, Robert, Department of Energy, Washing-
ton, DC
MOLECULAR APPROACHES TO MICROBIAL PATHOGENICITY
AND VIRULENCE
M. So, D. Kwoh, C. H. Lee, K. Messina, T. Meyer and D. Mlawer
The emphasis in this laboratory is on factors that
influence the pathogenicity and virulence of
microorganisms. In particular, we are interested in
examining the genetic nature of these factors
(how they are expressed, how they are dissem-
inated) and in manipulating these genes biochem-
ically in the hopes of finding a solution to the
disease process. Enterotoxigenic E. coli (ETEC) are
responsible, in part, for the syndromes known as
infantile diarrhea and "Traveller's Diarrhea." The
disease affects both man and agriculturally impor-
tant animals and is particularly severe in the
newborn. It can come about only if the bacteria
produce (1) colonization factor (CF), a cell-surface
antigen that initiates the disease process by
allowing the invading cells to colonize the intes-
tines of the host, and (2) heat-labile (LT) or heat-
stable (ST) toxins, which actually elicit the clinical
symptoms of diarrhea.
Two groups of heat-stable toxins are produced
by ETEC. One, STA or STI, affects only newborn
(suckling) animals and the other, STB or STII,
affects only the adult (weaned) of the species. Both
are low-molecular-weight and not antigenic un-
less coupled to a carrier protein. We have
characterized the gene coding for one of the STI
toxins and found it is on a transposable segment of
DNA bounded by inverted repeats of 151 (Tn168/).
We have deduced an amino acid sequence from
the DNA sequence of the STI gene. A comparison
of this deduced amino acid sequence with the
amino acid sequence of another STI toxin ob-
tained by R. Giannella has shown that the two
sequences are identical at the C'-terminal end
except for two substitutions. In collaboration with
R. Giannella, using one STI DNA sequence as
probe in Southern hybridizations and his anti-STI
antibodies in radioimmunoassays of ST-producing
clinical isolates, we have shown that the STI toxins
are not a homogeneous group, but do share some
common sequences, and these regions of homo-
logy probably lie in the C'-terminal region of the
protein. We are now in the process of characteriz-
ing the nature of the STII gene.
The colonization-factor antigens (CFAs) are
both species- and tissue-specific. Recently, we
have started to examine the genes encoding the
CFAs specific to humans (in conboration with
Dolores and Doyle Evans, University of Texas,
Houston). There are two, and possibly more,
antigenically different CFAs. It is our intention to
study the relatedness of these genes, to isolate and
mutate them in vitro and in vivo to examine the
attachment functions of their proteins, and to
examine their evolutionary behavior in vivo and in
vitro in response to environmental (antigenic)
pressures.
Neisseria gonorrhea also have interesting cell-
surface antigens that function as virulence factors.
We have also started to study the genetics of this
organism, concentrating on the regulatory mech-
anisms responsible for the expression and anti-
genic diversity of these factors.
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MOLECULAR MECHANISM OF TRANSPOSITION
F. Heffron, R Kostriken, T. Meyer, C. Morita, R. Bialt, J. Celenza
Transposable elements are discrete DNA sequences
that can transpose from one location on a DNA
molecule to another. In prokaryotes, transposons
frequently carry genes, such as for antibiotic
resistance, that are advantageous to the bacterial
cell. Such transposons have revolutionized bac-
terial genetics, where they are now universally
used to produce mutations and simplify strain
construction.
Our laboratory is dissecting the molecular
mechanism of bacterial transposition. Tn3, one of
the earliest transposons identified, encodes resist-
ance to penicillin. In the last few years we have
identified three genes and three sites that are
essential to Tn3 transposition and are encoded
within the transposon itself. Tn3 encodes a
transposase that is essential for its transposition
and that is negatively regulated by a repressor. On
the basis of our genetic studies, it appears that
transposition is a two-step process. The first step
involves formation of cointegrates or fusions
containing the donor DNA molecule linked to the
recipient via a direct repreat of the transposon. In
the second step, the fusions are resolved. Accord-
ingly, the transposon contains two types of
functions. Formation of the cointegrate requires
the two ends of the transposon and the transpos-
ase. We have demonstrated that the resolution
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step requires the repressor (described above) and
an additional internal site. Thus, the repressor/
resolvase is a bifunctional protein (Kostriken et al.,
Proc. Natl. Acad. Sci. [1981], in press). Resolution
of cointegrates takes place through a unique
internal site (the IRS) within an A +T-rich se-
quence located between the transposase and the
resolvase. We have constructed an overproducer
of the resolvase and are using this to purify this
protein and examine its in vitro binding and
recombination activities (R. Kostriken, T. Meyer,
and F. Heffron, in prep.). By studying these
intermediates, we hope to understand how the
recombination takes place. In the next few years
the major emphasis of our work will be to
understand the complex way in which transposi-
tion is regulated and to establish an in vitro system
in which the complete or partial transposition
reactions take place. The transposition frequency
is controlled by the expression of a transposase
negatively regulated by a repressor, yet there are
many molecules in which Tn3 will not integrate.
One of the Tn3-encoded regulatory systems acts in
cis to prevent insertion of Tn3 into a molecule with
a resident Tn3. To establish an in vitro transposi-
tion system, it will be necessary to understand this
complex regulation.
Vertebrate Gene Structure and Expression
Until the advent of recombinant DNA, genes of higher organization were foreclosed from
effective study, and those molecular biologists who wished to focus on higher-cell DNA
were for the most part restricted to work on the DNA viruses of higher cells. As a
consequence, SV40, polyoma, and adenovirus DNAs have, for over a decade, been
intensively examined and are now among the best studied of all nucleic acids. It was thus not
at all surprising that RNA splicing was first observed through their study, and the great
scientific benefits that have arisen through the focusing of tumor virus DNA have already
been universally acclaimed.
The arrival of the recombinant DNA procedures, together with the marvelous new
methodologies for sequencing DNA, now provides the opportunity for studying equally
successfully the genomes of higher cells. Given our already major commitment to tumor
virus reseLrch, it seemed obvious that as soon as expanded resources became available, we
should also focus on the DNAs of their respective host cells. Toward this end, we have
created the new research division of Vertebrate Gene Structure and Expression. Major
support for it will come in the next several years from a Program Project Grant from the
National Cancer Institute that commenced April 1, 1981. This new division occupies space in
both Demerec and James Labs and was initially set up with four sections: Mammalian Cell
Genetics, Hormonal Control of Gene Expression, Genes for Major Structural Proteins, and
Structure and Expression of Polypeptide Hormone Genes.
Our Mammalian Cell Genetics section, headed by Mike Wigler, was until now connected
to both our Tumor Virus and Movable Genetic Elements Divisions. It will now belong
exclusively to the Vertebrate Gene Structure and Function Division. Heading the Hormonal
Control section is Dave Kurtz, who came here to be part of Mike Wigler's research team.
Dave has been promoted to the Senior Staff Investigator level, and will soon have his own lab
facilities in which to run an expanded group focusing on how steroid hormones control
gene expression. Heading our section on Genes for Structural Proteins is Steve Hughes, who
initially moved here to be part of our Tumor Virus Division. Newly arrived to head up our
efforts on Polypeptide Hormones is John Fiddes, who came to us from the University of
California at San Francisco, where he postdoced for several years with Howard Goodman,
after doing his Ph.D. in Fred Sanger's Lab at Cambridge. John has already been joined by




M. Wig ler, M. Perucho, K. Shimizu, J. Kwoh, M. Goldfarb, D. Levy, C. Fraser, C. Lama
In our second year at Cold Spring Harbor, we have
continued the explorations of gene expression in
cultured mammalian cells made possible by tech-
niques of gene cloning and gene transfer, have
consolidated insights and developments of the
previous year, and have opened up new areas for
experimentation. We have been joined by Mitchell
Goldfarb, a postdoctoral fellow from R. Weinberg's
lab at MIT; Jesse Kwoh, formerly with the
Molecular Genetics section at Cold Spring Har-
bor; and Kenji Shimizu, a microbial geneticist and
biochemist from the University of Kyushu, Japan.
In addition, Manuel Perucho has been given a staff
appointment.
The Physical State of Exogenous DNA
in Transformed Cells
M. Perucho, M. Wig ler
The genetic content of cultured mammalian cells
may be altered-a process classically referred to as
transformation-by exposure of cells to DNA as
a calcium phosphate precipitate. Transformants
are most readily identified by their acquisition of a
new phenotype. Previously, we established that
under certain conditions cells will stably incor-
porate up to 4000 kb of exogenous DNA. An
extensive series of experiments demonstrating the
genetic linkage of acquired phenotypes led us to
postulate that transformed cells assemble a struc-
ture of up to 4000 kb comprised primarily, if not
exclusively, of foreign DNA and that most, if not
all, incorporated DNA persists in transformants in
one such structure, which we have called a
"pekelasome." This hypothesis was confirmed by
hybridization analysis of transforming elements
after their molecular cloning in prokaryote hosts.
Thus, foreign DNA incorporated by mammalian
cells undergoes a relatively efficient intermolecu-
lar ligation, a process as yet without parallel in
microorganisms. We do not yet know whether this
process is random or whether it favors certain
sequences or even certain molecular configura-
tions. Our initial studies, performed with a Tk-
(thymidine-kinase-deficient) murine cell, LTk-,
have now been further confirmed in that cell and
also extensively confirmed in a Tk- rat cell line,
Rat-2, derived by Bill Topp (Tumor Virus section).
Other workers have also confirmed our initial
observations and have, in addition, demonstrated
that foreign DNA is usually integrated into a host
chromosome as a single unit. This organization of
foreign DNA in transformants may be an impor-
tant factor to consider in the analysis of expression
of newly acquired genes. Moreover, the pheno-
typic linkage between previously unlinked, newly
acquired markers provides a very strong criterion
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for true gene-transfer events, a point to which we
shall return when discussing the isolation of tumor
genes.
The Expression of Genes
in Transformed Cells
M. Perucho, M. Wigler
Previously, we studied the expression of the
simian virus 40 (SV40) early region when cotrans-
ferred into LTk- cells using tk as the selectable
marker. Following expression of the early region
by indirect immunofluorescent staining for T
antigen, we (in collaboration with D. Lane, D.
Hanahan, and M. Botchan) established that cloned
populations of cells expressed T antigen in a
heterogeneous pattern (Hanahan et al., Cell
21: 127 [1980]). Only a portion of the population
were found expressing at any one time, and yet it
was impossible to clone out a pure nonexpressing
subpopulation. We concluded that expression of
the early region was switching off and on during
the progression of individual cell lineages. The
molecular basis for this switching is uncertain, as is
its generality. However, in 1974, Risser and Pollack
observed similar patterns of expression in unse-
lected populations of 3T3 cells infected with SV40
(Virology 59: 477 [1974]). Moreover, we have
observed certain "ambivalent" phenotypes in the
expression of the endogenous tk gene in avian and
rodent cells, which are consistent with rapid
switching (see below). Evidence from blot hybrid-
ization suggests that switching is not due to large-
scale sequence rearrangements, and so other
mechanisms are now beginning to be studied. The
following major questions can be asked: Is
switching peculiar to SV40? Does it occur coordi-
nately to several independently integrated tran-
scription units? Is the constitutively switched-on
state (which occurs in a minor proportion of inde-
pendent transformants) due to a host mutation or
to an SV40 mutation, or is it due to a mutation at
all? Is switching correlated with changes in DNA
methylation patterns?
In a manner similar to that employed in our SV40
studies, both the cloned chicken and herpes tk
genes were introduced into doubly mutant mouse
LTk-Aprt- cells using aprt as the selection system.
As judged by the ability of cotransformants to
grow in tk-selection (HAT) medium, all cell
populations that contained either the herpes tk
3.4-kb BamHI fragment or the 2.25-kb EcoRI/
Hindlll fragment of chicken tk were capable of
growing in HAT. Thus, these genes are completely
encoded on their respective fragments. Work in
progress indicates that the pattern of expression of
the chicken tk gene in mouse cells resembles the
expression of mouse tk in so far as levels of the
gene product are greatly reduced in stationary cell
cultures. If this regulation is at the level of
transcription, it may be possible to identify the
control region for modulation of expression.
Neither in the case of the herpes tk gene nor that
of the chicken tk gene have we studied expression
at the single cell level as we did for SV40, and so
our results are not comparable. Preparations for
such studies, based on the construction of chi-
meric genes, are in progress. Future studies
include the construction of chimera between
selectable genes and genes under differential
control in order to apply the techniques of
mutation and selection to obtain information
about the mechanisms of cellular differentiation.
Characterization of the Chicken tk Gene
K. Kwoh, M. Goldfarb, M. Perucho, M. Wig ler
As described in last year's report, we have isolated
the chicken tk gene by the technique of plasmid
rescue. The gene has been cloned both as a 2.25 -
kb EcoRI/Hind111 fragment in pBR322 and as a 15-
kb clone in the X vector Charon 4A. As described
in the previous section, we believe that the 2.25-kb
fragment is complete-encoding information for
its own transcription and regulation. Our aim is to
provide a complete anatomical description of this
gene, and to this end we are sequencing it, have
made an extensive collection in vitro of pseudo-
random linker (Xhol) insertion mutants, and have
a preliminary characterization of the transcription
unit-its size, splicing pattern, and orientation.
Characterization of Tk Mutants in Cultured
Chicken Cells
M. Wigler
We have obtained a permanent chicken cell line
courtesy of G. Shutz and T. Graf (University of
Heidelberg, Germany). Called 249, it is derived
from an MC29-induced hepatoma in chickens.
The availability of this line and the cloned chicken
tk gene has made possible a molecular investiga-
tion of mutations that arise at the tk locus after
selection of cells resistant to killing by BrdU. 249
cells plate in medium containing BrdU at about 5
colonies per 108 cells plated. It is possible to select
mutants in that way or by gradually selecting cells
resistant to ever-increasing BrdU concentrations.
We have used both approaches to obtain 10
independent BrdU-resistant mutants. All the mu-
tants that have been analyzed to date appear to
have a normal blot hybridization pattern for tk but
one of reduced intensity relative to the 249 parent,
suggesting that one step to BrdU resistance has
been deletion of all tk sequences from one locus.
A similar deletion of the remaining tk locus has not
occurred in any line and is presumably lethal. The
second step appears to differ in various mutants,
since there are at least two distinct phenotypes:
mutants that cannot grow in HAT medium (plating
efficiencies less than 101 and mutants that grow in
HAT medium with high efficiency. The latter class
appears analogous to the cells that demonstrated
heterogeneous, expression of the SV40 early
region as discussed earlier, in that efforts to clone a
pure population have so far failed. Work is
currently directed at determining whether the
ambivalent phenotype does represent rapid switch-
ing and, if so, whether this phenotype can be
regarded as due to a mutation at the DNA
sequence level.
Isolation of Human Tumor Genes
M. Perucho, M. Goldfarb, K. Shimizu, M. Wigler
Recent work of R. Weinberg's laboratory (MIT)
and G. Cooper (Sidney Farber Cancer Institute)
has demonstrated the feasibility of transforming
normal-growth-controlled rodent cells to the
tumor phenotype using DNA from chemically
transformed or virally transformed cells as donor.
These experiments, together with our ability to
clone the active gene by plasmid rescue, raise the
possibility of a genetic analysis of tumorigenesis.
We have begun screening DNAs from a variety of
cells derived from various human tumors for their
ability to serve as donors of the tumor phenotype
using NIH-3T3 cells as the normal recipient.
Several human cell lines have been identified that
are excellent donors of the tumor phenotype, and
we are now attempting to isolate these genes for
further study. The techniques we will employ
involve plasmid rescue, which we used to isolate
the chicken tk gene, and a new approach utilizing
a bacterial tRNA suppressor gene as the pro-
karyotic factor. The latter will complement a X
packaging phage containing an amber mutation in
the lysis function. Only recombinant phage will be
able to grow on wild-type hosts.
Inheritance and Function of DNA
Methylation
D. Levy, M. Perucho, M. Wigler
The DNAs of higher eukaryotes contain a low
proportion of modified cytosine residues (5-
methylcytosine [5-MeC]), whose function has
been the subject of much speculation and interest.




and this sequence is also found as part of the
recognition site of several restriction enzymes that
will not cleave methylated recognition sequences.
By using such "CpG" enzymes, many workers
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have investigated the distribution of methylation
within specific gene sequences in specific tissues.
To a first approximation, methylation patterns are
not random: There appears to be a master pattern,
present in germ cells, of which the somatic cells
partake, the exact variation in methylation pattern
differing between tissues but being characteristic
for particular tissues. This distribution is consistent
with the idea that methylation patterns are
inherited by somatic cells. Moreover, there is a
rough inverse correlation between degree of
methylation and expression, consistent with the
idea that methylation patterns might function in
some way to control specific expression patterns
in differentiated tissues. We have decided to
explore these questions using the methods of
gene transfer. We purified M-Hpall, the meth-
ylase from Haemophilus parainfluenzae that
methylates the internal cytosines of the sequence
5' CpCpGpG
3' GpGpCpC
a subset of potentially methylatable sites in higher
vertebrates. Using M-Hpal I, we demonstrated that
methylation patterns established on cloned DNA
in vitro are replicated in vivo when that DNA is
introduced into living cells. In other words,
methylation is its own genetic determinant. We
estimate that the fidelity of inheritance is at least
95% per site per cell generation. Moreover, we
observed that the methylated herpes or chicken tk
genes transform cells less efficiently than un-
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methylated genes, indicating that there is a causal
relationship between expression and methylation.
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HORMONAL CONTROL OF GENE EXPRESSION
D. T. Kurtz, D. Bishop, C. Nicodemus, A. Baxter
The hormonal control of the synthesis of specific
proteins has proved to be a fruitful model system
for the study of differential gene expression in
higher eukaryotes. The response of specific genes
to hormonal stimuli is tissue-specific, and, within a
given cell type, the modulation involves only a few
specific markers. A general model for the mech-
anism of action of steroid hormones has evolved
on the basis of experiments done in a large
number of model systems: The steroid hormone
enters the cell and binds to a cytoplasmic receptor
protein. The steroid-hormone receptor enters the
nucleus, wherein it interacts with the genetic
material, resulting in the appearance or disap-
pearance of a few select mRNAs in the cytoplasm.
The events that occur after the localization of the
steroid-receptor complex in the nucleus, leading
to this modulation of cytoplasmic mRNA levels,
remain a mystery. The well-accepted models of
prokaryotic gene regulation have led some to
speculate that hormonal induction may be the
result of a simple repressor-operator-type mecha-
nism in which the steroid-receptor complex itself
binds near the target gene. However, until recent-
ly, it was virtually impossible to test even the
rudiments of such a model. The recent advances in
recombinant DNA technology and the ability to
transform mammalian cells with defined DNA
segments now allow us to approach some funda-
mental questions concerning the molecular mech-
anism of action of steroid hormones.
Rat oe, Globulin
Several years ago a protein was discovered in the
urine of male rats that was absent from the urine of
females. This protein, with a molecular weight of
20,000, was designated 02 globulin. This protein
was first thought to be a prostatic secretion, but it
was later found to be synthesized in the liver of
mature male rats (wherein it represents 1% of
hepatic protein synthesis), from which it was
secreted into the serum and then excreted in the
urine. The function of this protein remains unclear,
but it appears to be necessary to maintain normal
spermatogenesis in male rats. The synthesis of a,
globulin is under extremely complex hormonal
control in vivo. Glucocorticoids, androgens, thy-
roid hormone, and growth hormone are neces-
sary to maintain a normal level of as-globulin
synthesis, and estrogens administered to male rats
strongly repress the synthesis of this protein. No
an-globulin synthesis occurs in adult female rats,
but it can be induced in females by ovariectomy
followed by androgen or glucocorticoid admini-
stration.
a, Globulin Is Encoded by
a Multigene Family
The cDNA for a, globulin was cloned in Escher-
ichia coli, using a high-efficiency "double-linker"
technique for cloning cDNAs. This cloned a2 -
globulin cDNA was used as a probe in Southern
hybridization analysis of rat genomic DNA cleaved
with several restriction enzymes that do not cleave
the cDNA. An extremely complex pattern of
bands appeared, suggesting the presence of
multiple a2,,-globulin genes. This was confirmed
by DNA-excess solution hybridization using
cDNAs for a2 globulin and albumin, which is
known to be a single-copy gene in the rat. This
analysis indicated that there are 18-20 as-globulin
genes per haploid genome. In situ hybridization to
rat metaphase chromosomes, using a2.-globulin
cDNA labeled with 1251, indicates that most, and
perhaps all, an-globulin genes are clustered on
the long arm of chromosome 5. (The finding that
a2 globulin may be encoded by several genes is
not surprising in that the corresponding protein in
the mouse, designated MUP, is encoded by
approximately 20 genes.) The finding that as.
globulin(s) may be encoded by a multigene family
immediately raises the possibility that the com-
plexity of the hormonal modulation, i.e., the large
number of hormones that affect as-globulin
synthesis, may be the result of the individual a2-
globulin genes responding to different hormones.
«,-Globulin Gene Structure
The as-globulin cDNA was used to screen a library
of rat genomes cloned in the X vector Charon 4A.
Six independent clones were obtained that con-
tained the entire an-globulin gene, and these
were analyzed by a combination of restriction
enzyme mapping and electron microscopy of
RNA:DNA heteroduplexes.
It was found that the six genes had most
restriction enzyme sites in common and, in fact,
shared sites that were in the 5' and 3' flanking
regions. However, some heterogeneity was found:
Two of the genes were found to contain a portion
(- 400 bp) at the extreme 3' end that did not
hybridize to the cloned a,globulin cDNA, al-
though these two variant genes seemed to be
identical with the other four in the 5' and middle
portions of the mRNA-coding portions and in the
intron regions. It is possible that these represent
"pseudogenes that are never transcribed or are
transcribed in another tissue rather than liver.
Electron microscopic analysis revealed that the
a2-globulin genes are interrupted by six inter-
vening sequences. The length of the gene was
estimated to be approximately 3.5 kb. (This
corresponds to the length of the largest a2 -
globulin RNA precursor found in rat liver nuclear
RNA.) It was also found that there is a sequence
(50-100 bp) in the third intron of the as-globulin
gene that has a complementary inverted sequence
approximately 4 kb from the 5' end of the gene. This
is visible as a stem-loop structure under the
electron microscope. The intron-exon pattern for
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all of the as- globulin genes analyzed was identi-
cal, and the inverted repeat was found in every
case.
Expression of Rat Globulin in Mouse Cells
To define the DNA sequences in or around the
as- globulin gene that are responsible for its
hormonal modulation, two of the oz-globulin
genes were cotransformed into mouse LTIC cells,
using the herpes simplex virus (HSV) thymidine
kinase (tk) gene as a vector. (These experiments
were done using total A DNA containing the a2-
globulin gene and 3-6 kb of flanking rat DNA on
either side.) Several TV clones were isolated and
were found to have incorporated from three to
ten copies of the a2 globulin gene.
When these clones were induced with dexa-
methasone, it was found that in more than 50% of
the clones, az.-globulin mRNA and protein were
produced in response to these hormones and that
the protein produced was secreted into the
medium. The induced level of az-globulin mRNA
was estimated to be -. 200 copies/cell, approxi-
mately one-tenth the level in a normal adult male
rat.
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This indicates that the information necessary for
hormonal response is contained in the DNA
fragment used for transfer. Site-specific muta-
genesis and deletions of specific regions in and
around the az.-globulin genes, followed by trans-
fer into L cells, should help define the DNA
sequences responsible for this hormonal modu-
lation.
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GENES FOR THE MAJOR STRUCTURAL PROTEINS:Organization and Control of Expression
S. H. Hughes, A. Barros, J. Feramisco, J. Sorge, G. P. Thomas
We began studying avian sarcoma virus (ASV) both
because it has distinctive properties as a virus and
because it is a good model system for studying
gene expression in higher eukaryotes. We believe
that the unique properties of ASV should allow us
to prepare a new class of eukaryotic vectors that
could efficiently reintroduce a variety of cellular
genes into avian cells. To use the virus successfully
as a vector, however, its life cycle must be well
understood. A very useful property of ASV is the
stable integration of a DNA copy of the viral
genome into the host chromosomes, and we have
just completed an analysis of the structure of the
integrated provirus of ASV.
The Structure of Integrated ASV DNA
As an obligate step in their life cycle, retroviruses
insert a DNA copy of their genome into host DNA.
This recombination event is known to be relatively
specific with respect to the site in viral DNA and
relatively nonspecific with respect to the site in the
host DNA. The retroviral genome is RNA, and an
essential step that must occur before integration is
the copying of the RNA genome into DNA by the
viral enzyme RNA-dependent DNA polymerase.
The first stable intermediate, a double-stranded
linear DNA molecule, is made in the cytoplasm of
infected cells. This viral DNA, which has a full-
length minus (-) strand and segmented plus (+)
strands, is slightly larger than the RNA from
which it is derived. Sequences from both the 3' and


















The stable intermediates in the replication of the ASV
genome. Virion RNA (top) is copied by the virion RNA-
dependent DNA polymerase to yield a linear DNA
molecule. This linear DNA is the precursor of both the
large and small circular forms of viral DNA. It is not
known which of these three unintegrated viral DNAs is
the direct antecedent of the integrated provirus
(bottom). Cellular RNA polymerase copies the provirus
into RNA, which completes the virus life cycle. Adapted
from Shank et al., Cell 15: 1473 [1978] and Hughes et al.,
Cell 15: 1397 [1974)
5' ends of the genomic RNA are found at each end
of linear viral DNA (see Fig. 1). These sequences
form a direct repeat at the termini of the linear
DNA (called the LTR), which varies in size from one
species of retrovirus to another. The LTR of ASV
is 330 by long. Each repeat has the structure U1RUs,
where U3 is a unique sequence from the 3' end of
viral RNA and Us is a unique sequence from the 5'
end of viral RNA. The R sequences are repeated at
both the 5' and 3' ends of viral RNA (see Fig. 1). In
the case of ASV, U3 is 230 by long, R is 21 by long,
and Us is 80 by long. The linear viral DNA migrates
from the cytoplasm of an infected cell to the
nucleus, where it is converted to two major forms
of circular molecules. The smaller circle has a
single LTR and presumably is formed by homolo-
gous recombination between the LTRs. The larger
circle presumably is formed by a ligation event
that brings together the ends of the linear viral
DNA. The nature of this event is unknown, partly
because the exact termini of the linear DNA have
not been defined. It is not known whether the
linear form or one of the circular forms of DNA is
the direct antecedent of the integrated provirus.
The structure of the integrated provirus is
superficially similar to the unintegrated linear ASV
DNA, with cellular DNA attached to the ends of
the LTR. The structures of viral RNA, the three
forms of unintegrated viral DNA, and the provirus
are given in Figure 1.
To learn more about ASV integration, we have
cloned segments of DNA that include the junc-
tions between viral and host DNA, and we have
compared these to the unaltered host sequences
into which the viral DNA integrated. These clones
were derived from the DNA of the transformed
line ASV NRK-2 (Hughes et al., Cell 15: 1397
[1978]), which contains a single complete ASV
provirus.
The ends of the integrated provirus are flanked
by a 6-bp repeat of cellular DNA. This repeat
apparently is created by the integration event,
since this 6-bp sequence is present only once in
the host DNA into which the provirus integrated
(see Fig. 2). The provirus appears to have lost 2 by
from the right end and either 1 or 2 by from the left
end, compared with the circular forms of uninte-
grated ASV DNA. The last base in the 6-bp repeat
could be of either cellular or viral origin, since the
same base (A) is found at the corresponding sites
in the viral and cellular sequences (see Fig. 2).
A survey of eight other independent ASV-
transformed rat cell lines demonstrates, in agree-
ment with our earlier results, that the ASV
proviruses are found in different segments of rat-
cell DNA. We have also sequenced a junction

































Sequences of unintegrated viral DNA, the integration
site in the host genome, and at the ends of the
integrated provirus. The sequence of the joint between
Us and Us in the large circular form of viral DNA is that
given by Swanstrom et al. (1981) for the SR-A strain of
ASV. The integration site in the host genome and the
junctions between host DNA and viral DNA at both
ends of the provirus are all derived from the line ASV
NRK-2, which contains a single complete provirus
(Hughes et al., Cell 15: 1397 [1978]).
ASV-transformed rat cell line (ASV NRK-4) and
have found that there are no obvious similarities
between the two integration sites, although the
host sequences to the right of both proviruses are
rich in A-T base pairs. Integration of ASV therefore
is similar, as far as we know, to the integration of
the other retroviruses, murine sarcoma virus
(MSV), spleen necrosis virus (SNV), and mouse
mammary tumor virus (MMTV), which lose 2 by at
each end during integration and are flanked by
repeats of cellular DNA of 4 bp, 5 bp, or 6 by (Dhar
et al., Proc. Natl. Acad. Sci. 77: 3937 [1980];
Shimotohno et al., Nature 285: 550 [1980]; Majors
and Varmus, Nature [1981], in press). Furthermore,
the integration of MSV and MMTV create the
repeat of cellular DNA (Majors and Varmus, 1981;
G. Vande Woude, pers. comm.); i.e., there is only
one copy of the 4-bp or 6-bp repeat in cellular
DNA before the provirus integrated. The product
of integrative recombination of retroviral DNA
also seems to resemble closely the product of
integrative recombination of a bacterial or yeast
transposon, the bacterial virus Mu, and the
Drosophila movable elements such as copia. This
suggests that the mechanisms of integration of
these diverse DNA molecules are likely to be
related.
Construction of ASV Vectors
Certain retroviruses are natural recombinants that
have picked up a gene (or genes) originally
encoded by the host, and, at least in some cases,
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the level of both the mRNA and protein produced
from the incorporated gene are profoundly en-
hanced. We have chosen to modify one of the
naturally occurring retrovirus recombinants-ASV.
The DNA genome of this helper-independent
virus is approximately 10,000 by long and is known
to encode four genes. Three of the genes, gag, pol,
and env, are required for virus replication. The
fourth gene, src, is derived from a cellular gene
c-src. src is responsible for the induction of
sarcomas in the animal and the transformation of
fibroblasts in culture. The src gene is lost from ASV
at high frequency, to yield a nonsarcomagenic
transformation-defective (td) virus that replicates
at least as well as the ASV parent. From a cloned
ASV genome (kindly provided by W. DeLorbe of
the Bishop-Varmus Lab, University of California,
San Francisco), we have produced a series of
derivatives that superficially resemble a naturally
occurring td virus. By appropriate manipulations,
src has been removed, and a unique restriction site
(Cal) has been inserted. This allows us to cleave
the DNA specifically and to substitute a variety of
other genes for src. The choice of Clal is
advantageous, since ASV has no Clal sites; in
addition, the products of a Clal digestion can be
ligated directly to the products of a Taql digestion
without the addition of linkers.
What are the potential uses of these cloning
vectors? They should provide a stable association
between host DNA and a gene to be introduced.
The parental virus infects cultured cells efficiently;
it should be possible with recombinants to infect
every cell in a dish. The ASV vectors have been
designed to be helper-independent, which would
eliminate problems of overgrowth by helper
viruses.
Since the viral genome is RNA, a question arises:
What will happen if a fragment containing inter-
vening sequences (as opposed to cDNA) is
introduced into a retrovirus vector? Will the
intervening sequences be removed or not? Retro-
viral RNA is apparently unique in that approxi-
mately equal amounts of spliced and unspliced
RNAs are found in the cytoplasm of infected cells.
Genomic retroviral RNA is obviously unspliced; of
the messages, at least env and src are spliced. One
could imagine that the expression of viral func-
tions (such as coating a portion of the viral RNA
with viral proteins) somehow abrogates normal
splicing for at least a portion of the viral RNA. In
this case, a cellular gene that would normally
produce a spliced message might, if introduced
into a retrovirus, produce unspliced or partially
spliced RNAs. Alternatively (and we favor this
alternative), retroviruses may not contain sites that
are spliced efficiently. If this is the case, it may be
possible, after introducing into a retrovirus vector
a cellular gene with intervening sequences, to
allow the retrovirus to complete its life cycle and to
recover, by cloning, a copy of the gene with all of
its intervening sequences precisely removed.
Finally, it should be possible to use ASV
derivatives to search for genes that, when ampli-
fied, have transforming potential. The retroviruses
that are highly oncogenic all appear to have
picked up a cellular gene. Considering all known
retroviruses, there are approximately a dozen
known cellular genes with transforming potential.
Apparently, high levels of expression of these
genes can transform certain cell types. We do not
know how retroviruses acquired cellular genes,
nor do we know whether the set of acquired genes
that have been found in the naturally occurring
retroviruses represent most (or all) of the potential
transforming genes. We propose to "shotgun" the
chicken genome into the ASV vector (which will
lack the transforming src gene) and to screen for
new transforming viruses in tissue culture.
Isolation and Identification of Genes
for Major Structural Proteins
We have devised a protocol for directly screening
genomic libraries for highly expressed genes and
for identifying the genes encoded by individual
recombinants. A highly labeled (- 109 cpm/aug)
copy of any RNA or mixture of RNAs can be
prepared with reverse transcriptase, using as prim-
ers oligonucleotides derived from calf thymus
DNA. A recombinants that carry genes corre-
sponding to the major RNAs in the fraction used to
prepare the labeled cDNA hybridize strongly and
are readily identified. To determine which gene(s)
is carried by an individual A recombinant, the
recombinant is used to purify, by hybridization
selection, the homologous mRNA. This mRNA is
translated in vitro, and the resulting protein
products were analyzed by one-dimensional and
two-dimensional gels and/or by immunoprecipi-
tation with specific antibodies. We have chosen
for study the set of genes that encode the
cytoskeletal proteins of nonmuscle cells and the
related proteins that make up the contractile
apparatus of muscle cells. The clones will be used
(1) for comparative studies of gene structure, (2)
for studies of the relationships between gene
organization and development/differentiation, (3)
to examine the relationship between transforma-
tion and gene expression, and (4) to study effects
of the presence of inappropriate homologs of
cytoskeletal proteins (i.e., the actins) on cell
structure and motility. The system has several
inherent advantages: (1) The muscle-specific pro-
teins exhibit coordinate regulation during chick
myoblast differentiation. This differentiation takes
place in culture, and the differentiation in culture
can be specifically inhibited by the expression of
the ASV src gene. (2) The proteins and mRNAs for
both the cytoskeleton and muscle proteins are
present in large amounts, which facilitates cloning
and analysis. (3) There is a major commitment to
the study of the protein products of these genes by
the Cell Biology section. These proteins have been
extensively studied both here and elsewhere, and
we have access to antibodies (in many cases hy-
bridoma antisera) specific for many of these
proteins, which will permit us to characterize,
immunologically, cells into which we have intro-
duced cloned genes. (4) In contrast to the
relatively large amounts of information available
about the proteins, very little is known about the
genes themselves, their structure, chromosome
location, or what controls transcription in either
normal or transformed cells.
We have isolated individual clones that encode
actin, tubulin, and 100-A filament genes. We are
currently concentrating on the physical character-
ization of clones that contain a complete copy of
the chicken /3 -actin gene, which is expressed in
nonmuscle cells. The gene contains four interven-
ing sequences, and we are now sequencing the
region around the 5' end of the gene. Although
there is considerable work still to be done in
isolating and characterizing the genes, we expect
to begin experiments soon in which we reintro-
duce cloned genes back into various differenti-
ated and transformed cells. The cloned genes will
be reintroduced by either microinjection or by the
use of the ASV vector. We plan to monitor
expression at the protein level; and since many of
the proteins are ubiquitous, we will, in some cases,
be forced to make recombinants that will produce
hybrid proteins whose expression we can con-
veniently monitor immunologically. Our long-
term goal is both to understand how individual
of a series of genes that encode closely related
proteins (e.g., striated-muscle cells express one of
approximately six actin genes) and to ask what are
the functional differences between these closely
related proteins (e.g., What are the effects on a
nonmuscle cell if it is forced to make large
amounts of muscle actin?).
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THE STRUCTURE AND EXPRESSION
OF POLYPEPTIDE HORMONE GENES
J. C. Fiddes, N. C. Vamvakopoulos, W. R. Boorstein
Over the past few years the development of
molecular cloning technology has allowed the
structure and expression of several polypeptide
hormone genes to be studied in considerable
detail. The genes that encode polypeptide hor-
mones are particularly interesting because they
frequently comprise multigene families. For ex-
ample, the growth-hormone family consists of
three polypeptides, growth hormone itself, pla-
cental lactogen, and prolactin; the insulin-related
peptides are encoded by another multigene
family. In addition to these intrinsic structural
features, the factors that control the expression of
polypeptide hormone genes are important be-
cause of the wide range of complex physiological
functions that are under hormonal control.
The aim of this newly established group at Cold
Spring Harbor, which only started working in
November, is to study two distinct groups of
polypeptide hormones. These are the glycopro-
tein hormones made in the pituitary and the
placenta and the releasing factors made in the
hypothalamus. Although these two groups of
hormones are not structurally related, their physi-
ological roles are very closely linked since the
hypothalamic factors are responsible for the
release of the glycoprotein hormones from the
pituitary.
The Glycoprotein Hormones
There are four glycoprotein hormones in the
human: chorionic gonadotropin (CG), luteinizing
hormone (LH), follicle-stimulating hormone (FSH),
and thyroid-stimulating hormone (TSH). Chori-
onic gonadotropin is produced by the placenta;
the other three are made in the pituitary. All four
hormones are dimeric, consisting of dissimilar a
and /3 subunits. The a subunit appears to be
common to all four hormones, whereas the /3
subunits are unique and confer biological speci-
ficity on each hormone. The amino acid se-
quences of the /3 subunits show that they are
related to each other and are therefore encoded
by a multigene family. A distant relationship has
also been proposed between the common a
subunit and the /3 subunits.
Previously, we have isolated and sequenced
full-length cDNA clones for the a and /3 subunits
of the placental hormone CG. The cDNA for the a
subunit of CG has now been used as a hybrid-
ization probe to isolate and characterize chromo-
somal gene sequences that code for the a subunit.
The cloned a-subunit gene encompasses a total
of 9.4 kb of DNA and contains three intervening
sequences whose precise locations have been
established by restriction enzyme mapping and by
DNA sequencing. One of the intervening se-
quences is located in the 5' untranslated region,
generating a leader sequence that is separated
from the rest of the gene by 6.4 kb. The other two
intervening sequences are 1.7 and 0.4 kb long and
are located within codon number 6, between
codons 67 and 68, respectively. Restriction endo-
nuclease digestion of total human DNA suggests
that the common a subunit is encoded by a single
gene that is identical to the cloned copy. This gene
is therefore expressed in the pituitary for synthesis
of LH, FSH, and TSH and in the placenta for
synthesis of CG. Similar-size transcripts of the a-
subunit gene have been detected in both tissues.
A marked correlation between malignancy and
the production of chorionic gonadotropin has
been reported. Preliminary characterization of
this observation, using the cloned cDNAs as
hybridization probes, shows that several trans-
formed cell lines, including, for example, HeLa,
which is derived from a human cervical cancer, do,
in fact, produce either a- or /3-subunit mRNAs that
apparently are of the same length as in normal
tissue.
The organization of the /3- subunit genes is
considerably more complex than that of the single
a-subunit gene. Hybridization of the /3 CG cDNA
to restriction-endonuclease-digested human DNA
gives a complex pattern consistent with there
being several copies of the gene. Two chromo-
somal isolates have been obtained and have been
characterized by DNA sequencing, restriction
enzyme mapping, and electron microscopy. These
two segments of cloned chromosomal DNA
contain four or five /3- subunit genes and account
for about one half of the total number of
hybridizing fragments observed in total human
DNA. It appears that all of the copies of the gene
for /3 CG are physically linked on the chromosome.
The overall organization of each of these genes
seems to be the same in that they all have one
intervening sequence within the signal peptide
and one within the coding region. The locations of
the 5' ends of these genes have not yet been
established. The coding regions for each of the /3
CG genes apparently are the same, but small
differences of sequence are found in the interven-
ing sequences. It is not known which of these
genes is actively transcribed.
In at least one case, and probably in more, two
apparently identical /3- subunit genes are arranged
in pairs with convergent transcription. When
viewed under the electron microscope, this pair of
genes forms a "snap back" structure with a loop.
No information is as yet available on the chromo-
somal organization of the genes for the /3 subunits
of LH, FSH, or TSH.
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The Hypothalamic Releasing Factors
The glycoprotein hormones are stored within
secretory granules in the pituitary. The release of
these hormones from the granules is directly
controlled by factors synthesized in the hypothala-
mus. The decapeptide, gonadotropin releasing
hormone (gnRH), controls the release of both LH
and FSH, and the tripeptide TRH (TSH releasing
hormone) controls the release of TSH. Due to the
extremely low levels of these peptides, no infor-
mation is available concerning their biosynthesis.
It is not known, for example, whether the
releasing factors are initially synthesized as larger
precursors that are subsequently processed by
proteolytic cleavage, as in the case of pro-
opiomelanocortin.
In collaboration with A. Markham (ICI, England)
and J. Roberts and M. Evinger (Columbia Uni-
versity), we are attempting to isolate cDNA clones
for the putative precursor to gnRH. To do this, we
are making use of synthetic oligonucleotides to
prime specific cDNA synthesis from hypothalamic
RNA. The sequences of these oligonucleotides are
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CELL BIOLOGY
The Cell Biology group continued to probe into the functional and spatial organization of
the cytoplasm of mammalian cells in culture. Even though the amount of information about
the composition and distribution of cytoplasmic components is rapidly increasing among
cell biologists, the understanding of their function is still at best sketchy. Nevertheless, there
is a general feeling that cell biologists are at the brink of understanding the cytoplasmic
organization of this giant, self-replicating, multienzyme complex which we call a cell. We
hope that we have contributed this past year to furthering this understanding.
Newcomers to our group were Fumio Matsumura from the National lnsitute for Basic
Biology, Okazaki, and Steve Norris, who replaced Carter Burwell as programmer of the PDP
11. Birgitte Lane left us after one year of postdoctoral training and is continuing her
successful work on cytokeratins at the University College, London.
A terrible fire destroyed the entire biochemistry laboratory at 4 A.M. on March 30th. It
caused severe smoke damage in almost every other room of the McClintock building.
Nevertheless, restoration proceeded swiftly, and we were back in operation in less than
one month's time. We are very grateful to the crew of the Buildings and Grounds
Department, who responded quickly, cleared out the rubble, and restored the building
by efforts far beyond the call of duty.
Detailed reports of published work by the group are given below.
CELL MOTILITY
G. Albrecht-Buehler, S. Bose, A. Bushnell, A. Ca lasso, T. Lukralle, M. Schwartz, M. Szadkowski
The Autonomous Movements of
Cytoplasmic Fragments
G. Albrecht-Buehler
Most cell biologists in the past and many today
believe that animal-cell movement is random.
Regardless of how complex a machine, if it acts
randomly, at least one of its mechanisms must be
intrinsically indeterminate. Tissue-cell migration
involves complex extension and ruffling of the
cell's leading edge, the appropriate sequence of
making and breaking attachments to the substrate,
and the retraction of the ever-narrowing tail at the
rear of the cell. Consequently, at least one or
another of these crucial mechanisms is ultimately
caused by random thermal fluctuations of the
cytoplasm or by a similarly stochastic event, if cell
movement is to be random. (In the machines of
human technology, such random causes can
occur accidentally as "bad electrical contacts" or
"loose screws" or deliberately as built-in "random
number generators.") It seems safe to assume that
moving cells do not carry around "bad electrical
contacts" or "loose screws" all the time. A billion
years of development of cells should have greatly
reduced the occurrence of such faults in the
design. Therefore, the hypothetical randomizer of
cell movement should be considered a deliberate
feature of the construction of the cell's motile
machinery.
How so? Animal-cell movement is crucial for
embryonic development, wound healing, and for
the immunocompetent cells to reach and attack
invading microorganisms. In each case, the cells
arrive at certain goals with accuracy. Even the
destructive aspect of cell migration, namely, the
metastasis of malignant cells, shows amazing
accuracy in the way cancer cells reach target
organs. Why then should the mechanisms of cell
motility need a built-in randomizer if the cells are
to reach their goals accurately? Are there not
enough unforeseeable disturbances along the way
of migrating cells?
Therefore, the question of control of movement
is central to my interest. If there is control, we have
to conclude that cells are able to collect and
process data about their spatial environment and
do not merely react chemically to their chemical
environment. Data-processing capacity in single
tissue cells would open entirely new avenues of
thinking and research. In particular, malignancy
and aging may be approached with the thought in
mind that possible changes of molecular com-
ponents are causes or consequences of changes in
the "programs" of data-processing cell centers.
One experimental result of this past year seems to
be of particular importance to this question.
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A moving cell appears to contain smaller units,
each able to move autonomously. I suggest these
units be called "microplasts." One can prepare
them experimentally by treating the cells with the
drug cytochalasin B, which causes the cells to
retract their cytoplasm, leaving many thin strands
of cytoplasm still spanning the distance to the
former cell periphery ("arborization"). After the
cells are washed away from the substrate, their
peripheral attachment points are left behind on
the substrate and heal at the breakage points. They
can be removed from the substrate in order to be
plated on new ones. Once plated on new
substrates, the former attachment areas of the
cells, now isolated from the cell, show a surprising
spectrum of cellular movement. They are able to
flatten; ruffle (Fig. 1A); bleb; wave filopodia;
retract from the contact with another cell; or-
ganize microfilaments, microtubules, and inter-
mediate filaments (Fig. 1B); and respond to drugs
that interfere with cellular movement, such as
colchicine and cytochalasin B. All these expres-
sions of motility are usually only observed in intact
cells, but they are found in those portions of the
cytoplasm that consist of about 2% of the cell
volume. The only known living fragments of
cytoplasm that are smaller than microplasts are
blood platelets. They are about 25% of the
microplast volume and are able to express very
limited movement. In other words, microplasts
may be the smallest units of cytoplasm that can
autonomously express the entire spectrum of cell
movement. In a sense, one may consider them to
be elements of amoeboid movement ("amoeboid
movement" is meant to indicate cell movement
involving complex shape changes, as opposed to
the longitudinal contraction of a muscle cell or
locomotion by beating cilia and flagella). It is
important to note that microplasts cannot migrate,
and whatever type of movement they express,
they seem to continue it indefinitely in a stereo-
typical way.
Considering the problem of control of cell
movement, the existence and properties of micro-
plasts have far-reaching implications:
1. Since cells contain cytoplasmic fragments that
move autonomously, there must be communi-
cation between parts that attunes them to
one another. Without such communication,
each part would engage in its own autonomous
movements, thus causing paralysis, tremor, or
fibrillation of the entire cell.
2. Such communication would still be insufficient
to allow the cell to migrate, because each
portion is incapable of displacement. Con-
sequently, there must be a mechanism that









Aspects of microplasts. Bar indicates 1 cm. (A) Sequence of a ruffling microplast taken from a time-lapse video
recording. The microplast ruffles all around its perimeter; it is essentially an isolated ruffle. (For size comparison,
see C.) (B) Typical ultrastructure of microplasts from human fibroblasts. A circular arrangement of microfilaments
(mf) surrounds a core of intermediate filaments (if) which are intermingled with vesicles and organelles.
Microtubules (not shown) loop freely through the interior of microplasts despite the absence of centrioles.
(C,D) Size comparison between the edge of a 3T3 cell (C) and one of the smallest blebbing microplasts (D) we found.
cytoplasmic portions by appropriate strategies. the proper time sequences, which are neces-
The extension of the leading cell edge followed sary for cell migration, cannot arise from
by the retraction of its trailing tail and the communication alone. Therefore, one has to
making and breaking of substrate contacts in postulate the existence of a strategy-issuing
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mechanism in cells, i.e., a control center of
movement.
3. There seem to exist long-lived determinants
for each type of cell movement within micro-
plasts, as suggested by the stereotypical repeti-
tion of their movement.
Therefore, the existence of microplasts points to
the existence of one or more communicating
cellular control centers of movement. Whatever
this control center may turn out to be-one may
consider centrioles as suitable candidates-its
existence calls for a revision of the concept of
random movement and also more seriously poses
the question of whether important expressions of
aging and cancer lie in alterations of such a control
center of cells.
The Use of Monoclonal Antibodies to Probe
the Common Antigenic Sites between
Tropomyosin and the vimentin -type of
10-nm Filaments in Nonmuscle Cells
S. Blose and J. Lin
Several studies have suggested an association be-
tween tropomyosin and 10-nm filaments (Uehara
et al., J. Cell Biol. 50: 484 [1971]; Blose and Chacko,
J. Cell Biol. 70: 459 [1976]; Lazarides, in Cell
Motility, p. 347, Cold Spring Harbor Laboratory,
NY [1976]). To investigate this possibility, mono-
clonal antibodies were prepared against gizzard
tropomyosin according to the methods of Kohler
and Milstein (Nature 256: 495 [1975]). Supernates
from the cloning wells were screened by immuno-
fluorescence to locate clones that stained cells
with the tropomyosin pattern and/or the 10-nm-
filament pattern. A clone was found, LCK-16, that
exhibited both staining patterns in the same gerbil
fibroma cells (IMR-33). Both staining patterns
were blocked by preabsorbing the LCK-16 anti-
body with either purified vimentin (from IMR-33
cells) or gizzard tropomyosin. Furthermore, if the
IMR-33 cells were extracted with 0.1% Triton X-
100,1 M KCI, 2 mm DTT in 10 mm Na/PO4 at pH 7.5,
the tropomyosin staining pattern was abolished
but not the 10-nm-filament pattern. Tropomyosin
and vimentin were then purified from 35S-labeled
IMR-33 cells. Binding of LCK-16 antibody to both
of these proteins could be demonstrated by
immunoprecipitation. Studies in progress are
directed at (1) determining the kinetics of LCK-16
antibody binding to both molecules to determine
whether they have equivalent affinities and (2),
determining, by proteolytic cleavage and immu-
nologic methods, the peptides that share common
antigenic sites.
Maintenance of Cytoplasmic Continuity
between Daughter Cells Long after Mitosis
S. Blose and E. Schulze
Daughter HeLa cells and IMR-33 (gerbil fibroma)
cells connected by a fine cytoplasmic bridge,
containing the midbody, were unilaterally micro-
injected with small fluorescent molecules to
determine whether cytoplasmic continuity is main-
tained. Sodium fluorescein (SF; Mr= 376.3) and
fluorescein isothiocyanate-conjugated goat IgG
(FITC-IgG; M, = 148,000) were pressure-microin-
jected (Feramisco, Proc. Natl. Acad. Sci. 76: 3967
[1979]), and Lucifer Yellow CH (LY; M, = 457.3) was
injected by iontophoresis with constant-current
hyperpolarizing pulses (Stewart, Cell 14: 741
[1978]). Cells were observed immediately after
microinjection. In each case, the fluorescent
molecules were introduced into one of the two
daughter cells connected by the cytoplasmic
bridge. Cells injected with SF and LY showed
diffuse fluorescence equally distributed between
daughter cells. Cells injected with the larger
molecule, FITC-IgG (Fig. 2A-D), showed diffuse
fluorescence unequally distributed (higher in the
injected daughter cell) together with nuclear
exclusion of FITC-IgG. It could be argued that
pressure microinjection may force the dye through
a diaphragm created by the midbody, but the
iontophoretic injection of LY is a less-invasive
technique and gives the same results. The fact that
FITC-IgG was excluded from the nucleus of
injected cells shows that a larger-M, protein can
cross through the cytoplasmic bridge and was not
contaminated with unbound fluorochrome. On
the basis of video-tape, time-lapse studies, in HeLa
cells the cytoplasmic bridge between two daugh-
ter cells is maintained for an average time of 4.25
hours (range 1-16.8 hr) and in IMR-33 cells, for an
average time of 2.5 hours (range 1.25-3.6 hr). There
is considerable movement of this bridge (Fig. 2E,F),
as observed by oscillations in the position of the
midbody. Peristaltic undulations of the membrane
and vacuole movement (Fig. 2E,F), reminiscent of
slow axoplasmic flow (Pomerat et al., in The
Neuron, p. 119. Elsevier, NY [1967]), were fre-
quently observed. These results indicate that
postmitotic HeLa and IMR-33 cells maintain cyto-
plasmic continuity, through the cytoplasmic bridge,
to small molecules. This continuity can remain for
Figure 2
Phase (A and C) and fluorescence (B and ID) micrographs of living daughter HeLa cells unilaterally microinjected
with FITC-IgG. Unequal diffuse fluorescence (more intense in the injected cell) was observed in the cell pairs
together with nuclear (Nu) exclusion of the molecules. Arrowheads indicate the position of the midbody and
cytoplasmic bridge. Sequences observed with video-tape, time-lapse microscopy (E and F) of the cytoplasmic
bridge revealed movements of vacuoles (arrowheads) and oscillation of the midbody(*). The vacuole inE moved
an average velocity of 1.54 pm/min, and the vacuole in F moved 1.22 pm/min. Sequences in E are 1.16 min apart,
and the sequences in F are 24 sec apart.
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a considerable length of time, extending into G,
and even S or Gz. Passive diffusion might be
augmented by the dynamic movement of the
cytoplasmic bridge to facilitate transport of mo-
lecules between daughter cells.
E. Schulze (University of California at Berkeley), was
a participant in the Undergraduate Summer Research
Program.
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CELL BIOCHEMISTRY
K. Burridge, J. Feramisco, J. Lin, L. McCullough, B. McLaughin, S. Queally
Living cells display an impressive range of move-
ments that involve both the internal organelles
and the cell surface, the latter frequently leading
to cell locomotion. It is the objective of this group
to understand the function and organization of
the structural proteins involved in generating
these movements.
a-Actinin
K. Burridge, J. Feramisco
During the past year, we have continued our
studies on the protein a-actinin. This protein was
first identified in the Z lines of skeletal muscle but
has since been recognized as an integral compo-
nent of the bundles of microfilaments that are
prominent in many cultured cell types. Because of
its location at the Z line in muscle, attention has
for some time been focused on its possible role in
the attachment of actin filaments to the Z line.
Likewise in nonmuscle systems, a role was pro-
posed for a-actinin in the attachment of actin
filaments to membranes. In last year's report, we
described experiments that we had done which
suggested that such a role was unlikely. One of the
most interesting properties of a-actinin is its ability
to cross-link actin filaments. When a-actinin is
mixed with filamentous actin in vitro, it will cause
marked gelation of the actin. This property of
gelation is particularly interesting, since crude
extracts of various nonmuscle cells and tissues will
also form gels under appropriate conditions.
Analysis of these gels shows actin to be the major
constituent, but a number of other proteins are
also seen and some have been identified as actin
cross-linking proteins or gelation factors. A pro-
tein with a similar molecular weight to that of a-
actinin has been identified in these gelled extracts,
and we hope to resolve whether it is, indeed, a-
actinin. One of the characteristics of this gelation
of crude cell extracts is that gel formation is
inhibited by low calcium concentrations. We are
currently investigating whether the gelation of
actin by a-actinin is also sensitive to calcium.
We not only are examining the gelation activity
of muscle a-actinin, but also have been studying
nonmuscle a-actinin in this respect. We have
purified a-actinin from HeLa cells and are examin-
ing the properties of this isolated nonmuscle a-
actinin in detail. In our previous work, we
identified the a-actinin in HeLa cells as a tight
doublet of bands on SDS gels, and now we have
been able to separate these two forms chromato-
graphically. It appears unlikely that one is a
proteolytic breakdown product of the other, since
both types can be identified as products of cell-
free translations of mRNA (in collaboration with
Paul Thomas, Protein Synthesis section). The
properties of the two forms appear very similar;
both show binding to actin that is competed by
tropomyosin at 37°C and both will cause actin
gelation. The significance of two forms of non-
muscle a-actinin within a single cell remains to be
resolved.
Vinculin (Focin)
J. Feramisco, K. Burridge
Last year we described our work on a new smooth-
muscle protein that has a molecular weight of
130,000. This protein was first described by Geiger
(Cell 18: 193 [1979]), who showed that it was also
found in fibroblasts at the ends of the actin
microfilament bundles where these terminate at
adhesion plaques. We confirmed Geiger's finding
and also showed that the protein was found in
close association with the cell-surface protein
fibronectin, another region of interaction be-
tween actin filaments and the membrane. On
account of its prominent focal distribution, as seen
by immunofluorescence, we suggested the name
"focin" for this protein. Geiger and his colleagues,
however, have adopted a different name for this
protein, "vinculin," derived from the Latin vincu-
lum, meaning a link in a chain, with the implica-
tion that this protein has a role in linking actin to
the membrane (Geiger et al., Proc. Natl. Acad. Sci.
77: 4127 [1980]). We have adopted this name for
the protein, although we question whether it does
have a linking function. Examining this possible
function, we looked for the presence of vinculin in
isolated HeLa plasma membranes, but we were
able to detect little or no vinculin in these
preparations, even though they were rich in
associated actin. It may be, therefore, that vinculin
functions not in the attachment of individual
filaments, but in the organization of whole
bundles of filaments at attachment sites. Such
bundles are absent from the HeLa membranes we
have analyzed. The HeLa cells are rich in vinculin,
and, as with the a-actinin, we have purified
vinculin from these cells. Jockusch and Isenberg
(Cold Spring Harbor Symp. Quant. Biol. [1981], in
press) have found that vinculin from smooth
muscle causes a decrease in the viscosity of F-actin,
which they interpret as the formation of large
bundles of actin induced by vinculin. By in vitro
biochemical analysis, we have also found that
vinculin causes a decrease in the viscosity of F-
actin. However, we believe that this is due to the
binding of vinculin to the end(s) of the filaments
and blockage of the elongation reaction of actin.
Interestingly, we have found that the vinculin
from HeLa cells requires Ca++ to exhibit this
activity. Knowing what vinculin interacts with
might give us a clue as to its function, and so we are
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currently using a variety of techniques to try to
identify the cellular components that interact with
thiS protein. Likewise., the function of vinculin may
be' revealed by the microinjection into live cells of
antibodies against vinculin so as to block its
function. The recent successes with antibodies
against components of intermediate filaments (see
below) encourage us in this direction.
A New Muscle Protein
J. Feramisco, G.P. Thomas
As part of our continuing efforts to understand the
organization of the cytoskeleton and its compo-
nents, we have been investigating some of the
minor proteins that copurify with known cyto-
skeleton components. In the course of fraction-
ating smooth muscle, we recognized a hitherto
undescribed protein with a molecular weight of
152,000 (152K), which has proved to be of particu-
lar interest because of its restricted tissue distribu-
tion and its relationship to vinculin.
We have shown that the 152K protein and
vinculin are very closely related: Peptide mapping
indicates that these two proteins share extensive
structural homology, although as yet we have not
determined in what respect(s) they differ. Im-
munologically, the two proteins are indistinguish-
able, using polyclonal sera, because of extensive
cross-reactivity: Rabbit antiserum raised against
either one of the purified proteins recognizes
both in immunofluorescence and immunopre-
cipitation assays.
The 152K protein appears to be restricted to
muscle tissue (mainly smooth muscle), whereas
vinculin seems to be ubiquitous. This result is
obtained when either 152K or vinculin antiserum
is used. Immunoprecipitation of the cell-free
translation products of mRNA derived from dif-
ferent tissues not only supports the results ob-
tained by fluorescence and precipitation, but also
argues against a precursor-product relationship
between 152K and vinculin. Vinculin, but not
152K protein, is programmed with fibroblast
mRNA; however, both are synthesized in re-
sponse to smooth-muscle mRNA and to a mixture
of fibroblast and smooth-muscle mRNA prepa-
rations.
The discovery of the 152K protein emphasizes
the need for a thorough characterization and
determination of the antigens present in different
tissues when employing antibodies characterized
in one tissue as probes for an antigen in other
tissues. Thus, in smooth-muscle cells, anti-vinculin
serum will recognize both 152K protein and
vinculin and will indicate coincident localization,
whereas in truth there may be distinct intracellular
distributions of the two proteins, a problem that
may be important in the work of Geiger et al.
(Proc. Natl. Acad. Sci. 77: 4127 [1980]) which
examined vinculin in smooth muscle. Since they
appear to be separate gene products (either of the
same gene via differential processing or of related
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genes), it is attractive to hypothesize that the
restricted tissue distribution of the 152K protein
indicates distinct roles for these two related
proteins in the organization of the cytoplasm and
that expression of the gene(s) is strictly regulated
in different tissues reflecting these different roles.
A Regulatory Element of Nonmuscle
Stress Fibers
J. Feramisco, K. Burridge
The contractile cycle of skeletal muscle is regu-
lated by the influx of calcium. Calcium ions bind to
troponin, which permits the active interaction be-
tween myosin and actin, leading to ATP hydroly-
sis and contraction. Initially, it was anticipated that
both smooth-muscle and nonmuscle cells would
employ the same mode of regulating actomyosin
interaction. Troponin, however, appears to be
absent from these cells, and, instead, a Ca"-
regulated protein kinase has been found that will
phosphorylate the 20K myosin light chain. In vitro
this has two effects on myosin. First, this leads to a
stimulation of the actin-activated ATPase of myo-
sin, an effect that is functionally similar to the
effect of Ca'. on troponin in skeletal muscle.
Second, this phosphorylation induces the aggre-
gation of myosin molecules into short bipolar
filaments. It will be important in our understand-
ing of the regulation of nonmuscle contractile
events to know whether the myosin light chain
kinase exerts these effects on myosin in living cells.
As a first step toward answering this question, we
have asked where the light-chain kinase is local-
ized in nonmuscle cells and whether this location
is such that it could regulate the interaction of
actin and myosin in these cells.
In collaboration with P. de Lanerolle and R. S.
Adelstein (NIH), we have used immunofluor-
escence microscopy to study the localization of
the light-chain kinase. This has revealed that the
most prominent location of this enzyme in several
cell types (chick fibroblasts, human fibroblasts,
and gerbil fibroma cells) is along the stress fibers or
bundles of actin microfilaments. In some cell types
(e.g., the gerbil fibroma cells), this enzyme displays
a regular periodic distribution along the stress
fibers (see Fig. 1). By double antibody staining
techniques, we have shown that this distribution
closely corresponds to the distribution of both
myosin and tropomyosin but alternates with the
distribution of a-actinin. This close association
with both actin and myosin in nonmuscle cells
suggests that it is localized such that it could
regulate their interaction and also regulate the
formation of myosin filaments in live cells.
MicroinJection of Fluorescently Labeled
Proteins into Living Cells
J. Feramisco
Our interests in the molecular mechanisms of cell
movement have led us to look at the dynamic
Figure 1
Fluorescent micrograph of a gerbil fibroma cell stained
with myosin light-chain kinase antibodies.
changes of several of the actin-stress fiber com-
ponents within the living fibroblast. As described
in last year's report, we have been involved in the
development of the experimental approach ex-
tended from Taylor and Wang's work (Proc. Natl.
Acad. Sci. 75: 857 [1978]), in which purified
structural proteins of the cells, labeled with
fluorescent dyes to render them visible to the eye
with a microscope, are microinjected into living,
motile fibroblasts, using the injection technique of
Graessmann (Proc. Natl. Acad. Sc!. 73: 366 [1976];
Feramisco, Proc. Natl. Acad. Sci. 76: 3967 [1979]).
Similar experiments with a different component of
cells were done independently by Kreis et al.
(Proc. Natl. Acad. Sci. 76: 3814 [1979]) in Switzer-
land. We have documented that for fluorescently
labeled a-actinin and vinculin (focin), the proteins
are assembled into the appropriate supramolec-
ular structures within the living cells within 1-2
hours after injection (Feramisco and Blose 1980;
Burridge and Feramisco 1980a).
Working in collaboration with C. Keith and M.
Shelanski (New York University), we have been
able to apply this experimental approach to a
second filamentous system in cells: microtubules
(Keith et al., 1981). Microtubules have been
implicated in many cellular events, including
mitosis, certain types of prey-catching, and organ-
elle movements; thus, the ability to observe the
dynamics of these filaments during these cellular
events should prove to be useful in establishing
the functions of the microtubules.
Detailed recordings of the distributions of these
important components of the actin filamentous
network and the microtubular network have yet
to be made; work in our laboratory and further
collaborative efforts with Keith and Shelanski, who
are setting up a sophisticated time-lapse system for
this purpose, are under way to carry out these
experiments.
Monoclonal Antibodies to Cytoskeletal
Proteins
J. Lin
Monoclonal antibodies against cytoskeletal com-
ponents have the potential not only for improving
the immunofluorescent localization of specific
proteins within cells, but also for analyzing the
functional sites of specific proteins and identifying
the previously unidentified proteins. Furthermore,
they can be used together with microinjection
techniques to investigate the physiological roles of
specific proteins.
We have prepared several monoclonal anti-
bodies against a variety of cytoskeletal com-
ponents by fusing myeloma cells with the spleen
cells of mice immunized with crude cytoskeletal
preparations from chicken gizzard. This strategy
was designed with the aim of generating mono-
clonal antibodies not only against known cyto-
skeletal proteins, but also against previously
unidentified components. Such fusions have given
rise to monoclonal antibodies directed against
known structural proteins, such as actin, filamin,
and fibronectin, and against new components
that we are now characterizing. The monoclonal
antibody (JLA20) against actin shows wide species
and cell-type cross-reactivity, binding to both
muscle and nonmuscle actin types. JLA20 may
become useful as a standardized reagent for cell
biology. Three different monoclonal antibodies
(JLA8, JI.A10, and JLA17) were raised against
filamin. These antibodies interact with different
tryptic fragments of the protein.
We have also prepared two interesting mono-
clonal antibodies, JLB1 and JLB7, from fusion
experiments using a total myofibril fraction as the
antigen and screening the resulting hybrids on
fibroblasts. This screening method would detect
only those hybrids that produced antibodies
reacting with antigenic determinants shared in
common between the myofibrils and fibroblasts.
Monoclonal antibody JLB1 recognizes an antigen
that is distributed in the M-line region and on
either side of the Z line of myofibrils, whereas
monoclonal antibody JLB7 reacts with an antigen
located at the M-line region of myofibrils. Both
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JLB1 and JLB7 antibodies decorate the typical
intermediate filaments of a variety of cultured
cells. Immunoprecipitation, using chicken em-
bryo fibroblasts, has revealed protein bands at
210K and 95K, and these have been identified as
the antigens recognized by JLB1 and JLB7 anti-
bodies, respectively. The biochemical properties
of these intermediate-filament-associated proteins
remain to be determined. Starger et al. (I. Cell Biol.
78: 93 [1978]) have found a minor protein com-
ponent with a molecular weight between 250,000
and 350,000 that copurified with the intermediate-
filament preparations from BHK-21 cells. Also,
Granger and Lazarides (Cell 22: 727 [1980]) have
found a protein, synemin (230K), of the inter-
mediate filaments from smooth muscle. The larger
antigen (210K) recognized by JLB1 antibody may
correspond to these other proteins.
Three monoclonal antibodies (LCK16, J LH2, and
JLF15) have been obtained from fusion experi-
ments using purified tropomyosin as the antigen.
Figure 2 shows the periodic stress-fiber staining
pattern and the polygonal network staining pat-
tern on gerbil fibroma cells by monoclonal
antibody JLF15. Surprisingly, when cells were
stained with monoclonal antibody LCK16, the
intermediate-filament staining pattern, in addition
Figure 2
Fluorescent micrograph of gerbil fibroma cells stained
with monoclonal antibody JLF15 against tropomyosin.
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to the stress-fiber staining pattern, was also
observed. This may suggest that both vimentin, a
major protein of fibroblastic intermediate fila-
ments, and tropomyosin share a common anti-
genic site.
The intracellular localization of vinculin (focin)
to adhesion plaques and the tips of microfilament
bundles led to the suggestion that it may be one of
the components involved in actin microfilament-
membrane interactions (Geiger, Cell 18: 193
[1979]; Burridge and Feramisco, Cell 19:587
[1980]). To study its function, we have made
monoclonal antibodies directed against vinculin.
It is hoped that some of these antibodies will block
functional sites of vinculin, and then we can
introduce the antibody into cells by microinjec-
tion to assess the in vivo function of this protein
(see Microinjection of Monoclonal Antibodies
into Living Cells).
Because our group is interested in the protein a-
actinin, we have also prepared monoclonal anti-
bodies against this molecule purified from chicken
gizzard. Preliminary screening by indirect im-
munofluorescence shows many clones producing
antibodies that can decorate the stress fibers of
chicken embryo fibroblasts. These antibodies will
be powerful reagents and may provide a useful
tool to study in vivo function of a-actinin in muscle
and nonmuscle cells.
Microinjection of Monoclonal Antibodies
Living Cells
J. Feramisco, J. Lin
Complementing our experiments on the in vitro
biochemical analysis of the structural proteins and
their dynamic behavior in vivo, we have embarked
on another approach to determine the physio-
logical functions of those proteins in cell move-
ment and organization. The basic idea is to
introduce into living cells by microinjection highly
specific monoclonal antibodies against selected
intracellular components and to identify the
cellular defects caused by complexing the target
antigen with the antibody. Our first experiments
of this type deal with the intermediate-filament
network of fibroblasts (Lin and Feramisco, 1981).
Monoclonal antibodies that recognize minor
components of the intermediate filaments (Lin,
1981) were introduced into living fibroblasts by
microinjection. Five minutes after injection of the
JLB7 antibody, virtually all of the intermediate
filaments of the cells were found to be aggregated
into tight bundles near the nucleus (see Fig. 3). In
contrast, injection of the JLB1 antibody caused
little or no aggregation of the intermediate
filaments. Electron microscopy showed that the
perinuclear bundles that formed after injection of
the JLB7 antibody each consisted of ten or more
intermediate filaments apparently cross-linked to-
gether. Double-label immunofluorescence showed
Figure 3
Fluorescent micrographs of gerbil fibroma cells stained (A) or microinjected (B) with monoclonal antibody JLB7
against 95K protein.
that virtually all of the vimentin-containing inter-
mediate filaments in these cells were redistributed
to the nuclear region and would remain there for
at least 24 hours. The distributions of the actin
microfilaments and microtubules were seemingly
undisturbed following microinjection. No ob-
vious changes in cell morphology or cell behavior
were apparent in the injected cells; they displayed
a flat appearance; showed a polarity; were able to
bleb and ruffle; and even appeared to show the
normal saltatory movements of intracellular vesi-
cles, granules, and mitochondria, suggesting that
the intermediate filaments are not involved in these
activities. Further experiments to determine what
defects, if any, are present in these cells lacking a
normal intermediate-filament distribution are un-
der way.
Molecular Biology of the Structural Proteins
S. Hughes, G. P. Thomas, J. Feramisco
As work is progressing in our analysis of the
biochemical and functional properties of the
proteins involved in cell motility, we have begun a
major effort toward the analysis of structure,
organization, and expression of the genes en-
coding the structural proteins. By using cDNAs
made against the total mRNA of chicken embryos
as probes, we have selected several hundred
genomic clones from a bacteriophage A library of
the chicken genome. We are in the process of
identifying the proteins encoded by the clones
through the selective hybridization of mRNA to
the genomic DNA clones and cell-free translation
of the mRNA. Two-dimensional gel electropho-
resis is used to aid in the identification of the
proteins (in collaboration with Jim Carrels, Quest-
2D Gel Laboratory). The first structural protein
gene to be analyzed in this manner is that of the ,e-
actin gene; we have obtained an extensive
restriction map, intron-exon structure by R-
looping (in collaboration with Louise Chow and
Tom Broker, Electron Microscopy section), and a
portion of the nucleotide sequence. Studies on
the structure, organization, and expression of this
gene and several others are continuing. (For more
detailed information, see Eukaryotic Gene Struc-
ture and Function section in this Annual Report.)
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QUEST-2D GEL LABORATORY
I. Garrets, F. Matsumura, T. Kelly, C. Burwell, S. Norris, J. Leibold, D. Gibson
Our specialized laboratory for two-dimensional
gel electrophoresis and computer analysis of pro-
teins is now operating routinely. The types of
specially designed equipment in our new facility
were described in last year's report. During the
past year, we have refined and further developed
our equipment, improved some of the electro-
phoretic procedures, carried out control experi-
ments to test the reproducibility of our system,
and further developed our computer software.
We are well into several projects to study the
patterns of protein synthesis and phosphorylation
in human, rat, and mouse cells, and collaborative
work has been done with various other sections of
the laboratory.
The Computerized Laboratory
The gel lab now operates at a steady-state rate of
20 large (22 x 22 cm) two-dimensional gels per day.
Two trained technicians, Tom Kelly and Jessica
Leibold, carry out the daily operation of the gel
lab, as well as other duties such as sample
preparation and cell culture. The use of a micro-
computer to monitor and control various aspects
of gel processing has been very successful in terms
of greater convenience and reproducibility. For
example, each slab gel can be controlled at any
(programmable) wattage, the actual current and
voltage to each gel is automatically recorded
throughout the run, and the gels are automatically
shut off when the ion front reaches the bottom.
Improved procedural aspects include a much-
simplified slab-casting system, a simpler method
for counting TCA-precipitable radioactivity in
samples, and a fast method for preparation of
calibration strips (strips of acrylamide containing
known amounts of radioactive protein that are
used to calibrate the response of each film).
We have designed the gel laboratory for the
routine production of many standardized gels
each week, knowing that such a facility would be
essential for our own work and anticipating that
many others would also find it useful. As can be
seen from the work described below, this has
certainly been the case. The running of this lab at
full capacity means the production of several
thousand samples, over 5000 gels, and over 10,000
films per year. The record-keeping necessary to
handle this load is immense. We have therefore
taken the time to develop a powerful computer-
ized data-management system. The system is based
on intelligent laboratory terminals that can display
many different forms for entry of data. The various
investigators using this system enter the descrip-
tion of their experiments and samples on one of
the forms. After receiving the sample numbers
from the computer, the investigator leaves his
samples in numbered racks in a freezer. To have
his samples run, he merely fills out a simple gel-
request form on which he specifies the types of
gels to be run, the cpm to be loaded, and the
desired exposure levels. The computer then
calculates the dilutions and loads of the samples to
be applied to each gel, and it automatically
schedules the exposures. The lab technicians use
forms compiled by the computer to know what
gels to run each day, what gels to expose to film,
and which films to develop each day. Other forms
are used to record the exact composition, lot
numbers, and quality control data for each
solution that is prepared for gel electrophoresis.
For each gel that is run, we can easily look up the
batch numbers and quality control data for each
reagent that was used. The system has been highly
successful and is being extended to record-
keeping for cell culture and for other laboratory
data-management applications.
Studies of Human Disease
We have used our high-resolution gel system to
analyze numerous human fibroblast lines in the
study of two genetic diseases, cystic fibrosis and
Huntington's chorea. The latter study is being
done in collaboration with I. Fand (State University
of New York at Stony Brook). The lines have each
been labeled with [35S]methionine to study rates of
protein synthesis and with [33P]- phosphate to
study protein phosphorylation. Several thousand
proteins have been detected and are being
carefully compared in the hope that a difference
indicative of the basic genetic defect can be
detected. Differences have been found between
the lines, but most appear to be normal polymor-
phisms in the population. Because so many
proteins are being examined, it is necessary to
look for a protein that is present in many lines that
have the genetic defect, but not in any normal
lines. This is to exclude polymorphism that could
otherwise correlate with the genetic defect only
by chance. No consistent differences between the
normal and mutant fibroblasts have yet been
discovered by visual inspection of the patterns;
however, the examination of more lines and
subcellular fractions is necessary. We have not yet
subjected our data to detailed computer analysis,
which will be necessary to find quantitative
differences, especially among the minor proteins.
A secondary outcome of this study will be a much
better estimate of the degree of polymorphism in
the proteins of normal unrelated individuals.
Cytoskeletal Proteins
With the arrival of Fumio Matsumura, a new
postdoctoral fellow from Japan, we have begun to
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map the major and minor proteins of the cyto-
skeleton of rat fibroblasts and myoblasts. The
objectives are, first, to use two-dimensional gel
electrophoresis to better define the minor com-
ponents of the cytoskeleton and, second, to iden-
tify the regulatory proteins. By examination of
the synthesis and phosphorylation of cytoskeletal
proteins at times of massive cytoskeletal reorgani-
zation, such as mitosis, respreading after trypsini-
zation, or myogenesis, we hope to detect changes
in the critical regulatory proteins. Phosphorylation
is known to regulate nonmuscle contractile sys-
tems, and phosphorylation has been implicated in
cytoskeletal alterations in transformed cells. There-
fore, knowledge of the phosphoproteins of the
cytoskeleton and of the changes of phosphoryla-
tion in different states of cytoskeletal organization
will be important.
We have found that metabolic labeling with
[33P]phosphate, followed by two-dimensional gel
analysis, can give rise to sharp patterns of hun-
dreds of phosphoproteins, in contrast to the result
when 32P is used, which gives much more diffuse
patterns. We have already mapped the phospho-
proteins of L6 myoblasts and myotubes, and
differences of phosphorylation in Rat-1 cells have
been detected during spreading. More studies will
tell us how these changes correlate with other
cytoskeletal states and how the metabolism of
these proteins differs in other cell types. Efforts will
be made to purify the most interesting proteins for
further characterization.
Transformation by SV40
A series of experiments has been initiated leading
to a detailed characterization of rat fibroblasts
before and after transformation by simian virus 40
(SV40). We have obtained many clones of the Rat-1
cell line from Bill Topp (Tumor Virus section), and
these have been analyzed for heterogeneity. Very
little difference has been found between the
clones, although significant differences are appa-
rent when dividing and stationary-phase cells are
compared. Further controls to determine the
effect of serum lots and types are being pursued.
The demonstration of consistent patterns of
protein synthesis, with only small quantitative
differences, between clones indicates that normal




In collaborative work with Steve Hughes (Euka-
ryotic Genes section), Paul Thomas (Protein Syn-
thesis section), and Jim Feramisco (Cell Biochem-
istry section), we have examined the products of
translations directed by mRNA selected from
cloned chick DNA fragments. These experiments
have led to the identification of cloned genes
for several of the actins, tubulin, vimentin, and
other yet unknown proteins. In collaborative work
with Jim Lewis and Mike Mathews (Protein
Synthesis section), we have identified most of the
adenovirus-specific proteins from infected cells
and from in vitro translations directed by adeno-
virus-specific RNA. With Lee Silver (Visiting Scien-
tist from Sloan-Kettering), we have examined the
proteins of mouse cells that carry the mutant t
locus. Consistent with theories that these mutants
are in fact altered over a substantial portion of
chromosome 17, we have found numerous pro-
tein differences (such as small shifts of charge and
molecular weight) that correlate strictly with the
presence or absence of the mutant t chromosome.
The full power of the two-dimensional gel
system relies on detailed computer analysis of our
protein patterns. Our development of image-
processing programs has been carried out in the
past year by Carter Burwell and Steven Norris. A
complete set of programs for scanning the films,
for detection of spots, for combining long and
short exposures of each gel, for matching each
new pattern to standards, and for integration of
the detected spots has been developed. Since the
image-analysis process is time-consuming, we are
presently writing supervisory programs that will
automatically run the merging, matching, and
integration programs in the proper sequence
overnight. With the completion of program test-
ing and debugging, we will begin to match each of
our new patterns to standard patterns and to store
the quantitative data in a set of permanent data
files. Data in this standardized format can be used
for immediate comparison of related cell lines and
cell fractions, and it will be available in our
computer files for comparison to data obtained in
subsequent experiments.
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NEUROBIOLOGY
The Neurobiology summer program underwent two innovative changes during the past
year. In addition to our traditional lecture and laboratory courses, we are now offering a
new type of workshop designed to facilitate the development and the dissemination of
selected new techniques important for neurobiological research. The topic in 1980 was the
internal perfusion or dialysis of isolated nerve cell bodies. The extension and development
of such current techniques are achieved by bringing together several pioneers in the field
who have independently developed versions of a particular method along with
investigators who are interested in learning these techniques.
The second current development was the introduction of small conferences, held at
Banbury Center, whose proceedings are to be published as Cold Spring Harbor Reports in
the Neurosciences. Two such meetings were held this past year: "Molluscan Nerve Cells"
and "Monoclonal Antibodies against Neural Antigens" (see Summer Meetings section).
The year-round Neurobiology group has been greatly enhanced by the addition of Susan
Hockfield to our staff. Susan's expertise in vertebrate neuroanatomy as well as in light and
electron microscopy techniques promises to add an exciting new dimension to the work
already in progress in Jones Lab.
A central issue in Neurobiology concerns the principles underlying neural network
formation. Another major question involves the mechanisms by which network activity
subserving organized behaviors is modulated by chemical moieties such as monoamine
neurotransmitters and peptides. Here at Cold Spring Harbor, we use the leech central
nervous system, with its relatively small number of large, identifiable neurons, as a model
system to address these issues.
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NEUROBIOLOGY
B. Lipser, S. Hockfield, R. McKay
Monoclonal Antibodies Specific for
Identifiable Leech Neurons
B. Zipser, R. McKay
The ability of a nervous system to generate
coherent behavior is dependent on a vast number
of precise connections between neurons. Virtually
nothing is known about the molecular mecha-
nisms that generate these connections, but all
tenable hypotheses ultimately postulate the exist-
ence of molecules that differ in kind or quantity
from cell to cell to mediate the necessary recogni-
tion. The problem of neural specificity is apparent,
since neurons typically receive inputs from and
send outputs to whole sets of other cells, each of
which, in turn, has its own extremely complex
characteristic connection pattern. Connections
are established during development, but the
degree to which marker molecules may be
present in adults is unknown, although regenera-
tion studies in adults imply long-term persistence
of at least some molecular specificity. It has long
been known that there are many chemical dif-
ferences between neurons which involve such
functions as transmitter synthesis. Recent studies
on the identification and localization of neuronal
peptides have now greatly widened the scope of
detectable molecular variation among nerve cells.
The relationship of this chemical variation to the
mechanism of connection is still unknown. To
make progress in this area it will be necessary to
develop ways of relating chemical specificity to
unique connectivity. Since, by hypothesis, the
markers of interest will differ in each neuron with
different connections, these molecules must some-
host be identified in structured material where the
same neuron can be easily identified in repeated
experiments. Such a simple system is required not
only for the identification of specific neuronal
markers, but also for analyzing the rules that
govern the establishment of neuronal connections.
As a step toward this goal, we asked whether
individual cells and subnetworks of the relatively
simple leech nervous system could be distin-
guished by specific antibodies. Since the putative
antigens could, in principle, not be purified a
priori, we used the technique of hybridoma
formation, which allows the isolation of lympho-
cyte clones secreting antibodies specific for indi-
vidual molecules, even though a complex mixture
of antigens was used for immunization. Mono-
clonal antibodies were obtained from lymphocytes
of mice immunized with the entire isolated
nervous system of the leech and screened on
intact ganglia. The results of this study give a clear
answer to the question of the existence of
chemical markers in individual cells and sub-
networks. These specific markers are surprisingly
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abundant, and extrapolation from our initial
sample indicates that it is possible that every cell
has one or more chemical markers shared by only
small subsets of neurons. Although we still know
little about the exact cellular locations of these
markers, many are present in all parts of the cell,
including in the long axonal projections and
neural terminals. Indeed, the situation seems quite
analogous to a color-coded electric cable contain-
ing many wires, where each wire has its own
unique molecule (dye) to facilitate proper recog-
nition and connection at terminals. The existence
of specific markers is far from sufficient to explain
the mechanism of neural connection specifity, but
it does give us a handle on how the problem can
be attacked at a previously inaccessible level. In
addition to any light these monoclonal antibodies
may throw on the mechanism of connectivity, they
will be of value in broadening our understanding
of leech neurobiology, since they clearly elucidate
whole systems of neurons together with their
axonal patterns.
Of the 475 individual hybridomas screened, 3
came from a small preliminary test, 43 from one
major fusion, and 429 from another. Of these, 64%
secreted antibodies that bound to the leech
nervous system. Most showed no obvious prefer-
ence for subsets of neurons but react* with
general nerve-cell components. A few bdund to
interesting subcellular or extracellular structures,
e.g., to antigens specific for the axon hillock of
leech neurons (Lan3-15). Two antibodies recog-
nized muscle antigens and stained the large
muscle fiber present in each ganglion. Of central
concern to us is group 41, which reacted with
restricted subsets of neurons or fibers.
An example is illustrated in Figure 1, which
shows Lan3-1, a monoclonal antibody that binds to
a pair of small bilateral neurons in a midbody
ganglion (Fig. 1B). The right and left cell bodies are
located at homologous positions on the dorsal
surface in each of the 21 midbody ganglia, as
shown diagrammatically in Figure 2, which is a
schematic representation of the leech nerve cord.
In addition to labeling these cell bodies, the
antibody also binds to clouds of varicosities in the
central ganglionic neuropiles as well as to specific
axons in the "connective," the fiber tract that links
all ganglia in the 34-ganglion nerve cord.
Several antibodies that bind to homologous
neurons in successive midbody ganglia bind to
extra neurons in specialized ganglia, in the fused
head ganglion or in the supraesophageal ganglion.




Micrographs of neuronal cell bodies labeled by Lan3-1 in (A) the supraesophageal ganglion, (B) a standard
midbody ganglion, and (C) ganglion 6. The identical cell body that is stained immunocytochemically in C (arrow) is
identified in D through a double-labeling experiment.
twice as many neurons as the standard midbody
ganglion, are specialized to subserve reproductive
function, and many of their supernumerary neu-
rons innervate the genitalia. Lan3-1 recognizes
pairs of large cells in G5 and G6 (Fig. 1C) in
addition to the characteristic pair of small cells
(Fig. 1B). From previous studies it is known that
there is a pair of penile evertor motor neurons (PE)
in G6 with the same position and axonal pattern as
those stained by Lan3-1 in G6 and a homologous
pair in G5 of unknown function. To demonstrate
unequivocally that the large cells stained by Lan3-1
in G6 are the previously identified PE neurons, a
double-labeling experiment using art injected dye
was carried out. A cell body believed to be the left
lateral PE cell was impaled with a microelectrode,
and its identity was confirmed by its characteristic
action potential (20 mV, nonovershooting) and its
synaptic relationship with another major PE cell,
the rostral PE motor neuron. Following electro-
physiological identification, the fluorescent dye
Lucifer Yellow was injected through the recording
electrode (Fig. 1D). To control for the effect of
Lucifer Yellow on antibody staining, the left
Retzius cell in the center of the ganglion was also
injected. After the ganglion was fixed, it was first
incubated with hybridoma supernatant and then
treated with rhodamine-conjugated rabbit anti-
mouse IgG. The results illustrated in Figure 1, C
and D, confirmed that the lateral PE cell contained
the antigen to which the monoclonal antibody
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Figure 2
Diagrammatic representation of the Lan3-1 staining pattern along the entire leech nerve cord.
the intrasomatically applied marker Lucifer Yellow
(Fig. 1D) and red with the rhodamine-labeled
mouse antibody (Fig. 1C).
The subset of neurons labeled by Lan3-1 extends
into the head and tail ganglia as well as into the
supraesophageal ganglion. The head and tail
ganglia contain small pairs of neurons probabl
analogous to the small pair of icells that regularly
repeat in the midbody ganglia. In addition, several
large cells occur in the supraesophageal ganglion
(Figs. 1A and 2).
A
Figure 3
Staining pattern of Lan3-9.
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B
Other antibodies were found that labeled cell
bodies of neurons in the head, supraesophageal
ganglia, or the anterior ganglia but not in any of
the regularly repeating midbody ganglia. An
example is Lan3-9, which binds to neurons in the
supraesophageal ganglion (Fig. 3A). In addition,
antigenically related processes occur throughout
the entire nerve cord, since fibers in the con-
nective and nerve terminals in midbody ganglia
are stained (Fig. 3B,D).
Several of the monoclonal antibodies we iso-
lated bind to mechanosensory neurons present in
the typical 400-neuron midbody ganglion, which
selectively respond to touch, pressure, and pain in
clearly defined receptive fields on the skin of the
leech. The typical mechanosensory cell body
sends its axons (1) into the ipsilateral roots to
innervate its own ganglion's receptive field and (2)
via the ipsilateral connective into neighboring
ganglia to innervate partial receptive fields in
adjacent body segments. These neurons have
been extensively characterized electrophysiolo-
gically and through intracellular marker injections.
The four neurons responding to noxious me-
chanical stimuli (the nociceptive cells) all share a
common antigen recognized by the monoclonal
antibody Lan3-2 (Fig. 4D). This antigen is present in
the cell body and all along the axonic and neuritic
processes. It labels the ipsilateral projections and
A
highlights a dense railroad-track-like pattern aris-
ing from the close packing of right and left axons
running through the nerve cord. The monoclonal
antibody Lan3-5 (Fig. 4C) labels the cell bodies and
processes of three pairs of unidentified neurons
and the two pairs of pressure cells. The pressure
cells confine their axons to the ipsilateral ganglion
and connective, whereas the unidentified neu-
rons cross to the contralateral side, which allows
them the possible role of integrative interneurons.
The antibody Lan3-6 binds to about 26 neurons,
including the pressure cells, possibly the touch
cells, and unidentified neurons (Fig. 4B) in the
typical posterior midbody ganglion. An additional
antibody that binds to pressure cells is Lan3-7 (Fig.
4A). It is likely that these antibodies bind to
different pressure-cell antigenic determinants as
they stain different sets of neurons.
Figure 4




Opioid Peptides and Receptors
B. Zipser, G. Stefano, J. Farrar
During this past year research aimed at peptidergic
network modulation was carried out largely by
collaborative efforts during winter workshops
and the Pain Workshop (see below). J. Farrar
(Uniformed Services University of Health Sciences,
Bethesda, Maryland) has assayed leech tissue for
Met-enkephalin in a radioimmunoassay using an
antiserum with very low cross-reactivity to Leu-
enkephalin. A whole leech nerve cord contains
2-3 pmoles of Met-enkephalin-like immunore-
activity. Currently, we are using the same anti-
serum to localize in immunocytochemical experi-
ments neurons carrying this chemical moiety.
Collaborative experiments with G. Stefano (Med-
gar Evers College, Brooklyn, NY), have provided
evidence for opiate-receptor-binding sites in the
leech CNS (Fig. 5). Experiments aimed at their
anatomical localization are in progress in col-
laboration with C. Pert (NIH). In electrophysio-
logical research, Leu-enkephalin and Met-en-
kephalin effects or those of their more stable
analogs are now being assayed on identified
neurons.
The Effect of Serotonin on the Leech Mating
Behavior
E. Mc Glade, W. Higgins, B. Zipser
Experiments directed at the monoaminergic mod-
ulation of leech mating behavior were begun in















Opiate-receptor-binding sites demonstrated in bio-
chemical experiments using the stable Met-enkaphalin
analog (o-Ala2)-Met-Enkephalin.
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Maryland) during a winter workshop. They are
currently being continued full time by E. Mc Glade
and W. Higgins (University of Maryland, Balti-
more). Cholinergic and serotonergic neurons are
found in the vicinity of the leech penile eversion
muscle (PEM), and acetylcholine introduces con-
tractures of this muscle. Contractures of the PEM
induced by either acetylcholine or electric-field
stimulation are potentiated by low doses of
serotonin (5 x 10-9 n.4). In addition, serotonin
accelerates relaxation. However, serotonin by
itself does not alter the resting tension. Other
biogenic amines investigated (norepinephrine,
epinephrine, and dopamine) do not alter the
resting tension or the acetylcholine-induced re-
sponse. The purpose of this investigation is to
determine the basis for the change in acetyl-
choline responses produced by serotonin. This
information would help to characterize the role of
serotonin in the regulation of PEM contractility
and perhaps clarify a modulatory role that amines
play in intercellular communication.
To characterize the effects of serotonin, the site
of action of serotonin must be determined. If the
cholinergic receptor sites on the muscle are
effectively blocked and serotonin still alters the
events induced by electric-field stimulation, then
serotonin acts on the muscle. The PEM acetyl-
choline receptor is atypical; it is not blocked by
conventional cholinergic blocking agents (D-tubo-
curarine, hexomethonium, or atropine). How-
ever, benzoquinonium is a potent acetylcholine
antagonist in this system (5 x 10-6M benzoquinon-
ium inhibits 10-' M acetylcholine). Knowledge of
the potent acetylcholine antagonist should facili-
tate further study of the site and mode of the
action of serotonin.
In experiments utilizing benzoquinonium, sero-
tonin continued to potentiate the response elicited
by electric-field stimulation and accelerated re-
laxation. These data suggest that serotonin acts on
the muscle, but they do not exclude the possibility
that serotonin also acts at the cholinergic motor-
neurons.
Publications
McGlade, E., W. Higgins, and B. Zipser. Effect of
serotonin on leech mating behavior. (In prepa-
ration.)
Zipser, B. 1980. Identification of specific leech
neurons immunoreactive to enkephalin. Nature
283: 857.
Zipser, B. and R. McKay. 1981. Monoclonal
antibodies distinguish identifiable neurons in
the leech. Nature (in press).
Stefano, G. and B. Zipser. Opiate receptor binding
in the leech. (In preparation.)
Invertebrate Neurobiology Workshop, April 3-April 30
ORGANIZER
Augustine, George J., Ph.D., University of Maryland, College Park
In 1980 the Invertebrate Neurobiology Workshop
followed closely the spirit and intent of the
previous year's workshop. The major emphasis
was again on localized neural networks and how
they may be influenced by neurohormones. This
problem, although of general relevance to the
function of all nervous systems, can be advan-
tageously studied in invertebrates because of the
relative simplicity of many invertebrate nervous
systems and the ease with which these simple
nervous networks can be isolated and maintained
in vitro. Much attention was focused on the
nervous system of the horseshoe crab ( Limulus),
with other work done on the leech. One novel
feature of the workshop was the interest of several
participants in neuropeptides, molecules that are
currently receiving much attention_ as potential
neurotransmitters or neurohormones in many
nervous systems.
One avenue of study in Limulus involved
identification of potential neurohormones and
their sites of action. J. Benson, W. Watson, and G.
Augustine found that the neuropeptide proctolin
excited Limulus heart muscle and, in conjunction
with R. Sullivan at the University of Hawaii, found
that a proctolinlike peptide was found in the
cardiac ganglion, in close association with the
heart muscle. Another peptide was isolated from
the Limulus nervous system by R. Dores; this novel
peptide was found to act upon neurons of the
Limulus cardiac ganglion in experiments by W.
Watson and G. Augustine. W. WatsoWand G. Wyse
considered the role of biogenic amines as neuro-
hormones in Limulus by measuring circulating
levels of amines and correlating these measure-
ments with behavioral activity. They found that
dopamine, an amine previously found in the
Limulus nervous system, fulfilled many of the
criteria required of a circulating neurohormone.
The clotting reaction of Limulus blood cells was
studied by E. McGlade, to consider how blood
clotting was affected by biogenic amines that
circulate in the blood.
The second series of Limulus projects involved
characterization of the cardiac ganglion, a small
neural network that is the target of several
apparent neurohormones. P. Riordan and G.
Augustine examined the ultrastructure of cardiac
ganglion neurons to identify individual neurons,
their connectivity, and content. The physiological
properties of cardiac ganglion motoneurons were
analyzed by D. McCulloh and G. Augustine in an
attempt to determine the ionic mechanisms that
permit these cells to generate rhythmic electrical
activity. M. ladarola also examined the cardiac
ganglion network, determining the effects of
antiepileptic drugs on cardiac ganglion electrical
activity.
The possible physiological roles of opiate pep-
tides in the leech nervous system were considered
by J. Farah and B. Zipser. They used immuno-
cytochemical techniques to discover identifiable
neurons that may contain the opiate peptide
Met-enkephalin.
In summary, through the use of a variety of
approaches, the participants in this workshop
were able to identify several roles that various
neuropeptides and amines may play in regulating
the activity of neural networks.
PARTICIPANTS
Benson, Jack A., Ph.D., Friedrich-Miescher Institut, Basel, Switzerland
Dores, Robert M., Ph.D., University of Colorado, Denver
Farah, John M., B.S., Uniformed Services University, Bethesda, Maryland
ladarola, Michael J., Ph.D., Georgetown University, Washington, DC
McCulloh, David H., M.S., University of Maryland, College Park
McGlade, Ellen K., M.S., University of Maryland, College Park
Riordan, G. Patrick, M.S., Georgetown University, Washington, DC
Watson, Winsor H., Ph.D., University of New Hampshire, Durham
Wyse, Gordon A., Ph.D., University of Massachusetts, Amherst
PRESENTATIONS
Augustine, G. Alterations in neurotransmitter release produced by the food dye Erythrosin B.
Benson, J. Cyclic AMP is the second messenger in the physiological response of a mollusc neuron to
5-hydroxytryptamine.
Dores, R. Endorphins in the lizard nervous system.
Farah, J. Dopaminergic inhibition of /3- endorphin secretion in the rat.
ladarola, M. Compartmentalization and metabolism of GABA in the mammalian central nervous
system.
McCulloh, D. Membrane events associated with fertilization of the rabbit egg.
Stewart, W., National Institutes of Health, Bethesda, Maryland. Use of the fluorescent dye Lucifer
Yellow in the study of neuronal structure.
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Workshop on Intracellular Staining withLucifer Yellow, April 3-April 30
ORGANIZERS
Stewart, Walter W., B.A., NIAMDD, National Institutes of Health, Bethesda, Maryland
Keyser, Kent, Ph.D., NIAMDD, National Institutes of Health, Bethesda, Maryland
To facilitate our work on the morphology of
identified neurons in isogenic lines of snails, we
needed some fairly rapid ways of characterizing
both the physiology and the morphology of a
single cell. Two methods were developed from
studies carried out jointly at Cold Spring Harbor
Laboratory and the National Institutes of Health.
These new methods, which we are currently using,
will probably be useful to other neurophysiolo-
gists as well.
Locating Individual Neurons in the Electron
Microscope by means of a Fluorescent Dye
Ordinarily, it is quite difficult to recognize a
particular neuron in thin section using an electron
microscope. A couple of methods have been
used, but none were suitable for our purpose. We
developed a novel method based on the intra-
cellular injection of the fluorescent dye Lucifer
Yellow CH.
A single live neuron is impaled with a dye-filled
electrode, and the dye is ejected iontophoreti-
cally. The tissue is then fixed in an aldehyde-
containing fixative and processed as usual for
electron microscopy, but with one important
difference. Osmium tetroxide quenches the fluor-
escence of Lucifer Yellow (and of almost all
fluorescent compounds) and therefore cannot be
used. It was possible to generate adequate con-
trast by treating the tissue with an acetone solution
of hafnium tetrachloride in the cold. Typical
results are shown in Figure 1. A giant neuron in the
right parietal ganglion of the snail B. glabrata was
injected with dye, treated as described, and thin-
sectioned. The silver section, about 700 A thick,
was picked up on a hexagonal grid and viewed in a
fluorescence microscope (Fig. 1A). The injected
cell is immediately apparent. When the same
section was viewed with the electron microscope
after lead and uranium staining (Fig. 1B), the
injected cell was easy to identify in the electron
micrograph by correspondence with the light
micrograph. Figure 1 C and D, which are details
PARTICIPANTS
from Figure 1 A and B, respectively, show that a
very precise match can be made between the two
images. In the same way, very fine processes of the
injected cell can be recognized in complex
neuropil. Figure 1E is a further enlargement of the
electron micrograph and shows that the ultra-
structural preservation is quite good, although the
definition of the membranous structures is not as
good as when osmium postfixation is employed. It
also shows the characteristic granules that occur in
the soma and the processes of this particular
neuron.
In Vivo Backfilling with Lucifer Yellow CH and
Subsequent Physiological Characterization
Backfilling is a morphological technique for identi-
fying the neuronal somata that send processes
out a particular nerve. Unfortunately, with all
previously available techniques, the cells them-
selves are killed by the backfilling or by the
subsequent procedure for visualizing the backfill-
ing. As a result, they cannot be characterized
physiologically. We needed a technique for locat-
ing a cell body morphologically that would also be
compatible with physiological characterization of
the live neuron. A successful procedure was
developed using a fluorescent dye. The left
salivary nerve of a B. glabrata was cut, immersed in
a pool of Lucifer Yellow CH, and backfilled using
30 nA of current for 60 minutes. Two large dye-
filled cell bodies were easily seen in the buccal
ganglion by their fluorescence. The two neurons
were impaled with microelectrodes and shown
to be electrically coupled. The electrophysiologi-
cal behavior of these cells appears quite normal
even though they are filled with fluorescent dye.
The live preparation was then removed and
photographed using epifluorescence. After pho-
tography, the cells were then impaled again and
were shown to be still electrically coupled. Thus,
neither the backfilling nor the photography
caused detectable damage to the cells.
Ned Feder, M.D.; Enid Applegate, B.S.; Leslie Knipling, B.S.; Margaret Shea, B.A.; Hope Stanton, B.S.;
NIAMDD, National Institutes of Health, Bethesda, Maryland
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Figure 1
Light and electron micrographs of a dye -injected neuron in the right parietal ganglion of the snail B. glabrata.
111
Exploratory Synapse Workshop, July 13-July 14
ORGANIZERS
Byrne, John H, Ph.D., University of Pittsburgh, Pennsylvania
Meiri, Halina, Ph.D., Hebrew University Medical School, Jerusalem, Israel
Rahamimoff, Rami, M.D., Hebrew University Medical School, Jerusalem, Israel
Following the Synapse Course, a 2-day workshop
was held to demonstrate experimental techniques
utilized in electrophysiological analysis of synaptic
transmission. Two different experimental prepara-
tions were utilized. Using abdominal ganglia of
the Aplysia, students examined some of the basic
properties of synaptic transmission and synaptic
plasticity with current-voltage clamp technique.
Students also examined the time- and voltage-
dependence of ionic currents underlying the
synaptic somatic action potential. Using the frog
neuromuscular junction, the properties of minia-
ture end-plate potentials were examined. In
addition, the students voltage-clamped the mus-
cle and examined the voltage-dependence of the
end-plate current in the presence and absence of
various cholinergic blocking agents.
PARTICIPANTS
Hoch, Daniel B., M.S., University of North Carolina, Chapel Hill
Kolton, Lihu, M.S., Hebrew University Medical School, Jerusalem, Israel
Lewis, Richard S., B.S., California Institute of Technology, Pasadena
Schehr, Robert S., B.A., Columbia University, New York, New York
Pain Workshop, August 1-August 28
INSTRUCTOR
Jessell, Thomas M., Ph.D., St. George's Hospital Medical School, London, England
GUEST LECTURERS
Black, I., M.D., Cornell University, New York
Kelley, D.B., Ph.D., Princeton University, New Jersey
In a continuation of the theme of the 1979 Pain
Workshop, a number of varied and complemen-
tary approaches have been used to investigate the
cellular mechanisms that underlie pain transmis-
sion and its regulation within the spinal cord.
Studies on dissociated neurons maintained in cell
culture provided the opportunity to examine the
membrane properties and cellular interactions be-
tween identified sensory and central neurons. A.
Mudge and M. Yamamoto used immunocyto-
chemical techniques to identify the potential
transmitters substance P and somatostatin in dorsal
root ganglion neurons maintained in culture.
Techniques to isolate and grow neurons from the
raphe nuclei of embryonic rats were developed by
M. Yamamoto, S. Hockfield, and E. Glazer, in
order to examine the role of monoamine-contain-
ing neurons in the regulation of nociceptive input
to the spinal cord. Using an antibody directed
against synaptosomal plasma membranes from rat
cortex, A. Matus was able to demonstrate both
intracellular and surface staining of cultured
dorsal root ganglion neurons, whereas nonneu-
ronal cells were devoid of staining, suggesting that
primary sensory neurons derived from the neural
crest share common antigenic determinants with
central synaptic plasma membranes. P. Hand and
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A. Mudge developed [3Hp-deoxyglucose-label-
ing techniques to provide a method of detecting
the activity of individual primary sensory neurons
grown in culture. The electrophysiological pro-
perties of the same neurons were examined by R.
McBurney and J. Kelly. Intracellular recording
from individual neurons revealed that the homo-
vanillic acid derivative capsaicin, which activates
and then destroys nociceptive sensory afferents,
produced a marked prolongation of sensory
neuron action potentials, probably due to the
inactivation of potassium channels. If these events
were reproduced at the central terminals of
sensory neurons, a large increase in transmitter
release from nociceptive afferents might be ex-
pected. C. Pert used autoradiographic techniques
to visualize opiate receptors on dorsal root
ganglion neurons in culture in an attempt to
compare the density of receptors on the soma and
processes of individual neurons.
The use of lectins as neuronal tracers was
developed by J.D. Coulter and M.A. Ruda at the
1979 Pain Workshop. J.D. Coulter, D. Katz, and T.
Jessell, with E. Theriault, used the same techniques
this past year to trace cutaneous and visceral
sensory projections in vertebrates and, with M.
Yamamoto, successfully used peroxidase double
staining to visualize the distributions of vibrissal
sensory afferents and substance P within the
trigeminal nucleus. In complementary studies, P.
Hand and C. Hand used 2-deoxyglucose auto-
radiographic techniques to trace ascending sen-
sory pathways activated by capsaicin applied to the
vibrissal region.
In addition to the experimental projects out-
lined above, each participant presented an infor-
mal description of their own year-round research
activities. I. Black visited from Cornell University
and provided a detailed account of the develop-
mental neurobiology of monoamine and peptide
neurons, and D. Kelly discussed the technical
advances in [3H] 2-deoxyglucose labeling of single
neurons initiated at Princeton University. The
interaction with Birgit Zipser and Ron McKay
throughout the workshop was also fundamental in
generating both ideas and discussion.
PARTICIPANTS
Coulter, Joe Dan, Ph.D., Marine Biomedical Research Institute, Galveston, Texas
Glazer, Ellyn J., Ph.D., University of California Medical School, San Francisco
Hand, Carol, B.S., University of Pennsylvania, Philadelphia
Hand, Peter J., Ph.D., University of Pennsylvania, Philadelphia
Hockfield, Susan, Ph.D., University of California, San Francisco
Katz, David M., Ph.D., State University of New York, Stony Brook
Kelly, John S., M.D., Ph.D., St. George's Hospital Medical School, London, England
Matus, Andrew I., Ph.D., Friedrich Miescher Institut, Basel, Switzerland
Mc Burney, Robert N., Ph.D., University of Newcastle-upon-Tyne, England
Mudge, Anne W., Ph.D., Harvard Medical School, Boston, Massachusetts
Pert, Candace B., Ph.D., National Institutes of Health, Bethesda, Maryland
Theriault, Elizabeth, B.S., McMaster University, Ontario, Canada
Yamamoto, Miyuki, M.D., Ph.D., St. George's Hospital Medical School, London, England
Perfusion Workshop, August 12-August 22
ORGANIZER
Horn, Richard, Ph.D., Yale University, New Haven, Connecticut
INSTRUCTORS
Byer ly, William L., Ph.D., University of California, Los Angeles
Horn, Richard, Ph.D., Yale University, New Haven, Connecticut
Lee, Kai S., Ph.D., Yale University, New Haven, Connecticut
Reuter, Harald, M.D., Pharmakologisches Institut, Bern, Switzerland
Thompson, Stuart, Ph.D., Hopkins Marine Station, Pacific Grove, California
In recent years, many different scientists have
developed methods that permit them to vary, in a
controlled manner, the intracellular content of
isolated cells. Although such manipulations had
been possible in cylindrical structures (such as the
squid giant axon) for some time, the ability to
perform such experiments on spherical structures
is quite a recent development. First accomplished
by Kostuk's group (Bogomoletz Institute) in snail
neurons, similar techniques were later developed
by other scientists, each of whom made his own
personal modification.
The main objective of the Perfusion Workshop
was to allow a critical comparison of the variations
of the internal perfusion method and, at the same
time, to train other scientists so that the technique
could become more generally available. In the
workshop, molluscan neurons were used as the
experimental preparation. The students moved
from one setup to the next, learning from each of
the five "innovators" the technique that he had
developed. Following this period of "training,"
the students did a research project with one of the
instructors. These projects centered either on a
technical problem or on the use of the internal
perfusion technique for better understanding a
physiological phenomenon.
The experimental sessions were complemented
by extensive discussions in which the different
techniques were compared and evaluated, and in
which the limitations of the techniques were
brought to light. J. Stern (Brandeis University) gave
a seminar describing the use of the technique for
the study of cells of very small dimensions.
The extent to which the instructors continued to
modify their own setups as a function of what
they learned from one another made it very clear
that the workshop was as useful for them as it was
for the "uninitiated," who returned to their own
labs with a new and important experimental tool
for studying membrane functions.
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PARTICIPANTS
Ascher, Phillipe, Ph.D., Ecole Norma le Superieure, Paris, France
Ashcroft, Fran, Ph.D., University of Leicester, England
de Peyer, Jacques, Ph.D., Pharmakologisches Institut, Bern, Switzerland
Huang, Mae, Ph.D., National Institutes of Health, Bethesda, Maryland
lunge, Douglas, Ph.D., University of California, Los Angeles
Kehoe, Jac Sue, Ph.D., Ecole Norma le Superieure, Paris, France
Lewis, Richard, B.S., California Institute of Technology, Pasadena
Moody, Bill, Ph.D., University of California, Los Angeles
Stimers, Joseph R., Ph.D., University of Southern California, Los Angeles
Tillotson, Douglas, Ph.D., Boston University Medical School, Massachusetts
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45th COLD SPRING HARBOR
SYMPOSIUM ON
QUANTITATIVE BIOLOGY
Movable Genetic Elements, May 28 -June 4
In the early 1950s, Barbara McClintock's analy-
sis of crosses between genetically marked corn
plants led her to postulate that the activity of key
genes was under the control of genetic elements
that had the capacity to move from one chromo-
somal site to another. She called them "control-
ling elements," noting that when one was
inserted next to a gene it inhibited that gene's
activity. Conversely, when a control element
moved away from a gene, the activity of that
gene suddenly reappeared. Movement of con-
trol elements thus results in abrupt phenotypic
changes, and, because of their high mutability,
the respective genes they affect were first erro-
neously thought to be basically different from
ordinary genes.
The idea that genetic elements could move
with such facility from one chromosomal site to
another flew strongly in the face of conventional
genetic wisdom. Confirmation in other organ-
isms thus had to occur before the far-reaching
consequences of the corn plant message be-
came generally appreciated.
Most important were the independent obser-
vations in the late 1960s of Jim Shapiro and Peter
Star linger that certain highly pleiotropic muta-
tions in E. coil were the result of the insertion of
descrete DNA segments (insertion sequences or
IS's) that had the capacity to jump from one
chromosomal site to another. Molecular charac-
terization of these elements became possible
soon afterward with the arrival of the restriction
enzymes and the recombinant DNA cloning pro-
cedures. Quickly it became obvious that IS-like
elements were to be found not only in bacteria,
but perhaps in all organisms. Equally important
was the discovery that closely spaced pairs of
IS's can move as units ("transposons") carry-
ing along the genes lying between them. Such
transposons bore many similarities with the
phage Mu, leading Ahmad Bukhari, Jim Shapiro,
and Sankar Adhya to convene a meeting on DNA
insertion elements at Cold Spring Harbor in May
of 1976. With this meeting, IS elements and
transposons moved to the center of the genetic
world, commencing a frenzy of experimentation
that has shown no sign of abatement.
Choosing "Movable Genetic Elements" as
our 1980 Symposium topic was a virtually un-
avoidable decision, one that became even more
appropriate after the invitations went out, when
rumors began that the structures of integrated
retroviruses were remarkably similar to those of
transposons. So our most able Symposium orga-
nizers, Ahmad Bukhari and Jim Hicks, had great
difficulty in keeping the number of presenta-
tions within the bounds of sanity. In doing so,
they received invaluable advice from Sidney
Brenner, Peter Day, Harrison Echols, J. R. S. Fin-
cham, Walter Gehring, Mel Green, Ira Hersko-
witz, Lee Hood, Amar Klar, Phil Leder, Barbara
McClintock, Howard Nash, Heinz Saedler, Jim
Shapiro, Peter Starlinger, Jeff Strathern, and Bob
Weisberg.
We were obviously most pleased that Barbara
McClintock, who typically not wanting to give a
formal presentation, nevertheless gave an infor-
mal summary of her latest ideas. And most ap-
propriately on the opening night, Bentley Glass
briefly recapitulated many of Barbara's key con-
tributions to genetics.
The program contained 103 scheduled presen-
tations and 14 informal presentations. The total
attendance at this Symposium was 302. That we
could invite so many participants reflects the
substantial financial support again provided by
the National Institutes of Health, the National
Science Foundation, and the Department of En-
ergy. Because of the rapidly escalating air fares,
we needed still additional help, and we wish to
acknowledge major support from the Cetus Cor-
poration, Bethesda Research Laboratories, and
New England BioLabs.
Welcoming Remarks: J. D. WATSON, Cold Spring Harbor Laboratory
Introduction: H. BENTLEY GLASS, State University of New York, Stony Brook: Movable Genetic Elements and
Barbara McClintock
Opening Address: A. CAMPBELL, Stanford University, California
Session 1: Inversion Elements in Bacteria
Chairperson: D. BorsmiN, Massachusetts Institute of Technology, Cambridge
T. IINO and K. KUTSUKAKE, Dept. of Biology, Faculty of Science, University of Tokyo, Japan: The trans-acting genes of
bacteriophages PI and Mu mediating inversion of a specific DNA segment involved in flagellar phase variation
of Salmonella.
M. SILVERMAN, J. ZIEG, and M. SIMON, Biology Dept., University of California, San Diego: The mechanism of phase
variation.
R. HARSHLY, Cold Spring Harbor Laboratory, New York: Flip-flop control of gene expression in bacteriophage Mu.
Session 2: Characterization of Transposable Element Families
Chairperson: H. SAEDLER, University of Freiburg, Federal Republic of Germany
J. GAFNER, H. EIBEL, M. BRENNAN, A. STOTZ, and P. PHILIPPSEN, Dept. of Microbiology, Biozentrum, University
Switzerland: Characterization of a mobile element in yeast.
G. M. RUBIN, W. J. BROREIN, JR., P. DUNSMUIR, R. LEVIS, E. STROBEL, and E. YOUNG, Dept. of Biological Chemistry, Sid-
ney Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts: "Copia-like" transposable
elements in the Drosophila genome.
H. E. SCHWARTZ and M. W. YOUNG, Rockefeller University, New York, New York: Expression of middle repetitive
DNA in Drosophila melanogaster.
N. A. TCHURIKOV,1 E. S. ZELENTSOVA,1 Y. V. ILYIN,' E. V. ANANIEV,' and G. P. GEORGIEV,1 'Institute of Molecular
Biology and 'Institute of Molecular Genetics, USSR Academy of Sciences, Moscow: Mobile dispersed genes
in Drosophila melanogaster.
E. 0. LONG and I. B. DAWID, Laboratory of Biochemistry, NCI, National Institutes of Health, Bethesda, Maryland:
Structure and expression of type-2 ribosomal DNA insertions in Drosophila melanogaster.
J. K. Lim, Biology Dept., University of Wisconsin, Eau Claire: Restrictive modifications of the Drosophila X
chromosome.
Session 3: Genetic Effects of Transposition in Drosophila and Yeast
Chairperson: P. STARLINGER, University of Kdln, Federal Republic of Germany
G. ISING and K. BLOCK, Institute of Genetics, University of Lund, Sweden: Derivation-dependent distribution of
insertion sites for a Drosophila transposon.
B. RASMUSON, Dept. of Genetics, University of Umea, Sweden: A case of gene regulation in Drosophila
melanogaster associated with the dispersed gene family Dm plasmid 225.
H. GREER, M. IGO, and F. DEBRUIIN, Biology Dept., Harvard University, Cambridge, Massachusetts: A yeast
transposable element which carries the his4C gene.
G. R. FINK, D. CHALEFF, T. DONAHUE, P. FARABAUGH, S. SILVERMAN, and S. ROEDER, Dept. of Biochemistry, Molecular and
Cell Biology, Cornell University, Ithaca, New York: Unusual genetic events associated with a transposable
element in yeast.
S. SCHERER and R. W. DAVIS, Dept. of Biochemistry, Stanford University School of Medicine, California: Recombin-
ation and expression of DNA sequences in or near a yeast transposable element.
F. SHERMAN, J. I. STILES, B. ERREDE, T. S. CARDILLO, L. FRIEDMAN, and S. CONSAUL, Dept. of Radiation Biology and
Biophysics, University of Rochester School of Medicine and Dentistry, New York: Overproduction of isocyto-
chromes c due to transposable rearrangements in mutants of yeast.
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Session 4: Mechanisms of DNA Transposition in Bacteria. I.
Chairperson: J. SHAPIRO, University of Chicago, Illinois
W. ARBER, S. IIDA, and H. J. REIF, Dept. of Microbiology, Biozentrum der Universitat Basel, Switzerland: Biology otransposable elements in E. coli.
R. KLAER, S. KUHN, P. HABERMANN, D. PFEIFER, E. TILLMANN, I. ST. GIRONS, H.-J. FRITZ,and P. STARLINGER, Institut furGenetik, Universitat Ka In, Federal Republic of Germany: The transposition of IS4.
D. F. GRINDLEY and C. P.A. CLARKE, Dept. of Molecular Biophysics and Biochemistry, Yale University, New Haven,Connecticut: Structure and function of the transposon, Tn903.
M. S. GUYER and J. L. ROSNER, Laboratory of Molecular Biology, N IAMDD, National Institutes of Health, Bethesda,Maryland: The functional components of Tn9.
Session 5: Mechanisms of DNA Transposition in Bacteria. II.
Chairperson: N. ZINDER, Rockefeller University, New York, New York
S. ROTHSTEIN, R. JORGENSEN, J. YIN, Z. YONG-DI, R. JOHNSON, and W. REZNIKOFF, Dept. of Biochemistry,University ofWisconsin, Madison: Genetic organization of Tn5-The inverted repeats are different.
E.-A. AUERSWALD and H. SCHALLER, Dept. of Microbiology, University of Heidelberg, Federal Republic of Germany:Structural analysis of transposon Tn5 and of its imprecise excision.
D. E. BERG, C. EGNER, B. J. HIRSCHEL, and T. D. Tisrv, Dept. of Microbiology, Washington University Medical School,St. Louis, Missouri: A mobile recombinational switch derived from transposon Tn5 (Km').
D. BIEK and J. R. ROTH, Dept. of Biology, University of Utah, Salt Lake City: Regulation ofTn5 transposition.
Session 6: Mechanisms of DNA Transposition in Bacteria. III.
Chairperson: S. COHEN, Stanford University, California
N. KLECKNER,' S. M. HALLING,1 and T. J. FOSTER,'
'The Biological Laboratories, Harvard University, Cambridge,
Massachusetts; 'Moyne Institute, Trinity College, Dublin, Ireland: The tetracycline-resistance transposonTn/O.
J. H. MILLER, M. P. C.ALOS, M. HOFER, and D. GALAS, Dept. of Molecular Biology, University of Geneva, Switzerland:
Genetic and sequence analysis of transpositions in the lac region of E. coll.
H. SAEDLER, J. CULLUM, P. NEVERS, B. SCHUMACHER, and H. SOMMER, Institute fur Biologie III, University of Freiburg,Federal Republic of Germany: IS1-induced deletions and inversions.
G. B. SMIRNOV, T. S. ILYINA, Y. M. ROMANOVA, A. P. MARKOV, and E. V. NECHAEVA, Gamaleya Institute for Epidemiology
and Microbiology, Moscow, USSR: Mutants of E. coli affected in the processes of transposition and genomic
rearrangements.
N. DATTA, M. NUGENT, and H. RICHARDS, Bacteriology Dept., Royal Postgraduate Medical School, London,England: Transposons in medically important bacteria.
M. So, Cold Spring Harbor Laboratory, New York: Studies on the mechanism of dissemination of apathogenic determinant of enterotoxigenic E. coli.
R. NOVICK,' E. MURPHY,' S. KHAN,' and J. KROLEWSKI,3 'Public Health Research Institute; 'New York
University School of Medicine, New York: Hitchhiking transposons and other site-specific recombination
systems in Staphylococcus aureus.
M. CHANDLER, M. CLERGET, and L. CARO, Dept. of Molecular Biology, University of Geneva, Switzerland: IS/-promoted events associated with drug-resistance plasmids.
Session 7: Controlling Elements and Unstable Genes in Plants
Chairperson: G. FINK, Cornell University, Ithaca, New York
P. A. PETERSON, Agronomy Dept., Iowa State University, Ames: Diverse expression of controlling element
components in maize-Test of a model.
H. K. DOONER, Dept. of Genetics, University of Wisconsin, Madison: Effects of the controlling element Ds onBz-gene function in maize.
B. BURR and F. A. BURR, Biology Dept., Brookhaven National Laboratory, Upton, New York: Detection of
changes in maize DNA at the Shrunken locus due to the intervention of Ds elements.
F. SALAMINI, Istituto sperimentale per la Cerealicoltura, Sezione di Bergamo, Italy: Controlling elements and
insertion mutations at the opaque-2 locus of maize.
G. R. K. SASTRY, K. M. ARAM, and V. JEFFRIES, Dept. of Genetics, University of Leeds, England: The role of con-
trolling elements in the instability for flower color in Antirrhinum majus and Impatiens balsamina.
R. FLAVELL, M. O'DELL, J. R. BEDBROOK, and J. HUTCHINSON, Plant Breeding Institute, Trumpington, Cambridge,
England: Evidence for and the role of sequence translocation during the evolution of plant chromosomes.
R. J. MANS,' B. D. Km,' M. F. CONDE,' D. R. PRING,' C. S. LEVINGS 111,3 S. J. GABAY-LAUGHNAN,4 and J. R.
LAUGHNAN,4
'Dept. of Biochemistry and Molecular Biology; 'Department of Plant Pathology, University of
Florida, Gainesville; 'Genetics Department, North Carolina State University, Raleigh; 'Dept. of Genetics
and Development, University of Illinois, Urbana: Transposition events in maize mitochondrial DNA.
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B. DECARIS, F. FRANCOU, A. KOUASSI, C. LEFORT, and G. RIZET, Laboratoire de Genetique, University Paris-Sud,
Orsay, France: Genetic instability in Ascobolus immersus-Modalities of back-mutations, intragenic map-
ping of unstable sites, and unstable insertion. Preliminary biochemical data.
Session 8: Mechanisms of DNA Transposition in Bacteria. IV.
Chairperson: S. BRENNER, Medical Research Council, Cambridge, England
G. CHACONAS, R. HARSHEY, N. SARVETNICK, and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York:
Molecular mechanism of transposition.
N. SYMONDS, A. COELHO, D. LEACH, and S. MAYNARD-SMITH, School of Biology, University of Sussex, Brighton,
England: Transposition studies with phage Mu.
D. KAMP and R. KAHMANN, Max-Planck-Institut fiir Biochemie, Munchen, Federal Republic of Germany: Two
pathways in bacteriophage Mu transposition?
M. M. HOWE and J. W. SCHUMM, Dept. of Bacteriology, University of Wisconsin, Madison: Transposition of
bacteriophage Mu-Properties of lambda phages containing both ends of Mu.
P. VAN DE PUTTS, M. GIPHART-GASSLER, N. GOOSEN, T. GOOSEN, and E. VAN LEERDAM, Laboratory of Molecular
Genetics, University of Leiden, The Netherlands: The integration and replication of multicopy plasmids
containing different fragments of bacteriophage Mu.
L. DESMET,' M. FAELEN,1 N. LEFEBVRE,. A. RESIB015,2 A. TOUSSAINT,' and F. VAN GIJSEGEM,1 'Laboratoire deGenetique, 'Laboratoire de Microscopie Electronique, 'Laboratoire de Microbiologie, University Libre de
Bruxelles, Belgium: Mu-induced chromosomal rearrangements in enterobacteria.
E. PIRUZIAN, V. ANDRIANOV, M. MOGUTOV, E. KRIVTSOVA, V. YUZEEVA, and A. VETOSHKIN, Institute of Molecular
Genetics, Moscow, USSR: Specificity of bacteriophage Mu integration in DNA from different sources.
Session 9: Organization of Immunoglobulin Genes
Chairperson: P. LEDER, NICHHD, National Institutes of Health, Bethesda, Maryland
S. TONEGAWA, H. SAKANO, R. MAKI, W. RODER, A. TRAUNBACHER, and Y. KUROSAWA, Basel Institute for Immunology,
Switzerland: Somatic recombination and differential RNA splicing during lymphocyte differentiation.
P. LEDER, E. MAX, J. SEIDMAN, and P. HIETER, Laboratory of Molecular Genetics, NICHHD, National Institutes of
Health, Bethesda, Maryland: Organization and reorganization of immunoglobulin genes.
T. H. RABBMS, D. L. BENTLEY, G. E. A. R. MArrHyssENs, Medical Research Council Laboratory of Molecular
Biology, Cambridge, England: Multiple organizational changes during the differentiation of immunoglobu-
lin genes.
R. WALL,' E. CHOI,' M. KEUHL,. and J. RoGERs,"Molecular Biology Institute, University of California, Los
Angeles; 'Dept. of Microbiology and Immunology, University of Virginia School of Medicine,Charlottes-
ville: DNA rearrangements and RNA processing in immunoglobulin-gene expression.
L. HOOD, K. CALAME, S. CREWS, M. DAVIS, P. EARLY, S. KIM, H. HUANG, T. HUNKAPILLER, D. LIVANT, K. MOORE, and B.
TAYLOR, Division of Biology, California Institute of Technology, Pasadena: The organization and rearrange-
ment of immunoglobulin heavy-chain genes.
K. B. MARCO, N. ARNHEIM, J. BANERJI, N. A. PENNCAVAGE, R. LANG, P. SEPERACK, and R. MIESFELD, Biochemistry
Dept., State University of New York, Stony Brook: Studies on the nature and instability of DNA sequences
flanking the mouse immunoglobulin heavy-chain constant-region genes.
F. R. BLATTNER,' J. L. SLIGHTOM,1 N. NEWELL,' J. RICHARDS,' G. GOLDBERG,' C.-P Liu,' P. W. TUCKER,. K. MARCU,3
and J. F. MUSHINSKI,4 'Dept. of Genetics, University of Wisconsin, Madison; 'University of Mississippi
Medical Center, Jackson; 'State University of New York, Stony Brook; 'National Institutes of Health,
Bethesda, Maryland: Studies on the structure of the heavy-chain locus of the mouse.
T. HONJO, T. KATAOKA, Y. YAMAWAKI-KATAOKA, M. OBATA, N. TAKAHASHI, T. KAWAKAMI, Y. YAOITA, and A. SHIMIZU,
Dept. of Genetics, Osaka University Medical School, Japan: Deletion of immunoglobulin heavy-chain
genes accompanies the class switch recombination.
R. P. PERRY, C. COLECLOUGH, and M. WEIGERT, Institute for Cancer Research, Fox Chase Cancer Center,
Philadelphia, Pennsylvania: Reorganization and expression of immunoglobulin genes-The statusof allelic
elements.
Session 10: Movable Elements in Differentiation
Chairperson: I. HERSKOWITZ, University of Oregon, Eugene
P. BORST,' A. C. C. FRASCH,1 A. BERNARDS,' J. H. J. HOEIJMAKERS,' and G. A. M. CROSS,. 'Laboratory of
Biochemistry, University of Amsterdam, The Netherlands; 'The Wellcome Research Laboratories, Becken-
ham, Kent, England: Antigenic variation in trypanosomes involves rearrangements in nuclear DNA.
R. 0. WILLIAMS,' K. B. MARCU,. J. R. YOUNG,' and P. A. 0. MAMA,' 'International Laboratory for Research
on Animal Diseases (ILRAD), Nairobi, Kenya; 'Dept. of Biochemistry, State University of New York, Stony
Brook: Contextural genomic rearrangements of variant antigen genes in Trypanosoma brucei.
S. LONGACRE,1 U. HIBNER,1 T. BAL-rz,2 and H. EISEN,' 'Unite d'Immunoparasitologie, Institut Pasteur, Paris,
France; 2Universite de Bordeaux, France: Antigenic variation in T. equiperdum.
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P. NISEN and L. SHAPIRO, Albert Einstein College of Medicine, Bronx, New York: Insertion element nucleotide
sequences in precursor and mature E. coli ribosomal RNA and cell-cycle-associated rearrangement of
Caulobacter crescentus inverted-repeat DNA.
J. RINE, D. HAGEN, R. JENSEN, G. SPRAGUE, JR., and I. HERSKOWITZ, Institute of Molecular Biology and Dept. of Bi-
ology, University of Oregon, Eugene: The switching pattern of homothallic yeast and its control.
K. A. NASMYTH,' K. TATCHELL,' B. D. HALL,' C. ASTELL,2 and M. SMITH' 'Dept. of Genetics, University of
Washington, Seattle; 'Dept. of Biochemistry, University of British Columbia, Vancouver: The transcripts
made at the yeast mating-type locus.
A. KLAR,' J. HICKS,' H. STRATHERN,1 and J. BROACH' 'Cold Spring Harbor Laboratory, New York; 'State
University of New York, Stony Brook: Mechanism of transposition and transcriptional regulation of the
mating-type genes in yeast.
J. HABER, B. WEIFFENBACH, D. ROGERS, and J. MCCUSKER, Dept. of Biology, Brandeis University, Waltham,
Massachusetts: Chromosomal rearrangements accompanying yeast mating-type conversions.
Session 11: Biochemistry of Recombination and X Integration
Chairperson: F. STAHL, University of Oregon, Eugene
H. POTTER,' D. DRESSLER,' C. DASGUPTA,2 T. SHIBATA,2 R. CUNNINGHAM' and C. RADDING,2 'Harvard University,
Cambridge, Massachusetts; 'Yale University, New Haven, Connecticut: Homologous pairing in genetic
recombination.
N. R. COZZARELLI, P. O. BROWN, A. MORRISON, K. N. KREUZER, and R. OTTER, University of Chicago, Illinois: The
shaping of DNA by E. coli topoisomerases.
M. GELLERT, L. M. FISHER, K. MIZUUCHI, and M. H. O'DEA, Laboratory of Molecular Biology, NIAMDD, National
Institutes of Health, Bethesda, Maryland: Studies on the mechanism of DNA gyrase.
H. IKEDA, K. MORIYA, and T. MATSUMOTO, Institute of Medical Science, University of Tokyo, Japan: Studies of
illegitimate recombination-In vitro insertion of plasmid DNA into phage A genome.
H. A. NASH, NIMH, National Institutes of Health, Bethesda, Maryland: A integration-Genes and proteins.
R. WEISBERG,' C. FOELLER,2 L. ENQUIST,' and A. LANDY,2 'National Institutes of Health, Bethesda, Maryland;
'Division of Biology and Medicine, Brown University, Providence, Rhode Island: A integration-Exchange
of genetic information between virus and host.
K. MIZUUCHI,' M. MIZUUCHI,' P.-L. Hsu,' W. Ross' and A. [ANDY,' 'Laboratory of Molecular Biology,
NIAMDD, National Institutes of Health, Bethesda, Maryland; 'Division of Biology and Medicine, Brown
University, Providence, Rhode Island: The A phage att sites-Interaction with Int protein, functional
limits, and the crossover event.
H. I. MILLER," J. ABRAHAM, B. BENEDIK,2 A. CAMPBELL' D. COURT,' H. ECHOES,' R. FISCHER," G. GUARNEROS,4 D.
MASCARENHAS,2 and D. ScHiNDLEB,"University of California, Berkeley; 'Stanford University, California;
'NCI, National Institutes of Health, Bethesda, Maryland; 'Centro de Investigacion, Mexico City, Mexico:
Regulation of the integration-excision reaction by bacteriophage A.
Session 12: Mechanisms of DNA Transposition in Bacteria. V.
Chairperson: W. SZYBALSKI, University of Wisconsin, Madison
F. HEFFRON,' C. MORITA,' R. E. GILL,' and S. FALKOW,' 'Cold Spring Harbor Laboratory, New York; 'Dept. of
Microbiology and Immunology, University of Washington, Seattle: Studies on the internal resolution site
(IRS) of Tn3.
L. A. MACHATTIE, C. J. MUSTER, J. A. SHAPIRO, and D. M. SHAH, Dept. of Microbiology, University of Chicago, Il-
linois: Origin and breakdown of replicon fusion cointegrates mediated by transposable elements.
M. J. CASADABAN, J. CHOU, P. G. LEMAUX, C. A. MILLER, C.-P. D. Tu, and S. N. COHEN, Stanford University School
of Medicine, California: Tn3-Mechanism and control of transposition.
D. SHERRATT and A. ARTHUR, Dept. of Genetics, University of Glasgow, Scotland: Transposon-specified site-
specific recombination systems.
E. OHTSUBO, M. ZENILMAN, H. OHTSUBO, M. MCCORMICK, C. MACHIDA, and Y. MACHIDA, Dept. of Microbiology,
State University of New York, Stony Brook: Mechanisms of plasmid cointegration mediated by translocata-
ble DNA elements.
N. STERNBERG, D. HAMILTON, M. YARMOLINSKY, S. AUSTIN, and R. HOESS, Cancer Biology Program, Frederick
Cancer Research Center, Frederick, Maryland: Site-specific recombination and the P1 plasmid way of life.
L. J. WALLACE, J. M. WARD, P. M. BENNETT, M. K. ROBINSON, and M. H. RICHMOND, Dept. of Bacteriology,
University of Bristol, England: Transposition immunity.
R. SCHMITT,' J. ALTENBUCHNER,' K. WIEBAUER,1 W. ARNOLD,' A. PUHLER,2 and F. ScHOFFL,2 'Lehrstuhl far
Genetick, Universitat Regensburg; 'Institut far Mikrobiologie, Universitat Erlangen-Nurnberg, Federal
Republic of Germany: Basis of transposition and gene amplification by Tn1721 and related Tc transposons.
119
Session 13: Virus as a Movable Element
Chairperson: J. SAMBROOK, Cold Spring Harbor Laboratory, New York
K. R. YAMAMOTO, V. L. CHANDLER, J. C. RING, and D. S. UCKER, Dept. of Biochemistry and Biophysics, University
of California, San Francisco: Mammary tumor virus DNA-A movable genetic element that specifies
hormone-regulated transcription.
G. F. VANDE WOUDE,' D. G. BLAIR,' R. DHAR,' L. ENQUIST,' W. L. MCCLEMENTS,' and M. OSKARSSON,' Laboratory
of 'Molecular Virology and 'Viral Carcinogenesis, NCI, National Institutes of Health, Bethesda, Mary-
land: Properties of the terminal-repeat sequence of integrated Moloney sarcoma provirus.
J. G. SUTCLIFFE, T. M. SHINNICK, and R. A. LERNER, Scripps Clinic and Research Foundation, La Jolla, California:
Moloney leukemia virus is a transposon-Nucleotide sequence analysis identifies genes and replication
details.
D. BALTIMORE, C. SHOEMAKER, S. GOFF, M. PASKIND, E. GILBOA, and S. MITRA, Massachusetts Institute of
Technology, Cambridge: Structure of cloned retrovirus circular DNA-Implications for viral integration.
H. M. TEMIN and K. SHIMOTOHNO, McArdle Laboratory, University of Wisconsin, Madison: Similarity of
nucleotide sequences of cell-virus junctions of an avian retrovirus and of transposable elements.
J. MAJORS, R. SWANSTROM, S. HUGHES, W. DELORBE, A. P. CZERNILOFSKY, J. M. BISHOP, and H. E. VARMUS, Dept. of
Microbiology, University of California, San Francisco: Structural and functional homologies between
retroviral proviruses and transposable elements.
M. BOTCHAN,' S. CONRAD,' P. BULLOCK,' W. GISH,' D. HANAHAN,' and Y. GLUZMAN,2 'University of California,
Berkeley; 'Cold Spring Harbor Laboratory, New York: Excision of SV40 sequences from cellular
chromosomes.
R. SAGER, A. ANISOWICZ, and N. HOWELL, Sidney Farber Cancer Institute, Cambridge, Massachusetts: DNA
rearrangements in SV40-transformed mouse cell lines, hybrids, and cybrids.
Session 14: Arrangements of Clustered and Dispersed Gene Families
Chairperson: J. CAIRNS, Imperial Cancer Research Fund Laboratories, London, England
J. R. BEDBROOK,' J. JONES' and R. FLAVELL,2 'Division of Plant Industry, CSIRO, Canberra, Australia; 'Plant
Breeding Institute, Cambridge, England: Evidence for nonhomology-dependent recombination in the
evolution of repeated sequences in Seca le species.
E. F. FRITSCH, C . K. J. SHEN, R. M. LAWN, and T. MANIATIS, Division of Biology, California Institute of
Technology, Pasadena: The organization of repetitive sequences in mammalian globin-gene clusters.
B. DE CROMBRUGGHE, G. VOGELI, H. OHKUBO, V. E. AWEDIMENTO, M. MUDRYJ, and I. PASTAN, National Institutes of
Health, Bethesda, Maryland: Repetitive structure in the chick «2-collagen gene.
R. T. SCHIMKE, P. C. BROWN, C. SIMONSEN, M. MCGROGAN, D. P. SETZER, D. SLATE, and G. CROUSE, Dept. of
Biological Sciences, Stanford University, California: Organization and localization of dihydrofolate-reduc-
tase-gene sequences in methotrexate-resistant cultured cells and in the mouse genome.
M. CARLSON, B. OSMOND, and D. BOTSTEIN, Dept. of Biology, Massachusetts Institute of Technology, Cam-
bridge: The SUC genes of yeast-A dispersed multigene family of known function.
L. SINGH, I. F. PURDOM, and K. W. JONES, Institute of Animal Genetics, University of Edinburgh, Scotland:
Conserved sex-chromosome-associated transposable nucleotide sequences in eukaryotes.
K. SAIGO,' L. MILLSTEIN' and C. A. THOMAS' 'Scripps Clinic and Research Foundation, La Jolla, California;
'Mitsubishi -Kasei Institute of Life Sciences, Tokyo, Japan: The reshuffling of the histone-gene cluster in
Drosophila melanogaster and the insertion of a mobile element.
Session 15: Recombination of Heterologous Genomes
Chairman: H. LEWIS, National Science Foundation, Washington, DC
J. COLLINS, Gesellschaft fur Biotechnologische Forschung, Braunschweig-Stockheim, Federal Republic of
Germany: On the instability of palindromic DNA in E. coli-Use as a method of super-high-frequency site-
specific mutagenesis.
M. WIGLER, M. PERUCHO, D. LEVY, and D. HANAHAN, Cold Spring Harbor Laboratory, New York: DNA-mediated
gene transfer in animal cells-Theory and applications.
G. B. RUVKUN and F. M. AUSUBEL, Dept. of Biology, Harvard University, Cambridge, Massachusetts: Replace-
ment of nitrogen fixation (nif) genes from Rhizobium meliloti with Tn5-mutagenized, cloned homologous
nif genes.
M. VAN MONTAGU,' M. DE BEUCKELEER,' M. LEMMERS,' M. HOLSTERS,' P. O'FARRELL' A. DEPICKER,' P. DHAESE,'
G. ENGLER,' J. P. HERNALSTEESN,' and J. SCHELL,' 'Depts. of Genetics and Histology, State University Gent,
Belgium; 'Dept. of Biophysics and Biochemistry, University of California, San Francisco: T-DNA-A
transferrable element of the Ti plasmids of Agrobacterium tumefaciens.
Summary: M. Yarmolinsky, Frederick Cancer Research Center, Frederick, Maryland
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SUMMER MEETINGS
Biology of the Vascular Endothelial Cell, May 6-May 11
Arranged by
Stephen Blose, Cold Spring Harbor Laboratory, New York
Eric Jaffe, Cornell University Medical College, New York, New York
Denis Gospodarowicz, University of California, San Francisco
105 participants
Opening Remarks: S. H. BLOSE, Cold Spring Harbor Laboratory, New York
Session 1: Cell Structure and Motility
Chairperson: S. BLOSE, Cold Spring Harbor Laboratory, New York
S. H. BLOSE, Cold Spring Harbor Laboratory, New York: Functions of 10-nm filaments in vascular endothelial
cells.
A. I. GOTLIEB,' W. SPECTOR,' L. SUBRAHMANYAN,' and V. I. KALNINS,2 'Dept. of Pathology; 'Dept. of Anatomy,
University of Toronto, Ontario, Canada: Cytoskeleton and cell movement in cultured endothelial and
smooth-muscle cells.
R. R. BOW P. CLOPATH,' and K. MOLLER,2 'Friedrich Miescher-lnstitut, Basel, Switzerland; 'Research Dept.,
Pharmaceuticals Division, Ciba-Geigy Ltd., Basel, Switzerland: An inhibitor of endothelial-cell migration.
B. R. ZETTER, C. J. SCHEINER, and M. KLAGSBRUN, Harvard Medical School and Children's Hospital Medical
Center, Boston, Massachusetts: Quantitative analysis of capillary endothelial-cell migration.
E. BOGENMANN and B. SORDAT, Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland:
Characterization of primary and cloned bovine endothelial cells grown on collagen gels.
I. HOTTNER,1 P. MOCOSTABELLA,2 C. DE CHASTONAY,' and G. GABBIANI,2 'Dept. of Pathology, McGill University,
Montreal, Quebec, Canada; 'Dept. of Pathology, University of Geneva, Switzerland: Organization of cell
junctions in rat aortic endothelium during normal and hypertensive states.
U. S. RYAN and J. W. RYAN, Dept. of Medicine, University of Miami School of Medicine, Florida: Morphologi-
cal interactions between pulmonary endothelial cells.
Session 2: Growth Factors. I.
Chairperson: D. GOSPODAROWICZ, University of California Medical Center, San Francisco
R. A. BROWN,' J. B. WEISS, S. KUMAR,2 and P. PHILLIPS? 'Dept. of Rheumatology, Manchester University,
England; 'Dept. of Paediatric Oncology, Christie Hospital, Manchester, England: A low-molecular-weight
endothelial-cell-stimulating angiogenesis factor (ESAF) from synovial fluids of diseased articular joints.
S. WATT, K. WALLIS, and A. FENSELAU, Dept. of Physiological Chemistry, Johns Hopkins University, Baltimore,
Maryland: Partial purification of an endothelial-cell-growth stimulatory factor from Walker 256 rat tumor.
A. M. SCHOR,1 S. L. SCHOR,' J. B. WEISS,2 R. A. BROWN,' S. KUMAR,' and P. PHILLIPS,' Clinical Research
Laboratory, 'CRC Dept. of Medical Oncology, Christie Hospital, Manchester, England; 'Dept. of Rheuma-
tology and Medical Biochemistry, University of Manchester, England: Collagen substratum required for
the stimulation of capillary endothelial cells in vitro by a low-molecular-weight angiogenic factor.
R. S. LANCER''' H. CONN,' J. VACANTI,' and J. FOLKMAN,2'3 'Dept. of Nutrition and Food Science, Massachu-
setts Institute of Technology, Cambridge; 'Dept. of Surgery, Children's Hospital Medical Center,
Boston, Massachusetts; 'Dept. of Surgery, Harvard Medical School, Boston, Massachusetts, Inhibition of
tumor angiogenesis.
J. J. CASTELLOT JR.,' M. J. KARNOVSKY,' and B. M. SPIEGELMAN,' 'Dept. of Pathology, Harvard Medical School,
Boston, Massachusetts; 'Dept. of Biology, Massachusetts Institute of Technology, Cambridge: A potent
stimulation of vascular endothelial-cell growth by differentiated 3T3-adipocytes.
P. D'AMORE, B. GLASER, S. BRUNSON, and A. FENSELAU, Dept. of Physiological Chemistry and Wilmer Ophthal-
mological Institute, Johns Hopkins School of Medicine and Hospital, Baltimore, Maryland: Demonstration
and partial purification of a vasoproliferative substance from mammalian retina.
Session 3: Growth Factors. II.
Chairperson: B. ZET1ER, Children's Hospital Medical Center, Boston, Massachusetts
J. J. CASTELLOT, JR., M. L. ADDONIZIO, and M. J. KARNOVSKY, Dept. of Pathology, Harvard Medical School, Boston,
Massachusetts: Vascular endothelial cells produce a heparinlike inhibitor of smooth-muscle-cell growth.
P. BOWMAN, A. L. BETZ, and G. W. GOLDSTEIN, Depts. of Pediatrics and Neurology, University of Michigan, Ann
Arbor: Brain capillary endothelial cells in culture.
J. FOLKMAN,1 C. HAUDENSCHILD,' and B. ZETrER,"Children's Hospital Medical Center, Harvard Medical
School, Boston, Massachusetts; 'Mallory Institute, Boston City Hospital, Massachusetts: Long-term
culture of capillary endothelial cells.
E. McCALL, J. POVEY, and D. C. DUMONDE, Dept. of Immunology, St. Thomas' Hospital, London, England:
Culture of porcine endothelial cells on expanded microporous polytetrafluoroethylene (PTFE) membranes.
B. J. WEIMANN, H. KUHN, and H. R. BAUMGARTNER, Pharma Research 3, F. Hoffman-La Roche & Company Ltd.,
Basel, Switzerland: Human (HEC) and bovine (BEC) endothelial-cell injury by homocysteine (HO).
C. K. DOREY and S. B. RYBICKI, School of Dental Medicine, Southern Illinois University, Edwardsville: Ornithine
decarboxylase levels depressed in endothelial cells exposed to EGI in vitro.
Session 4: Cell Metabolism. I.
Chairperson: L. L. SLAKEY, University of Massachusetts, Amherst
S. F. CHING, L. W. HAYES, and L. L. SLAKEY, Dept. of Biochemistry, University of Massachusetts, Amherst:
Synthesis of angiotensin-converting enzyme by swine arterial endothelial cells.
D. B. RUBIN, Cardio-Vascular Research Institute, University of California, San Francisco: Hydrolysis of an
angiotensin analog by endothelial cells and fibroblasts in vitro.
W. E. LAUG, Children's Hospital, University of Southern California School of Medicine, Los Angeles:
Secretion of different plasminogen activators and anchorage-independent growth of bovine endothelial
cells.
D. J. LOSKUTOFF, Dept. of Molecular Immunology, Scripps Clinic and Research Foundation, La Jolla, California:
Effect of thrombin on endothelial-cell-mediated fibrinolysis.
J. -P. TAUBER and D. GOSPODAROWICZ, Cancer Research Institute and Dept. of Medicine, University of California
Medical Center, San Francisco: Interaction of HDL with -cullared vascular endothelial cells and up-
regulation of HDL receptor sites by 25-hydroxycholesterol.
C. BUSCH,' J. DAWES,' D. S. PEPPER,' and A. WASTESON,4 'Dept. of Pathology and 'Medical Chemistry, Uni-
versity of Uppsala, Sweden; 'MRC Radioimmunoassay Team, 'South -East Scotland Regional Blood
Transfusion Centre, Edinburgh: Binding of platelet factor 4 to cultured human umbilical-vein endothelial
cells.
J. W. RYAN, L. R. HENDRICKS, G. H. FISHER, and U. S. RYAN, Dept. of Medicine, University of Miami School of
Medicine, Florida: Metabolism of bradykinin by bovine pulmonary endothelial cells in culture.
Session 5: Cell Metabolism. II.
Chairperson: E. JAFFE, Cornell University Medical College, New York, New York
R. I. LEVIN,' B. B. WEKSLER,' and E. A. JAFFE,' Depts. of Medicine, 'New York University School of Medicine,
New York; 'Cornell University Medical College, New York, New York: Nitroglycerin induces production
of prostacyclin by human endothelial cells.
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W. HOPE; T. J. MARTIN,' R. D. NOLAN,' C. N. CHESTERMAN,2 and F. J. MORGAN,3 'Dept. of Medicine,
University of Melbourne, Repatriation General Hospital, Australia; 'St. Vincent's Hospital, 'St. Vin-
cent's School of Medical Research, Victoria, Australia: Human /3-thromboglobulin inhibits 6-oxo-prosta-
glandin F, a production by bovine aortic endothelial cells.
C. SEILLAN; , C. ODY,' F. RUSSO-MARIE,' W. SiEss,' and F. DRAY,' 'INSERM Unite 7, Necker Hospital, Paris;
'Pasteur Institute, Paris, France: Determination of cyclooxygenase products using high-pressure liquid
chromatography and radioimmunoassay in pig endothelial and smooth-muscle cells in culture.
J. D. PEARSON, J. S. CARLETON, and J. L. GORDON, ARC Institute of Animal Physiology, Babraham, Cambridge,
United Kingdom: Metabolism of exogenous nucleotides by endothelial cells.
D. SHEPRO' and H. B. HECHTMAN,' 'Biological Science Center, Boston University, Massachusetts; 'Harvard
Medical School, Boston, Massachusetts: Saturable-carrier-mediated and nonfacilitative diffusion of sero-
tonin by intimal and microvessel endothelium in vitro.
P. A. CANCILLA and L. E. DEBAULT, Dept. of Pathology and Arteriosclerosis, Specialized Center of Research,
College of Medicine, University of Iowa, Iowa City: Demonstration of an A and L system for neutral amino
acid transport in a cerebral endothelial cell line.
Session 6: Endothelial-cellWhite-blood-cell Interaction
Chairperson: J. L. GORDON, ARC Institute of Animal Physiology, Cambridge, England
D. BURGER,' D. FORD,' A. HAMBLIN,' and D. C. DUMONDE,' 'Surgical Research Laboratory, VA Medical Center,
Portland, Oregon; 'Department of Immunology, St. Thomas' Hospital, London: Activation of human
T- lymphocytes by lymphocyteendothelial-cell interaction.
H. HIRSCHBERG' and 0. J. BERGH,' 'Dept. of Neurosurgery, 'Tissue Typing Laboratory, The National Hospital,
Oslo, Norway: Immunological function of human vascular endothelial cells.
D. C. DumoNDE,1 E. KASP-GROCHOWSKA; P. JOSE,' and T. J. WILLIAMS,' 'Dept. of Immunology, St. Thomas'
Hospital, London; 'Dept. of Pharmacology, Royal College of Surgeons, London: Modulation of lympho-
cyte transformation by soluble products of cultured endothelial cells.
W. L. FORD, P. ANDREWS, S. Fossum, M. E. SMITH, and R. W. STODDART, Dept. of Experimental Pathology,
University of Manchester, England: The interaction of lymphocytes with vascular endothelium.
J. L. GORDON, J. D. PEARSON, and J. E. BEESLEY, ARC Institute of Animal Physiology, Babraham, Cambridge,
United Kingdom: Granulocyte adhesion to and migration through vascular endothelium in culture.
R. AUERBACH, D. M. FORM, L. KUBAI, V. MUTHUKKARUPPAN, D. J. RHUDE, and Y. A. SIDKY, Dept. of Zoology,
University of Wisconsin, Madison: A comparison of lymphocyte-induced and tumor-induced angiogenesis
in the mouse.
Session 7: Cell Attachment and Substrate
Chairperson: H. KLEINMAN, NIDR, National Institutes of Health, Bethesda, Maryland
V. P. TERRANOVA,' D. H. ROHRBACH; J. C. MURRAY,' G. R. MARTIN,' and S. H. VUSPA,3 'NIDR, 'NCI, National
Institutes of Health, Bethesda, Maryland: The role of laminin in epidermal-cell attachment to basement-
membrane collagen.
G. R. GROTENDORST, H. K. KLEINMAN and G. R. MARTIN, Laboratory of Developmental Biology and Anomalies,
NIDR, National Institutes of Health, Bethesda, Maryland: Attachment of arterial smooth-muscle cells to
collagens.
E. PEARLSTEIN, Dept. of Pathology, New York University Medical Center, New York: Comparison of fibronectin-
mediated cellular adhesion to extracellular microexudates and vascular subendothelial matrices.
D. H. AUSPRUNK, Dept. of Surgery, Children's Hospital Medical Center and Dept. of Anatomy, Harvard
Medical School, Boston, Massachusetts: Glycosaminoglycans in the extracellular matrix of regenerating
and nonregenerating endothelial cells.
R. F. DYCK,' M. LocKwooD,' V. DUANCE,3 M. KERSHAW,4 and M. B. Prns,"Immunological Medicine Unit and
'Renal Unit, Dept. of Medicine, Royal Postgraduate Medical School, London, England; 'University of
Bristol, England; 'St. Mary's Hospital Medical School, London, England: Amyloid P-component-A
constituent of normal human basement membrane.
Session 8: Tumor-cell Interaction with Endothelial Cells
Chairperson: G. NICOLSON, College' of Medicine, University of California, Irvine
R. GONZALEZ,' R. H. KRAMER,' E. RUOSLAHTI,3 and G. L. NICOLSON,t3 'Dept. of Developmental and Cell
Biology, 'Dept. of Physiology, College of Medicine, University of California, Irvine; 'La Jolla Cancer
Research Foundation, California: Adhesion of metastatic human and mouse melanoma cells to vascular
endothelial cells and their extracellular matrix-role of fibronectin.
R. H. KRAMER,' K. G. VOGEL,' R. GONZALEZ,' and G. L. NicoLsoN,13 'Dept. of Developmental and Cell Biology,
'Dept. of Biology, University of New Mexico, Albuquerque; 'Dept. of Physiology, College of Medicine,
University of California, Irvine: Metastatic tumor-cell invasion of vascular endothelial-cell monolayers and
interaction with associated extracellular matrix.
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G . Poste, 1 J. Doll , 1 C . Akers, 2 and R. E. Baier, 2 1Dept, of Experimental Pathology, Roswell Park M em orial In- 
stitute, Buffalo, New York ; 2Calspan Corporation, Buffalo, N ew  York : The interaction of tum or cells with 
endothelial cells and subendothelial com ponents in perfused blood vessels.
P. A. Jones1 and H. B. NeusteiKi, 2 1Division of Hem atology-Oncology and 2Dept, of Pathology, Ch ild ren 's  
Hospital, University of Southern California School of M edicine, Los Angeles: Construction  of an artificial 
blood-vessel wall and its destruction by human tum or cells.
L. O ssowski and E. Reich, Rockefeller University, New  York, New  York : A  quantitative m odel for experim ental 
study of metastasis.
W . DOchting and G . Dehl, Dept, of Electrical Engineering, University of Siegen, Federal Republic of G erm any: 
Spatial structure and temporal propagation of normal and malignant cell growth— M odeling and com puter 
sim ulation.
Session 9: Endothelial-cell Matrix and Expression of Phenotype
Chairperson: D. Rifkin, New York University M edical Center, N ew  York
L. E. DeBault, Dept, of Pathology and the Atherosclerosis Specialized  Center of Research, University of Iowa, 
College of M edicine, Iowa City: Endothelial/glial cocultures and gamma-glutamyl transpeptidase induction  
mediated by cell־to־cell contact.
D . G ospodarowicz, C ancer Research Institute, University of Californ ia M edical Center, San Francisco : Cell 
proliferation and the extracellular matrix.
f| V lodavsky, G . G reenburg, L. K. Johnson, N. Savion, and D. G ospodarowicz, C a n cer Research Institute, 
University of California M edical Center, San Francisco: Structural and  functional alterations in vascular 
endothelial cells associated with the formation of a confluent cell m onolayer and with the withdrawal of fi- 
broblast growth factor.
D . Moscatelli, 1 E. Jaffe, 2 and D. B. RifkiKi, 1 1Dept, of Cell Biology, N ew  York University M edical Center, New  
York; 2Division of Hem atology-Oncology, Cornell University M edical Co llege , N ew  York, N ew  York: 
Tetradecanoyl phorbol acetate stimulates latent collagenase production by cultured hum an endothelial 
cells.
J. B. W eiss and R. A. Brown, K. A. Sedowofia, Dept, of Rheumatology, University of M anchester, England: 
Endothelial-cell-stimulating angiogenesis factor (ESAF) stim ulates a latent collagenolytic enzym e to partially 
degrade basem ent-m em brane collagen.
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Forms of Microtubule Organization in Cells, May 14-May 17
Arranged by
Guenter Albrecht-Buehler, Cold Spring Harbor Laboratory, New York
Richard G. W. Anderson, University of Texas Health Science Center, Dallas
59 participants
Opening Remarks: K. R. PORTER, University of Colorado, Boulder
Session 1: Structure and Chemistry of Microtubules
Chairperson: L. Amos, Medical Research Council Laboratory, Cambridge, England
L. A. Amos, MRC Laboratory of Molecular Biology, Cambridge, England: Microtubule structure and polarity.
L. WILSON, R. MARGOLIS, and K. FARRELL, Dept. of Biological Sciences, University of California, Santa Barbara:
Pharmacological probes in the elucidation of microtubule assembly and function.
D. B. MURPHY, Dept. of Cell Biology and Anatomy, Johns Hopkins Medical School, Baltimore, Maryland: The
identity and purification of a microtubule-associated ATPase.
P. B. SCHIFF, J. PARNESS, and S. B. HoRwrrz, Depts. of Cell Biology and Molecular Pharmacology, Albert Einstein
College of Medicine, Bronx, New York: Taxol stabilizes labile microtubules.
Session 2: Microtubules in the Cytoplasmic Matrix
Chairperson: F. SOLOMON, Massachusetts Institute of Technology, Cambridge
J. WOLOSEWICK, University of Illinois, Chicago: Observations on microtubules in cells embedded in an
extractable matrix (polyethylene glycol).
A. DUERR, D. PALL'S, G. ZIEVE, and F. SOLOMON, Dept. of Biology and Center for Cancer Research, Massachu-
setts Institute of Technology, Cambridge: Proteins associated with microtubules in cultured cells.
K. LUBY, Dept. of Molecular, Cellular and Developmental Biology, University of Colorado,Boulder: Micro-
tubules and intracellular transport-What can we learn from the fish chromatophore?
E. FRIXIONE1 and L. TILNEv,"Centro de Investigacion del IPN, Mexico City, Mexico; 'Dept. of Biology,University of Pennsylvania, Philadelphia: Association of microtubules and pigment granules, as observed
in isolated cytoplasm of crayfish retinula cells.
M. SCHLIWA, Dept. of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder:
Structural association of microtubules with cytoplasmic filaments.
R. J. LASEK, S. BRADY, and M. TYTELL, Dept. of Anatomy, Case Western Reserve University, Cleveland, Ohio:
Axonal transport of microtubules and associated proteins.
Session 3: Poster Session
B. CHERKSEY, J. A. ZADUNAISKY, and R. B. MURPHY, Dept. of Chemistry and Dept. of Physiology and Biophysics,
New York University, New York: Cytoskeletal involvement in regulation of antagonist-beta-adrenergic
receptor interaction in frog erythrocyte membrane.
M. DE BRABANDER, G. GEUENS, R. NUYDENS, R. WILLEBRORDS, and J. DE MEY, Laboratory of Oncology, Janssen
Pharmaceutica Research Laboratories, Beerse, Belgium: The effects of metabolic inhibitors on nucleated
and random microtubule assembly in intact cells.
J. DE MEY, M. MOEREMANS, G. GEUENS, R. NUYDENS, and M. DE BRABANDER, Laboratory of Oncology, Janssen
Pharmaceutica Research Laboratories, Beerse, Belgium: A colloidal gold labeled antibody method
for LM
and EM visualization of microtubules and
microtubule-associated calmodulin in cultured cells.
G. ERLER, Institute of Zoology, Wilhelms University, MUnster, Federal Republic of Germany: Are microtubules
involved in mechanosensory transduction?
I. GOZES' and C. J. BARNSTABLE' 'Laboratory of Neural and Endocrine Regulation, Massachusetts Institute of
Technology, Cambridge; 'Dept. of Neurobiology, Harvard Medical School, Boston, Massachusetts:
Identification of multiple tubulin forms by monoclonal antibodies.
I. GOZES' and K. J. SWEADNER' 'Laboratory of Neural and Endocrine Regulation, Massachusetts Institute of
Technology, Cambridge; and 'Dept. of Neurobiology, Harvard Medical School, Boston, Massachusetts:
Multiple tubulin forms are expressed by a single neuron.
D. SCANDELLA, E. WHITE, M. COLE, and E. R. KA-rz, Dept. of Microbiology, State University of New York, Stony
Brook: Mutants resistant to mitotic inhibitors in the cellular slime mold, Dictyostelium discoideum.
Session 4: Microtubules in Various Cell Types
Chairperson: J. B. TUCKER, St. Andrews University, Fife, Scotland
J. S. HYAMS' and H. STEBBINGS,2 'Dept. of Botany and Microbiology, University College, London; 'Dept. of
Biological Sciences, University of Exeter, England: Microtubule-associated transport in the insect ovary.
J. B. TUCKER, Dept. of Zoology, St. Andrews University, Fife, Scotland: Intercellular coordination of micro-
tubule organization in certain insect epithelia.
R. E. SINDEN, Dept. of Zoology and Applied Entomology, Imperial College, University of London, United
Kingdom: Microtubule organization during microgametogenesis of malarial parasites.
W. E. Foot, Dept. of Biological Sciences, Wayne State University, Detroit, Michigan: Microtubules and
microfilaments within nematode spermatocytes and spermatozoa.
D. PHILLIPS, Center for Biomedical Research, Rockefeller University, New York, New York: Insect sperm
flagella.
D. T. WOODRUM, and R. W. LINCK, Dept. of Anatomy, Harvard Medical School, Boston, Massachusetts:
Arrangement of microtubules and crossbridges in the axostyle of Saccinobaculus.
Session 5: Centrioles and Basal Bodies
Chairperson: R. G. W. ANDERSON, University of Texas, Dallas
R. G. W. ANDERSON and A. K. FLOYD, Dept. of Cell Biology, University of Texas Health Science Center, Dallas:
Biochemical properties of isolated oviduct basal bodies.
B. R. BRINKLEY and D. A. PEPPER, Dept. of Cell Biology, Baylor College of Medicine, Houston, Texas: Analysis of
centrioles and kinetochores as tubulin assembly sites in mammalian cells.
M. BORNENO, Dept. de Biologie Moleculaire, Institute Pasteur, Paris, France: Centrioles and the nuclear
envelope.
M. W. BERNS,' S. BRENNER' and S. P. PETERSON,' 'Dept. of Developmental and Cell Biology, University of
California, Irvine; 'Dept. of Cell Biology, Baylor College of Medicine, Houston, Texas, 'Ph.D.-M.D.
Program, University of Miami School of Medicine, Florida: The centriolar region in mitosis.
G. ALBRECHT-BuEHLER and A. BUSHNELL, Cold Spring Harbor Laboratory, New York: Centrioles in migrating
tissue-culture cells.
J. P. CHANG and P. C. MOLLER, Division of Cell Biology, University of Texas Medical Branch, Galveston: Tubulin
and basal body formation during ciliogenesis.
S. TAMM, Boston University Marine Program, Marine Biological Laboratory, Woods Hole, Massachusetts:
Large-scale formation of free kinetosomes in Australian termite flagellates.
Session 6: Microtubules and Sensory Processes
Chairperson: R. A. BLoomocio, Albert Einstein College of Medicine, New York, New York
R. A. BLOODGOOD, Dept. of Anatomy, Albert Einstein College of Medicine, Bronx, New York: Flagellar
membrane dynamics.
D. T. MORAN, Dept. of Anatomy, UniveAity of Colorado Health Sciences Center, Denver: Miclotubule
organization in sensory cilia.
U. THURM, J. GODDE, H. KASTRUP, T. KEIL, W. VOLKER, and B. VOHWINKEL, Institute of Zoology, University Munster,
Federal Republic of Germany: A microtubule-cytomembrane complex serving mechano-electric
transduction.
H. MAGNEMER,1 A. °CUBA,' and J. DE PEYER,' 'Abteilung fUr Biologie, Ruhr-Universitat Bochum, Federal
Republic of Germany; 'Zoological Institute, University of Tokyo, Japan; 'Pharmakologisches Institut,
Universitat Bern, Switzerland: Ciliate protozoan mechanosensitivity-No microtubules involved?
A. J. HUDSPETH, D. P. COREY, and R. JACOBS, Division of Biology, California Institute of Technology, Pasadena:
The transduction apparatus of vertebrate hair cells.
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Session 7: Cilia and Flagella
Chairperson: S. L. TAMM, Marine Biology Laboratory, Woods Hole, Massachusetts
D. N. WHEATLEY, Dept. of Pathology, University of Aberdeen, Scotland: Special features of primary cilia in
cultured cells.
S. L. TAMM, Boston University Marine Program, Marine Biological Laboratory, Woods Hole, Massachusetts:
Ciliary beat direction-Ionic, nervous, and structural control.
P. SATIR, J. WAIS-STEDER, and J. Avouo, Albert Einstein College of Medicine, Bronk, New York: 'Mechanomor-
phology of microtubule sliding.
C. K. OMOTO and G. B. WITMAN, Dept. of Biology, Princeton University, New Jersey: Rotation of the central
pair of microtubules in cilia and flagella.
D. R. MITCHELL and F. D. WARNER, Dept. of Biology, Syracuse University, New York: Dynein-microtubule
interactions in tetrahymena cilia.
C. SILFLOW; P. LEREBVRE,2 T. MCKEITHAN,3 and J. ROSENBAUM; 'Dept. of Biology, Yale University, New Haven,
Connecticut; 'Dept. of Biology, Massachusetts Institute of Technology, Cambridge; 'Dept. of Pathology,
University of Chicago School of Medicine, Illinois: Control of flagellar protein synthesis during flagellar
regeneration in Chlamydomonas.
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RNA Tumor Viruses, May 21-May 25
Arranged by
William S. Hayward, Rockefeller University, New York, New York
John Taylor, Institute for Cancer Research, Fox Chase, Pennsylvania
376 participants
Session 1: Synthesis and Structure of Viral DNA
Chairperson: H. VARMUS, University of California, San Francisco
J. MAJORS and H. E. VARMUS, Dept. of Microbiology and Immunology, University of California, San Francisco: The
structure of integrated mouse mammary tumor virus DNA.
K. SHIMOTOHNO, S. MIZUTANI, and H. M. TEMIN, McArdle Laboratory for Cancer Research, University of Wisconsin,
Madison: Nucleotide sequence of the terminal repeat of integrated spleen necrosis virus and the junctions
between cellular and viral DNA.
C.-M. WEI,' G. L. HAGER,' and D. R. Lowy,' 'Tumor Virus Genetics Branch; 'Dermatology Branch, NCI, National
Institutes of Health, Bethesda, Maryland: Molecular cloning of infectious circular DNA intermediate of
Moloney murine leukemia virus.
D. R. Lowv and E. H. CHANG, Dermatology Branch, NCI, National Institutes of Health, Bethesda, Maryland:
Functional organization of the Harvey murine sarcoma virus genome.
W. L. MCCLEMENTS,' D. G. BLAIR,2 M. OSICARSSON,' T. G. WOOD,' and G. F. VANDE WOUDE,' Laboratories of
'Molecular Virology and 'Viral Carcinogenesis, NCI, National Institutes of Health, Bethesda, Maryland:
Leukemia virus sequences required for transformation by src/sarc.
J. G. SUTCLIFFE, T. M. SHINNICK, and R. A. LERNER, Scripps Clinic and Research Foundation, La Jolla, California:
Nucleotide sequence of Moloney leukemia virus-The 3' end reveals details of replication, analogy to
bacterial transposons, and an unexpected gene.
P. Luciw, H. OPPERMAN, H. VARMUS, and J. M. BISHOP, Dept. of Microbiology, University of California, San
Francisco: Transfection with cloned avian sarcoma virus (ASV) DNA-Integration and gene expression in
nonpermissive cells.
L. BOONE and A. M. Sic/km, Roche Institute of Molecular Biology, Nutley, New Jersey: Kinetics of synthesis and
structure of proviral DNA made in vitro by the melittin permeabilized RAV-2 virion.
R. P. JUNGHANS, L. BOONE, and A. M. SKALKA, Roche Institute of Molecular Biology, Nutley, New Jersey: Models for
reverse transcription and recombination from electron microscope analysis of in vitro synthesized products.
R. SWANSTROM, W. DE LORBE, P. HACKETT, J. M. BISHOP, and H. E. VARMUS, Dept. of Microbiology and Immunology,
University of California, San Francisco: Functional aspects of nucleotide sequences in the genome of avian
sarcoma virus.
G. Ju and A. M. SKALKA, Roche Institute of Molecular Biology, Nutley, New Jersey: Size heterogeneity and
nucleotide sequence analysis of the direct repeats of avian retroviruses.
A. P. CZERNILOFSKY,' E. TISCHER,' B. DELORBE,' H. VARMUS,' R. SWANSTROM,' H. GOODMAN,' and J. M. BISHOP,'
'Dept. of Microbiology and Immunology; 'Dept. of Biochemistry and Biophysics, University of California,
San Francisco: The src gene of ASV-Nucleotide sequence of the gene and its flanking regions in the viral
genome.
C. SHOEMAKER, S. GOFF, E. GILBOA, S. MITRA, and D. BALTIMORE, Massachusetts Institute of Technology, Cambridge:
Structure of a molecularly cloned Moloney virus circular DNA with an inverted segment-Implications for
integration.
Session 2: Viral RNA Structure and Expression
Chairperson: W. HAYWARD, Rockefeller University, New York, New York
T. YAMAMOTO, J. S. TYAGI, J. FAGAN, G. JAY, B. DE CROMBRUGGHE, and I. PASTAN, Laboratory of Molecular Biology, NCI,
National Institutes of Health, Bethesda, Maryland: Structural and functional features of the common region of
avian sarcoma virus.
G. P. GASIC and W. S. HAYWARD, Rockefeller University, New York, New York: Sequence analysis of the 5' leader of
ALV.
D. DINA, E. W. BENZ, JR., R. WYDRO, and B. NADAL-GINARD, Albert Einstein College of Medicine, Bronx, New York:
Moloney murine sarcoma virus DNA is a transcriptional unit.
D. SCHWARTZ, R. TIZARD, and W. GILBERT, The Biological Laboratories, Harvard University, Cambridge, Massachu-
setts: The nucleotide sequence of Rous sarcoma virus determined by analysis of single-stranded cDNA.
C. M. STOLTZFUS, Dept. of Microbiology, University of Iowa, Iowa City: Evidence for a possible role of RNA
methylations in the formation of subgenomic avian sarcoma virus RNAs.
D. L. ROBERTSON and H. E. VARMUS, Dept. of Microbiology, University of California, San Francisco: Gene regulation
of mouse mammary tumor virus.
D. S. UCKER and K. R. YAMAMOTO, Dept. of Biochemistry and Biophysics, University of California, San Francisco:
Analysis of transcription at the integration site of a hormone-responsive MTV provirus.
N. A. JENKINS and G. M. COOPER, Sidney Farber Cancer Institute, Boston, Massachusetts: Integration, expression
and infectivity of exogenously-acquired RAV -O DNAs.
J. J. O'REAR, S. MIZUTANI, and H. M. TEMIN, McArdle Laboratory for Cancer Research, University of Wisconsin,
Madison: Infectious and noninfectious proviruses of spleen necrosis virus cloned in Charon 4A.
J. I. MULLINS,' M. NICHOLSON,2 J. CASEY,' K. BURCK,' and N. DAVIDSON,' California Institute of Technology,
Pasadena; qhe Childrens Hospital of Los Angeles, California: Sequence arrangement and biological activity
of cloned integrated forms of FeLV DNA.
D. JAHNER, H. STUHLMANN, and R. JAENISCH, Heinrich-Pette-Institut fur Experimentelle Virologie and Immunologie,
Hamburg, Federal Republic of Germany: Germ line integration of Moloney leukemia virus-Characterization
of independently derived mouse sublines.
R. MICHALIDES,' R. VAN Na,' R. NussE,' N. HYNES,2 and B. GRONER,2 'Netherlands Cancer Institute, Amsterdam;
2Swiss Cancer Institute, Lausanne, Switzerland: Regulation of mouse mammary tumor virus (MMTV) expres-
sion in mouse strains GR and GR/Mtv-2-.
Session 3: Poster Session-Retrovirus Biochemistry
Synthesis and Structure of Viral DNA
C. A. OMER and A. J. FARAS, Dept. of Microbiology, Minneapolis, Minnesota: DNA sequence analysis of tRNAtrl, ini-
tiated RSV cDNA longer than 101 nucleotides.
E. C. WOODLAND and P. R. SHANK, Division of Biology and Medicine, Brown University, Providence, Rhode Island:
Detection of supercoiled avian sarcoma virus DNA molecules of 1/3 to 1/2 genome length.
T. GILMER, L. RAFIELD, P. HIGHFIELD, T. PUGATSCH, G. GILMARTIN, and J. PARSONS, Dept. of Microbiology, University of
Virginia, Charlottesville: Structure and biological activity of cloned avian sarcoma virus DNA.
J. C. OLSEN and K. F. WATSON, Dept. of Chemistry, University of Montana, Missoula: Reverse transcription of avian
myeloblastosis virus 35S RNA-Identification and characterization of (+) DNA of discrete sizes synthesized in
the reconstructed reaction.
R. FRIEDRICH, Institute of Tumor Immunology, University of Freiburg, Federal Republic of Germany: Are both
retroviral RNA subunits involved in the synthesis of one DNA molecule?
L. DESGROSEILLERS, E. RASSART, and P. JOLICOEUR, Institut de Recherches CI iniques, University de Montreal, Quebec,
Canada: Study of in vitro synthesis of Balb/c endogenous MuLV DNA.
C. VAN BEVEREN,' J. G. GODDARD,2 A. BERNS,' and I. M. VERMA,2 'Laboratory of Biochemistry, University of
Nijmegen, The Netherlands; 2Turnor Virology Laboratory, Salk Institute, San Diego, California: Structure of
Moloney murine leukemia viral DNA-Nucleotide sequence of the 5'-long terminal repeat and adjacent
cellular sequences.
W. L. MCCLEMENTS, R. DHAR, and G. F. VANDE WOUDE, Laboratory of Molecular Virology, NCI, National Institutes of
Health, Bethesda, Maryland: Nucleotide sequence of provirus-host junctions of integrated Moloney sarcoma
virus.
L. BACHELER and H. FAN, Tumor Virology Laboratory, Salk Institute, San Diego, California: Cloning of integrated
Moloney murine leukemia virus DNA sequences from infected mouse cells.
N. TSUCHIDA and S.-1.UEsuci, Wistar Institute, Philadelphia, Pennsylvania: Molecular cloning of Ki-MSV genome
size DNA.
E. BUETII, B. GRONER, N. HYNES, and H. DIGGELMANN, Swiss Institute for Experimental Cancer Research, Epalinges,
Switzerland: Molecular cloning of cellular unintegrated DNA forms of mouse mammary tumor virus (MMTV).
N. HYNES,' .2 B. GRONER,' '2 R. MICHALIDES,3 and N. KENNEDY,2 'Swiss Institute for Experimental Cancer Research,
Lausanne, Switzerland; 2Kernforschungszentrum, Karlsruhe, Germany; .Dutch Cancer Institute, Amster-
dam, The Netherlands: Isolation of the endogenous MMTV proviruses of the GR mouse and their molecular
comparison.
M. NODA, T. TAMURA, and T. TAKANO, Dept. of Microbiology, Keio University School of Medicine, Tokyo, Japan: Re-
striction mapping and integration mechanism of baboon endogenous virus (M7) DNA.
E. GELMANN, S. JosEpHs, A. CErrA, R. C. GALLO, and F. WoNG-SrAAL, NCI, National Institutes of Health, Bethesda,
Maryland: Molecular cloning and restriction enzyme maps of two strains of baboon endogenous virus.
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N. BATTULA and G. J. TODARO, NCI, National Institutes of Health, Bethesda, Maryland: Physical map of infectious
baboon type C viral DNA and sites of integration.
S. J. O'BRIEN, C. A. WINKLER, W. G. NASH, R. S. LEMONS, and J. S. MARTENSON, NCI, National Institutes of Health, Be-
thesda, Maryland: Control of integration of baboon endogenous virus in human chromosomes by the BEV1
locus-Genetic studies.
Viral RNA-Structure and Expression
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Viruses, NCI, National Institutes of Health Bethesda, Maryland: Translation products of the 124 strain of
Moloney murine sarcoma virus (Mo-MuSV)-Characterization of a 23,000 dalton candidatesrc gene product.
S. RASHEED' and H. YOUNG,' 'Dept. of Pathology, University of Southern California School of Medicine, Los
Angeles; 'Frederick Cancer Research Center, Frederick, Maryland: Independent rat sarcoma virus isolates
code for the same transforming protein in rat or heterologous transformed cells.
D. A. SCHEINBERG and M. STRAND, Johns Hopkins University School of Medicine, Baltimore, Maryland: Transforma-
tion sensitive antigens associated with Kirsten sarcoma virus pseudotypes and transformed cells.
G. R. ANDERSON, Dept. of Microbiology, University of Pittsburgh School of Medicine, Pennsylvania: A thermola-
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A. B. VAIDYA,' C. A. LONG," and J. B. SHEFFIELD,. 'Hahnemann Medical College, Philadelphia; 'Temple
University, Philadelphia, Pennsylvania: Biochemical and biological studies on Mu-MTV produced by a
lymphoma cell line-A possible morphogenesis mutant?
A. HABERMAN and L. F. VELICER, Dept. of Microbiology and Public Health, Michigan State University, East
Lansing: A feline oncornavirus with envelope properties of both feline leukemia virus and RD-114.
S. S. VEDBRAT and W. PRENSKY, Memorial Sloan-Kettering Cancer Center, New York, New York: Monoclonal
antibody to FOCMA, the feline oncornavirus-associated cell membrane antigen.
F. K. YOSHIMURA and J. YAMAMURA, Fred Hutchinson Cancer Research Center, Seattle, Washington: Character-
ization of replication-defective mutants of Moloney murine leukemia virus.
J. LINKS and 0. TOL, Netherlands Cancer Institute, Amsterdam: Chemical and spontaneous induction of B-
type and C-type retroviruses in mouse kidney cells.
A. PINTER,' N. M. TEICH,' and T. M. DEXTER,. 'Imperial Cancer Research Fund, London; 'Paterson Laborato-
ries, Manchester, England: Characterization of a bone marrow cell line transformed by Friend murine
leukemia virus.
M. PETTIGREW and M. LINIAL, Fred Hutchinson Cancer Research Center, Seattle, Washington: Nonrescuable
clones of ASV transformed rat cells.
G. S. MARTIN,' W. -H. LEE,. Depts of 'Zoology and 'Molecular Biology, University of California, Berkeley:
Recombination between deletion mutants of Rous Sarcoma virus.
M. F. D. NorrER,1 J. F. LEARY,. and P. B. BALDUZZI,' Depts. of 'Microbiology and 'Pathology, University of
Rochester School of Medicine and Dentistry, New York: Specific and nonspecific receptors for avian
tumor viruses.
D. NIWA,' and K. TOYOSHIMA,. M. YUTSUDO,. H. SUGIYAMA,2 S. TAHARA,' and T. SucAHARA,"Faculty of
Medicine, Kyoto University; 'Research Institute for Microbial Diseases, Osaka University, Suita, Japan:
Sensitivity to y-ray of avian sarcoma and murine leukemia viruses.
T. KAWAKAMI and L. SUN, and Comparative Oncology Laboratory, University of California, Davis: Replication-
defective gibbon ape leukemia virus infection in human lymphoctyes.
E. HEFTI," C. RAINERI,' S. PANEM,' E. CLARK,. and W. E. GIDDENS, JR.,. 'Dept. of Pathology, University of
Chicago, Illinois; 'Regional Primate Research Center, University of Washington, Seattle: Comparison of a
new macaque viral isolate, macacca nemestrina virus (MNV-1), to type C and type D retroviruses.
J. LOWER, R. LOWER, and R. KURTH, Friedrich-Miescher-Laboratory, Max-Planck-Institut, Tubingen, Federal
Republic of Germany: Human teratocarcinoma cells can be induced to produce retrovirus particles.
J. M. PREVOST,' C. BIRKENWALD,' R. KETTMANN,. D. DEKEGEL,.. and A. BURNT,' and 'Institut J. Bordet;
'Universit(e Libre de Bruxelles; ' Institut Pasteur du Brabant, Bruxelles, Belgium: Molecular characteriza-
tion of a retrovirus isolated from a human osteosarcoma cell line.
R. C. MELLORS, J. W. MELLORS, S. MAEDA, L. JERABEK, H. UENO, and I. ZERVOUDAKIS, Hospital for Special Surgery
and New York Hospital-Cornell University Medical College, New York: Normal human placental antigen is
immunologically related to major structural (p26) protein of simian sarcoma associated virus as shown by
solid phase enzymoimmunoassay.
D. HUGHES, D. FRISBY,' I. B. PRAGNELL,' F. SMADJA-JOFFE,. B. KLEIN,. K. VEHMEYER,4 B. FAGG,5 and W. OSTERTAG,'
'Beatson Institute, Glasgow, Scotland; 'ICIG, Villejuif, France; 'Hopital St. Elo, Montpellier, France;
'Max- Planck -Institut, Goettingen, Federal Republic of Germany; 'University of California, Irvine: A murine
myeloproliferative virus-molecular and biological analysis.
Session 8: Endogenous Viruses
Chairperson: S. ASTRIN, Institute for Cancer Research, Philadelphia, Pennsylvania
A. TEREBA,' S. ASTRIN,. and M. M. C. LAI,. 'Division of Virology, St. Jude Children's Research Hospital,
Memphis, Tennessee; 'Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylva-
nia; 'Dept. of Microbiology, University of Southern California Medical Center, Los Angeles: Nonrandom
chromosomal distribution of endogenous retrovirus loci in white leghorn chickens.
F. HISHINUMA," P. J. DEBONA,' S. ASTRIN,. and A. M. SKALKA,"Roche Institute of Molecular Biology, Nutley,
New Jersey; 'Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pennsylvania: Studies
on integrated endogenous avian proviruses and their integration sites.
S. HUGHES,' P. SHANK,. J. M. BISHOP,. and H. VARmus,3 'Cold Spring Harbor Laboratory, New York; 'Division
of Biology and Medicine, Brown University, Providence, Rhode Island; 'Dept. of Microbiology and
Immunology, University of California, San Francisco: Organization of the endogenous proviruses of
chickens-Implications for origin and expression.
W. KANE, T. Hsu, G. MARDEN, and J. TAYLOR, Institute for Cancer Research, Philadelphia, Pennsylvania:
Application of a novel strategy for the detection of retrovirus-related RNA sequences in uninfected cells.
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S. K. CHATTOPADHYAY; M. R. LANDER,' E. RANDS' and D. R. LOWY,' 'Pediatric Oncology and 'Dermatology
Branches, NCI, National Institutes of Health, Bethesda, Maryland: The structure of endogenous murine
leukemia virus DNA genomes.
D. L. STEFFEN,' B. A. TAYLOR' and R. A. WEINBERG,' 'Center for Cancer Research and Dept. of Biology,
Massachusetts Institute of Technology, Cambridge; 'Jackson Laboratory, Bar Harbor, Maine: Genetic
instability of endogenous murine leukemia proviruses.
A. BERNS,' W. QUINT,' H. V.D. RUFFEN,' W. QUAX,1 M. LAI,2 R. BOSSELMAN,2 and I. VERMA,2 'Dept. of
Biochemistry, University of Nijmegen, The Netherlands; 'Salk Institute, La Jolla, California: The character-
ization of endogenous Moloney and AKR viral sequences.
E. KESHET, Y. SHAUL, J. KAMINCHICK, and H. Aviv, Dept. of Virology, Weizmann Institute of Science, Rehovot,
Israel: Heterogeneity of "virus-like" genes encoding retrovirus-associated 30S RNA and their organiza-
tion within the mouse genome.
H. A. YOUNG,' M. A. GONDA,' D. JONES; K. NAGASHIMA,' R. ELLIS' and E. M. SCOLNICK,2 'Biological
Carcinogenesis Program, Frederick Cancer Research Center, Maryland; 'Laboratory of Tumor Virus
Genetics, NCI, National Institutes of Health, Bethesda, Maryland: Comparison of endogenous rat replica-
tion defective (30s) retrovirus and Harvey sarcoma virus DNA - Analysis by restriction enzyme mapping,
southern blotting and hetero-duplex conditions.
R. CALLAHAN,' E. L. KUFF,2 K. K. LUEDERS,' and E. BIRKENMEIER,' Laboratories of 'Viral Carcinogenesis and
'Biochemistry, NCI, National Institutes of Health, Bethesda, Maryland: A structural comparison of the
genomes of intracisternal A-particles of Mus muscu/us and the endogenous retrovirus (M432) of M.
Cervicolor.
Session 9: Mechanisms of Transformation. I.
Chairperson: E. SCOLNICK, NCI, National Institutes of Health, Bethesda, Maryland
S. GOFF, 0. N. WirrE, and D. BALTIMORE, Massachusetts Institute of Technology, Cambridge: Analysis of
Abelson viral mutants and the homologous cellular gene using cloned Abelson viral DNA.
V. RorrER, 0. N. WITH, and D. BALTIMORE, Massachusetts Institute of Technology, Cambridge: Abelson virus-
induced tumors elicit antibodies against a host cell protein, P50.
D. J. GRUNWALD, K. MILLER, P. JELEN, C. SINAIKO, J. TIMMINS, and R. RISSER, McArdle Laboratory for Cancer
Research, University of Wisconsin, Madison: Characterization of Abelson 'virus lymphomas and antisera
made to them.
A. OLIFF, D. LINEMEYER, S. Rusarn, and E. SCOLNICK, Laboratory of Tumor Virus Genetics, NCI, National
Institutes of Health, Bethesda, Maryland: A subgenorrtic fragment of molecularly cloned Friend murine
leukemia virus (F-MuLV) DNA contains the gene(s) responsible for F -MuLV induced proliferation of
hematopoietic precursors.
R. ANAND; S. RUSCETTI,2 R.A. STEEVES,' and F. LILLY,' 'Albert Einstein College of Medicine, Bronx, New York;
'NCI, National Institutes of Health, Bethesda, Maryland: The spleen focus-forming virus is specifically
neutralized by antisera to certain gag gene-encoded proteins.
R. A. BOSSELMAN,' L. J. L. D. VAN GRIENSVEN,' M. VOGT; and I. M. VERMA,' 'Tumor Virology Laboratory, Salk
Institute, San Diego, California; 'Dept. of Experimental Pathology, Erasmus University, Rotterdam, The
Netherlands: F-SFFV, Mo-MCF virus and xenotropic viruses Balb-virus 2 and NZB virus share env gene
sequence homology between 1.7 and 2.5 KB for the genomic 3' end.
B. G. NEEL,' S. M. ASTRIN,2 and W. S. HAYWARD,' 'Rockefeller University, New York, New York; 'Institute for
Cancer Research, Philadelphia, Pennsylvania: Avian lymphoid leukosis is correlated with the appearance
of discrete new RNA5 containing viral and cellular genetic information.
G. RAYNE,' L. B. CRITTENDEN,' J. M. BISHOP; and H. E. VARMUS; 'Dept. of Biochemistry and Biophysics,
'Dept. of Microbiology, University of California, San Francisco; 'Regional Poultry Research Laboratory,
United States Department of Agriculture, East Lansing, Michigan: The structure of RAV-2 proviruses
present in tumors from chickens with RAV-2 induced leukosis.
G. M. COOPER; and P. E. NEimAN,2 'Sidney Farber Cancer Institute, Boston, Massachusetts; 'Fred Hutchin-
son Cancer Research Center, Seattle, Washington: Transforming genes of avian leukosis virus-induced
neoplasms.
M. ROUSSEL, D. LEPRINCE, S. SAULE, M. B. RAES, C. LAGROU, and D. STEHELIN, INSERM, Pasteur Institute, Lille,
France: Genomic structure of avian myeloblastosis viruses.
B. VENNSTROM, D. SHEINESS, T. GONDA, and J. MICHAEL BISHOP, Dept. of Microbiology, University of California,
San Francisco: The cellular progenitor of the oncogene of AEV-Characterization of the DNA locus and its
RNA transcripts.
Session 10: Mechanisms of Transformation. II.
Chairperson: D. BALTIMORE, Massachusetts Institute of ,Technology, Cambridge, Massachusetts
E. M. DURBAN and D. BoErricER, Dept. of Microbiology, University of Pennsylvania, Philadelphia: Differential
effects of transforming avian RNA tumor viruses on avian macrophages.
T. J. GONDA, D. SHEINESS, B. VENNSTROM, H. OPPERMANN, J. M. BISHOP, M. G. Moscovia, and C. Moscovia,
University of California, San Francisco; and Veterans Administration Hospital, Gainesville, Florida: Avian
defective leukemia viruses - Strategies of oncogene expression
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P. N. TsicHus," J. M. COFFIN' and H. L. ROBINSON' 'Tufts University School of Medicine, Boston, Massachu-
setts; 'Worcester Foundation for Experimental Biology, Massachusetts: Differences between endogenous
and exogenous avian oncovirus genomes - Role of the C region.
P. N. TSICHLIS, C. BARKER, and J. M. COFFIN, Tufts University School of Medicine, Boston, Massachusetts: Agenetic region that maps between env and src affects the growth of the transforming avian retroviruses.
H. HANAFUSA, L.-H. WANG, S. M. ANDERSON, R. E. !CARESS, R. FELDMAN, M. SHIBUYA, and T. HANAFUSA, Rockefeller
University, New York, New York: A new transforming gene of Fujinami sarcoma virus.
W.-H. LEE,' K. BUSTER,' A. PAWSON,2 T. ROBINS,' C. MOSCOVICI,' and P. DUESBERG,1 Departments of 'Molecular
Biology and 'Zoology, University of California, Berkeley; 'Virus Research Laboratory, Veterans Adminis-
tration Hospital, Gainesville, Florida: Fujinami sarcoma virus - An avian RNA tumor virus with a uniquetransforming gene.
M. YOSHIDA,' S. KAwAi,2 H. SUGIVAMA,' and K. TOYOSHIMA,' 'Cancer Institute, Tokyo; 'Institute of Medical
Science, University of Tokyo; 'Research Institute for Microbial Diseases, Osaka University, Japan: Newly
isolated avian sarcoma virus, Y73, contains transforming gene unrelated to src sequences of RSV.
J. C. NEIL, M. L. BREITMAN, and P. K. VOGT, Dept. of Microbiology, University of Southern California School of
Medicine, Los Angeles: A new transforming gene in avian sarcoma.
M. L. LUNG,' N. HOPKINS,' J. W. HARTLEY,' and W. P. RowE,2 'Center for Cancer Research, Massachusetts
Institute of Technology, Cambridge; 'Laboratory of Viral Diseases, NIAID, National Institutes of Health,
Bethesda, Maryland: "Identifying and localizing nucleotide sequences that distinguish the genomes of
two biologically defined classes of MCF viruses."
W. A. HASELTINE, F. S. PEDERSEN, and R. A. CROWTHER, Harvard Medical School and Sidney Farber Cancer
Institute, Boston, Massachusetts: Origin of leukemic AKR viruses.
E. P. REDDY,' S. ZA/N,2 S. TRONICK,' K. ROBBINS,' E. CANAANI,1 and S. A. AARONSON,' 'National Cancer
Institute, Bethesda, Maryland; 'University of Rochester Medical School, New York, 'Hazleton Laborato-
ries, Inc., Vienna, Virginia: Nucleotide sequence analysis of the transforming gene of Moloney sarcoma
virus.
Session 11: Genetics and Biology
Chairperson: H. HANAFUSA, Rockefeller University, New York, New York
B. POIESZ, F. RUSCETTI, H. RHO, A. GAZDAR, P. BUNN, J. MINNA, and R. GALLO, NCI, National Institutes of Health,
Bethesda, Maryland: Isolation of novel type-C retrovirus particles from cultured and fresh lymphocytes
from two patients with cutaneous T-cell lymphomas.
F. RuscErn, B. POIESZ, M. REITZ, V. KALYANARAMAN, and R. GALLO, NCI, National Institutes of Health, Bethesda,
Maryland: Analysis of novel type-C retroviral particles isolated from cultured and fresh lymphocytes from
two patients with cutaneous T-cell lymphomas.
P. JOLICOEUR and E. RASSART, Institut de Recherches Cliniques, University de Montreal, Quebec, Canada:
Studies of linear viral DNA from Fv-1 permissive and resistant mouse cells infected with MuLV.
W. K. YANG,' J. 0. KIGGANS, JR.,1 C. Y. Ou,' D. M. YANG,' R. H. BASSIN,' R. W. TENNANT,' and A. BROWN,' 'Bi-
ology Division, Oak Ridge National Laboratory, Tennessee; 'NCI, National Institutes of Health, Bethesda,
Maryland; 'University of Tennessee, Knoxville: Covalent ly closed circular DNAs of murine ecotropic type
C retroviruses - Effects of Fv-1 restriction and inhibition of early protein synthesis.
S. KAWAI,' T. KOYAMA,' and F. HARADA,2 'Institute of Medical Science, University of Tokyo; 'National Cancer
Center, Tokyo, Japan: A mutant of Rous sarcoma virus which contains 30-40S RNA instead of 70S RNA in
virions.
D. W. STACEY,' B. R. CULLEN,' and L. -H. WANG 'Roche Institute of Molecular Biology, Nutley, New Jersey;
'Rockefeller University, New York, New York: Participation of env mRNA in active provirus formation and
recombination.
L.-H. WANG, M. BECKSON, and H. HANAFUSA, Rockefeller University, New York, New York: Generation of
replication-defective sarcoma virus via recombination between viral and cellular sequences.
S. CHEN,' F. DURAN-STRUUCK,2 F. LILLY' and M. DURAN-REYNALS,2 'Dept. of Biological Sciences, Columbia
University, New York; Depts. of 'Pathology and 'Genetics, Albert Einstein College of Medicine, Bronx,
New York: Genetic and nongenetic factors in MuLV expression in the DBA/2 X RF cross.
E. STOCKERT, P. V. O'DONNELL, Y. OBATA, and L. J. OLD, Memorial Sloan-Kettering Cancer Center, New York,
New York: Inhibition of AKR leukemogenesis by SMX-1, a dualtropic murine leukemia virus.
R. RISSER, D. J. GRUNWALD, P. JELEN, and J. TIMMINS, McArdle Laboratory for Cancer Research, University of
Wisconsin, Madison: The unusual "anti-self H-2" response of hybrid mice to immunization with a semi-
syngeneic Abelson virus lymphoma.
J. Azoc.AR,1 M. G. BALDINI,' and M. ESSEX' 'Hematology Research, Memorial Hospital, Pawtucket, Rhode
Island; 'Harvard University School of Public Health, Boston, Massachusetts: Mechanism of incorporation
of histocompatibility antigens in the envelope of RNA tumor viruses during virus maturation.
C. A. LONG, A. B. VAIDYA, and U. J. DUMASWALA, Hahnemann Medical College and Hospital, Philadelphia,
Pennsylvania: Influence of the major histocompatibility complex on susceptibility to MuMTV's.
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Session 1: SV40/Polyoma-Transcription
Chairperson: R. KAMEN, Imperial Cancer Research Fund Laboratories, London, England
L. DANDOLO,L. D. BLANCY,1 and R. KAMEN,. 'Institut de Rescherches Scientifiques sur le Cancer, Villejuif,
France; 'Imperial Cancer Research Fund, London, England: Regulation of polyoma virus transcription in
murine teratocarcinoma cells.
C. KAHANA, D. GIDONI, D. CANAAN!, and Y. GRONER, Dept. of Virology, Weizmann Institute of Science, Rehovot,
Israel: Transcriptional initiation and subsequent capping of SV40 early and late mRNAs occur in vivo and in
vitro at multiple nucleotide sequences including pyrimidines.
D. MATHIS, C. BENOIST, and P. CHAMBON, Laboratoire de Genetique Moleculaire des Eucaryotes du CNRS, Unite
de Biologie Moleculaire et de Genie Genetique de I'INSERM, Strasbourg, France: Comparison of the in
vivo and in vitro expression of the SV40 early region.
P. K. GHOSH,1 Y. GLUZMAN,. R. FRISQUE,. and P. LEBowrrz,"Dept. of Medicine, Yale University, New Haven,
Connecticut; 'Cold Spring Harbor Laboratory, New York: Studies on the 5' termini of early viral mRNAs
in cells infected and transformed by wild-type SV40 and transformed by "origin-defective" mutants.
U. HANSEN, H. HANDA, C. CEPKO, D. TENEN, D. LIVINGSTON, J. MANLEY, M. GEFTER, and P. A. SHARP, Center for Can-
cer Research and Dept. of Biology, Massachusetts Institute of Technology, Cambridge: Transcription in
vitro of SV40 DNA.
R. TJIAN, D. Rio, A. ROBBINS, and R. MYERS, Dept. of Biochemistry, University of California, Berkeley:
Modulation of SV40 early transcription in vitro by a purified tumor antigen.
E. B. JAKOBOVITS,' S. BRATOSIN,' 0. LAUB,' S. SAROGOSTI,. M. YANIV,. and Y. Atom,' 'Dept. of Genetics,
Weizmann Institute of Science, Rehovot, Israel; 'Dept. of Molecular Biology, Institut Pasteur, Paris,
France: Correlations between the structure of the SV40 minichromosome and the regulation of its gene
expression.
C. DEVERE-TYNDALL and R. KAMEN, Imperial Cancer Research Fund, London, England: Deletion mutants of
polyoma virus DNA in the noncoding sequences between the replication origin and the beginning of the
late region.
P. GRUSS and G. KHOURY, NCI, National Institutes of Health, Bethesda, Maryland: Use of recombinant DNA
molecules to investigate regulatory signals for mRNA biosynthesis.
M. FITZGERALD and T. SHENK, Dept. of Microbiology, University of Connecticut Health Center, Farmington: The
hexanucleotide, AAUAAA, forms part of the signal for polyadenylation of SV40 late mRNAs.
Session 2: Adenoviruses-Transcription
Chairperson: J. FLINT, Princeton University, New Jersey
S.-L. Hu' and J. L. MANLEY,. 'Cold Spring Harbor Laboratory, New York; 'Dept. of Biology, Massachusetts
Institute of Technology, Cambridge: Identification of major late promoter of Ad2.
G.-J. Wu, Dept. of Microbiology, Emory University School of Medicine, Atlanta, Georgia: Transcription of Ad2
DNA by calf thymus RNA polymerase II and KB cellular RNA polymerase II ih a soluble nuclear extract.
V. W. YANG,' S. J. FLINT,' M. R. LERNER,' and J. A. STEITZ,. 'Dept. of Biochemical Sciences, Princeton
University, New Jersey; 'Dept. of Molecular Biophysics and Biochemistry, Yale University, New Haven,
Connecticut: The role of small nuclear ribonucleoproteins (snRNPs) in the splicing of Ad2 early RNA
precursors.
A. J. BERK,' T. F. OSBORNE,' R. E. SCHELL,' and S. J. BERGET,2 'Molecular Biology Institute, University of
California, Los Angeles; 'Dept. of Biochemistry, Rice University, Houston, Texas: Upstream DNA se-
quence required for expression of the Ad2 pre-early genes in He La cells.
M. C. WILSON, F. CROSS, and J. E. DARNELL, JR., Rockefeller University, New York, New York: Metabolism of
E1A and E1B mRNA species during adenovirus lytic cycle.
A. BABICH and J. R. NEVINS, Rockefeller University, New York, New York: The stability of the early adenovirus
mRNAs is controlled by the 72K DNA binding protein.
A. R. SHAw and E. B. ZIFF, Rockefeller University, New York, New York: Transcripts from the Ad2 major late
promoter are initiated at early times and processed to yield mRNA.
G. P. THOMAS and M. B. MATHEWS, Cold Spring Harbor Laboratory, New York: DNA replication obligatorily
precedes late gene expression of adenovirus and SV40.
H. PERSSON, H.-J. MONSTEIN, and L. PHILIPSON, Biomedical Center, University of Uppsala, Sweden: A transla-
tional control of adenovirus early gene expression.
R. GUILFOYLE and R. WEINMANN, Wistar Institute of Anatomy and Biology, Philadelphia, Pennsylvania: Deletion
mutants around the control regions of VAl RNA.
D. M. FOWLKES and T. SHENK, Dept. of Microbiology, University of Connecticut Health Center, Farmington: In
vitro analysis of the adenovirus VA RNA polymerase III initiation site.
Session 3: Poster Session-SV40 and Polyoma
J. C. ALWINE1 and G. KHOURY,' 'Dept. of Microbiology, University of Pennsylvania School of Medicine,
Philadelphia; 'NCI. National Institutes of Health, Bethesda, Maryland: The SV40-associated small RNA
(SAS-RNA)- Mapping on the SV40 genome and characterization of its synthesis.
E. AMTMANN and G. SAUER, Institute for Virus Research, German Cancer Research Center, Heidelberg, Federal
Republic of Germany: Transformation by episomal papilloma virus DNA.
M. BASTIN and C. PARENT, Dept. de Microbiologie, Centre Hospitalier Universitaire de Sherbrooke, Quebec,
Canada: Tumorigenicity of recombinant plasmids containing defective polyoma virus DNA molecules.
E. A. BAUMANN, D. STEDMAN, A. Fuss, and R. HAND, McGill Cancer Centre, Montreal, Quebec, Canada:
Comparison of the immunoreactivity of SV40 large T antigen and D2 hybrid protein.
P. BEARD, M. KANEKO, and K. NYFELER-SCHRIEFER, Swiss Institute for Experimental Cancer Research, Epalinges,
Switzerland: The carcinogen acetylaminofluorene binds preferentially to a specific region on the SV40
chromosome.
M. A. R BENDER and W. W. BROCKMAN, Dept. of Microbiology, University of Michigan, Ann Arbor: SV40
sequences in untransformed mouse cells.
A. BEN-ZEEV, M. HOROWITZ, H. SKOLNIK, R. ABULAFIA, 0. LAUB, and Y. ALONI, Dept. of Genetics, Weizmann
Institute of Science, Rehovot, Israel: SV40-specific RNA is associated with the cytoskeletal framework.
J. BUITENWERF, W. DE JONG, and J. VAN DER NOORDAA, Laboratorium voor de Gezondheidsleer, Universiteit van
Amsterdam, Mauritskade, The Netherlands: Characterization of SV40-transformed human liver cells.
K. CHANDRASEKARAN and P. T. Morin, NCI, National Institutes of Health, Bethesda, Maryland: Synthesis of
55,000-m.w. cellular protein as a correlate of the SV40 early gene expression and not of tumorigenicity in
the mouse.
D. COSMAN and M. J. TEVETHIA, Dept. of Microbiology, Pennsylvania State University College of Medicine,
Hershey: Characterization of an atypical tsA mutant of SV40.
L. CRAWFORD and D. PIM, Imperial Cancer Research Fund, London, England: The presence of 53K protein in
human tumor cell lines.
L. DAILEY, V. COLANTUONI, R. FENTON, G. DELLA VALLE, and C. BASILIC°, Dept. of Pathology, New York University
School of Medicine, New York: Excision and the evolution of polyoma-transformed cell lines.
L. DAYA-GROSJEAN, A. SARASIN, and R. MONIER, Institut de Recherches Scientifiques sur le Cancer, Villejuif,
France: The effect of 12- O- tetradecanoyl -phorbol -13- acetate (TPA) on cell transformation by SV40 mutants.
R. J. DEANS and W. R. FOLK, Dept. of Biological Chemistry, University of Michigan, Ann Arbor: Cloning of
polyoma virus tumor antigen coding sequences in E. colt.
L. DELBECCHI and P. BOURGAUX, Dept. de Microbiologie, Centre Hospitalier Universitaire de Sherbrooke,
Quebec, Canada: Absence of complementation between resident and superinfecting polyoma virus
genomes in permissive transformed cells.
W. DEPPERT,' E. GURNEY,' and R. HARRISON' 'Dept. of Biochemistry, University of Ulm, Federal Republic of
Germany; 'Dept. of Biology, University of Utah, Salt Lake City: Monoclonal antibodies against 5V40 tumor
antigens-Characterization of antigenic binding sites using Ad2/SV40 hybrid viruses.
R. G. FENTON and C. BASILIC°, Dept. of Pathology, New York University School of Medicine, New York:
Transcription in polyoma-transformed rat cells and their cured derivatives.
M. M. FLUCK,' R. SHAIKH' and T. L. BENJAMIN' 'Microbiology Department, Michigan State University, East
Lansing; 'Pathology Department, Harvard Medical School, Boston, Massachusetts: The role of the hr-t
and ts-a functions of polyoma virus.
E. GEORGES, M. VASSEUR, J. AGHION, and D. BLANGY, Institut de Recherches Scientifiques sur le Cancer, Villejuif,
France: Control of polyoma virus expression in murine embryonal carcinoma cells.
R. D. GERARD and W. A. Scorn, Dept. of Biochemistry, University of Miami, Florida: Deletion mutant mapping
of the nuclease-sensitive region in SV40 chromatin.
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P. K. GHOSH,1 J. MERTZ,' A. BARKAN,2 S. WEISSMAN,3 M. PIATAK,' T. SHENK,4 P. Roy,3 and P. LEBOWITZ,' Depts.
of 'Medicine and 'Human Genetics, Yale University, New Haven, Connecticut; 2McArdle Laboratory for
Cancer Research, University of Wisconsin, Madison; 4Dept. of Microbiology, University of Connecticut
Medical Center, Farmington: Structure of late mRNAs produced by SV40 late leader deletion mutants.
M. GRIGORYAN, D. KRAMEROV, and E. LUKANIDIN, Institute of Molecular Biology, Academy of Sciences of USSR,
Moscow: Initiation points for DNA replication in mammalian cells.
J. D. HARE,' B. J. POMERANTZ,2 and E. K. THomAs,' 'Dept. of Microbiology, University of Rochester Medical
Center, New York; 'McGill University, Montreal, Quebec, Canada; 'Dept. of Pathology, Harvard Univer-
sity, Cambridge, Massachusetts: A mutation in polyoma virus affecting expression of late functions at a
post transcriptional level.
C. A. HEILMAN, M.-F. LAW, and P. M. HOWLEY, NCI, National Institutes of Health, Bethesda, Maryland: Cloning
of human papillomavirus genomic DNAs and analysis of homologous polynucleotide sequences.
W. C. HEISER and W. ECKHART, Tumor Virology Laboratory, Salk Institute, San Diego, California: Transcription
in polyoma-virus-infected 3T6 cells.
K. HERCULES, E. BURCH-JAFFE, and B.J. RYDER, Dept. of Biological Chemistry and the Molecular Biology Institute,
University of California, Los Angeles: Metastasis of mutant SV40-induced tumors.
A. NORWICH,' A. H. KOOP,2 and W. EcKHAR-r,"Tumor Virology Laboratory, 'Regulatory Biology Laboratory,
Salk Institute, San Diego, California: Expression of the polyoma small-T-antigen gene in E. coll.
H. C. Isom,' M. J. TEVETHIA,' J. M. TAYLOR,' and J. W. KREIDER,''' Depts. of 'Microbiology and 'Pathology,
Pennsylvania State University College of Medicine, Hershey: Tumorigenicity of SV40-transformed rat
hepatocytes.
P. KAHN and S. SHIN, Dept. of Genetics, Albert Einstein College of Medicine, Bronx, New York: Tumor
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T. MATSUO, S. HASHIMOTO, K. BRACKMANN, J. SYMINGTON, W. Wow, and M. GREEN, Institute for Molecular Virology,
St. Louis University Medical Center, Missouri: Ad2 early polypeptides in Ad2-infected and -transformed
cells-Cell free translation, immunoprecipitation, 2D-gel electrophoresis, and peptide map analysis.
A. MIRZA and J. WEBER, Dept. de Microbiologie, Centre Hospitalier Universitaire de Sherbrooke, Quebec,
Canada: Structure of adenovirus chromatin.
J. R. NEVINS and M. C. WILSON, Rockefeller University, New York, New York: A portion of the major late adenovirus
transcription unit is expressed during early infection.
S. PINCUS, J. MCDONOUGH, and D. REKOSH, Dept. of Biochemistry, State University of New York, Buffalo: Studies on
the protein covalently bound to the ends of adenovirus DNA.
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University, Hamilton, Ontario, Canada: Studies on the proteins involved in oncogenic transformation by
human Ad5.
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fiber in Ad2-infected monkey-human cell hybrids and reconstructed cells.
Session 8: SV40 and Adenoviruses-Replication
Chairperson: M. HORWITZ, Albert Einstein College of Medicine, New York, New York
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replication.
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mappings of Ad12 mRNAs transcribed from the transforming region in infected cells and in transformed cells.
C. PARASKEVA,' P. H. GALLIMORE,' and A. R. DUNN,2 'Dept. of Cancer Studies, University of Birmingham Medical
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Properties of a cloned rat liver epithelial cell strain and its adenovirus-transformed derivatives.
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School, Boston, Massachusetts; 'Center for Cancer Research, Massachusetts Institute of Technology, Cam-
bridge: An acidic protein encoded within the E1A region of Ad5 DNA is required for the expression of adjacent
genes.
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Chairperson: A. LEVINE, State University of New York Medical School, Stony Brook
D. P. LANE, Dept. of Zoology and Cancer Research Campaign Unit of Eukaryotic Molecular Genetics, Imperial
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by a monoclonal antibody.
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Chairperson: P. TEGTMEYER, State University of New York Medical School, Stony Brook
W. ECKHART, M. A. HUTCHINSON, and T. HUNTER, Tumor Virology Laboratory, Salk Institute, San Diego, California:
Tyrosine phosphorylation in polyoma T antigens and transformed cells.
B. SCHAFFHAUSEN and T. BENJAMIN, Dept. of Pathology, Harvard Medical School, Boston, Massachusetts: Studies on
middle T antigens of polyoma virus.
P. GAUDRAY, M. CENTER, P. CLERTANT, and F. CUZIN, Centre de Biochimie du CNRS, Nice, France: ATPase activity and
binding to chromatin of a polyoma virus early protein.
S. E. LIGHT,' F. HIRATA,' and Y. lio,"NIAID, 'NIMH, National Institutes of Health, Bethesda, Maryland:
Characterization of middle T antigen in the plasma membrane of polyoma-virus-transformed mouse cells.
R. HENNING, J. LANGE-MUTSCHLER, and W. DEPPERT, Dept. of Biochemistry, University of Ulm, Federal Republic of
Germany: Serological demonstration of SV40 T-antigen-related cell-surface antigens on SV40-transformed
cells.
H. R. SOULE and J. S. BUTEL, Dept. of Virology and Epidemiology, Baylor College of Medicine, Houston, Texas:
Detection and characterization of SV40 surface-associated tumor antigen by enzyme-catalyzed cell-surface
iodination.
M. BRADLEY, J. GRIFFIN, and D. LIVINGSTON, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: Structural and functional heterogeneity of the large SV40 T antigen.
D. GIDONI,' B. BARNET,' and C. PRIVES,2 'Dept. of Virology, Weizmann Institute of Science, Israel; 'Dept. of
Biological Sciences, Columbia University, New York, New York: Properties of different sedimenting forms of
SV40 T antigen.
E. FANNING, C. BURGER, and B. NOWAK, Fakultat fur Biologie, Universitat Konstanz, Federal Republic of Germany:
Detection and characterization of multiple forms of SV40 large T antigen.
E. GURNEY and R. HARRISON, Dept. of Biology, University of Utah, Salt Lake City: A collection of monoclonal
antibodies against SV40 T antigens.
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Bacteriophage Meeting, August 19 -August 24
Arranged by
Thomas R. Broker, Cold Spring Harbor Laboratory, New York
Ahmad Bukhari, Cold Spring Harbor Laboratory, New York
143 participants
Session 1: Reactions at Replication Origins and DNA Termini
K. HORIUCHI, Rockefeller University, New York, New York: Origin of DNA replication of bacteriophage f1 as
the signal for termination.
M. KREVOLIN and R. CALENDAR, Dept. of Molecular Biology, University of California, Berkeley: Initiation of P4
DNA replication in vitro.
L. KORSNES and B. H. LINDQVIST, Institute of Medical Biology, University of Tromso, Norway: A comparison of
the DNA sequences in the COS regions of phage P2 and its satellite P4.
D. W. BOWDEN and P. MODRICH, Dept. of Biochemistry, Duke University Medical Center, Durham, North
Carolina: In vitro characterization of the P2 terminase reaction.
J. M. HERMOSO and M. SMAS, Centro de Biologia Molecular, Universidad Autdmoma, Madrid, Spain: Protein
p3 is linked to the DNA of phage 4,29 through a phosphoester bond between serine and 5' dAMP.
C. ESCARMIS and M. SALAS, Centro de Biologia Molecular, Universidad AutOnoma, Madrid, Spain: Nucleotide
sequence at the termini of the DNA of B. subtilis phage ,t29.
M. SUMNER-SMITH, A. BECKER, and S. BENCHIMOL, Dept. of Medical Genetics, University of Toronto, Ontario,
Canada: DNA packaging in the lambdoid phages-Identification of the products of 080 genes 1 and 2.
C. E. SNYDER, Jr,' R. H. BENZINGER,1 and H. J. BURKARDT,2 'Dept. of Biology, University of Virginia,
Charlottesville; 'Institute of Microbiology, University of Erlangen, Federal Republic of Germany: Second-
step transfer of bacteriophage T5 DNA-Interaction of the T5 gene-A2 protein with DNA.
Session 2: Repressors and Integration
D. CULLY and A. GARRO, Dept. of Microbiology, Mount Sinai School of Medicine, New York, New York:
Expression of superinfection immunity to phage 0105 by B. subtilis carrying a plasmid chimera of pUB110
and EcoRl fragment F of 0105 DNA.
F. H. STEPHENSON,' W. P. DIEHL,2 and H. ECHOLS,' 'Dept. of Molecular Biology, University of California,
Berkeley; 'Dept. of Biology, San Diego State University, California: Chromosomal rearrangements be-
tween the operators in the bacteriophage X.
A. JOHNSON, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Action of the A
repressor and cro protein at 01,
D. HAWLEY and W. MCCLURE, Dept. of Biochemistry and Molecular Biology, Harvard University, Cambridge,
Massachusetts: Activation of transcription initiation from the X P. promoter.
B. LANGE-GUSTAFSON and H. A. NASH, NIMH, National Institutes of Health, Bethesda, Maryland: A Integrative
recombination-Analysis of mutant int gene products.
D. K. CHATroRAJ and R. A. WEISBERG, NICHHD, National Institutes of Health, Bethesda, Maryland: New
attachment-site mutants of phage X.
K. ABREMSKII and S. GorrEsmxN,"Cancer Biology Program, Frederick Cancer Research Center, Maryland;
'NCI, National Institutes of Health, Bethesda, Maryland: Excisive recombination of bacteriophage A-
Properties of the in vitro reaction.
R. GOLDSTEIN,' J. SEDIVY,' and E. LJUNGQUIST,2 'Dept. of Microbiology and Molecular Genetics, Harvard
Medical School, Boston, Massachusetts; 'Dept. of Microbial Genetics, Karolinska Institutet, Stockholm,
Sweden: P4 maintenance as a plasmid in the absence of helper phage.
Session 3: Regulation of P22
R. T. SAUER,' P. HOPPER,' K. KING,' F. WINSTON,' and A. R. POTEETE,2 'Biology Dept., Massachusetts Institute of
Technology, Cambridge; 'The Biological Laboratories, Harvard University, Cambridge, Massachusetts: c2
protein of phage P22.
A. R. POTEETE, The Biological Laboratories, Harvard University, Cambridge, Massachusetts: Control of overlap-
ping promoters by P22 repressor.
P. YOUDERIAN, S. CHADWICK, and M. M. SUSSKIND, Dept. of Microbiology, University of Massachusetts Medical
School, Worcester: Autogenous regulation by the P22 arc gene product.
S. BOUVIER, P. YOUDERIAN, and M. M. SUSSKIND, Dept of Microbiology, University of Massachusetts Medical
School, Worcester: Characterization of the P22 Pant promoter and transcript.
J. E. RUTILA and E. JACKSON, Dept. of Microbiology and Immunology, University of Michigan, Ann Arbor:
Regulation in the imm I region of P22-An analysis of sieA and mnt expression.
E. JACKSON and T. WEIGHOUS, Dept. of Microbiology and Immunology, University of Michigan, Ann Arbor:
Control of transcription in the late region of the P22 chromosome.
M. STRAUCH,' S. ZEIGLER,' B. BIGELOW,' L. BARON,' and D. FRIEDMAN,' 'Dept. of Microbiology, University of
Michigan, Ann Arbor; 'Dept. of Bacterial Immunology, Walter Reed Army Institute of Research, Washing-
ton, DC: An E. coli mutation affecting the growth of Ximm-P22 hybrid phage.
M. J. ORBACH and E. JACKSON, Dept. of Microbiology and Immunology, University of Michigan, Ann Arbor:
P22-mediated transduction of plasmid DNA by homologous recombination.
B. WIGGINS, M. SCHLEIN, and S. HILLIKER, Dept. of Biology, Bucknell University, Lewisburg, Pennsylvania: DNA
heteroduplex mapping of the early gene regions of Salmonella phages P22 and L.
Session 4: T4 and N4
P. R. TEMPEST and L. S. RIPLEY, National Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina: Mutagenic properties of hydroxylamine derivatives of hydroxymethylcytosine and cyto-
sine in T4.
N. B. SHOEMAKER and L. S. RIPLEY, National Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina: The effects of DNA polymerase mutants on the reversion of frameshift mutants in the r11
region of T4.
P. M. MACDONALD and D. H. HALL, School of Biology, Georgia Institute of Technology, Atlanta: Mutations in
bacteriophage T4 genes 41 and 61 cause folate analog resistance.
J. R. ALLEN, G. W. LASSER, and C. K. MATHEWS, Dept. of Biochemistry and Biophysics, Oregon State University,
Corvallis: The deoxyribonucleoside-triphosphate-synthesizing complex in phage-T4 infected bacteria.
J. KARAM,' L. GOLD' M. DAWSON,' B. SINGER,, and L. HUNTER' Dept. of Biochemistry, Medical University of
South Carolina, Charleston; 'Dept. of Molecular, Cellular, and Developmental Biology, UniverSity of
Colbrado, Boulder: Identification of a translational control site on a T4 mRNA.
L. HAYNES, C. MALONE, and L. B. ROTHMAN-DENES, Dept. of Biophysics and Theoretical Biology, University of
Chicago, Illinois: Specificity of transcription of the N4 virion-associated RNA polymerase.
W. ZEHRING' and L. B. ROTHMAN-DENES,2 Depts. of 'Microbiology and 'Biophysics and Theoretical Biology,
University of Chicago, Illinois: Transcription of coliphage N4 middle (class Ill RNAs.
D. GUINTA, R. ZIVIN, and L. B. ROTHMAN-DENES, Depts. of Microbiology and Biophysics and Theoretical Biology,
University of Chicago, Illinois: In vivo requirements for bacteriophage N4 late RNA synthesis.
D. MARCHETTI and L. B. ROTHMAN-DENES, Dept. of Biophysics and Theoretical Biology, University of Chicago,
Illinois: A DNA-dependent ADPase activity in bacteriophage N4 virions.
Session 5: Regulation of A Lysogenization
M. Horr, J. ABRAHAM, F. STEPHENSON, and H. ECHOLS, Molecular Biology and Virus Laboratory, University of
California, Berkeley: Regulation of lysogenization by bacteriophage A -Role of cll protein.
H. I. MILLER, University of California, Berkeley: Multi-level regulation of X lysogeny by the E. coli himA gene.
M. BENEDIK, D. MASCARENHAS, and A. CAMPBELL, Dept. of Biological Sciences, Stanford University, California:
Probing the regulation of PI using A-Up-lac fusions.
D. MASCARENHAS, M. BENEDIK, and A. CAMPBELL, Dept. of Biological Sciences, Stanford University, California:
Effect of the b2 region on integrase synthesis in X.
D. SCHINDLER and H. ECHOLS, University of California, Berkeley: Regulation of lysogenization by bacteriophage
A -Role of the b region.
U. SCHMEISSNER, D. COURT, and M. ROSENBERG, Laboratories of Molecular Biology and Biochemistry, NCI,
National Institutes of Health, Bethesda, Maryland: Transcription of gene int in phage X.
H. SHIMATAKE and M. ROSENBERG, Laboratory of Biochemistry, NCI, National Institutes of Health, Bethesda,
Maryland: Regulation of lysogenization by bacteriophage X. I. Cloning and purification of Xcll gene
product.
H. SHIMATAKE and M. ROSENBERG, Laboratory of Biochemistry, NCI, National Institutes of Health, Bethesda,
Maryland: Regulation of lysogenization by bacteriophage A. II. Reconstruction of PRE and P, activation in
vitro.
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H. SHIMATAKE and M. ROSENBERG, Laboratory of Biochemistry, NCI, National Institutes of Health, Bethesda,Maryland: Regulation of lysogenization by bacteriophage X. W. Characterization of cy, cll-independent(cin) promoter.
Session 6: DNA Recombination
D. W. ScHuaz, J. SWINDLE, and G. R. SMITH, Institute of Molecular Biology, University of Oregon, Eugene:Characterization of pseudorevertants of Chi recombinational hotspots.
I. KOBAYASHI,' F. W. STAHL,' M. M. STAHL,' J. M. CRASEMANN,' L. YOUNG,' and H. MURIALD0,2 'Institute of Mo-lecular Biology, University of Oregon, Eugene; 'Dept. of Medical Genetics, University of Toronto,Ontario, Canada: Why do Chi sequences promote recombination in only one orientation in A?N. A. DOWER and F. W. STAHL, Institute of Molecular Biology, University of Oregon, Eugene: Chi activity in Alysogens.
B. E. KORBA and J. B. HAYS, Dept. of Chemistry, University of Maryland, Catonsville: Recombinogenicity andSi - sites in DNA isolated from E. co /i an mutants.
M. LIEB, Dept. of Microbiology, University of Southern California School of Medicine, Los Angeles: Aninsertion sequence (IS5) increases recombination in adjacent regions of the repressor gene of X.E. M. PHIZICKY, N. L. CRAIG, C. W. ROBERTS, and J. W. ROBERTS, Dept. of Biochemistry, Cornell University, Ithaca,New York: Regulation of recA function.
R. BRENT, Harvard University, Cambridge, Massachusetts: Control of recA, lexA, and SOS functions by thelexA gene product.
N. E. MELECHEN and G. Go, Dept. of Microbiology, St. Louis University School of Medicine, Missouri: Sulfatedeprivation joins the list of adverse states known to induce A lysogens.
Session 7: T-Phage DevelopmentMorphogenesis
J. M. RUNNELS and L. R. SNYDER, Dept. of Microbiology and Public Health, Michigan State University, EastLansing: The physiological effect of RNA ligase deficiency in T4 development-Evidence for an in vivointeraction between the T4-induced RNA ligase and polynucleotide kinase.
W. COOLEY,' K. SIROTKIN,2 and L. SNYDER;
'Dept. of Microbiology and Public Health, Michigan StateUniversity, East Lansing; 'Division of Biochemistry, California Institute of Technology, Pasadena: A site onT4 DNA which affects expression of all T4 late genes.
G. MOSIG, D. GHOSAL, and S. BOCK, Dept. of Molecular Biology, Vanderbilt University, Nashville, Tennessee:Interactions between replication, recombination, and maturation genes during growth of bacteriophageT4.
D. J. MCCORQUQDALE and R. WOYCHIK, Dept. of Biochemistry, Medical College of Ohio, Toledo. A putativepre-early modification of RNA polymerase from E. co/i by bacteriophage T5.
S. H. SAHNBLATI, M. P. ONTELL, and D. NAKADA, Dept. of Biochemistry, University of Pittsburgh School ofMedicine, Pennsylvania: Involvement of E. co /i RNA polymerase in the development of T7 bacteriophage.P. B. BERGET and M. CHIDAMBARAM, Dept. of Biochemistry and Molecular Biology, University of Texas MedicalSchool, Houston: In vitro assembly of the first intermediate in T4 base-plate 1/6th arm assembly.D. GOLDENBERG, D. SMITH, and J. KING, Dept. of Biology, Massachusetts Institute of Technology, Cambridge:Use of is mutations to probe the subunit composition and assembly of the P22 tail spike protein.F. T. FERRUCCI and H. MURIALDO, Dept. of Medical Genetics, University of Toronto, Ontario, Canada: Evidencefor an early gpB-gpNu3 interaction in A prohead assembly.
A. OKABE and D. B. WILSON, Dept. of Biochemistry, Cornell University, Ithaca, New York: Identification of theAS gene product as one of six A-coded inner membrane proteins.
R. A. GRANT and R. E. WEBSTER, Dept. of Biochemistry, Duke University Medical Center, Durham, NorthCarolina: Localization of the minor coat proteins of the filamentous bacteriophage 11 to the ends of thephage particle.
Session 8: Transposition and Inversion
E. R. OLSON, K. R. LEASON, and D. I. FRIEDMAN, Dept. of Microbiology and Immunology, University of Michigan,Ann Arbor: Xa/tSF-A phage variant that has the ability to substitute sets of genes at high frequency.R. R. ISBERG and M. SYVANEN, Dept. of Microbiology and MolecularGenetics, Harvard Medical School, Boston,
Massachusetts: Tn5-promoted replicon fusions between phage A and pBR322.C. KAISER and M. SYVANEN, Dept. of Microbiology and Molecular Genetics, Harvard Medical School, Boston,Massachusetts: Transposition of Tn5 onto nonreplicating A DNA.
D. Y. KwoH and D. ZIPSER, Cold Spring Harbor Laboratory, New York: Analysis of mutations in the G-loop ginregion of Mu.
J. W. SCHUMM and M. M. HOWE, Dept. of Bacteriology, University of Wisconsin, Madison: X-Mu clones andtheir use in the analysis of Mu transposition.
R. M. HARSHEY and A. I. BUKHARI, Cold Spring Harbor Laboratory, New York: Studies on Mu transposition.
G. CHACONAS, N. SARVETNICK, R. M. HARSHEY, and A. I. BUKHARI, Cold Spring HarborLaboratory, New York: The
role of cointegrate structures in the transposition of Mu DNA.
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W. SCHUMANN, C. A. BARRON, C. UmoGL, and E. G. BADE, Fakultat fur Biologie, Universitat Konstanz, Federal
Republic of Germany: Gene expression during Mu development.
L. H. WESTPHAL, R. CLAYTON, and E. G. BADE, Fakultat fur Biologie, Universitat Konstanz, Federal Republic of
Germany: Early replication of phage Mu DNA.
J. TEIFEL and H. SCHMIEGER, Genetisches Institut der Universitat Munich, Federal Republic of Germany: The
structure of transducing Mu DNA.
Session 9: Regulation of X Transcription
D. DRAHOS' and R. HENDRIX' 'McArdle Laboratory for Cancer Research, University of Wisconsin, Madison;
'Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: X-Directed regulation of the synthe-
sis of gpgroE, and several other important host proteins.
J. KOCHAN and H. MURIALDO, Dept. of Medical Genetics, University of Toronto, Ontario, Canada: The
mechanism of gpgroE induction in X-infected cells.
R. W. HENDRIX, Dept. of Biological Sciences, University of Pittsburgh, Pennsylvania: Purification and character-
ization of X early protein Ea10.
E. L. FLAMM and D. I. FRIEDMAN, University of Michigan, Ann Arbor: Characterization of a XnutR mutant.
A. T. SCHAUER,' L. S. BARON' M. F. BAUMANN,' E. J. MASHNI,' L. C. PLANTE-FABER,' M. STRAUCH,' and D. I. FRIED-
MAN,' 'Dept. of Microbiology and Immunology, University of Michigan, Ann Arbor; 'Dept. of Bacterial
Immunology, Walter Reed Army Institute of Research, Washington, DC: Host factors involved in antiter-
mination by XN product.
D. WARD and M. GarrEsmAN, NCI, National Institutes of Health, Bethesda, Maryland: E. coli mutants affecting
AN function.
K. MCKENNEY, C. BRADY, and M. ROSENBERG, Laboratory of Biochemistry, NCI, National Institutes of Health,
Bethesda, Maryland: The effect of translation on transcription termination.
J. N. ALEGRE and J. W. ROBERTS, Dept. of Biochemistry, Cornell University, Ithaca, New York: Late-gene
regulatory regions of X, 082, and P22.
E. J. GRAYHACK and J. W. ROBERTS, Dept. of Biochemistry, Cornell University, Ithaca, New York: The AQ protein
mediates increased transcription of the A late genes in vitro.
Session 10: Bacterial ProteinsPhage Genome Structure
H. AIBA and J. S. KRAKOW, Dept. of Biological Sciences, Hunter College, City University of New York, New
York: Isolation and characterization of the amino and carboxyl proximal fragments of the E. coli cAMP
J. S. HEILIG and R. CALENDAR, Dept. of Molecular Biology, University of California, Berkeley: Suppression of a
ts mutation of the sigma subunit of E. coli RNA polymerase by a second site event.
T. EDLIND and G. IHLER, Dept. of Medical Biochemistry, Texas A&M University College of Medicine, College
Station: Long-range base pairing in 0174 single-stranded DNA.
P. B. MOSES, J. D. BOEKE, K. HORIUCHI, and N. D. ZINDER, Rockefeller University, New York, New York:
Restructuring the f1 genome-Expression of gene VIII in the intergenic space.
T. S. B. YEN, R. A. GRANT, and R. E. WEBSTER, Dept. of Biochemistry, Duke University Medical Center, Durham,
North Carolina: Identification of f1 X and gene II proteins in vivo.
F. BRUNEL and J. DAVISON, Unit of Molecular Biology, Institute of Cellular Pathology, Brussels, Belgium:
Expression of cloned T5 DNA fragments in E. coli mini-cells.
K. HABERER,' A. I. HAL.ERER,' and J. MANILOFF,' 'Abteilung Mikrobiologie, Universitat Ulm, Federal Republic of
Germany; 'Dept. of Microbiology, University of Rochester Medical Center, New York: Isolation and
partial characterization of ts mutants of mycoplasmavirus MVL3.
C. F. MARRS and M. M. HOWE, Dept. of Bacteriology, University of Wisconsin, Madison: Avail and Bgll
restriction maps of bacteriophage Mu.
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Herpesviruses, August 26 - August 31
Arranged by
Gary S. Hayward, Johns Hopkins University, Baltimore, Maryland
William C. Summers, Yale University, New Haven, Connecticut
228 participants
Session 1: Plenary Lectures
A. LEVINE, State University of New York, Stony Brook
G. VANDE WOUDE, NCI, National Institutes of Health, Bethesda, Maryland
J. CLEMENTS, Johns Hopkins University, Baltimore, Maryland
Session 2: Virus Proteins
Chairperson: R. COURTNEY, University of Tennessee, Knoxville
A. BUCHAN, L. TOMKINS, L. HARPER, and-,4: FULLER, Dept. of Medical Microbiology, University of Birmingham Medical
School, England: Serological comparison of the intracellular polypeptides synthesized by various
herpesviruses.
C. J. HEILMAN, JR.,' M. ZWEIG,' and B. HAMPAR,2 'Frederick Cancer Research Center, Maryland; 'NCI, National
Institutes of Health, Frederick, Maryland: Immunoprecipitation of antigenically type-specific and cross-
reactive peptides from digests of HSV-1 and HSV-2 protein p40.
V. BIBOR-HARDY, M. SUH, and R. SIMARD, Institut du Cancer de Montreal, Centre Hospitalier Notre-Dame, Quebec,
Canada: Analysis of proteins in the nuclear envelope of BHK cells infected with HSV-1.
W. GIBSON, D. WEINER, K.-T. JEANG, and.C. Rosy, Dept. of Pharmacology and Experimental Therapy, Johns Hopkins
School of Medicine, Baltimore, Maryland: Comparisons of CMV proteins-Human and simian isolates.
J. E. SHAW, C. MOORE, and J. GRIFFITH, Cancer Research Center, University of North Carolina School of Medicine,
Chapel Hill: Polypeptides associated with the EBV DNA of superinfected Raji cells.
G. J. BAYLISS and H. WOLF, Max von Pettenkofer Institute, Munich, Federal Republic of Germany: The control of
protein synthesis in EBV-superinfected Raji cells.
R. W. HONESS and R. E. RANDALL, National Institute for Medical Research, London, England: Proteins of herpesvirus
saimiri-Location and functions of virus-specified polypeptides in productively infected cells.
S. MODROW and H. WOLF, Max von Pettenkofer Institute, Munich, Federal Republic of Germany: Herpesvirus
saimiri-induced proteins in lytically infected cells.
Workshops: CMV DNA Structure and Cloning; Immunology; Proteins of HSV and Related Viruses
Session 3: Poster Session
J. F. BASKAR, I. BOLDOGH, and E.-S. HUANG, Cancer Research Center, University of North Carolina, Chapel Hill:
Persistent infection of murine CMV in murine carcinoma F9 cells.
R. BLANTON and M. J. TEVETHIA, Dept. of Microbiology, Pennsylvania State University College of Medicine,
Hershey: Immunoprecipitation of immediate early and early polypeptides from cells lytically infected with
CMV strain AD169.
Y. M. CENTIFANTO-FITZGERALD and H. KAUFMAN, Eye Center, Louisiana State University Medical Center School of
Medicine, New Orleans: Avirulent HSV strains in the rabbit trigeminal ganglia.
G. DARAI, R. M. FLUCEL, L. ZOLLER, B. MATZ, H. GELDERBLOM, H. DELIUS, and R.H. LEACH, Institut tut Medizinische
Virologie, Universitat Heidelberg, Robert-Koch Institut, Berlin; Institut fiir Virusforschungam DKFZ, Heidel-
berg; European Molecular Biology Laboratory, Heidelberg, Federal Republic of Germany; Mycoplasma
Reference Laboratory, Norwich, England: The plaque-inducing factor for mink lung cells present in cytome-galo- and herpes zoster virus identified as a mycoplasma.
N. DELucA, D. BZIK, S. PERSON, A. KEITH, and W. SNIPES, Biophysics Program, Pennsylvania State University,
University Park: Photodynamic-induced crosslinking of HSV-1 glycoproteins and the study of glycoprotein-
mediated viral functions.
R. D. Dix, J. G. STEELE, and J. R. BARINGER, Dept. of Neurology, Veterans Administration Medical Center, and
University of California School of Medicine, San Francisco: Isolation of HSV-1 from the cerebrospinal fluid of
a patient with recurrent aseptic meningitis (Mollaret's meningitis).
R.I. FEIGHNY, B. E. HENRY, and J. S. PAGANO, Cancer Research Center, University of North Carolina, Chapel Hill: EBV
early polypeptides-Identification, synthesis, glycosylation, and phosphorylation.
C. GLAUBIGER and L. F. VELICER, Michigan State University, East Lansing: Molecular characterization of Marek's
disease herpesvirus antigens.
M. HILTY and D. MANN, Children's Hospital, Ohio State University, Columbus: Identification and characteriza-
tion of HSV-1 and 2 polypeptides complexed with HSV-1 and 2 specific sera.
J. H. JoNcAs," C. ALFIERI,' M. LEYRITZ,' I. BOLDOGH' and E. S. Humc,"Pediatric Research Center, Ste.-Justine's
Hospital, Montreal, Quebec, Canada;' Cancer Research Center, University of North Carolina, Chapel Hill:
Dual congenital infection with EBV and CMV.
K. G. KOUSOULAS and S. PERSON, Biophysics Program, Pennsylvania State University, University Park: NH4CIinhibits cell fusion and the accumulation of mature HSV-1 glycoproteins.
B. F. LADIN, M. L. BLANKENSHIP, and T. BEN-PORAT, Dept. of Microbiology, Vanderbilt University Schoolof Medicine,
Nashville, Tennessee: Processing of a capsid protein (35K) and assembly of the capsid ofpseudorabies (PR)virus are interrelated.
W. LAWRENCE,' L. KASTRUKOFF,2 D. GILDEN' and N. W. FRASER'
'School of Veterinary Medicine, University of
Pennsylvania; 'Wistar Institute, Philadelphia, Pennsylvania: HSV-1 sequences in brain.
E.-C. MAR and E.-S. HUANG, Dept. of Medicine and Cancer Research Center, University of North Carolina School
of Medicine, Chapel Hill: Virus-specific structural proteins, DNA-binding proteins and phosphorylatedproteins in CMV human virions and virus-infected WI-38 cells.
S. MODROW and H. WOLF, Max von Pettenkofer Institute, Munich, Federal Republic of Germany: Strain compari-
son of various HVS- and HVA-isolates.
P. O'HARE, R. W. HONESS, and R. E. RANDALL, National Institute for Medical Research, Mill Hill, London, England:
Proteins of herpesvirus saimiri-Regulation of virus protein synthesis in productively infected cells.
D. PURTILO,' K. SAKAMOTO,' J. L. SULLIVAN' L. PAQUIN,' A. SAEMUNDSON,' A. C. SYNNERHOLM,' and G. KLEIN,' Depts.
of 'Pathology and 'Pediatrics, University of Massachusetts Medical School, Worcester;
'Dept. of Tumor
Biology, Karolinska Institute, Stockholm, Sweden: Documentation of EBV-induced lymphoproliferativedisease in the X-linked lymphoproliferative syndrome.
Y. Suzuki and H. A. BLOUGH, Scheie Eye Institute, University of Pennsylvania, Philadelphia: Effect of herpesvirusinfection and 2-deoxy-D-glucose on the synthesis of ceramide monohexosides in vitro.
L. TURTINEN and G. ALLEN, Dept. of Veterinary Sciences, University of Kentucky, Lexington: Identification of theglycoproteins of equine herpesvirus type 1.
A. VAHLNE, E. NILHEDEN, and B. SVENNERHOLM, Institute of Medical Microbiology, University of Goteborg,Sweden:Multiplicity activation of HSV in mouse neuroblastoma (C1300) cells.
E. WENSKE, R. Dix, R. EBERLE, and R. COURTNEY, Dept. of Microbiology, University of Tennessee, Knoxville:
Intermediates of HSV-1 glycoproteins synthesized in the presence of inhibitors of glycosylation.
H. WOLF and E. WILMES, Max von Pettenkofer Institute, Munich, Federal Republic of Germany: Evidence for thepersistence of EBV in the parotid gland.
Session 4: The S Region of HSV DNA and Genome Replication
Chairperson: G.S. HAYWARD, Johns Hopkins Medical School, Baltimore, Maryland
V. G. PRESTON, A. J. DAVISON, and M.-J. MURCHIE, Institute of Virology, Glasgow, Scotland: Location of temperature-
sensitive mutations within the short repeat sequences of the HSV-1 genome.
S. P. LITTLE' and P. A. SCHAFFER'
'Sidney Farber Cancer Institute, 'Harvard Medical School, Boston, Massachu-
setts: A new essential gene of HSV-1 in the repeated sequences in S.
D. J. McGEocH, M. J. MURCHIE, and A. DOLAN, Institute of Virology, Glasgow, Scotland: Nucleotidesequence
analysis of portions of the genome of HSV-1.
R. J. WATSON and G. F. VANDE WOUDE, NCI, National Institutes of Health, Bethesda, Maryland: Structures of HSV-1
immediate-early mRNAs mapping in the virus DNA S component.
F. J. RIXON, A. J. EASTON, and J. B. CLEMENTS, Institute of Virology, Glasgow, Scotland: Fine structure of HSVimmediate-early mRNA.
D. CIUFO, P. MouNrs, K. PEDEN, G. REYES, and G. S. HAYWARD, Dept. of Pharmacology and ExperimentalTherapeu-
tics, Johns Hopkins Medical School, Baltimore, Maryland: The HSV genome-L-segment defectives and crosshomology with mammalian cell DNA.
R. J. JACOB,' L. S. MORSE' and B. ROIZMAN,' 'Dept. of Pathology, University of Kentucky, Lexington; 2KovIerViral
Oncology Laboratory, University of Chicago, Illinois: Restricted synthesis of HSV DNA in cells treated with
phosphonoacetate (PA) and its application for locating the origin of DNA synthesis.
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C. V. JONGENEEL and S. L. BACHENHEIMER, Dept. of Bacteriology and Immunology, University of North Carolina,Chapel Hill: Replicative intermediates of HSV-1 DNA.
T. BEN-PORAT, B. F. LADIN, R. A. VEACH, and L. BROWN, Dept. of Microbiology, Vanderbilt University School of
Medicine, Nashville, Tennessee: Genetic analysis of the genome of pseudorabies (PR) virus indicates acircular map.
A. J. DAVISON and N. M. WILKIE, Institute of Virology, Glasgow, Scotland: Nucleotide sequences of the jointbetween the L and S segments of HSV-1 (strain 17) and HSV-2 (strain HG52).
Session 5: Glycoproteins and Immunology
Chairperson: J. S. PAGANO, University of North Carolina, Chapel Hill
T. C. HOLLAND, R. M. SANDRI, J. C. GLORIOSO, and M. LEVINE, University of Michigan, Ann Arbor: HSV-1 (KOS)
mutants altered in the expression of viral cell-surface glycoproteins and susceptibility to complement-
mediated immune cytolysis.
B. A. PANCAKE and P. A. SCHAFFER, Sidney Farber Cancer Institute, Boston, Massachusetts: Genetic and biochemical
characterization of temperature-sensitive mutants of HSV-1 resistant to immune cytolysis.
K. ROSENTHAL' and H. SHAPIRO'
'Northeastern Ohio Universities College of Medicine, Rootstown, Ohio;
'Sidney Farber Cancer Institute, Boston, Massachusetts: Changes in membrane potential induced byherpesvirus.
G. J. BAYLISS and H. WOLF, Max von Pettenkofer Institute, Munich, Federal Republic of Germany: EBV inducescellfusion.
L. PEREIRA, D. GALLO, D. DONDERO, and N. SCHMIDT, California Dept. of Health Services, Berkeley: Monoclonal
antibody to HSV-An immunologic tool for typing of virus isolates.
N. BALACHANDRAN, R. A. KILLINGTON, L. NEWHOOK, W. E. RAWLS, and S. BACCHETTI, Dept. of Pathology, McMaster
University, Hamilton, Ontario, Canada: Production and characterization of hybridoma lines secreting anti-
bodies against HSV.
L. LOH and E.-S. HUANG, Cancer Research Center, University of North Carolina, Chapel Hill: Production of
monoclonal antibodies against human CMV structural antigens.
D. A. THORLEY-LAWSON and C. M. EDSON, Sidney Farber Cancer Institute, Boston, Massachusetts: EB virion antigens
- Characterization of strain differences.
H. RABIN, B. C. STRNAD, R. H. NEUBAUER, R. F. HOPKINS, Ill, and T. J. WITMER, Biological Carcinogenesis Program,
Frederick Cancer Research Center, Maryland: Antigenic heterogeneity of EBV nuclear antigen (EBNA).
S. L. SILVERMAN and C. L. MILLER, Dept. of Medicine, University of Pennsylvania, Philadelphia: Heterogeneous
patterns of nuclear antigen expression in WIL2, an EBV-positive cell line, following differential fixation and
staining.
D. J. VOLSKY, G. KLEIN, and I. M. SHAPIRO, Dept. of Tumor Biology, Karolinska Institutet, Stockholm, Sweden:
Implantation of EBV receptors into membranes of receptor-negative cells-Virus binding, penetration, and
viral antigen expression.
Workshops: Glycoproteins; Proteins of Lymphotropic Viruses; Transcription
Session 6: Poster Session
G. ALLEN and L. TURTINEN, Dept. of Veterinary Science, University of Kentucky, Lexington: Cloning in E. coliof the
BamHI fragment of equine herpesvirus 1 (EHV-1) DNA that carries an active thymidine kinase (TK) gene.S. S. ATHERTON, R. A. ROBINSON, and D. J. O'CALLAGHAN, Dept. of Microbiology, University of Mississippi MedicalCenter, Jackson: Equine herpesvirus type 3 (EHV-3)-Genomic structure and transforming potential.
S. BOGGER-GOREN and P. L. OGRA, Children's Hospital, State University of New York, Buffalo: Characteristics of
antibody response to varicella zoster virus (VZV) in the nasopharyngeal secretions after naturally acquired
chicken pox.
H. DELIUS,' B. MATz,2 R. M. FLUGEL,2 and G. DARAI,2
'European Molecular Biology Laboratory; 'Institute fur
Medizinische Virologie der Universitat Heidelberg; 'Institut ftir Virusforschung am Deutschen Krebs-
forschungszentrum, Heidelberg, Federal Republic of Germany: Properties of DNA of tupaia herpesviruses.
K. DENNISTON-THOMPSON, L. W. ENQUIST, and G. F. VANDE WOUDE, NCI, National Institutes of Health, Bethesda,
Maryland: Three structural groups of EcoRl fragments from HSV-1 patton-defective DNA molecules cloned
into bacteriophage X.
A. D. DONNENBERG and L. AURELIAN, Johns Hopkins Medical Institutions, Baltimore, Maryland: Cell-mediatedimmunity in recurrent HSV-2 disease.
J. R. ECKER and R. W. HYMAN, Dept. of Microbiology, Pennsylvania State University College of Medicine,Hershey:Analysis of interruptions in the phosphodiester backbone of HSV DNA.
M. ENGEts,' H. Luowic,' and C. MULDER,' 'Institut fur Virologie, Universitat Zurich, Switzerland; 'Institut fur
Virologie, Freie Universitat Berlin, Federal Republic of Germany; 'Depts. of Pharmacology and Microbiology,
University of Massachusetts Medical School, Worcester: Mapping of genomes from attenuated strains ofinfectious bovine rhinotracheitis virus and infectious pustular vulvovaginitis virus.
J. D. HALL and K. SCHERER, Dept. of Cellular and Developmental Biology, University of Arizona, Tucson: HSV as aprobe for repair of DNA damaged by 4,5',8-trimethylpsoralen plus light.
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L. HU-Fr-FLETCHER; E. FOWLER,' B. SULLIVAN,' R. FEIGHNY,' J. D. LAMBRIS,2 and G. D. Ross' 'Cancer Research
Center and 'Division of Rheumatology and Immunology, University of North Carolina School of Medicine,
Chapel Hill: EBV receptor-Partial purification and relationship to the C3d receptor.
F. J. JENKINS, M. K. HOWETr, and F. RAPP, Dept. of Microbiology, Pennsylvania State University College of Medicine,
Hershey: Cloning of HSV-2 (333) DNA fragments in the bacteriophage vector Charon 4A.
H. C. KAERNER, A. Orr-HARTMANN, and R. SCHATTEN, Institute of Virus Research, German Cancer Research Center,
Heidelberg, Federal Republic of Germany: Multiple insertions of a short nucleotide sequence into the repeat
Units of three different classes of defective HSV-1 ANG DNA.
Y.-S. LEE and M. NONOYAMA, Life Sciences Biomedical Research Institute, St. Petersburg, Florida: Structural
analysis of MDV DNA.
P. C. PATEL and J. MENEZES, Ste.-Justine Hospital, University of Montreal, Quebec, Canada: EBV replication cycle
determines the type of cellular effector mechanism utilized to destroy EBV-infected cells.
M. ROGGENDORF, G. J. BAYLISS, D. WAGNER, and H. WOLF, Max von Pettenkofer Institute, Munich, Federal Republic
of Germany: New approaches in the development of enzyme-linked immunosorbant assay (ELISA) for
antibodies to EBV.
R. M. SANDRI, A. L. GOLDIN, M. LEVINE, and J. C. GLORIOSO, University of Michigan, Ann Arbor: Cloning of HSV-1
DNA.
C. H. SCHRODER, R. AUGUSTIN, and B. HENNES-STEGMANN, Institute for Virus Research, German Cancer Research
Center, Heidelberg, Federal Republic of Germany: Processing of progeny DNA in the infectious cycle of HSV
and its control by interfering particles.
I. M. SHAPIRO, G. KLEIN, and D. J. Voisxv, Dept. of Tumor Biology, Karolinska Institute, Stockholm, Sweden:
Reconstitution of EBV with Sendai virus envelopes and EBV-receptor transplantation as a means for overcom-
ing cellular resistance to the virus.
S. E. STRAUS,' H. S. AULAKH,' W. T. RUYECHAN,. J. A. HAY,. G. F. VANDEWOUDE,2 J. OWENS; and H. A. SMITH, 'Lab-
oratory of Clinical Investigation, N IAID, 'Laboratory of Molecular Virology, NCI, National Institutes of Health;
'Depts. of Biochemistry and Microbiology, Uniformed Services University of the Health Sciences, Bethesda,
Maryland: Structural studies of varicella zoster virus DNA.
R. SZIGETI, G. KLEIN, J. LuKA, D. PURTILO, and D. J. VOLSKY, Dept. of Tumor Biology, Karolinska Institute, Stockholm,
Sweden: Leukocyte migration inhibition induced by EBV-associated antigens.
Session 7: Thymidine Kinase 1
Chairperson: J. SUBAK-SHARPE, Institute of Virology, Glasgow, Scotland
M. J. WAGNER, J. A. SHARP, and W. C. SUMMERS, Yale University School of Medicine, New Haven, Connecticut:
Nucleotide sequence analysis and control of expression of HSV-1 thymidine kinase.
S. L. MCKNIGHT, Dept. of Embryology, Carnegie Institution of Washington, Baltimore, Maryland: Studies on
the structure and expression of the HSV-1 thymidine kinase gene.
A. MINSON and K. BASTOW, Dept. of Pathology, University of Cambridge, England: Properties and virus DNA
sequence content of cells carrying the HSV-2 thymidine kinase gene.
C. M. PRESTON, Institute of Virology, Glasgow, Scotland: Analysis of HSV-1 BamHI p-specific mRNAs by
hybrid-selected and hybrid-arrested translation.
W.-C. LEUNG,' B. FONG,' S. BACCHETTI,' P. E. BRANTON,' and R. COURTNEY,' 'Dept. of Pathology, McMaster
University, Hamilton, Ontario, Canada; 'Dept. of Microbiology, University of Tennessee, Knoxville:
Function and in vitro phosphorylation of HSV a polypeptides.
S. KIT, H. OTSUKA, H. QAVI, and M. HAZEN, Division of Biochemical Virology, Baylor College of Medicine,
Houston, Texas: Expression of HSV thymidine kinase (TK) in TK E. coii K12 mutant transformed by hybrid
plasmids.
F. COLBERE- GARAPIN,' M. COHEN-SOLAL,2 A. GARAPIN,' and P. KOURILSKY,' 'Institut Pasteur, Paris, 'Unite
INSERM, Creteil, France: Structure of the 5' end of the HSV-1 thymidine kinase gene and expression of
the cloned gene in E. soli.
J. R. SMILEY and J. CAMPIONE-PICCARDO, Dept. of Pathology, McMaster University, Hamilton, Ontario, Canada:
In vitro mutagenesis of the tk region of HSV-1 DNA.
L. LIPSICH, M. WIGLER, and D. ZIPSER, Cold Spring Harbor Laboratory, New York: Mapping the operator for cell
resident HSV TK induction by herpes infection.
D. M. COEN,' M. H. ST. CLAIR' P. A. FURMAN' and P. A. SCHAFFER,' 'Sidney Farber Cancer Institute, Harvard
Medical School, Boston, Massachusetts; 'Burroughs Wellcome Company, Research Triangle Park, North
Carolina: Mutations in the HSV DNA polymerase and thymidine kinase genes and resistance to acyclovir.
Session 8: Thymidine Kinase II and Latency
Chairperson: B. HAMPAR, NCI, National Institutes of Health, Frederick, Maryland
B. M. COLBY,' P. A. FURMAN' J. E. SHAW,' G. B. EDON' and J. S. PAGANO,' 'Cancer Research Center,
University of North Carolina Medical School, Chapel Hill; 'Burroughs Wellcome Company, Research
Triangle Park, North Carolina: Phosphorylation of acyclovir in EBV-infected lymphoblastoid cell lines.
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A. CALENDER,' T. 001<A; M. DE TURENNE,' G. LENOIR' and J. DAILLIE,' 'University Claude Bernard, 'Interna-
tional Agency for Research on Cancer, Lyon, France: Effect of 1-13-0 arabinofuranosylthymine on EBV
replication and relationship with a virally induced thymidine kinase activity.
H. arsuicA, M. MICHALAK, and S. KIT, Division of Biochemical Virology, Baylor College of Medicine, Houston,
Texas: Resistance of cells biochemically transformed by HSV DNA fragments to thymidine and deoxyaden-
osine cytotoxicity.
R. B. TENSER, M. DUNSTAN, and S. RESSEL, Dept. of Microbiology, Pennsylvania State University College of
Medicine, Hershey: Trigeminal ganglion infection by thymidine kinase positive, negative, and intermedi-
ate HSV and in vivo complementation.
A. A. NASH, H. J. FIELD, P. G. H. GELL, and P. WILDY, Dept. of Pathology, Cambridge, England: Cellular immune
phenomena in relation to herpes simplex latency in the mouse.
R. L. THOMPSON, J. G. STEVENS, and M. L. COOK, Dept. of Microbiology and Immunology, University of
California School of Medicine, Los Angeles: Mapping of the gene(s) responsible for HSV neurovirulence
in mice.
A. L. GOLDIN, R. M. SANDRI, M. LEVINE, and J. C. GLORIOSO, University of Michigan, Ann Arbor: Persistence of
viral genes in neuronal cells surviving HSV-1 infection.
J. K. McDouGALL,1 D. A. GALLOWAY,' and C. M. FENOGLIO' 'Fred Hutchinson Cancer Research Center,
Seattle, Washington; 'College of Physicians and Surgeons, Columbia University, New York, New York:
Expression of HSV in latent infection and in neoplastic cells.
M. J. K. SELGRADE," J. G. NEDRUD,2 A. COLLIER,' and J. S. PAGANO'" 'Environmental Protection Agency,
Research Triangle Park, 'Cancer Research Center, Depts. of 'Pediatrics and °Medicine, University of
North Carolina, Chapel Hill: Attenuation of murine cytomegalovirus (MCMV) in vitro and in vivo.
K. SAKAMOTO; M. AIBA,' I. KATAYAMA; R. HUMPHREYS,' J. SULLIVAN; and D. PURTILO,' Depts. of 'Pathology,
'Pharmacology, and °Pediatrics, University of Massachusetts Medical School, Worcester; 'Dept. of
Pathology, Saitama Medical School, Japan: EBV antibody responses in patients with hairy cell leukemia.
Workshops: HSV DNA, Genetics and Cloning; Acycologuanosine; Latency and Persistence
Session 9: Poster Session
T. BECK, A. SESKO, and R. MILLETrE, Dept. of Immunology and Microbiology, Wayne State University School of
Medicine, Detroit, Michigan: In vitro transcription of HSV-1 DNA by RNA polymerase II from HEp-2 cells.
W. BODEMER, E. KNUST, C. KASCHKA-DIERICH, and B. FLECKENSTEIN, Institut fur Klinische Virusforschung, University
of Erlangen-NUrnberg, Federal Republic of Germany: Viral gene expression in lymphoid tumor cell lines
transformed 4y oncogenic primate herpesviruses.
D. R. BONE,' R. TORCZYNSKI,' H. MAGUIRE,' J. HARRIS,' and B. FRANCKE,' 'Depts. of Botany and Microbiology,
University of Oklahoma, Norman; 'Dept. of Human Genetics, Yale University Medical School, New
Haven, Connecticut: Selective isolation and initial characterization of temperature-sensitive mutants of
HSV-1.
B. M. COLBY, J. E. SHAW, A. K. DArrA, and J. S. PAGANO, Cancer Research Center, University of North Carolina
School of Medicine, Chapel Hill: Characterization of P3HR-1 cells following prolonged exposure to
acyclovir.
C. CRUMPACKER12 and K. W. KNOPF,13 'Medical Research Council Virology Unit, Glasgow, Scotland; 'Division
of Infectious Diseases, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts; 'Insti-
tute for Virusforshung, Deutsche Krebsforschungszentrum, Heidelberg, Federal Republic of Germany:
Physical mapping of mutations within the viral DNA polymerase locus of HSV resulting in an altered HSV
DNA polymerase activity conferring resistance to three antiviral drugs.
A. K. DATTA and J. S. PAGANO, Cancer Research Center, University of North Carolina, Chapel Hill: Mode of in-
hibition of EBV DNA polymerase by acyclovir triphosphate.
B. FLECKENSTEIN,' I. MULLER,' E. KNUST,' and J. CoviNs,2 'Institut fur Klinische Virologie, University of
Erlangen-NUrnberg; 'Gesellschaft fur Biotechnologische Forschung, Braunschweig, Federal Republic of
Germany: Cosmids as vectors for gene banks of herpesviruses.
A. GARCIA, B. JACQUEMONT, A. EPSTEIN, and A. NIVELEAU, Unite de Virologie Fondamentale et Appliquee INSERM
U51, Groupe de Recherche CNRS, Lyon, France: Effect of N-6 methyl adenosine analogues on maturation
of viral RNA in HSV-1-infected cells.
D. GROSSBERGER and W. CLOUGH, Dept. of Molecular Biology, University of Southern California, Los Angeles:
Dependence of the phosphonoacetic acid sensitivity of the EBV-induced DNA polymerase upon availabil-
ity of DNA 3'-OH ends and upon accessory proteins.
E. R. KAUFMAN, R. L. DAVIDSON, and L. E. SCHNIPPER, Harvard Medical School, Boston, Massachusetts: Genetic
and biochemical studies of the antiviral nucleoside analog acycloguanosine.
D. KNIPE and A. SPANG, Dept. of Microbiology and Molecular Genetics, Harvard Medical School, Boston,
Massachusetts: Genetic analysis of linked mutations conferring resistance to phosphonoacetate and
acycloguanosine.
K.-W. KNOPFI and C. C. CRUMPACKER,3 'Institute of Virology, Glasgow, Scotland; 'Institute fur Virusfors-
chung, Deutsche Krebforschungzentrum, Heidelberg, Federal Republic of Germany; 'Dept. of Medicine,
Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts: Resistance of HSV-1/HSV-2
intertypic recombinants both to ACG and to PAA is due to altered viral DNA polymerase.
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R. LAFEMINA and G. S. HAYWARD, Dept. of Pharmacology, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Physical mapping of the human CMV DNA molecule.
R. Y. LAu,' M. NONOYAMA,' and G. KLEIN' 'Laboratory of Molecular Virology, Life Sciences Biomedical
Research Institute, St. Petersburg, Florida; 'Dept. of Tumor Biology, Karolinska Institute, Stockholm,
Sweden: Resident viral genome structure and control of viral genome transcription in two EBV-DNA-
containing somatic hybrid cell lines.
Y.-S. LEE,' A. TANAKA,' R. Y. LAu,' M. NONOYAMA,' and H. RABIN,2 'Life Sciences Biomedical Research
Institute, St. Petersburg, Florida; 'Frederick Cancer Research Center, Maryland; The linkage map of
herpesvirus papio (HVP) and its relation to that of EBV DNA.
D. S. PARRIS and J. E. HARRINGTON, Dept. of Medical Microbiology and Comprehensive Cancer Center, Ohio
State University College of Medicine, Columbus: Characterization of acycloguanosine resistance in HSV
encephalitis strains.
J. SKARE,1 J. FARLEY,' J. STROMINGER,' and K. FRESEN,2 'Sidney Farber Cancer Institute, Boston, Massachusetts;
'Institute for Virology, Freiburg, Federal Republic of Germany: Restriction mapping of EBV recombinant
viruses.
D. H. SPECTOR, J. TAMASHIRO, and L. HOCK, University of California, San Diego: Molecular cloning and
characterization of human CMV DNA.
D. R. THOMSEN and M. F. STINKS!, Dept. of Microbiology, University of Iowa, Iowa City: Cloning human CMV
DNA Xbal restriction endonuclease fragments into bacterial plasmid pACYC184.
M. W. WESTRATE and J. L. M. GEELEN, Laboratorium voor de Gezondheidsleer, Universiteit van Amsterdam, The
Netherlands: Structural organization of the DNA of HCMV-Comparison of the physical maps of strain
AD169 and SG.
D. R. YAGER and S. L. BACHENHEIMER, Dept. of Bacteriology and Immunology, University of North Carolina,
Chapel Hill: Transcription of HSV-1 DNA in infected permeabilized cells.
Y. YArimA and R. GLASER, Dept. of Medical Microbiology and Immunology, and Comprehensive Cancer Center,
Ohio State University College of Medicine, Columbus: Transcription of the EBV genome in superinfected
Raji cells.
Session 10: Transformation
Chairperson: D. J. O'CALLAGHAN, University of Mississippi Medical Center, Jackson
I. R. CAMERON, N. M. WILKIE, and J. C. M. MACNAB, Institute of Virology, University of Glasgow, Scotland:
Transformation studies using defined fragments of HSV-2.
D. A. GALLOWAY and J. K. McDoucku., Dept. of Tumor Biology, Fred Hutchinson Cancer Research Center,
Seattle, Washington: Transformation of rodent cells by a cloned fragment of the HSV-2 genome.
F. M. VAN DEN BERG and J. M. M. WALBOONERS, Laboratory of Pathological Anatomy, University of Amsterdam,
The Netherlands: Oncogenic transformation of hamster embryo cells with DNA of HSV-2.
G. R. REYES and G. S. HAYWARD, Dept. of Pharmacology, Johns Hopkins University School of Medicine,
Baltimore, Maryland: Biochemical manipulation of cloned HSV DNA fragments and their subsequent
introduction into mammalian cells.
A. BOYD' and B. HAMPAR,2 'Frederick Cancer Research Center, 'NCI, National Institutes of Health, Freder-
ick, Maryland: Activation of endogenous retroviruses from BALB/c mouse cells by herpesvirus DNA.
I. BOLDOGH, J. F. BASKAR, E. C. MAR, and E. S. HUANG, Cancer Research Center, University of North Carolina,
Chapel Hill: Transformation of human embryonic lung cells by restriction endonuclease (Xba) fragmented
DNA of CMV.
R. A. ROBINSON, P. W. TUCKER, and D. J. O'CALLAGHAN, University of Mississippi Medical Center, Jackson:
Mapping and molecular cloning of host genomic and herpesvirus oncogenic DNA sequences.
B. HAMPAR,' S. D. SHOWALTER,' and J. G. DERGE,2 'NCI, National Institutes of Health; 'Frederick Cancer
Research Center, Maryland: Biochemical and morphological transformation by HSV-1 are independent
and unrelated events.
J. LEWIS,' L. KUCERA' R. EBERLE,' and R. CouraNEY,"Dept. of Microbiology, University of Tennessee,
Knoxville; 'Dept. of Microbiology and Immunology, Bowman Gray School of Medicine, Winston-Salem,
North Carolina: Identification of specific HSV-2 glycoproteins expressed in HSV-2-transformed cells.
M. M. MANAK, M. MCKINLAY, C. C. SMITH, L. AURELIAN, and P. 0. P. Ts'o, Baltimore City Hospital, Johns
Hopkins Medical Institutions, Maryland: Phenotypic properties and viral expression in HSV-2-transformed
Syrian hamster embryo cells.
G. DARAI,' L. ZOLLER,' and R. M. FLOca,"Institut fOr medizinische Virologie der Universitat Heidelberg;
'Institut fur Virusforschung, Heidelberg, Federal Republic of Germany: Attempts to immortalize human
umbilical-cord-blood leukocytes by HSV and its DNA.
T. AYA,' 0. SHIRATORI,' and T. OsKro,"Cancer Institute, Hokkaido University School of Medicine, Sapporo;
'Shionogi Research Laboratories, Osaka, Japan: Isolation of rapidly growing lymphocytes in semisolid agar
medium in primary infection with EBV.
R. A. RESPESS, L. S. KUCERA, and M. WAITE, Bowman Gray School of Medicine, Wake Forest University, Winston-
Salem, North Carolina: Aminoacyl-fucosides as in vitro markers of tumorigenic potential of tetradecanoyl
phorbol acetate (TPA)-treated and untreated HSV-2-transformed rat cells.
L. S. KUCERA, I. EDWARDS, and R. A. RESPESS, Bowman Gray School of Medicine, Wake Forest University,
Winston-Salem, North Carolina: The tumor promoter (tetradecanoyl-phorbol-13-acetate) enhances the
malignant potential of HSV-2-transformed cells.
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Session 11: EBV Molecular Biology
Chairperson: W. C. SUMMERS, Yale University, New Haven, Connecticut
G. N. BUELL and D. REISMAN, McArdle Laboratory, University of Wisconsin, Madison: Analysis of EBV genome
structure using X recombinants.
M. HELLER, T. DAMBAUGH, and E. KIEFF, Kovler Viral Oncology Laboratories, University of Chicago, Illinois:
Organization of the DNA of EBV-Variation in the viral DNAs in producer and nonproducer cell lines from
various origins.
S. LAZAROWITZ,' G. HAYWARD,2 and S. D. HAYWARD,2 Depts. of 'Microbiology and 'Pharmacology, Johns
Hopkins University School of Medicine, Baltimore, Maryland: Studies on the structure of EBV DNA in and
around the internal repeats.
V. L. VAN STANTEN, W. KING, A. CHEUNG, and E. KIEFF, Kov ler Viral Oncology Laboratories, University of Chicago,
Illinois: Cytoplasmic EBV-specific RNAs in an EBV-transformed continuous lymphoblastoid cell line.
J. R. ARRAND1 and L. Rymo,"Imperial Cancer Research Fund, London, England; 'Dept. of Clinical
Chemistry, University of Gothenburg, Sweden: The expression of EBV-related sequences in various
lymphoblastoid cell lines.
M. LERNER,' N. ANDREWS,' G. MILLER,' and J. A. STEITZ,' Depts. of 'Molecular Biophysics and Biochemistry,
'Pediatrics, Yale University, New Haven, Connecticut: Two new EBV-encoded RNAs are found in the form
of small ribonucleoproteins.
G. MILLER,' L. GRADOVILLE,' L. HESTON,' E. GROGAN,' J. BRANDSMA,' M. WESTERGAARD,2 and W. MARIS,2 'Dept.
of Pediatrics, Yale University School of Medicine, New Haven, Connecticut; 'University of Amsterdam,
Holland: Structure and infectivity of the genome of an EBV derived from saliva of a patient with infectious
mononucleosis.
A. TANAKA, S. YANO, and M. NONOYAMA, Life Sciences Biomedical Research Institute, St. Petersburg, Florida: A
study on probing possible integration of EB viral genome in transformed cells by Southern blot
hybridization.
J. BRANDSMA and G. MILLER, Dept. of Pediatrics, Yale University School of Medicine, New Haven, Connecticut:
Nucleic acid spot hybridization-Rapid quantitative screening of large numbers of samples for EB viral
DNA.
D. LAROCCA and W. CLOUGH, Dept. of Molecular Biology, University of Southern California, Los Angeles:
Methylation of viral and cellular DNA in EBV-infected cells.
Session 12: Nucleoproteins, Transcription, and Enzymes
Chairperson: S. KIT, Baylor College of Medicine, Houston, Texas
I. W. HALLIBURTON, Dept. of Microbiology, University of Leeds, England: Isolation and characterization of
recombinants between herpessimplex and bovine mammillitis viruses.
Y.-R. ROTH and S. L. BACHENHEIMER, Dept. of Bacteriology and Immunology, and Curriculum in Genetics,
University of North Carolina, Chapel Hill: Encapsidation of HSV DNA.
S. ST. ROR, C. HALL, C. MCGAw, and M. HALL, Dept of Microbiology, University of Nevada School of Medicine,
Reno: Characterization of human CMV nucleoprotein complexes.
J. M. DEMARCHI and A. S. KAPLAN, Dept. of Microbiology, Vanderbilt University School of Medicine, Nashville,
Tennessee: Analysis of the human cytomegalovirus (HCMV) transcripts accumulation in permissively and
nonpermissively infected cells.
K. P. ANDERSON, R. J. FRISK, B. H. GAYLORD, R. H. COSTA, G. B. DEVI, and E. K. WAGNER, Dept. of Molecular Biol-
ogy and Biochemistry, University of California, Irvine: High resolution mapping of HSV-1 mRNA.
F. WOHLRAB and B. FRANCKE, Dept. of Human Genetics, Yale University, New Haven, Connecticut: Control of
expression of the HSV-1-specific deoxypyrimidine triphosphatase in cells infected with temperature-
sensitive mutants of HSV-1 and HSV-2 and interytpic recombinants.
P. J. HOFFMANN, Dept. of Medical Microbiology and Comprehensive Cancer Center, Ohio State University,
Columbus: On the mechanism of action of the deoxyribonuclease specified by HSV.
B. E. HENRY, R. J. FEIGHNY, and J. S. PAGANO, Cancer Research Center, University of North Carolina, Chapel
Hill: An EBV-associated DNase activity appearing in superinfected Raji cells.
W. CLOUGH and J. MCMAHON, Dept. of Molecular Biology, University of Southern California, Los Angeles:
Biological role of the DNA polymerase activity associated with EB virions.
D. HUSZAR and S. BACCHETTI, Dept. of Pathology, McMaster University, Hamilton, Canada: Ribonucleotide
reductase induced by HSV infection of mammalian cells-Properties of the enzyme from crude and
partially purified extracts.
Session 13: Reports from Workshops
Summary: P. WI Loy, University of Cambridge, England
This meeting was partially funded by the National Institute of Allergy and Infectious Diseases, National Institutes
of Health.
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8th Cold Spring Harbor Conference on Cell Proliferation
Protein Phosphorylation, September 2 - September 7
Arranged by
Ora M. Rosen, Albert Einstein College of Medicine, New York, New York
Edwin G. Krebs, Howard Hughes Medical Institute, University of Washington, Seattle
267 participants
Session 1: Protein Kinases and Phosphoprotein Phosphatases. 1.
Chairperson: E. G. KREBS, Howard Hughes Medical Institute, University of Washington, Seattle
S. S. TAYLOR, A. R. KERLAVAGE, M. J. ZOLLER, N. C. NELSON, and R. L. POTTER, Dept. of Chemistry, University of
California, San Diego: The nucleotide binding sites and structural domains of cAMP-dependent protein
kinases.
K. TITANI,L2 S. SH0)1,2 L. H. ERicssoN,2 J. G. DEMAILLE,4 K. A. WALSH/ H. NEURATH,2 E. H. FISCHER,2 K. TAKio,2 S. B.
SMITH,''' and E. G. KREBS,''' 'Howard Hughes Medical Institute, Depts. of 'Biochemistry and 'Pharmacology,
University of Washington, Seattle; °Faculte de Medicine and CNRS, Montpellier, France: Primary structure of
cAMP-dependent protein kinase type II from bovine cardiac muscle.
S. E. 131_111_1)ER,, J. S. BrAvo,3 and E. G. KREBS? 'Merck, Sharpe & Dohme Research Laboratories, Rahway, New Jer-
sey; 'Howard Hughes Medical Institute, 'Dept. of Pharmacology, University of Washington, Seattle: The
mechanism of activation and inactivation of cAMP-dependent protein kinase-Several lines of evidence.
J. D. CORBIN, S. R. RANNELS, and D. A. FLOCKHART, Howard Hughes Medical Institute and Dept. of Physiology,
Vanderbilt University, Nashville, Tennessee: Structure-function relationships of cAMP-dependent protein
kinases.
S. B. SMITH, H. D. WHITE, J. B. SIEGEL, and E. G. KREBS, Howard Hughes Medical Institute, University of Washington,
Seattle: cAMP-dependent protein kinase-Cyclic nucleotide binding, structural changes, and release of the
catalytic subunits.
E. T. KAISER,' H. N. BRAmsoni,' R. N. ARMSTRONG,' H. KoNoo,' J. STINGELIN,' N. Mows,' J. GMNOT,2 and A. S.
MiLovAN,"Depts. of Chemistry and Biochemistry, University of Chicago, Illinois; 'Institute for Cancer
Research, Philadelphia, Pennsylvania: Mechanistic studies on the catalytic action of bovine cardiac muscle
cAMP-dependent protein kinase.
S. SHALTIEL, E. ALHANATY, R. CESLA, J. S. JIMENEZ, A. KUPFER, and Y. ZICK, Dept. of Chemical Immunology, Weizmann In-
stitute of Sciences, Rehovot, Israel: cAMP-dependent protein kinase-Biorecognition and bioregulation.
Session 2: Protein Kinases and Phosphoprotein Phosphatases. 11.
Chairperson: E. G. KREBS, Howard Hughes Medical Institute, University of Washington, Seattle
J. A. BEAvo and M. C. MUMBY, Dept. of Pharmacology, University of Washington, Seattle: Use of monoclonal
antibodies to cyclic nucleotide-dependent protein kinases as site-specific reagents.
H. HILZ, W. WEBER, H. SCHRODER, and G. SCHWOCH, Institut fur Physiologische Chemie, Universitat Hamburg,
Federal Republic of Germany: Analysis of cAMP-dependent protein kinases by immunotitration-Multiple
formsmultiple functions?
U. WALTER, P. DECAMILLI,2 S. M. LOHMANN' P. MILLER,' and P. GREENGARD' 'Depts. of Physiological Chemistry
and Medicine, University of WOrzburg, Federal Republic of Germany; 'Section of Cell Biology and 'Dept. of
Pharmacology, Yale University School of Medicine, New Haven, Connecticut: Regulation and cellular
localization of cAMP- and cGMP-dependent protein kinases.
N. PRASHAD, Dept. of Neurology, University of Texas Health Science Center, Dallas: Induction of free cAMP
binding protein in neuroblastoma cells.
R. A. STEINBERG, Biological Sciences Group, University of Connecticut, Storrs: cAMP-dependent protein phos-
phorylations in intact cultured cells.
M. M. GOTTESMAN, T. SINGH, A. LECAM, C. ROTH, F. CABRAL, J.-C. NICOLAS, and I. PASTAN, NCI, National Institutes of
Health, Bethesda, Maryland: cAMP-dependent phosphorylations in cultured fibroblasts-A genetic
approach.
B. P. SCHIMMER, J. Ts Ao, and P. DOHERTY, Banting and Best Dept. of Medical Research, University of Toronto,
Ontario, Canada: cAMP-dependent protein kinase and regulation of adrenocortical functions-A genetic
evaluation.
S. E. MAYER,' L. L. BRUNTON,' and J. S. HAYES' 'Division of Pharmacology, University of California, San Diego; 'Eli
Lilly Laboratories, Indianapolis, Indiana: Selective activation of subcellular fractions of cAMP-dependent
protein kinase in heart by isoproterenol and prostaglandin E,.
Y. NisFazUKA and Y. TAKAI, Dept. of Biochemistry, Kobe University School of Medicine, Japan: Calcium and
phospholipid in a new receptor mechanism for protein phosphorylation.
Session 3: Protein Kinases and Phosphoprotein Phosphatases. III.
Chairperson: E. G. KREBS, Howard Hughes Medical Institute, University of Washington, Seattle
G. N. GILL, University of California School of Medicine, San DiegO: cGMP-dependent protein kinase.
D. B. GLASS and L. H. MCFANN, Dept. of Pharmacology, Emory University School of Medicine, Atlanta, Georgia:
Initial velocity kinetics of the cGMP-dependent protein kinase using histone H2B or a synthetic peptide as
substrate.
D. J. GRAVES, R. UHING, J. MILLER, and M. KOBAYASHI, Depts. of Biochemistry and Biophysics, Iowa State University,
Ames: Phosphorylation and activation of glycogen phosphorylase.
L. M. G. HEILMEYER, JR., U. JAHNKE, M. W. KILIMANN, K. P. KOHSE, and J. E. SPERLING, Institut fur Physiological
Chemistry, Ruhr-Universitat, Bochum, Federal Republic of Germany: Intramolecular regulatory cascades in
phosphorylase kinase and troponin, interrelationship between Mg' or Ca" binding and phosphorylation.
B. E. KEMP and M. J. JOHN, Howard Florey Institute of Experimental Physiology and Medicine, University of
Melbourne, Parkville, Victoria, Australia: Synthetic peptide substrates for protein kinases.
H. S. SuL, R. H. COOPER, T. E. McCuLLoucH, C. A. PicxErr-GiEs, K. L. ANGELOS, and D. A. WALSH, Dept. of Biological
Chemistry, University of California School of Medicine, Davis: Mechanism of regulation of cardiac phosphor-
ylase kinase.
K.-P. HUANG, NICHHD, National Institutes of Health, Bethesda, Maryland: Phosphorylation of rabbit skeletal
muscle glycogen synthase by cAMP-dependent and -independent protein kinases.
K. SCHLENDER,' S. J. BEEBE,' and E. M. REIMAN,2 Depts. of 'Pharmacology and 'Biochemistry, Medical College of
Ohio, Toledo: Isolation of cAMP-independent glycogen synthase kinase from renal cortex and medulla.
Session 4: Protein Kinases and Phosphoprotein Phosphatases. IV.
Chairperson: E. G. KREBS, Howard Hughes Medical Institute, University of Washington, Seattle
J. W. MITCHELL,' W. LAU' and J. A. THOMAS' 'Monsanto Corp., St. Louis, Missouri; 'Dept. of Biochemistry, Iowa
State University, Ames: Covalent modification and regulation of bovine cardiac glycogen synthase.
T. R. SODERLING and M. E. PAYNE, Howard Hughes Medical Institute and Dept. of Physiology, Vanderbilt Medical
School, Nashville, Tennessee: Liver-calmodulin-dependent glycogen synthase kinase.
E. Y. C. LEE, S. R. SILBERMAN, H. PARIS, M. GANAPATHI, and S. PETROVIC, Dept. of Biochemistry, University of Miami
School of Medicine, Florida: Phosphorylase phosphatase- Isolation and properties of the enzymes from
rabbit muscle.
H.-C. Li, Dept. of Biochemistry, Mount Sinai School of Medicine, City University of New York, New York:
Properties of cardiac muscle phosphorylase phosphatase, glycogen synthase phosphatase, and alkaline
phosphatase isozymes.
D. L. BRAUTIGAN, L. M. BALLOU, and E. H. FISCHER, Dept. of Biochemistry, University of Washington Medical School,
Seattle: Formation of protein:glutathione disulfides in the regulation of sarcoplasmic protein phosphatase.
R. L. KHANDELWAL, S. K. SLOAN, and D. J. CRAW, Dept. of Oral Biology, University of Manitoba, Winnipeg, Canada:
Characterization and interaction of heat-stable inhibitor 2 and an activator with phosphoprotein phosphatase
from liver.
N. B. MADSEN, R. J. FLETTERICK, and P. J. KASVINSKY, Dept. of Biochemistry, University of Alberta, Edmonton, Canada:
Regulation of protein phosphatase 1 via glycogen phosphorylase.
J. R. VANDENHEEDE, S.-D. YANG, J. GORIS, and W. MERLEVEDE, Afdeling Biochemie Dept. Humane Biologie, Faculteit
der Geneeskunde, Katholieke Universiteit to Leuven, Belgium: Regulation of rabbit muscle ATP-Mg-depen-
dent protein phosphatase by cAMP- and Ca"-independent synthase kinase.
J. H. WANG, S. T. TAM, W. G. LEWIS, and R. K. SHARMA, Dept. of Biochemistry, University of Manitoba, Winnipeg,
Canada: The regulation of protein phosphorylation by calmodulin in skeletal muscle.
Session 5: Metabolism. I.
Chairperson: J. EXTON, Vanderbilt University, Nashville, Tennessee
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T. D. CHRISMAN and J. H. EXTON, Howard Hughes Medical Institute and Dept. of Physiology, Vanderbilt University
School of Medicine, Nashville, Tennessee: Hormonal regulation of liver glycogenolysis.
J. GARRISON, Dept. of Pharmacology, University of Virginia Medical School, Charlottesville: The role of Ca"- ion
and cyclic-nucleotide-independent protein kinases in the control of hepatic carbohydrate metabolism.
S. J. PILKIS, T. H. CLAUS, and R. EL-MAGHRABI, Dept. of Physiology, Vanderbilt University, Nashville, Tennessee:
Modulation of hepatic pyruvate kinase and phosphofructokinase activity.
L. ENGSTROM,' U. RAGNARSSON,2 and 0. ZErrmvis-r,"Institute of Medical and Physiological Chemistry; 'Institute
of Biochemistry, Biomedical Center, University of Uppsala, Sweden: Regulation of pyruvate kinase by
phosphorylation and proteolysis.
J. B. BLAIR and R. F. KLETZIEN, Dept. of Biochemistry, West Virginia University Medical Center, Morgantown:
Glucocorticoids and the phosphorylation of liver pyruvate kinase.
M.-S. SHIAO, R. F. DRONG, R. E. DUGAN, T. A. BAKER, and J. W. PORTER, Will iam S. Middleton Memorial Veterans Ad-
ministration Hospital, and Dept. of Physiological Chemistry, University of Wisconsin, Madison: Activators
and inactivators of rat liver acetyl-CoA carboxylase and HMG-CoA reductase activities.
R. A. PARKER, T. S. INGEBRISTEN; M. J. H. GEELEN,2 and D. M. GrasoN,1 'Dept. of Biochemistry, Indiana University
School of Medicine, Indianapolis; 'Laboratory of Veterinary Biochemistry, State University of Utrecht, The
Netherlands: Short-term modulation of HMG CoA reductase activity in rat hepatocytes in response to insulin
and glucagon.
H. B. BREWER, JR. and Z. H. BEG, NHLBI, National Institutes of Health, Bethesda, Maryland: Short-term regulation
of hepatic cholesterol synthesis.
Session 6: Metabolism. II.
Chairperson: J. EXTON, Vanderbilt University, Nashville, Tennessee
K.-H. KIM, Dept. of Biochemistry, Purdue University, West Lafayette, Indiana: Regulation of acetyl-CoA carboxy-
lase by covalent modification.
K. UYEDA, E. FURUYA, and T. KAGirvicrro, Veterans Administration Medical Center, and Dept. of Biochemistry,
University of Texas Health Science Center, Dallas: Regulation of liver phosphofructokinase by
phosphorylation.
J. C. KHOO and D. STEINBERG, Dept. of Medicine, University of California, San Diego: Hormone-sensitive neutral
triglyceride lipase in adipose tissue and in 3T3-L1 cells.
A. L. KERBEY, P. J. RANDLE, and G. J. SALE, Dept. of Clinical Biochemistry, University of Oxford, England: Regulation
of pyruvate dehydrogenase complex by phosphorylation and dephosphorylation.
L. REED and F. PErrrr, Clayton Foundation Biochemical Institute and Dept. of Chemistry, University of Texas,
Austin: Phosphorylation and dephosphorylation of pyruvate dehydrogenase.
Session 7: Insulin and Growth Factors
Chairperson: 0. M. ROSEN, Albert Einstein College of Medicine, New York, New York
L. JARErr,' F. L. KIECHLE,1 D. A. Popp,' and N. KOTAGAL,2 'Dept. of Pathology and Laboratory Medicine, University
of Pennsylvania Medical School, Philadelphia; 'Washington University School of Medicine, St. Louis,
Missouri: The role of a chemical mediator of insulin action in the control of phosphorylation.
K. CHENG, G. GALASKO, L. HUANG, J. KELLOGG, and J. LARNER, Dept. of Pharmacology, University of Virginia,
Charlottesville: Mediators of insulin action on protein phosphorylation and dephosphorylation.
N. S. RANGANATHAN, T. C. LINN, and P. A. SRERE, Pre-Clinical Science Unit, Veterans Administration Center; Dept. of
Biochemistry, University of Texas Health Science Center, Dallas: A phosphopeptide isolated from phospho
ATP citrate lyase.
S. RAMAKRISHNA and W. B. BENJAMIN, Dept. of Physiology and Biophysics, State University of New York, Stony
Brook: ATP-citrate lyase phosphorylation by a cyclic AMP-independent protein kinase.
M. C. ALEXANDER, J. L. PALMER, and J. AvRUCH, Howard Hughes Medical Institute Laboratory, Harvard Medical
School; Diabetes Unit, Massachusetts General Hospital, Boston: Hormonally stimulated phosphorylation of
ATP-citrate lyase.
C. J. SMITH, C. S. Rums, and 0. M. ROSEN, Dept. of Molecular Pharmacology, Albert Einstein College of
Medicine, Bronx, New York: Insulin-stimulated phosphorylation of ribosomal protein S6 in differentiated
3T3-L1 cells.
G. THOMAS and M. SIEGMANN, Dept. of Cell Biology, Friedrich Miescher-Institut, Basel, Switzerland: Increased
multiple phosphorylation of ribosomal protein S6 following serum-stimulation of quiescent 3T3 cells.
S. COHEN, Dept. of Biochemistry, Vanderbilt University, Nashville, Tennessee: Epidermal growth factor-
receptor-protein kinase interactions.
Session 8: Contractile Proteins
Chairperson: R. ADELSTEIN, NHLBI, National Institutes of Health, Bethesda, Maryland
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R. S. ADELSTEIN, M. D. PATO, J. R. SELLERS, and M. A. CONTI, NHLBI, National Institutes of Health, Bethesda,
Maryland: Regulation of the contractile proteins in muscle and nonmuscle cells by phosphorylation-
dephosphorylation.
J. T. STULL, Moss Heart Center and Dept. of Pharmacology, University of Texas Health Science Center, Dallas:
Phosphorylation of myosin in different types of muscles.
F. HOFMANN and H. WOLF, Pharmakologisches Institut der Universitat, Heidelberg, Federal Republic of
Germany: Regulatory protein kinases of cardiac muscle.
C. J. LEPEUCH, M. P. WALSH, J.-C. CAVADORE, A. Mou.A, and J. G. DEMAILLE, Faculte de Medecine and CNRS,
Montpellier, France: The concerted control of contraction by cyclic nucleotide and calcium-calmodulin
dependent phosphorylation. Modulation of myosin phosphorylation and of sarcoplasmic reticulum cal-
cium uptake.
A. M. KA-rz, University of Connecticut, Farmington: Regulation of calcium transport in cardiac sarcoplasmic
reticulum by cAMP-dependent protein kinase.
J. Y. J. WANG and D. E. KOSHLAND, JR., Dept. of Biochemistry, University of California, Berkeley: Protein
phosphorylation as a regulatory mechanism in procaryotes.
P. DE LANEROLLE,1 J. R. FERAMISC0,2 K. BURRIDGE,2 and R. S. ADELSTEIN,' 'NHLBI, National Institutes of Health,
Bethesda, Maryland; 'Cold Spring Harbor Laboratory, New York: Localization of myosin light chain
kinase -in nonmuscle cells.
M. BARANY,' K. BARANiv,' J. T. BARRON,' S. J. KOPP,' R. A. JANI5,2 D. D. DoYLE,' S. R. HAGER,' F. HomA,' and S. T.
SAYERS,' 'University of Illinois Medical Center; 'Northwestern University Medical Center, Chicago,
Illinois: Protein phosphorylation in live muscle.
W. G. L. KERRICK, P. E. HOAR, and P. S. CASSIDY, Dept. of Physiology and Biophysics, University of Washington,
Seattle: Skinned muscle fibers-The functional significance of phosphorylation in Ca "- activated tension.
R. J. SOLARO, M. J. HOLROYDE, T. H. CROUCH, S. ROBERTSON, J. D. JOHNSON, and J. D. PURER, Depts. of
Physiology, Pharmacology, and Cell Biophysics, University of Cincinnati College of Medicine, Ohio:
Myofilament protein phosphorylation in striated muscle.
J. L. DANIEL, I. R. MOLISH, H. HOLMSEN, and L. SALGANICOFF, Thrombosis Research Center, Temple University,
Philadelphia, Pennsylvania: Phosphorylation of myosin light chain in intact platelets.
Session 9: Protein Synthesis
Chairperson: I. M. LONDON, Harvard-MIT Division of Health, Science, and Technology, Cambridge,
Massachusetts
S. OCHOA, C. DE HARO, J. SIEKIERKA, and H. GROSFELD, Roche Institute of Molecular Biology, Nutley, New Jersey:
Protein phosphorylation and translational control.
I. M. LONDON, V. ERNST, R. FAGARD, A. LEROUX, D. H. LEVIN, and R. PETRYSHYN, Massachusetts Institute of
Technology, Cambridge: Regulation of protein synthesis by phosphorylation and heme.
B. HARDESTY and G. KRAMER, Clayton Foundation Biochemical Institute, University of Texas, Austin: Regulation
of peptide initiation by phosphorylation and dephosphorylation of eIF -2.
B. SAFER, R. JAGUS, and D, CROUCH, NHLBI, National Institutes of Health, Bethesda, Maryland: Both the redox
and phosphorylation states of eIF -2 regulate protein synthesis initiation.
T. HUNT, Dept. of Biochemistry, University of Cambridge, England: Protein phosphorylation and the control
of protein synthesis.
J. A. TRAUGH, P. T. TUAZON, and R. W. DEL GRANDE, Dept. of Biochemistry, University of California, Riverside:
Phosphorylation of translational components.
M. K. HADDOX and D. H. RUSSELL, Dept. of Pharmacology, University of Arizona Health Sciences Center,
Tucson: cAMP-dependent protein kinase implicated in the transcriptional induction of ornithine
decarboxylase.
Session 10: Nuclear and Cytoskeletal Proteins
Chairperson: T. LANGAN, University of Colorado, Boulder
T. A. LANGAN, C. ZEILIG, and B. LEICHTLING, Dept. of Pharmacology, University of Colorado School of Medicine,
Denver: Characterization of multiple-site phosphorylation of H1 histone in proliferating cells.
J. A. D'ANNA,' L. R. GURLEY,' R. R. BECKER' S. S. BARHAM ,3 R. A. WALTERS,' and R. A. TOBEY,1 'Los Alamos
Scientific Laboratory, New Mexico; 'Dept. of Biochemistry and Biophysics, Oregon State University,
Corvallis; 'Dept. of Cell Biology, Mayo Clinic, Rochester, Minnesota: Phosphorylation of the butyrate-
enhanced protein, histone H1°, in Chinese hamster cells.
L. R. GURLEY, R. A. TOBEY, J. A. D'ANNA, M. S. HALLECK, R. A. WALTERS, S. S. BARHAM, and J. J. JETT, LosAlamos
Scientific Laboratory, University of California, New Mexico: Relationships between histone phosphoryla-
tion and cell proliferation.
H. BAYDOUN, J. HOPPE, and K. G. WAGNER, Gesellschaft fur Biotechnologische Forschung mbH, Braunschweig-
StOckheim, Federal Republic of Germany: The quarternary structure and ligand specificity of two messen-
ger-independent protein kinases from porcine liver nuclei-A comparison with cAMP-dependent protein
kinases I.
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R. A. JuNGMANN and M. S. LAKS, Cancer Center, Northwestern University Medical School, Chicago, Illinois:
Modulation of nuclear cAMP-dependent protein kinase activity at times of gene activity.
J. L. MALLER, Dept. of Pharmacology, University of Colorado School of Medicine, Denver: Control of cell
division by protein phosphorylation.
D. L. PURICH, B. J. TERRY, H. D. WHITE, B. A. COUGHLIN, T. L. KARR, and D. KRISTOFFERSON, Dept. of Chemistry,
University of California, Santa Barbara: Microtubule associated protein phosphorylation and calcium ion
regulation of bovine brain microtubule self-assembly.
C. M. O'CONNOR, D. L. GARD, D. J. ASAI, and E. LAZARIDES, California Institute of Technology, Pasadena:
Phosphorylation of the intermediate filament proteins, desmin and vimentin.
Session 11: Viruses and Cell Transformation. I.
Chairperson: T. HUNTER, Salk Institute, San Diego, California
T. HUNTER, B. SEFTON, and J. COOPER, Salk Institute, San Diego, California: Phosphorylation of tyrosine-Its
importance in normal cell metabolism and viral transformation.
A. F. PURCHIO,' E. ERIKSON,' M. S. Courrr,' and R. L. ERKsoN,"Dept. of Pathology, University of Colorado
Health Sciences Center, Denver; 'Dept. of Microbiology, University of Minnesota, Minneapolis: Com-
parison of the Rous sarcoma virus transforming gene product, pp6V., and its homologue, pp60...r., from
normal cells.
Y.-S. E. CHENG, C.-Y. CHENG, and L. B. CHEN, Sidney Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts: Alteration in protein phosphorylations in RSV transformed cells.
J. G. BURR, S. R. LEE, and J. M. BUCHANAN, Dept. of Biology, Massachusetts Institute of Technology,
Cambridge: Association of the RSV src gene product with the cytoskeleton and identification of a possible
cellular substrate protein.
K. SHRIVER and L. R. ROHRSCHNEIDER, Fred Hutchinson Cancer Research Center, Seattle, Washington: Spatial
and enzymatic interaction of the Rous sarcoma virus transforming protein with components of the cellular
cytoskeleton.
Session 12: Viruses and Cell Transformation. II.
Chairperson: T. HUNTER, Salk Institute, San Diego, California
A. LEVINSON,' S. COURTNEIDGE,2 H. VARMUS' and J. M. BISHOP,' 'Genentech, Inc., South San Francisco;
'Dept. of Microbiology, University of California, San Francisco: Functional domains and substrate
specificity of the transforming protein of avian sarcoma virus.
D. LIVINGSTON, M. BRADLEY, and J. GRIFFIN, Sidney Farber Cancer Institute and Harvard Medical School, Boston,
Massachusetts: Enzymatic and DNA binding properties of the large SV40 T antigen.
K.-H. SCHEIDTMANN, A. KAISER, and G. WALTER, Institut fur Immunbiologie der Universitat Freiburg, Federal
Republic of Germany: The localization of phosphothreonine in the sequence of SV40 large T antigen.
B. SCHAFFHAUSEN and T. BENJAMIN, Dept. of Pathology, Harvard Medical School, Boston, Massachusetts:
Phosphorylation of polyoma virus T antigens.
Session 13: Membranes and Neural Function
Chairperson: C. RUBIN, Albert Einstein College of Medicine, New York, New York
P. GREENGARD, Dept. of Pharmacology, Yale University School of Medicine, New Haven, Connecticut: Protein
phosphorylation and brain function.
M. TAO, R. CONWAY, S. CHETA, H. C. CHIANG, and T. F. YAN, Dept. of Biological Chemistry, University of Illinois
Medical Center, Chicago: Role of protein kinases in erythrocyte membrane phosphorylation.
H. R. DE JONGE and F. S. VAN DOMMELEN, Dept. of Biochemistry I, Erasmus University, Rotterdam, The
Netherlands: Cyclic GMP-dependent phosphorylation and ion transport in intestinal microvilli.
C. S. RUBIN,' D. SARKAR,1 N. FLEISCHER' and J. ERLICHMAN,' Depts. of 'Molecular Pharmacology, 'Medicine,
Albert Einstein College of Medicine, Bronx, New York: Immunological characterization of a unique
subclass of type II cAMP-dependent protein kinases-Neural-specific protein kinase.
J. HERMOLIN and M. D. BOWNDS, Laboratory of Molecular Biology, University of Wisconsin, Madison: Light-
influenced outer segment protein phosphorylation in frog retina-Effects of cyclic nucleotides and
calcium.
C. G. PARIS, E. R. KANDEL, and J. H. SCHWARTZ, Division of Neurobiology and Behavior, Columbia University
College of Physicians and Surgeons, New York, New York: Serotonin stimulates phosphorylation of a
137,000 dalton membrane protein in the abdominal ganglion of Aplysia.
N. WEINER, J. MELIGENI, and P. R. Vuttio-, Dept. of Pharmacology, University of Colorado School of Medicine,
Denver: Regulation of tyrosine hydroxylase activity and alteration in the properties of the enzyme
following phosphorylation by protein kinases.
S. KAUFMAN, H. HAsEcAwA, H. WILGUS, and M. PARNIAK, NIMH, National Institutes of Health, Bethesda,




P. E. BRANTON,' S.-P. YEE,' J. F. DOWNEY,. S. MAK,. F. L. GRAHAM,''. and S. T. BAYLEY,. Depts. of 'Pathology,
2Biology, McMaster University, Hamilton, Ontario, Canada: Protein kinase activity associated with the
tumor antigens of human adenoviruses.
C. G. DAVIS, D. MILFAY, I. DIAMOND, and A. S. GORDON, University of California, San Francisco: Acetylcholine
receptor phosphorylation-Kinase localization and ligand regulation.
S. HALEGOUA and J. PATRICK, Neurobiology Laboratory, Salk Institute, San Diego, California: Nerve growth
factor mediates phosphorylation of specific proteins.
M. M. NOSEY and F. MARCUS, Dept. of Biochemistry, University of Health Sciences/Chicago Medical School,
Illinois: Analysis of fructose-1, 6-bisphosphatases as substrates for the cAMP-dependent protein kinase.
S.-Y. KAo and W. R. BAUER, Dept. of Microbiology, State University of New York, Stony Brook: Purification
and characterization of a superhelix binding protein from vaccinia virus.
R. G. KEMP, S. E. BAZAES, L. G. FOE, and S. P. LATSHAW, Dept. of Biochemistry, University of Health Sciences/Chi-
cago Medical School, Illinois: Phosphorylation of muscle phosphofructokinase in vivo and in vitro.
M. M. KING and G. M. CARLSON, Dept. of Chemistry, University of South Florida, Tampa: Synergistic effect of
Ca' and Mg' in promoting a Ca"-independent activity of phosphorylase kinase.
E. G. KRANIAS, L. M. BILEZIKJIAN, F. MANDEL, J. D. POTTER, and A. SCHWARTZ, Dept. of Pharmacology and Cell
Biophysics, University of Cincinnati College of Medicine, Ohio: cAMP and calmodulin dependent phos-
phorylation of cardiac sarcoplasmic reticulum.
M. D. PATO and R. S. ADELSTEIN, NHLBI, National Institutes of Health, Bethesda, Maryland: Properties of
myosin phosphatases from turkey gizzard.
K. M. ROSE, D. A. STETLER, and S. T. JACOB, Hershey Medical Center, Penn State University, Hershey,
Pennsylvania: Protein kinase activity of purified RNA polymerase I-Probable function of 42,000 and 24,600
molecular weight polypeptides.
J. R. SELLERS and R. S. ADELSTEIN, NHLBI, National Institutes of Health, Bethesda, Maryland: Preparation of
phosphorylatable subfragments from Limulus and gizzard myosin.
This meeting was supported in part by the National Institute of General Medical Sciences; National Institute
of Arthritis, Metabolism, and Digestive Diseases; National Cancer Institute; National Heart, Lung, and Blood
Institute; and Fogarty International Center, National Institutes of Health.
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Poxvirus-lridovirus, September 15-September 18
Arranged by
Bernard Moss, National Institutes of Health, Bethesda, Maryland
David C. Kelly, University of Oxford, England
65 participants
Session 1: DNA Structure
Chairperson: E. PAOLETfl, New York State Department of Health, Albany
R. WITFEK and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Tandem repeats within the
inverted terminal repetition of vaccinia virus DNA.
B. Moss and E. WINTERS, NIAID, National Institutes of Health, Bethesda, Maryland: Novel variants of vaccinia
virus that rapidly reiterate and delete terminal sequences.
R. W. MOYER and R. L. GRAVES, Department of Microbiology, Vanderbilt University, Nashville, Tennessee:
Transpositions and deletions lead to hypervariable poxvirus DNA termini.
L. C. ARCHARD, M. MACKETT, and K. R. DUMBELL, Department of Virology, St. Mary's Hospital Medical School,
London, England: Symmetrical, terminal aberration in orthopox virus genome structure.
J. ESPOSITO, C. CABRADILLA, J. NAKANO, and J. °BUSK!, Virology Division, Center for Disease Control, Atlanta,
Georgia: Intragenomic sequence transposition in monkeypox virus.
D. WING and A. WEISSBACH, Roche Institute of Molecular Biology, Nutley, New Jersey: Cloning of Hindi!! restricted
vaccinia DNA fragments.
A. TALAVERA, J. ALMENDRAL, V. LEY, and E. VINUELA, Centro de Biologia Molecular (CSIC-UAM), Canto Blanco,
Madrid, Spain: Order and cloning of DNA fragments from African swine fever virus genome.
R. GOORHA and K. G. Mown, Division of Virology, St. Jude Children's Research Hospital, Memphis,
Tennessee: Structure of the frog virus 3 genome.
M. H. LEE, D. B. Wiws, and A. GRANDEE, Division of Virology, St. Jude Children's Research Hospital,
Memphis, Tennessee: Restriction endonuclease mapping of the frog virus 3 genome.
D. WILLIS and A. GRANDEE, Division of Virology, St. Jude Children's Research Hospital, Memphis, Tennessee:
Frog virus 3 DNA is heavily methylated at CpG sequences.
Session 2: DNA Replication and Genetics
Chairperson: J. HOLOWCZAK, Rutgers Medical School, Piscataway, New Jersey
R. GOORHA, Division of Virology, St. Jude Children's Research Hospital, Memphis, Tennessee: Replication of
frog virus 3 DNA.
S. J. KELLER,* B. Jasivy,t and W. BAUER,t *Department of Biology, University of Cincinnati, Ohio; tDepart-
ment of Microbiology, State University of New York, Stony Brook: Location of the replication origin in
vaccinia virus WR.
C. K. SAM and K.R. DUMBELL, Department of Virology, St. Mary's Hospital Medical School, London, England:
Rescue of poxvirus DNA.
E. NAKANO, D. PANICALI, and E. PAOLETfl, Division of Laboratories and Research, New York State Department of
Health, Albany: Rescue of unique L-variant DNA sequences by S-variant vaccinia virus.
A. PELLICER* and M. ESTEBAN,t *Institute of Cancer Research, Columbia University, New York, New York;
tDepartment of Biochemistry, State University of New York, Downstate Medical Center, Brooklyn: Gene
transfer of vaccinia DNA into animal cells.
G. MCFADDEN,* E. FAusr,t G. MACKIE,* and S. DALES,* *Department of Microbiology and Immunology;
tCancer Research Unit; *Department of Biochemistry, University of Western Ontario, London, Canada:
Cloning of EcoRI fragment D of vaccinia virus IHD-W.
G. D. BROWN and R. W. MOYER, Department of Microbiology, Vanderbilt University, Nashville, Tennessee: The
behavior of "early" host range mutants of rabbit poxvirus (RPghr) mutants under permissive and
nonpermissive conditions.
K. Es5ANI and S. DALES, Department of Microbiology and Immunology, University of Western Ontario, London,
Canada: Further studies on recombination in group E mutants.
R. DRILLIEN, D. SPEHNER, and A. KIRN, INSERM U74 and Laboratory of Virology, Strasbourg, France: Complemen-
tation and recombination between vaccinia virus temperature-sensitive mutants.
R. C. CONDIT and A. Marvczrok, Biochemistry Department, State University of New York, Buffalo: Isolation and
characterization of temperature-sensitive mutants of vaccinia virus.
Session 3: Transcription
Chairperson: W. K. JOKLIK, Duke University Medical Center, Durham, North Carolina
J. MORGAN and B. ROBERTS, Department of Biological Chemistry, Harvard Medical School, Boston, Massachu-
setts: Viral gene expression in vaccinia infected L-cells.
A. MAHR and B. ROBERTS, Department of Biological Chemistry, Harvard Medical School, Boston, Massachu-
setts: Organization and expression of some cloned EcoRl vaccinia virus fragments.
H. BELLE ISLE, S. VENKATESAN, and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Mapping
of vaccinia virus early and late polypeptides by cell-free translation of mRNA selected by hybridization to
cloned DNA fragments.
R. WirrEK, J. A. COOPER, and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: Expression of
the vaccinia virus genome: Analysis and mapping of mRNAS and polypeptides encoded within the left 21
KB of the genome.
S. VENKATESAN and B. Moss, NIAID, National Institutes of Health, Bethesda, Maryland: In vitro transcription of
the inverted terminal repetition of the vaccinia virus genome.
D. E. HRUBY and L. A. BALL, Biophysics Laboratory, University of Wisconsin, Madison: Studies concerning the
temporal regulation of vaccinia virus thymidine kinase activity during infection.
E. PAOLEM, C. WHITKOP, and B. R. LIPINSKAS, Division of Laboratories and Research, New York State Depart-
ment of Health, Albany: Two-dimensional analysis of ribonuclease T, resistant 5'-terminal gligonucleotides
derived from vaccinia virus RNAs.
S. SHUMAN and J. HURWITZ, Department of Developmental Biology and Cancer, Albert Einstein College of
Medicine, Bronx, New York: 3TP- pyrophosphate exchange activity associated with vaccinia capping
enzyme: Implications for the mechanism of transguanylylation.
H. S. CAPLEN and J. A. HOLOWCZAK, College of Medicine and Dentistry, Rutgers Medical School, Piscataway,
New Jersey: Transcription in parapoxviruses.
Session 4: TranscriptionEffects on Host Cells
Chairperson: J. KATES, Scripps Clinic, La Jolla, California
M. L. SALAS, J. KUZNAR, and E. VINUELA, Centro de Biologia Molecular (CSIC-UAM), Canto Blanco, Madrid,
Spain: Characterization of the RNAs synthesized in vitro by the RNA polymerase associated to African
swine fever virus.
R. RAGHOW and A. GRANOFF, Division of Virology, St. Jude Children's Research Hospital, Memphis, Tennes-
see: Heterogeneity of methylated nucleotide sequences in frog virus 3 messenger RNAs.
B. G. T. POGO, P. FREIMUTH, and A. STEIN, Center for Experimental Cell Biology, Mount Sinai School of
Medicine,,New York, New York: Differences in structure and expression of two strains of Shope fibroma
virus.
A. RICE and B. ROBERTS, Department of Biological Chemistry, Harvard Medical School, Boston, Massachusetts:
Degradation of L cell messenger RNA during vaccinia infection.
G. BEAUD, F. BEN-HAMIDA, R. LEMIEUX, and A. PERSON, Institut de Recherche en Biologie Moleculaire du CNRS et
de l'Universite Paris, France: Shutoff of host protein synthesis by vaccinia virus.
A. M. AUBERTIN, P. DESCAMPS, L. TONDRE, and A. KIRN, INSERM U74 and Laboratory of Virology, Strasbourg,
France: Modification of the permeability of the plasma membrane by frog virus 3 soluble antigens-Rela-
tion to the inhibition of the host cell metabolism.
M. CERUTTI, J. ATTIAS, N. BALANGE, C. MONNIER, and G. DEVAUCHELLE, Laboratoire de Microbiologie, Centre de
Recherches de Biochimie et Physiologic Cellulaires, Mont-Saint-Aignan, France: Effects of reconstituted
vesicles from Chi lo iridescent virus on invertebrate cell cultures.
Session 5: Biology
Chairperson: S. DALES, University of Western Ontario, London, Canada
V. ZASLAVSKY* and P. H. HOFSCHNEIDER,f *Kimron Veterinary Institute, Bet Dagan, Israel; 1-Max-Planck-
Institute of Biochemistry, Martinsried, Federal Republic of Germany: Uncoating of vaccinia virus by cells
in an inhibited state.
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M. SILVER and S. DALES, University of Western Ontario, London, Canada: Biogenesis of vaccinia-Carbohy-
drate of the hemagglutin molecule.
H. SHIDA and S. DALES, Department of Microbiology and Immunology, University of Western Ontario, London,
Canada: Biogenesis of vaccinia-Carbohydrate of the hemagglutinin molecule.
L. G. PAYNE, Department of Virology, Karolinska Institute School of Medicine, Stockholm, Sweden: The effect
of glycosylation inhibitors on the release of enveloped vaccinia virus.
J. BYRNE and J. A. HOLOWCZAK, Rutgers Medical School, Piscataway, New Jersey: Immune response in DBA/2
mice challenged with vaccinia virus- Immunotherapy of murine melanoma tumors.
A. COLE,* G. 0. POINAR,t R. HEssit and T. J. MORRIS,* *Department of Plant Pathology and tDepartment of
Entomology, University of California, Berkeley: A new iridovirus of two species of terrestrial isopods also




The third year of the Banbury Center program on
the environmental health risks that are an urgent
concern of biological science and public policy
was a period of both fulfillment and difficulty.
The sense of fulfillment came from several
sources. Reports continued to emerge from
meetings that participants found both focused and
stimulating. There was continued praise from
participants for the facilities at Banbury and the
arrangements made by many people, most notably
by Beatrice To liver, the Banbury administrative
assistant, and by Katya Davey, our hostess and cook
in Robertson House. Further meetings were held
in 1980 on topics likely to produce reports of even
wider interest than those published previously.
Response was excellent to an appeal for confer-
ence ideas made to leaders in research on
environmental health risks. Small meetings at
Banbury on rapidly developing fields of funda-
mental biology continued to proliferate. Planning
for meetings in 1981 and 1982, several involving
collaboration with other institutions including
government agencies, pushed forward.
The difficulty came because early expectations
of funding the Banbury program entirely from
sources outside the Laboratory were not met.
About 30 percent of the program's cost so far has
come from appropriations of Laboratory funds by
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a Board of Trustees that vigorously endorses the
public service goals of the Banbury program but
insists, along with the Laboratory and Banbury
administrations, that the deficits must be removed
promptly through vigorous fund raising for both
short-term and long-term needs.
Environmental Health Risks
The three years since the start of the Banbury
program have been a time of intensifying concern
about the possibility that agricultural and industrial
chemicals, or factors in the diet, or such pleasur-
able habits as smoking-things that other people
do to us or that we do to ourselves-may
contribute to variations in cancer rates between
different localities or over time. In the same
period, scientific studies of the linkages between
the environment and cancer have intensified, in
the hope of better understanding of how cancers
may be prevented.
But as the studies continue, the goal of cancer
prevention is clouded by complications. Writing
in Nature in January 1981, John Cairns, former
Director of Cold Spring Harbor Laboratory, poin-
ted out that few types of cancer fit a simple model
of causation by damage to the genetic material it
the nuclei of cells, as would be caused b
Victor McElheny, Banbury Center Director
mutagenic chemicals in the workplace or the
general environment. Cairns, now at the Harvard
School of Public Health and one of Banbury
Center's scientific advisors, noted that more
complex models, involving several stages, drastic
rearrangements of chromosomes, the action of
the body's metabolism and the action of so-called
promoters, are thrusting themselves forward. The
new complexity is not discouraging. Instead, it
becomes clearer than ever that biology and
genetics at the molecular level-the subjects that
Cold Spring Harbor Laboratory works on-have a
multi-faceted relevance to the understanding of
the onset of cancer. Also clearer than ever is the
relevance of an environmental health-risk pro-
gram, focused on cancer prevention, at a funda-
mental biology laboratory.
Four New Books
Publication of the first two Banbury Reports in
1979, covering environmental mutagens and mam-
malian-cell mutagenesis tests, was followed in 1980
by Banbury Reports 3 through 6, covering low-tar
cigarettes, populations with low cancer rates,
ethylene dichloride, and the labeling of dangers.
The four books explore a wide range of issues:
whether cigarette-linked lung cancer, the largest
single environmental cancer cause, can be re-
duced; how we can improve our knowledge of
such risks as dietary factors by studying defined
populations with low cancer rates; how to resolve
conflicts between two different cancer tests of the
same substance; and whether labeling by itself can
be heavily relied on for public health protection
strategies.
The production of the four books was made
smoother and faster by good relations with
authors, typesetters, and printers, achieved by
Lynda Moran and Judith Cuddihy, the Banbury
editors, and Kathleen Kennedy, the Banbury
editorial assistant. Conferences held in October
and November of 1979 resulted in books pub-
lished in May, June, and August of 1980. The
conference on labeling in May 1980 produced a
book in December. Our book on cancer risks in
defined populations, appearing in June 1980,
came out five months earlier than the proceedings
of a conference involving many of the same
people-held one year before our conference.
The availability of a professional transcript of
each conference allowed us to increase the
interest of each book by including lively discussion
of the formal papers. Through strong sales,
including those to the National Cancer Institute,
the books came very close to meeting all publica-
tion expenses, including marketing and overhead.
Conferences
The first 1980 conference, in May, on environ-
mental health risks, represented a first foray into
the social-science aspects of this field. The confer-
ence concluded that labeling could not handle the
regulatory burden of public health protection
single-handedly. The conference on gastrointesti-
nal cancer in October focused new attention on
substances formed inside the body, rather than
those taken in, that may be important in causing
cancer of the colon. The conference on hormones
and breast cancer, also in October, explored the
notion of a close linkage between total estrogen
exposure and the risk of contracting breast cancer.
The uses of the Banbury estate continued to
expand. At the beginning of March, James Hicks of
the yeast group at the Laboratory, organized a
workshop on the molecular biology of plants. In
May, two members of the Laboratory's Neurobi-
ology Advisory Committee organized a small
conference on the molluscan nerve cell. To edit
the book resulting from this conference, which
received a very favorable review in the journal
Katya Davey Judith Cuddihy, Lynda Moran, Beatrice Toliver
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Science, on May 15, 1981, Judith Cuddihy of our
staff temporarily shifted to the editorial group in
Nichols. In November, Ron McKay of the scientific
staff organized a workshop on monoclonal anti-
bodies against neural antigens, which is expected
to result in a book in 1981. In December, the
Banbury staff worked with Joe Sambrook in
organizing the conference on construction and
use of mammalian vectors, which was summarized
in the British journal, Nature, on March 5, 1981.
Planning continued for what has been un-
doubtedly the most difficult and controversial of
the Banbury risk assessment conferences so far.
This was the conference at the end of March 1981
on the quantification of occupational cancer.
Elaborate consultations were held up to the last
minute with all sides of the complex arguments
about the true size of the cancer risk in the
workplace, to assure that major viewpoints were
represented. The 55 participants heard estimates
of cancer attributable to occupation that were
smaller than the most alarmist figures, but larger
than those put forward by opponents of govern-
ment regulation of workplace conditions.
In 1980, planning began for many meetings in
1981-82, including the conferences on gene
amplification and aberrant chromosomal struc-
tures, scheduled for October, patenting of life
forms, also scheduled for October, and environ-
mental risks for developing organisms (including
children), scheduled for Novemeber.
Funds were requested for conferences in Feb-
ruary and March 1982 on the possible role of
nitrosamines in human cancer and new tech-
niques of chemical dosimetry.
Courses
Occupying Banbury facilities almost continuously
from the end of the spring conference season in
early June to the beginning of the late-summer
conference season in mid-August was a series of
courses. The first of these, on the Neurobiology of
Behavior, was taught by Eric Kandel and John
Koester of the Columbia University College of
Physicians and Surgeons and Keir Pearson of the
University of Alberta. The second, called The
Synapse: Cellular and Molecular Neurobiology,
was taught by Rami Rahamimoff of the Hebrew
University Medical School in Jerusalem, Jack
McMahon of Stanford University, Bernard Katz of
University College, London, Charles Stevens of
Yale University and Doju Yoshikami of the Uni-
versity of Utah. The third course, on Principles of
Neural Development, was taught by Dale Purves
of Washington University in St. Louis and P. H.
Patterson of Harvard Medical School. After these
courses, Arnold J. Levine of the State University of
New York organized, along with D. P. Lane of
Imperial College, London, a former member of
the Laboratory scientific staff, a workshop on
Tumor and Development Antigens. Details on
attendance and programs are printed in the
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section on post-graduate training programs. Both
Dr. Stevens and Dr. Levine are scientific trustees of
Cold Spring Harbor Laboratory.
Support
Through the year, plans were made for the first of
our workshops for journalists under the $100,000
grant from the Alfred P. Sloan Foundation (noted
in the report for 1979). This workshop, for the
editorial staff of Newsday, was held in January
1981, and concerned issues of ground water
pollution, the disposal of chemical wastes, and the
influence of diet on cancer rates. The success of
that workshop triggered planning for several more
during 1981, including a highly successful work-
shop on DNA held for leading editorial managers
and writers of Time Inc. magazines on May 3 and 4,
1981.
Our fund raising in 1980 was greatly assisted by
the purchase of many books from four Banbury
conferences by the National Cancer Institute, for
wide distribution to institute grantees. Approaches
to each United States government agency with a
mission in the field of environmental health risks,
aimed at joint sponsorship of conferences, bore
fruit in the scheduling of two conferences in 1981.
Gratifying support was received from the Exxon
Education Foundation, the International Life Sci-
ences Institute, and the Environmental Protection
Agency for the labeling conference, and from
Hoffmann-LaRoche, Inc. and Merck Sharp and
Dohme Laboratories for the conference on gastro-
intestinal cancer. The conference on mammalian
vectors drew contributions from nearly a dozen
companies, including Abbott Laboratories, Cetus
Corporation, Collaborative Genetics Inc., E.I.
duPont de Nemours & Co., Genex Corporation,
Genentech Inc., Lilly Research Laboratories, Mo-
lecular Genetics Inc., Monsanto Company, and
New England BioLabs. Very welcome sustaining
support was received from New York Life Insur-
ance Company and the Bristol-Myers Foundation.
Product Labeling and Health Risks, May 21-May 23
Because of increasing public discussion of the use of labeling as a substitute for banning products which
might be hazardous to at least some people, Louis A. Morris of the Food and Drug Administration,
Michael B. Mazis of the American University and Ivan Barofsky of the Johns Hopkins Medical Institutions
were asked to organize a conference on the efficacy of labeling as the major reliance in schemes of
warning. This sixth of the Banbury conferences on the assessment of environmental health risks brought
a large number of behavioral scientists together with representatives of consumer-protection groups,
regulatory agencies, industry and the legal profession. The conclusion of the conference was that it
would be a mistake to rely wholly on labeling and voluntary action to handle a clearly identified risk.
Session 1: Labeling Case Studies
M. MAZIS, The American University, Washington, DC: Introduction, classification, integration.
D. MURPHY, Federal Trade Commission, Washington, DC: Cigarette warning labels.
L. MORRIS, Food and Drug Administration, Rockville, Maryland: Estrogenic drugs-PPls.
A. REICH, Occupational Safety and Health Administration, Washington, DC: Carcinogens at the work place.
R. STAELIN, Carnegie-Mellon University, Pittsburgh, Pennsylvania: Food, product safety, and performance labeling.
R. C. STOKES, Food and Drug Administration, Washington, DC: FDA's food labeling research program.
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Session 2: Labeling as a Communications Device
W. McGUIRE, Yale University, New Haven, Connecticut: Communications model.
J. C. OLSON, Pennsylvania State University, University Park: Attention/memory factors.
P. LEY, Plymouth Polytechnic, Devon, England: Practical methods of improving communication.
D. KANOUSE, Rand Corporation, Santa Monica, California: Critical aspects of communication.
P. Siovic, Decision Research, Eugene, Oregon: Convening risk information.
Session 3: Roundtable-Labeling Alcohol Bottles with Pregnancy Warnings
Chairperson: P. WHITE, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland
H. BRESLAWEC, Food and Drug Administration, Rockville, Maryland
M. DRESSIER, Bureau of Alcohol, Tobacco and Firearms, Washington, DC
S. FABRO, George Washington University Medical Center, Washington, DC
P. GAVAGHAN, Distilled Spirits Council of the United States, Inc. (DISCUS), Washington, DC
Session 4: Labeling as a Social Policy
W. SCHULTZ, Public Citizens Litigation, Washington, DC: Labeling, consumer needs, consumer rights.
J. WALDEN, The Proprietary Association, Washington, DC: From the producers' perspective.
H. BEALES, Federal Trade Commission, Washington, DC: Cost/benefit; economic perspectives.
I. BAROFSKY, Johns Hopkins Medical Institutions, Baltimore, Maryland: Psychosocial consequences.
P. RHEINSTEIN, Food and Drug Administration, Rockville, Maryland: Labeling and the health environment.
R. COOPER, Williams & Connolly, Washington, DC: Labeling as a regulatory alternative.
Carcinogen and Mutagen Formation in theGastrointestinal Tract, October 12-October 15
New interest in the relationship between diet and gastrointestinal cancer has been stirred by the
discovery of a mutagenic factor in human feces, possibly a bacterial product, and by the discovery that
mutagenic substances such as nitrosamines can be formed in the gastrointestinal tract. To summarize
current knowledge and to focus additional attention on the role that endogenous factors may play in
gastrointestinal cancer, W. Robert Bruce of the Ludwig Institute (then of the Ontario Cancer Institute),
Pelayo Correa of the Louisiana State University Medical Center, Martin Lipkin of the Memorial Sloan-
Kettering Cancer Center, Steven R. Tannenbaum of the Massachusetts Institute of Technology, and
Tracy Wilkins of the Virginia Polytechnic Institute, organized a conference of some 40 specialists to
consider such topics as the chemical structure of the mutagen found in feces, and epidemiological
studies indicating that, in Japan, daily meat consumption reduces the risk of colon and rectal cancer
while increasing the risk of pancreatic cancer, and that daily intake of yellow and green vegetables,
containing vitamin A, is protective against several types of cancer. The book reporting on this conference
was published in April 1981, exactly six months after the meeting.
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Session 1: Gastrointestinal Microbiology
Chairperson: T. D. WILKINS, Virginia Polytechnic Institute and State University, Blacksburg
T. D. WILKINS, Virginia Polytechnic Institute and State University, Blacksburg: Microbiological considerations in
interpretation of data obtained with experimental animals.
W. E. C. MOORE, Virginia Polytechnic Institute and State University, Blacksburg: The effect of diet on the human
intestinal flora.
P. GOLDMAN, Harvard Medical School, Boston, Massachusetts: Metabolism of xenobiotics by the gastrointestinal
flora.
B. GOLDIN, Tufts University School of Medicine, Boston, Massachusetts: Factors that affect intestinal bacterial
activity-Implications for colon carcinogenesis.
Session 2: Fiber
Chairperson: P. J. VAN SOEST, Cornell University, Ithaca, New York
P. J. VAN SOEST, Cornell University, Ithaca, New York: Some factors influencing the ecology of gut fermentation
in man.
J. H. CUMMINGS, MRC Dunn Clinical Nutrition Centre, Cambridge, England: Implications of dietary fiber
breakdown in the human colon.
N. D. NIGRO, Wayne State University School of Medicine, Detroit, Michigan: Fat, fiber, and other modifiers of
intestinal carcinogenesis-A strategy for prevention.
Session 3: Host Response to Carcinogens
Chairperson: M. LIPKIN, Memorial Sloan-Kettering Cancer Center, New York, New York
M. LIPKIN, Memorial Sloan-Kettering Cancer Center, New York, New York: Susceptibility of high-risk populations.
P. CORREA, Louisiana State University Medical Center, New Orleans: Mutagenesis and adenomatous polyps of the
colon.
M. E. BALIS, Sloan-Kettering Institute for Cancer Research, New York, New York: Enzymes in gastrointestinal cells
in cancer.
H. W. STROBEL, University of Texas Health Science Center, Medical School, Houston: Role of cytochrome P-450 in
the response of the colon to xenobiotics.
L. W. WATTENBERG, University of Minnesota Medical School, Minneapolis: Inhibitors of gastrointestinal neoplasia.
G. N. WOGAN, Massachusetts Institute of Technology, Cambridge, and others: Discussion.
Session 4: Mutagens
Chairperson: W. R. BRUCE, Ontario Cancer Institute, Toronto, Canada
G. M. STEMMERMANN, Japan-Hawaii Cancer Study, Honolulu, Hawaii: Mutagens in extracts of gastrointestinal
mucosa.
T. D. WILKINS, Virginia Polytechnic Institute and State University, Blacksburg: Isolation of a mutagen produced in
the human colon by microbial action.
D. G. I. KINGSTON, Virginia Polytechnic Institute and State University, Blacksburg: Structural studies on a mutagenic
bacterial product from human feces.
W. R. BRUCE, Ontario Cancer Institute, Toronto, Canada: Studies of a mutagen from human feces.
S. VErarr, Institute of Cancer Research, Chalfont St. Giles, Buckinghamshire, England: Detection of mutagens
in feces.
H. F. STICH, British Columbia Cancer Research Centre, Vancouver, Canada: Intake formation and release of
mutagens by man.
Session 5: N-nitroso Compounds
Chairperson: S. R. TANNENBAUM, Massachusetts Institute of Technology, Cambridge
S. R. TANNENBAUM, Massachusetts Institute of Technology, Cambridge: Metabolism of nitrates.
S. R. TANNENBAUM, Massachusetts Institute of Technology, Cambridge: Endogenous formation of N-nitroso
compounds.
G. EISENBRAND, Deutsches Krebsforschungszentrum, Heidelberg, Federal Republic of Germany: Assessment of
exposure.
H. NEWMARK and W. J. MERGENS, Hoffmann-La Roche Inc., Nutley, New Jersey: Blocking nitrosamine formation
using ascorbic acid and alpha-tocopherol.
E. BALISH, University of Wisconsin Medical School, Madison: Distribution of metabolism of nitrate and nitrite in
rodents.
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M. C. ARCHER, Ontario Cancer Institute, Toronto, Canada: Nitrate, nitrite, and N-nitroso compounds in the human
intestine.
D. H. FINE, New England Institute of Life Sciences, Waltham, Massachusetts; L. K. KEEFER, National Cancer Institute,
Bethesda, Maryland; P. N. Magee, Temple University School of Medicine, Philadephia, Pennsylvania:
Discussion.
Session 6: Bile Acids and Other Lipids
Chairperson: B. S. REDDY, American Health Foundation, Valhalla, New York
B. S. REDDY, American Health Foundation, Valhalla, New York: Bile salts and other constituents of the colon as
tumor promoters.
M. J. HILL, Central Public Health Laboratory, London, England: Bile acids and colorectal cancer.
S. HECHT, Naylor Dana Institute for Disease Prevention, Valhalla, New York: Analysis of feces for benzo[a]pyrene
after consumption of charcoal-broiled meat.
Session 7: Epidemiology and Design of Future Studies
Chairperson: P. CORREA, Louisiana State University Medical Center, New Orleans
S. GRAHAM, State University of New York at Buffalo: Epidemiologic tests of hypotheses of diet and cancer.
H. F. MOWER, University of Hawaii, Manoa, Honolulu: Identification of mutagens found in gastric mucosa.
T. HIRAYAMA, National Cancer Center Research Institute, Tokyo, Japan: A cohort study of life-style variables
in gastrointestinal cancer in Japan.
W. HAENSZEL, University of Illinois, Chicago: The methodology for analysis of the relationship between mutagens
and gastrointestinal cancer.
Hormones and Breast Cancer, October 26-October 28
Breast cancer, which tragically accounted for 19% of the 183,000 female cancer deaths recorded in the
United States in 1978, presents some of the most tangled puzzles faced by the researchers attempting to
sort out the influences of genetic endowment and the environment in cancer causation. Still
unidentified environmental factors apparently influence the sharp differences in breast cancer rates
between Japan and the United States. Work by epidemiologists and experiments on rodents have
underlined the importance of total exposure to estrogens in influencing the risk of breast cancer. But the
organizers of the conference, Malcolm Pike of the University of Southern California, Pentti K. Siiteri of
the University of California at San Francisco, and Clifford Welsch of Michigan State University, felt there
was a strong need for a joint review of what is known about the etiology of breast cancer by
epidemiologists, endocrinologists, and animal experimenters. They and the other conference
participants surveyed the exogenous and endogenous factors affecting breast cancer incidence,
summarized the underlying mechanisms by which hormones and carcinogens induce and promote
tumor growth, and projected future directions for epidemiological and clinical research in the field.
Session 1: Review of Epidemiology of Breast Cancer
M. C. PIKE, University of Southern California Medical School, Los Angeles: Epidemiology of breast cancer as it
relates to menarche, pregnancy, and menopause.
F. DE WAARD, University of Utrecht, The Netherlands: Body size as a risk factor for breast cancer.
Session 2: Endocrinology of Women at Risk to Breast Cancer
I. B. BROWN, University of Melbourne, Victoria, Australia: Hormone profiles.in young women at risk.
R. VIHKO, University of Oulu, Finland: Endocrine maturation in the course of female puberty.
S. S. KORENMAN, University of California, Los Angeles School of Medicine, Sepulveda: Abnormal ovarian function
and breast cancer risk.
P. K. SIITERI, University of California, San Francisco: Estrogen production and transport following the menopause.
Session 3: Review of Studies Attempting to Establish Endogenous Hormones as Important in Human Breast Cancer
P. COLE, University of Alabama, Birmingham: Estrogens and progesterone.
B. E. HENDERSON, University of Southern California Medical School, Los Angeles: Prolactin.
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R. D. BUIBROOK, Imperial Cancer Research Fund Laboratories, London, England: Androgens and thyroid.
B. ZUMOFF, Montefiore Hospital and Medical Center, Bronx, New York:, Hormonal studies in women with breast
cancer.
Session 4: In Vitro Studies of Human Breast Tissue
M. E. LIPPMAN, National Cancer Institute, Bethesda, Maryland: Hormonal regulation of breast cancercells.
R. P. C. Si-nu, University of Manitoba Faculty of Medicine, Winnipeg, Canada: Prolactin regulation of breast
cancer cells.
R. OTTMAN, University of California, Berkeley, and P. K. Sin ERI, University of California, San Francisco: Analysis of
estrogen receptor assay data.
Session 5: Exogenous Hormones and Breast Cancer
J. L. KELSEY, Yale University School of Medicine, New Haven, Connecticut: Epidemiological studies of exogenous
estrogens.
A. SEGALOFF, Alton Ochsner Medical Foundation, New Orleans, Louisiana: Hormonal therapy of breast cancer.
Session 6: Other Exogenous Factors and Breast Cancer
N. L PETRAKIS, University of California Medical School, San Francisco: Epidemiological studies of mutagenicity of
breast fluids-Relevance to breast cancer risk.
P. HILL American Health Foundation, Valhalla, New York: Diet and hormone levels.
Session 7: Hormones and the Genesis and Progression of Murine Mammary Tumors
T. L. DAO, Roswell Park Memorial Institute, Buffalo, New York: Role of ovarian and adrenal steroids in mammary
carcinogenesis.
C. W. WELSCH, Michigan State University, East Lansing: Prolactin and growth hormone in murine mammary
tumorigenesis.
R. HILF, University of Rochester Medical Center, New York: Insulin.
C. J. SHELLABARGER, Brookhaven National Laboratory, Upton, New York: Pituitary and steroid hormones in
radiation-induced mammary tumors.
R. C. MOON, Illinois Institute of Technology Research Institute, Chicago: Pregnancy, lactation, and thyroid
hormones.
J. MEITES, Michigan State University, East Lansing: Relation of neuroleptic drugs to mammary tumorigenesis.
Y. N. SINHA, Scripps Clinic and Research Foundation, La Jolla, California: Plasma prolactin analysis as a potential
predictor of murine mammary tumorigenesis.
Session 8: Mechanism of Hormone Action
J. ROSEN, Baylor College of Medicine, Houston, Texas: Regulation of casein gene expression in hormone-
dependent mammary cancer.
D. A. SIRBASKU, University of Texas Medical School, Health Science Center, Houston: Mechanism of estrogen
action-Estrogen-induced growth factors.
S. NANDI, University of California, Berkeley: Role of hormones in carcinogenesis.
173
Construction and Use of Mammalian Vectors
December 10-December 13
Expression of foreign genes in mammalian cells was the focus of this early example of what are
expected to be many small conferences on molecular aspects of biology to be held at Banbury Center.
Organized with support from a dozen industrial companies by Joseph Sambrook, the Laboratory's
Assistant Director for Research, the conference heard reports from academic, industrial, and
government scientists on progress with complementary methods of introducing foreign genes into
cultured mammalian cells. These methods include 1) microinjection; 2) attachment of the genes to
segments of viral DNA; and 3) the simultaneous transformation of the cells with two separate pieces of
DNA, one carrying the gene of interest and the other carrying a genetic marker, such as the gene for
the enzyme thymidine kinase, which confers a selective advantage on cells receiving the foreign
genes. Successes were reported in obtaining constitutive expression of microinjected genes and in
obtaining expression through viral transmission of such foreign genes as human growth hormone,
hepatitis surface antigen and human genomic globin sequences. The conference heard that some
disadvantages with the most commonly employed virus vector, simian virus 40, such as a sometimes-
small proportion of an SV40 population carrying the foreign genes and limits on how much foreign
DNA can be packed into SV40 particles, are being overcome. New selective markers were discussed,
along with the possibility that cotransformed genes can continue to respond to hormones.
Session 1: Delivery Systems
Chairperson: W. C. SUMMERS, Radiobiology Laboratories, New Haven, Connecticut
W. C. SUMMERS, Radiobiology Laboratories, New Haven, Connecticut: Structure and expression of the HSV-TK
locus.
F. RUDDLE, Yale University, New Haven, Connecticut: Gene transfer in mammalian cells.
M. WIGLER, Cold Spring Harbor Laboratory, New York: The stable transformation of animal cells with biochemically
selectable vectors.
G. MILMAN, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland: Efficient DNA
transfection and rapid detection of DNA expression.
M. L. PEARSON, Frederick Cancer Research Center, Maryland: Clonal analysis of the efficiency of tk and oua DNA-
mediated gene transfer in mouse L cell recipients.
M. CAPECCHI, University of Utah, Salt Lake City: The expression and stable integration of EDN injected into nuclei of
cultured mammalian cells.
C. Lo, University of Pennsylvania, Philadelphia: lontophoretic injection and integration of DNA into mouse L cells.
W. F. ANDERSON, National Heart, Lung, & Blood Institute, Bethesda, Maryland: Fate of eukaryotic genes
microinjected into mouse L cells.
Session 2: Papovaviruses as Vectors
(i) Replication/Integration/Excision
Chairperson: C. BASILICO, New York University Medical Center, New York
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C. BASILICO, New York University Medical Center, New York, New York: Requirements for integration, excision,
and amplification of polyoma virus genomes.
Y. GLUZMAN, Cold Spring Harbor Laboratory, New York: An SV40 host-vector system for carrying pure population
of recombinant viruses.
M. BOTCHAN, University of California, Berkeley: The stable transformation of animal cells with biochemically
selectable vectors.
W. JELINEK, Rockefeller University, New York, New York: Interspersed repetitious sequences in mammalian DNA.
J. T. ELDER, Yale University School of Medicine, New Haven, Connecticut: Structural and transcriptional analysis of
interspersed repetitive polymerase III transcription units in human DNA.
J. HASSELL, McGill University, Montreal, Canada: The organization, expression, and recovery of transfected genes-
The polyoma transforming gene as a model.
M. FRIED, Imperial Cancer Research Fund Laboratories, Landon, England: Polyoma virus expression.
C. ROGERS, Oregon State University, Corvallis: The cons' uction of recombinant DNA molecules containing the
yeast leucine gene for use as eukaryotic vectors.
R. BREATHNACH, Faculte de Medecine, Strasbourg, France: SV40 and polyoma based vectors.
A. WEISSBACH, Roche Institute of Molecular Biology, Nutley, New Jersey: The construction of recombinant DNA
molecules containing the yeast leucine gene for use as eukaryotic vectors.
(ii) Expression of Cloned Genes
Chairperson: T. SHENK, State University of New York, Stony Brook
P. GRUSS and G. Khoury, National Cancer Institute, Bethesda, Maryland: Expression of preproinsulin genes carried
in SV40.
P. T. LOMEDICO, Hoffmann-La Roche Inc., Nutley, New Jersey: Programming mammalian cells to synthesize insulin.
P. J. SOUTHERN, Stanford University Medical Center, California: SV40 vector systems.
S. SUBRAMANI, Stanford University Medical Center, California: Expression of the mouse dihydrofolate reductase
cDNA in SV40-based vectors.
P. MELLON, California Institute of Technology, Pasadena: Two assays correlating available structural and genetic
information with in vivo expression of globin genes.
G. PAVLAKIS, National Cancer Institute, Bethesda, Maryland: Expression of eukaryotic genes cloned in SV40 vectors.
Session 3: Adenoviruses
Chairperson: T. GRODZICKER, Cold Spring Harbor Laboratory, New York
D. SOLNICK, Cold Spring Harbor Laboratory, New York: Adenovirus recombinants containing an ectopic copy of
the major late promoter which directs the expression of downstream genes.
C. S. THUMMEL, University of California, Berkeley: An adenovirus vector system for the expression of foreign
eukaryotic proteins.
M. ROSSINI, Cold Spring Harbor Laboratory, New York: A study of expression and regulation of the adenovirus
genome using microinjection of mammalian cells.
Session 4: Retroviruses
Chairperson: G. VANDE WOUDE, National Cancer Institute, Bethesda, Maryland
J. SORGE and S. HUGHES, Cold Spring Harbor Laboratory, New York: Uses of an avian sarcoma virus vector.
W. McCumEnrs, National Cancer Institute, Bethesda, Maryland: Long terminal repeat (LTR) of Moloney sarcoma
virus.
I. M. VERMA, Salk Institute, San Diego, California: Retroviral DNAs as eukaryotic cloning vectors.
Session 5: Specialized Systems
Chairperson: G. KHOURY, National Cancer Institute, Bethesda, Maryland
M. J. CLINE, University of California School of Medicine, Los Angeles: Use of a mutant dihydrofolate reductase gene
to transform bone marrow cells of intact mice.
M. J. GETHING, Imperial Cancer Research Fund Laboratories, London, England: Expression of influenza virus
hemagglutinin in eukaryotic cells.
A. PELLICER, Columbia University College of Physicians & Surgeons, New York, New York: Control of expression of
transforming genes.
D. T. KURTZ, Cold Spring Harbor Laboratory, New York: Hormonal control of the expression of the rat Hi,
globin genes.
P. HOWLEY, National Institutes of Health, Bethesda, Maryland: Bovine papilloma virus DNA-A novel eukaryotic
cloning vector.
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Marie H. Robertson Fund for Neurobiology
Crucial support for Cold Spring Harbor Laboratory's program of conferences, courses and year-round
research in the neurosciences is provided by the Marie H. Robertson Fund for Neurobiology. This fund,
established in 1976 through the Banbury Foundation by the family of Mr. Charles S. Robertson, honors
the memory of Mr. Robertson's wife, who died in 1972. At first the fund, which provides $75,000 annually,
was used largely to support the summer teaching program in neurobiology, which includes laboratory
courses given on the main Laboratory grounds in the village of Laurel Hollow and lecture courses given
at Banbury Center in the village of Lloyd Harbor. But in 1979, after receipt of a substantial training grant
from the National Institutes of Health, and added support from the National Science Foundation, it was
decided to use some of the Marie H. Robertson funds to support specific summer workshops and to
make possible one or two specialized meetings each year at Banbury Center. The first two of these Marie
H. Robertson meetings were held in 1980. The programs are listed below.
Lessons from the Study of Molluscan Nerve Cells
May 18-May 20
To stimulate interaction between investigators of membrane biophysics and of neural control of
behavior, Eric Kandel of the College of Physicians and Surgeons of Columbia University and Charles
Stevens of the Yale University School of Medicine, both members of the Neurobiology Advisory
Committee of Cold Spring Harbor Laboratory, organized a three-day conference of 20 specialists and
five graduate-student rapporteurs who summarized the presentations and discussion for what became, a
few months later, the first of the Cold Spring Harbor Reports in the Neurosciences. The meeting was
designed to summarize what now appears to be a revolution in knowledge that allows neuroscience
researchers "to relate the biophysical properties of individual neurons to the features of the behavior
that they mediate," as John Koester of Columbia Physicians and Surgeons and John H. Byrne of the
University of Pittsburgh School of Medicine, the editors of the conference report, wrote in their
introduction.
Arranged by
Charles F. Stevens, Yale University, New Haven, Connecticut
Eric R. Kandel, Columbia University, College of Physicians & Surgeons, New York, New York
27 participants
Session 1
Chairperson: C. F. STEVENS, Yale University, New Haven, Connecticut
C. F. STEVENS, Dept. of Physiology, Yale University, New Haven, Connecticut: Introduction.
R. C. THOMAS, Dept. of Physiology, Yale University School of Medicine, New Haven, Connecticut: Ion pumps
in nerve cells.
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5, THOMPSON, Dept. of Biology, and Hopkins Marine Station, Stanford University, California: The delayed K+
channel and its inactivation.
J. CONNOR, Dept. of Physiology and Biophysics, University of Illinois, Urbana: The fast K+ channel and
repetitive firing.
Session 2
Chairperson: S. HAGIWARA, University of California School of Medicine, Los Angeles
R. W. MEECH, Dept. of Physiology, University of Utah Medical School, Salt Lake City: The calcium-dependent
K+ channel.
H. D. Lux, Max-Planck-Institut fur Psychiatrie, Munich, Federal Republic of Germany: The calcium-dependent
K+ channel.
Session 3
Chairperson: A. M. BROWN, University of Texas Medical Branch, Galveston
S. HAGIWARA, Dept. of Physiology, University of California School of Medicine, Los Angeles: The calcium
channel-Introduction.
D. TILLOTSON, Dept. of Physiology, Boston University Medical School, Massachusetts: Inactivation of the
calcium channel.
Session 4
Chairperson: F. J. BRINLEY, NINCDS, National Institutes of Health, Bethesda, Maryland
A. M. BROWN, Dept. of Physiology, University of Texas Medical Branch, Galveston: Noise analysis.
F. J. BRINLEY, Neurological Disorders Program, NINCDS, National Institutes of Health, Bethesda, Maryland:
Transmembrane flux and buffering of Ca++-Axon.
S. SMITH, Dept. of Physiology and Anatomy, University of California, Berkeley: Transmembrane flux and
buffering of Ca++-Cell body.
T. G. SMITH, JR., National Institutes of Health, Bethesda, Maryland: Ionic channels in burst-generating cells.
Session 5
Chairperson: R. LLINAS, New York University, New York
W. A. WILSON, Epilepsy Center, Veterans Administration Hospital, Durham, North Carolina: Synaptic transmis-
sion-Postsynaptic channels: Voltage sensitivity.
A MARTY, Laboratoire de Neurobiologie, Ecole Norma le Superieure, Paris, France: Synaptic transmission-
Postsynaptic channels: Noise analysis.
R, LLINAS, Dept. of Physiology, New York University, New York: Synaptic transmission-Presynaptic channels:
Ca++ channels and transmitter release.
Session 6
Chairperson: E. R. KANDEL, Columbia University College of Physicians & Surgeons, New York, New York
E. SHAPIRO, Division of Neurobiology and Behavior, Columbia University College of Physicians & Surgeons,
New York, New York: Modulation of presynaptic calcium channels.
M. KLEIN, Division of Neurobiology and Behavior, Columbia University College of Physicians & Surgeons,
New York, New York: Biophysics of behavior-Molecular mechanisms of habituation and sensitization.
J. KOESTER, Division of Neurobiology and Behavior, Columbia University College of Physicians & Surgeons,
New York, New York: Biophysics of behavior-Control of inking in Aplysia 1.
J. BYRNE, Dept. of Medicine, University of Pittsburgh School of Medicine, Pennsylvania: Biophysics of behav-
ior-Control of inking in Aplysia II.
R. LLINAS, Dept. of Physiology, New York University, New York: Applicability of channel analyses in molluscs
to vertebrate central neurons.
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Usage of Monoclonal Antibodies in Neurobiology
November 5-November 8
Our ability to generate specific immunoglobulin and nucleic acid probes allows quite new questions tobe answered in many complex biological systems. The nervous system is particularly open to study with
these new molecular tools. This meeting was the first gathering of scientists studying the nervous system
with monoclonal antibodies. We heard antibodies described which distinguish central and peripheral
neurons, subtypes of neurons in the neural crest, antigenic gradients in the retina, many tens of neuronal
types in the leech, the synaptic sites at the neuromuscular junction, neurotransmitters and their
enzymes.
Arranged by
Ron McKay, Cold Spring Harbor Laboratory, New York
Martin Raff, University College London, England
Louis F. Reichardt, University of California, San Francisco
39 participants
Session 1
M. RAFF, University College London, England: Introduction.
Session 2: Defining Cell Types and Cell Lines
Chairperson: H. KARTEN, State University of New York, Stony Brook
M. SCHACHNER, Dept. of Neurobiology, University of Heidelburg, Federal Republic of Germany: Monoclonal
antibodies recognizing subpopulations of glial cells in mouse cerebellum.
K. FIELDS, Dept. of Neurology, Albert Einstein College of Medicine, Bronx, New York: Indication for theuse of
monoclonal antibodies against brain filament proteins.
Y. BERWALD-NETEER,' F. COURAUD,2 and A. KOULAKOFF,2 'College of France, Paris; 'Faculty of Medicine, Marseille,
France: Specific surface membrane markers as probes for neuronal evolution in vivo and in vitro.
W. STALLCUP, J. LEVINE, and W. RASCHKE, Salk Institute, San Diego, California: Monoclonal antibody against the NG2
marker.
G. GiorrA, J. HEITZMANN, and M. COHEN, Developmental Biology Laboratory, Salk Institute, San Diego, California:
Monoclonal antibodies and the identification of cerebellar cell.
J. COHEN, R. MIRSKY, S. SELVENDREN, and T. VULLIAMY, Dept. of Zoology, University College London, England:
Monoclonal antibodies which define neuron-specific cell surface molecules in the mammalian central and
peripheral nervous system.
L. LAMPSON, Dept. of Anatomy, University of Pennsylvania, Philadelphia: Expression of the major histocompatibil-
ity antigens in the human nervous system.
Session 3: The Synapse
Chairperson: C. F. STEVENS, Yale University School of Medicine, New Haven, Connecticut
R. KELLY, Dept. of Biochemistry, University of California, San Francisco: Antibodies to cholinergic synaptic
vesicles.
W. MATTHEW, Dept. of Biochemistry, University of California, San Francisco: Monoclonal antibodies to synaptic
membranes and vesicles.
A. DE BLAS, N. Buses, and M. NIRENBERG, NHLBI, National Institutes of Health, Bethesda, Maryland: Monoclonal
antibodies to synaptic membrane molecules.
S. FUCHS, D. MOCHLV-ROSEN, M. SOUROUJON, and Z. ESHHAR, Dept. of Chemical Immunology, Weizmann Institute,
Rehovot, Israel: Monoclonal antibodies against the nicotinic acetylcholine receptor.
Session 4: The Retina
Chairperson: M. NIRENBERG, NHLBI, National Institutes of Health, Bethesda, Maryland
H. KARTEN and N. BRECHA, State University of New York, Stony Brook: Biochemical and morphological specificity of
retinal amacrine cells-Immunohistochemical findings.
G. EISENBARTH, K. SHIMIZU, M. CONN, B. MITTLER, and S. WELLS, Duke University Medical Center, Durham, North
Carolina: Monoclonal antibody F12A2B5-reaction with a plasma membrane antigen of vertebrate neurons and
peptide secreting endocrine cells.
C. BARNSTABLE, Dept. of Neurobiology, Harvard Medical School, Boston, Massachusetts: Developmental studies
of rat retina cells using cell-type specific monoclonal antibodies.
D. TRISLER, M. SCHNEIDER, and M. NIRENBERG, NHLBI, National Institutes of Health, Bethesda, Maryland: A gradient
of molecules in avian retina with dorsoventral polarity.
Session 5: Defined Antigens
Chairperson: L. F. REICHARDT, University of California, San Francisco
M. E. Ross, E. E. BAETGE, D. J. REIS, and T. H. JoH, Dept. of Neurobiology, Cornell University Medical College, New
York, New York: Monoclonal antibodies against catecholamine neurotransmitter synthesizing enzymes can
be used for immunochemistry and immunocytochemistry.
A. C. CUELLO' and C. MILSTEIN,' 'Dept. of Pharmacology and Human Anatomy, University of Oxford, England;
'Medical Research Council Molecular Biology Unit, Cambridge, England: Monoclonal antibodies against
neurotransmitter substances.
R. AKESON, J. S. RADMAN, K. GRAHAM, and A. ROBERTS, Children's Hospital Research Foundation, Cincinnati, Ohio:
Identification of a rat nervous system specific polypetide.
R. PRUSS,' R. MIRSKY,' M. C. RAFT,' R. THORPE,' and B. H. ANDERTON,' 'University College London, England; 'St.
George's Hospital Medical School, London, England: A monoclonal antibody recognizes a determinant
present on common as well as class-specific intermediate filament subunits.
G. E. LEMKE and J. P. BROCKES, Dept. of Biology, California Institute of Technology, Pasadena: An immunochemical
approach to the purification and characterization of glial growth factor.
E. YAviN,12 Z. YAVIN,' M. D. SCHNEIDER,3 and L. D. KOHN,' 'NIAMDD, National Institutes of Health, Bethesda,
Maryland; 'Dept. of Neurobiology, Weizmann Institute of Science, Rehovot, Israel; 'NHLBI, National
Institutes of Health, Bethesda, Maryland: Monoclonal antibodies to the thyrotropin receptor-Implications
for receptor structure and the action of autoantibodies in Graves' disease.
Session 6: The Neuromuscular Junction
Chairperson: M. RAFF, University College London, England
S. BURDEN, Dept. of Anatomy, Harvard Medical School, Boston, Massachusetts: Monoclonal antibodies directed
against the frog nerve-muscle synapse.
E. BAYNE, J. GARDNER, and D. M. FAMBROUGH, Dept. of Embryology, Carnegie Institution of Washington, Baltimore,
Maryland: Monoclonal antibodies against extracellular matrix antigens in chicken skeletal muscle.
D. Gorrum and J. GREVE, Department of Anatomy/Neurobiology, Washington University School of Medicine, St.
Louis, Missouri: Effects of monoclonal antibodies to the cell surface on cultured myogenic cells.
Session 7: Ganglia
Chairperson: E. JoNEs, Washington University School of Medicine, St. Louis, Missouri
G. CIMENT and J. WESTON, Dept. of Biology, University of Oregon, Eugene: Immunochemical studies of avian
peripheral neurogenesis.






The Postgraduate Training Program at Cold Spring Harbor Laboratory is aimed at meeting the special
need for training in interdisciplinary subjects which are either so new or so specialized that they are
not adequately treated by universities. Our aim is to provide intensive study in the most recent
developments and techniques in these subjects and to prepare students to enter directly into
research in a particular area. To ensure up-to-date coverage of current research work, we bring
together a workshop staff from many laboratories around the world and supplement this staff with a
series of seminar speakers.
Neurobiology of Behavior, June 6 -June 20
INSTRUCTORS
Kandel, Eric R., M.D., Columbia University, New York, New York
Pearson, Keir, Ph.D., University of Alberta, Edmonton, Canada
Koester, John, Ph.D., Columbia University, New York, New York
This course was designed to introduce students to cellular approaches to the study of behavior and
learning. The lectures provided an intensive coverage of four main areas: 1) general principles of
behavior and cellular neurobiology; 2) simple forms of behavior, learning, and motivation; 3)
initiation and maintenance of complex locomotor sequences, including voluntary movement and
motor learning; 4) communication. To illustrate general principles, suitable systems for study were
selected from both invertebrate and vertebrate behavior. To put the cellular work into perspective,
selected examples were also taken from human behavior and its abnormalities.
Jones Laboratory (right) as viewed from gazebo terrace
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PARTICIPANTS
Abrams, Thomas W., B.A., University of Alberta, Edmonton, Canada
Aletta, John, Columbia University Medical School, New York, New York
Bicker, Gerd, Ph.D., University of California, Santa Cruz
Evans, Randolph W., M.D., Baylor College of Medicine, Houston, Texas
Ganong, Alan H., B.S., University of California, Irvine
Gibson, Daniel J., B.S., Johns Hopkins University, Baltimore, Maryland
Haydon, Philip G., B.S., University of Leeds, England
Lupatkin, Joel F., B.A., Columbia University, New York, New York
MacDonald, Beth, B.A., University of Connecticut, Farmington
Mackey, Steve L., B.A., Columbia University, New York, New York
Masinovsky, Boris, M.S., University of Washington, Seattle
Murata, David N., B.S., University of Western Ontario, Canada
Murtaugh, Maryanne, M.S., Montefiore Hospital, Bronx, New York
Pardo, Francisco C., M.A., Johns Hopkins Hospital, Baltimore, Maryland
Randall, David C., Ph.D., University of Kentucky, Lexington
Tramo, Mark J., B.A., Cornell Medical College, Ithaca, New York
Wallen, Peter R., B.S., Karolinska Institute, Stockholm, Sweden
Warach, Steven J., B.S., Michigan State University, Ann Arbor
Zehring, William A., B.A., University of Chicago, Illinois
SEMINARS
Kandel, E.R., Columbia University. Introduction to the cellular study of behavior.
Koester, J., Columbia University. Introduction to biophysics of behavior.
. Repetitive firing properties and the control of behavior.
Kandel, E.R., Columbia University. Morphology and physiology of synaptic transmission.
. Learning. I. Habituation.
. Learning. II. Sensitization.
Wine, J., Stanford University. Nerve circuitry for simple behavioral acts and their control.
Lynch, G., University of California. Long-term plasticity in the vertebrate CNS.
Truman, J., University of Washington. Hormones and behavior. I.
Kupfermann, I., Columbia University. Hormones and behavior. II.
. Motivation.
Wurtz, R., National Institute of Mental Health. Attention.
Pearson, K., University of Alberta. Introduction to motor sequences.
. Central and reflex control of movements in motor systems.
Getting, P., Stanford University. Rhythm generation in invertebrate motor systems.
Kristan, W., University of California. Leech swimming.
Pearson, K., University of Alberta. Walking in the cat.
Ghez, C., Columbia University. Voluntary movements in mammals.
. Pyramidal and extra-pyramidal systems in motor control.
Thach, W.T., Jr., Washington University. Does the cerebellum learn motor programs?
Lisberger, S., National Institutes of Health. Adaptive regulation in the oculomotor system.
Mar ler, P., Rockefeller University. Introduction to communication.
. Communication in birds. I. Predispositions brought to the learning of a complex
motor task.
Sugo, N., Washington University. Communication in bats.
Arnold, A., University of California. Communication in birds. II. Brain pathways for vocal
learning.
Gazzaniga, M., Cornell University Medical Center. Lateralization of brain function.
Ross, E., Southwestern Medical School. Language and the brain.
Zigmond, R., Harvard Medical School. Neurotransmitters: Role in behavioral abnormalities.
Molecular Biology and Developmental Genetics of
Drosophila, June 8-June 28
INSTRUCTORS
Gelbart, William, Ph.D., Harvard University, Cambridge, Massachusetts
Pardue, Mary-Lou, Ph.D., Massachusetts Institute of Technology, Cambridge
ASSISTANT
Ribolini, Ann, Ph.D., Harvard University, Cambridge, Massachusetts
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Drosophila melanogaster is an especially favorable organism for use in studies of gene control inhigher animals. The course on The Molecular Biology and Developmental Genetics of Drosophila
consisted of laboratory work, lectures, and discussions on current problems and approaches to the
study of the molecular basis of developmental phenomena in this organism. Emphasis was placed onintegration of the classical genetic, cytogenetic, and developmental biological techniques with
microtechniques for molecular analysis. Topics covered included: chromosome mechanics,
chromosome structure, intragenic organization, gene-enzyme systems, neurogenetics, embryology
and early determinative events, pattern formation and regulation, regulation in specific gene
systems, genetics of mutable elements, and speciation in Drosophila. Students came from manyparts of the United States as well as Germany, France, Belgium, and England. Some of the students
were new to the field, having worked previously on bacteria or vertebrates. Other students werealready working on some aspect of Drosophila development.
PARTICIPANTS
Beckers, Christoph, Ph.D., Technische Hochschule, Darmstadt, Federal Republic of Germany
Dambly-Chaudiere, C.M., Ph.D., University of Brussels, Belgium
Dunn-Coleman, E. Janet, B.S., University of Virginia, Charlottesville
Hall, Nick A., B.S., University of Sussex, England
Ireland, Robert C., M.S., Dartmouth College, Hanover, New Hampshire
Kale, Purushottam, Ph.D., Brookhaven National Laboratory, Upton, New YorkMartin, Diana W., Ph.D., Rutgers University, New Brunswick, New JerseyPardo, Daniel, Ph.D., CNRS, Marseille, France
Spencer, Forrest A., B.A., Harvard University, Cambridge, Massachusetts
Vitek, Michael P., B.A., Dartmouth College, Hanover, New Hampshire
Wu, Ting, B.A., Sidney Farber Cancer Center, Harvard Medical School, Cambridge, MassachusettsYannoni, Claudine Z., B.A., Boston College, Massachusetts
SEMINARS
Spradling, A., Carnegie Institution of Washington. Gene amplification in Drosophila.
Cline, T., Princeton University. Determination, gene regulation, and maternal effects in theDrosophila embryo.
. A specific maternal-zygotic glue interaction controlling sex determination and X
chromosome dosage compensation in Drosophila.
. Micromanipulation of Drosophila embryos.
Cherbas, P., Harvard University. Insect endrochronology.
. Hormonal control of chromosome puffing.
Ecdysteroid effects on cultured Drosophila cells.
Ashburner, M., Cambridge University. The fine structure of genes in Drosophila.
. Hybrid dysgenesis and related phenomena in Drosophila.
. Speciation in Drosophila.
Young, M., Rockefeller University. Organization of repeated DNA in Drosophila.
. Transposable elements in Drosophila.
Shearn, A., Johns Hopkins University. Mutational analysis of imaginal development inDrosophila.
. Indirect homeosis.
Hall, J., Brandeis University. Everything you ever wanted to know about behavioral genetics.Kankel, D., Yale University. Developmental neurobiology.
Garcia-Bellido, A., Universidad Autonomia de Madrid. Compartments and development.
. The bithorax locus.
. The scute-achete locus.
Nervous System of the Leech, June 9-June 29
INSTRUCTORS
Nicholls, John, Ph.D., Stanford Medical School, California
Muller, Kenneth J., Ph.D., Carnegie Institution of Washington, D.C.
Parnas, Itzhak, Ph.D., Hebrew University, Jerusalem, Israel
Zipser, Birgit, Ph.D., Cold Spring Harbor Laboratory, New York
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The aim of this workshop was to provide students with an intensive lab and seminarcourse that
would enable them to pursue independent work on the leech. To this end, we hoped to provide the
students with techniques for recording from leech cells, now considered straightforward and
relatively easy, that took much time and effort to be refined. With this knowledge, they might avoid
many of the trivial technical difficulties that bedevil anyone starting on the nervous system of the
leech or other animals.
The initial work was devoted mainly to recognizing the individual cells, learning how to record
from them with intracellular and extracellular electrodes, getting familiar with the equipment, and
performing dissections. The students then progressed to more difficult experiments, such as
recording synaptic potentials while changing the fluid bathing the preparation or injecting
individual cells with marker substances to study their geometry.
The final phase of the course consisted of devising and performing original experiments, some of
which proved to be of sufficient interest to be pursued in greater detail. For example, the nervous
systems of various hitherto unexplored leeches were studied. In addition, the properties of a new
fluorescent dye, Lucifer Yellow, were tested by intracellular injection into identified cells, and
individual cells were killed by injection of proteotype enzymes.
PARTICIPANTS
Cline, Hollis T., B.A., University of California, Berkeley
Cohen, Ilan, B.S., Hebrew University, Jerusalem
Flanagan, Thomas R.J., M.S., Wesleyan University, Middletown, Connecticut
Marshall, Cameron G., B.S., Brown University, Providence, Rhode Island
Peterson, Eric L., Ph.D., Unversity of Sussex, England
Simonneau, Marc, M.D., CNRS, Gif-sur-Yvette, France
Small, Rochelle, Ph.D., Columbia University, New York, New York
Wenning, Angela, Ph.D., University of Konstanz, Federal Republic of Germany
Young, Steven R., B.S., University of Virginia, Charlottesville
Zimering, Mark B., B.S., Albert Einstein College, New York, New York
SEMINARS
Nicholls, J., Stanford Medical School. Introduction to the leech.
. Sensory and motor cells.
accumulation.
. Regeneration, cultured ganglia, and individual cells.
Muller, K.J., Carnegie Institution of Washington. Circuitry and recording techniques.
. Structure of synapses.
. The S cell.
Weisblat, D., University of California, Berkeley. Biology of leeches.
. Leech development.
Parnas, I., Hebrew University. Killing single cells.
Blackshaw, S., Stanford Medical School. Sensory neurons and the structure of their nerve
endings.
Stent, G., University of California, Berkeley. Development.
. Generation of rhythmic behavior.
Kristan, W., University of California, San Diego. Swimming in the leech.
. Demonstration of leech swimming.
Calabrese, R., Harvard University. Control of heartbeat.
Zipser, B., Cold Spring Harbor Laboratory. Synaptic interactions between sex neurons.
. A leu-enkephalin neuron.
. Monoclonal antibodies binding to specific leech neurons.
The Mammalian Central Nervous System, June 9-July 2
INSTRUCTORS
Hubei, David, M.D., Harvard Medical School, Boston, Massachusetts
Kirkwood, Peter, Ph.D., Institute of Neurology, London, England
Malpeli, Joseph, Ph.D., University of Illinois, Chicago
Sherk, Helen, Ph.D., Harvard Medical School, Boston, Massachusetts
Rymer, William Z., M.D., Northwestern Medical School, Chicago, Illinois
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ASSISTANT
Edwards, Frank, Ph.D., Northwestern Medical School, Chicago, Illinois
This workshop offered laboratories and lectures on the mammalian central nervous system. It began
with four days of lectures by Peter Kirkwood and David Hubei on the spinal cord, motor control,
and the visual system. These were followed by a day of demonstrations of recording from cat spinal
motorneurons and muscle afferents and lateral geniculate neurons. The remaining 18 days were
devoted to four series of laboratory experiments on the cat CNS, with the eight participants working
in pairs, spending four to five days on each series. In all labs, participants learned the appropriate
surgical techniques, the preparation of microelectrodes, and histological procedures for recon-
structing microelectrode tracks. In one lab participants studied the reflex activity of motorneurons
in the spinal cord using both intracellular and extracellular recording techniques. Functional
properties of the associated motor units were identified and synaptic connections from various
cutaneous and muscle afferent systems were examined. In another lab, the participants recorded
extracellularly from SIII of the somatosensory cortex, the medial geniculate nucleus, and the inferior
colliculus. They observed single neuron responses to the appropriate stimuli and mapped their
topographic organization. The other two labs focused on extracellular recording from visual cortex(areas 17, 18, 19, and the Clare-Bishop area) and subcortical visual structures (the lateral geniculate
nucleus and the superior colliculus). The single-cell responses to visual stimuli, retinotopic
organization, and functional cytoarchitecture of these structures were examined. A digital computer
was used to generate poststimulus histograms. In the subcortical vision labs the participants studied
orthodromic and antidromic shock-evoked driving, making use of the impulse collision technique.
Retrograde transport of horseradish peroxidase was used in the somatosensory, auditory, and vision
experiments to study the connections between cortical and subcortical structures.
PARTICIPANTS
Baker, Curtis L., B.S., University of California, San Diego
Edgley, Stephen A., B.S., University of Bristol, England
Ho lets, Vicky R., B.S., University of Minnesota, Minneapolis
Jeffrey, Glen, B.S., University of Oxford, England
Luini, Alberto, M.D., Weizmann Institute, Rehovot, Israel
Marcotte, Ronald R., M.S., Memphis State University, Tennessee
Petrides, Michael, Ph.D., McGill University, Montreal, Quebec, Canada
Schmidt, Marie Luise, Ph.D., Union College, Schenectady, New York
SEMINARS
Sparks, D.L., University of Alabama. The role of the superior colliculus in control of eye
movements.
Suga, N., Washington University. Bat echo-location system.
McClintock Laboratory
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Gilbert, C., Harvard Medical School. Interval circuitry of visual cortex.
Burke, R.E., National Institutes of Health. Peripheral inputs to spinal motor neuron.
Kitai, S.T., Michigan State University. Physiology and morphology of cells in the basal ganglia.
Animal Cell Culture in Serum-Free Medium, June 14-June 28
INSTRUCTORS
Sato, Gordon, Ph.D., University of California, San Diego
Barnes, David, Ph.D., University of Pittsburgh, Pennsylvania
Recent investigations into the role of serum in cell culture medium have shown that the serum
requirement for many established cell lines can be replaced by specific mixtures of hormones and
purified serum factors. Participants learned techniques for serum-free growth of cell lines of general
interest, such as He La, and cell lines expressing differentiated functions, such as the GC rat pituitary
line, B104 rat neuroblastoma line, and MDCK dog kidney line. Participants also designed and carried
out experiments in the use of hormone-supplemented medium for the selection of specific cell
types in primary cultures of normal and neoplastic tissues. Laboratory exercises were supplemented
by lectures and discussions with invited speakers expert in various aspects of cell culture and
hormonal control of cell proliferation and differentiation. Special thanks go to Dr. Coon, Dr. Mather
and Dr. Reid for arranging laboratory exercises in specialized aspects of the use of serum-free,
hormone-supplemented media.
PARTICIPANTS
Chepko, Gloria J., Ph.D., National Eye Institute, Bethesda, Maryland
Clark, Edward P., Ph.D., Stanford University, California
Christensen, Britta, M.S., Fibiger Laboratory, Copenhagen, Denmark
Coughlin, Shaun R., M.S., Massachusetts Institute of Technology, Cambridge
Dautry, Francois, Ph.D., Cancer Institute, Villejuif, France
Gordon, Carin R., Ph.D., University of Pennsylvania, Philadelphia
Harris, Wendelyn A., B.A., Vanderbilt University, Nashville, Tennessee
Iliakis, Georg, Ph.D., GSF, Frankfurt, Federal Republic of Germany
Kumbaraci, Nuran M., Ph.D., Stevens Institute of Technology, Hoboken, New Jersey
Markert, Claus, Ph.D., Goethe Universitat, Frankfurt, Federal Republic of Germany
Plouet, Jean, M.D., INSERM, Paris, France
Price, J. Michael, Ph.D., University of Massachusetts, Boston
Ross, Peter M., Ph.D., Yale University, New Haven, Connecticut
Shimada, Kazunori, Ph.D., Kyushu University, Japan
Taketo, Teruko, Ph.D., Rockefeller University, New York, New York
Van Tieghem, Nicole, University of Brussels, Belgium
SEMINARS
Sirbasku, D., University of Texas Medical School. Estromedins.
Coon, H., National Cancer Institute. Thyroid and neurons in low serum culture.
Sherman, M., Roche Institute. Development of mouse embryos in culture.
Lane, M.D., Johns Hopkins Medical School. Differentiation of preadipocytes in culture.
McKeehan, W., W.A. Jones Cell Science Center. Control of cell proliferation by nutritional
factors.
Yamada, K., National Institutes of Health. Fibronectin.
Sato, G., University of California, San Diego. A unifying hypothesis for cell culture.
Lippman, M., National Institutes of Health. Breast tumor cells in serum-free medium.
Mather, J., Rockefeller University. Serum-free media for primary culture.
Varga, J., Yale University. Melanoma cells in culture.
Barnes, D., University of Pittsburgh. Methods for serum-free cell culture.
Reid, L, Albert Einstein College of Medicine. Cell-substratum interactions.
Larner, J., University of Virginia. Mechanism of insulin action.
Glass, J., Beth Israel Hospital. Transferrin.
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The Synapse: Cellular and Molecular Neurobiology
June 22-July 12
INSTRUCTORS
Rahamimoff, Rami, M.D., Hebrew University Medical School, Jerusalem, Israel
McMahan, U. Jack, Ph.D., Stanford University, California
Katz, Bernard, Ph.D., University College London, England
Stevens, Charles F., M.D., Ph.D., Yale University, New Haven, Connecticut
Yoshikami, Doju, Ph.D., University of Utah, Salt Lake City
This course was designed for graduate students and research workers interested in the structure and
function of synapses. It consisted of lectures; readings of papers; group discussions; presentations
of selected topics by participants; seminars by instructors, faculty, and participants; and
demonstrations. After the course ended, some of the participants stayed on for a workshop.
PARTICIPANTS
Angelides, Kimon J., Ph.D., McGill University, Montreal, Quebec, Canada
Anholt, Roger R.H., M.S., University of California, San Diego
Boyarsky, Gregory, B.A., University of Kentucky, Lexington
Braun, Jochen, M.S., University of California, Berkeley
Castellucci, Lise B., M.S., Columbia University, New York, New York
Chaillet, John R., B.A., Yale University, New Haven, Connecticut
Connor, Elizabeth A., B.S., University of Vermont, Burlington
Cooper, Carol L., B.S., Case Western Reserve University, Cleveland, Ohio
Farber, Ira C., M.S., Weizmann Institute, Rehovot, Israel
Fleshman, James W., B.S., University of Florida, Gainesville
Hoch, Daniel B., M.S., University of North Carolina, Chapel Hill
Kerr, Lynne M., B.A., University of Virginia, Charlottesville
Kolb, Hans Albert, Ph.D., University of Konstanz, Federal Republic of Germany
Kolton, Lihu, M.S., Hebrew University, Jerusalem
Kristbjarnarson, Helgi, M.D., Karolinska Institute, Stockholm, Sweden
Lewis, Richard S., B.S., California Institute of Technology, Pasadena
MacDonald, Beth, B.A., University of Connecticut, Farmington
Matsumoto, Mitsuhiko, B.S., Iwate Medical University, Japan
Nerbonne, Jeanne M., Ph.D., California Institute of Technology, Pasadena
Ranscht, Barbara E., Ph.D., Max-Planck-Institut, Tubingen, Federal Republic of Germany
Schehr, Robert S., B.A., Columbia University, New York, New York
Wallace, Jean M., B.S., University of Pennsylvania, Philadelphia
SEMINARS
Jack McMahan, Stanford University. Structure of peripheral synapses.
. Structure of central synapses.
. Localization of the acetylcholine receptor and cholinesterase.
Structure of the presynaptic nerve terminal and vesicle recycling.
.
Histochemical demonstration of AChE and ACLR at the neuromuscular junction of
the frog.
. The effects of denervation on nerve and muscle.
Reinnervation.
Rami Rahamimoff, Hebrew University. Principles of signaling in the nervous system.
The ionic basis of membrane potentials: The forces.
. Ionic fluxes through excitable membranes.
The resting membrane potential.
The action potential: Phenomenology.
. Cable properties and the conductance of the action potential.
. The ionic basis of the action potential: Currents and conductances.
The Hodgkin-Huxley model of the axonal membrane.
. The role of extracellular and intracellular calcium in the regulation of transmitter
release.
. Frequency modulation of transmitter release.
Doju Yoshikami, University of Utah. The excitatory postsynaptic potential.
. The ionic basis of the excitatory postsynaptic potential.
. The inhibitory postsynaptic potential.
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. Excitatory electric synapses.
. Inhibitory electrical synapses.
. Microphysiology of the neuromuscular junction.
John Nicholls, Stanford University. Properties and formation ofsynapses in the nervous system
of the leech.
Dan Goodenough, Harvard University. Properties of gap junctions.
. Structure of gap junctions.
. X-ray diffraction.
Bernard Katz, University College London. Quantal units of transmitter release.
. Calcium and the vesicular hypothesis of transmitter release.
. The molecular action of the transmitter at the motor endplate.
Charles Stevens, Yale University. Inferences about molecular mechanisms from studies offluctuations.
. Physical approaches to studying membrane channels.
Mechanisms of permeation and ion selectivity.
. Molecular basis for channel gating.
. Calculation of single channel conductance from noise measurements.
Dale Purves, Washington University. Quantitative aspects of synapse formation: Synapse
elimination.
. Qualitative aspects of synapse formation: Neural specificity.
Alexander Mauro, Rockefeller University. The action of black widow spider venom on thepresynaptic nerve terminal.
Y.N. Jan, University of California. Substance P sensory transmitter.
. Autonomic ganglia as a model system for study of peptide action.
Edward Herbert, University of Oregon. Neuropeptides.
Birgit Zipser, Cold Spring Harbor Laboratory. Analysis of a synaptic connection in the mating
network in the leech.
Douglas Fambrough, Carnegie Institution. Structure of ACh receptors in membranes and
in isolation.
. ACh receptor metabolism and its regulation.
. Structure and properties of acetylcholine cholinesterase.
Ira Black, Cornell University Medical College. The catecholamine synapses.
. The development of the catecholamine synapses. I & II.
. Pathophysiology of the catecholamine system.
G. Albrecht-Buehler, Cold Spring Harbor Laboratory. Control of tissue cell movement.
Advanced Bacterial Genetics, June 30-July 20
INSTRUCTORS
Roth, John R., Ph.D., University of Utah, Salt Lake City
Davis, Ronald W., Ph.D., Stanford University School of Medicine, California
Botstein, David, Ph.D., Massachusetts Institute of Technology, Cambridge
ASSISTANTS
Schmid, Molly, B.S., University of Utah, Salt Lake City
Carlson, John, A.B., Stanford University School of Medicine, California
Riggs, Paul D., B.A., Massachusetts Institute of Technology, Cambridge
Starting with a random pool of X phages carrying cloned inserts of Salmonella DNA, students
identified phages carrying portions of the histone operon. These phages were identified by lytic
selection, lysogenic selection, and plaque hybridization. Phages were characterized by restriction
analysis, complementation tests, and electron microscopy.
A series of deletion mutants of the his operon were mapped genetically by transductional crosses.
The physical size of each of these same deletions was then determined by rfsh (restriction fragment
spectrum hybridization). By this procedure it was also possible to map the position of restriction sites
genetically.
Students performed a variety of genetic manipulations involving use of the Tn10 insertion
element. Auxotrophs were made by Tn10 insertion, and Tn10 insertions were selected near
particular genes. Tn10 was used as a selective marker to perform localized mutagenesis of aparticular region of the chromosome.
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Mutagenesis of cloned DNA was performed using the Tn3 S lactamase gene carried by phage X.
Students selected deletion and point mutations in this gene and characterized these mutants by
genetic crosses, restriction analysis, and electron microscopy heteroduplex analysis.
PARTICIPANTS
Boos, Winfried, Ph.D., University of Konstanz, Federal Republic of Germany
Condra, Jon H., Ph.D., NLMB, National Institutes of Health, Bethesda, Maryland
Fox, J. Lawrence, Ph.D., University of Texas, Austin
Gennis, Robert B., Ph.D., University of Illinois, Urbana
Goff, Christopher G., Ph.D., Haverford College, Pennsylvania
Kirsch, Donald R., Ph.D., Rutgers Medical School, New Brunswick, New Jersey
Kustu, Sydney, Ph.D., University of California, Davis
Lin, Edmund C.C., Ph.D., Harvard Medical School, Cambridge, Massachusetts
Mann, Barbara J., B.S., University of Virginia, Charlottesville
Newland, John W., B.A., University of Maryland, College Park
Oriel, Patrick J., Ph.D., Dow Chemical Co., Midland, Michigan
Plumbridge, Jacqueline A., Ph.D., Institut de Biologie Physico-Chimique, Paris, France
Price, Chester W., Ph.D., University of California, Berkeley
Purucker, Mary E., B.S., Albert Einstein College of Medicine, Bronx, New York
Steiner, Lisa A., M.D., Massachusetts Institute of Technology, Cambridge
Stewart, Valley, B.A., University of Virginia, Charlottesville
SEMINARS
Beckwith, J., Harvard Medical School. New techniques in bacterial genetics.
Walker, G., Massachusetts Institute of Technology. Analysis of SOS functions use Mu-lac
fusions.Campbell, A., Stanford University. Divergent transcription of the biotin operon.
Simon, M., University of California, San Diego. Analysis of the mechanism of phase variation in
Salmonella typhimurium.
Ptashne, M., Harvard University. Molecular mechanisms of X repressor function.
Friedman, D., University of Michigan Medical School. Host functions involved in X antitermina-
tion control.
Stahl, F., University of Oregon. Function of chi sequences in genetic recombination.
Molecular Cloning of Eukaryotic Genes, June 30-July 20
INSTRUCTORS
Maniatis, Thomas, Ph.D., California Institute of Technology, Pasadena
Fritsch, Edward, Ph.D., California Institute of Technology, Pasadena
Hopkins, Nancy, Ph.D., Massachusetts Institute of Technology, Cambridge
ASSISTANTS
Donis-Keller, Helen, Ph.D., Harvard Medical School, Cambridge, Massachusetts
O'Connell, Catherine D., B.A., Frederick Cancer Research Center, Maryland
This was a laboratory course in the application of recombinant DNA procedures to the study of
eukaryotic genes with emphasis on the isolation of cellular structural genes. Among the topics
covered were: construction of bacteriophage A and cosmid libraries of high molecular weight
eukaryotic DNA; screening DNA libraries with specific hybridization probes; purification and
characterization of recombinant clones using restriction endonuclease and blot hybridization
analyses; transfer of cloned DNA into cells in culture; and in vitro mutagenesis of cloned DNA to
study regulatory sequences. Mammalian globin genes and the herpes virus thymidine kinase gene
were utilized as model experimental systems.
PARTICIPANTS
Bernstine, Edward G., Ph.D., Oak Ridge National Laboratory, Tennessee
Brandsma, Janet L., M.S., Yale University, New Haven, Connecticut
Calva, Edmundo, Ph.D., National University of Mexico, Mexico City
Chan, Shu Jin, Ph.D., University of Chicago, Illinois
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Fenton, Robert G., B.S., New York University, New York
Garel, Annie, Ph.D., Universite Claude Bernard, Villeurbanne, France
Grindley, June N., Ph.D., University of Pittsburgh, Pennsylvania
Hayday, Adrian, B.A., Imperial Cancer Reserach Fund Laboratories, London, England
Krump-Konvalinkova, Vera, Ph.D., Radiobiological Institute, Rijswijk, The Netherlands
Lo, Cecilia W., Ph.D., Harvard Medical School, Cambridge, Massachusetts
Manson, Katherine I., M.S., Fred Hutchinson Cancer Center, Seattle, Washington
Martin, Sandra L., B.A., University of California, Berkeley
Shimada, Kazunori, Ph.D., Kyushu University, Japan
Sloof, Paul, Ph.D., Jan Swammerdam Institute, Amsterdam, The Netherlands
Wasmuth, John J., Ph.D., University of California, Irvine
Waterston, Robert H., Ph.D., Washington University School of Medicine, Seattle
SEMINARS
Roberts, R., Cold Spring Harbor Laboratory. Restriction enzymes.
Hamer, D., National Institutes of Health. Expression of f3-globin sequences cloned in 51/40.
Meyerowitz, E., California Institute of Technology. Drosophila and its genes.
Cloning large eukaryotic DNA segments using cosmid vectors.
Davis, R., Stanford University. Yeast transformation vectors for the functional analysis of yeast
genes.
. Electron microscopy of nucleic acids.
Bishop, J.M., University of California School of Medicine, San Francisco. The molecular biology
of retroviruses.
Roberts, B., Harvard Medical School. Application of hybrid arrested translation.
Vande Woude, G., National Institutes of Health. sarc and sarc of murine sarcoma virus.
Manley, J., Massachusetts Institute of Technology. Transcription of mammalian genes in vitro.
Wig ler, M., Cold Spring Harbor Laboratory. DNA transfection.
Axel, R., Columbia University. DNA transfection.
Weinberg, R., Massachusetts Institute of Technology. Transformation by DNA from chemically
transformed cells.
Lowy, D., National Institutes of Health. Molecularly cloned retroviral genomes.
Cooper, G., Sidney Farber Cancer Institute, Harvard Medical School. Transformation by DNAs
of normal and transformed cells.
Ptashne, M., Harvard University. Improved methods for maximizing expression of cloned
eukaryotic genes in E. coli.
Di Maio, D., Johns Hopkins University. In vitro mutagenesis of DNA.
Hood, L., California Institute of Technology. New microchemical techniques.
. Antibodies: Split genes and jumping genes.
Sambrook, J., Cold Spring Harbor Laboratory. Disintegration of DNA viral genomes.




Neuroanatomical Methods, July 8-July 28
INSTRUCTORS
Jones, Edward G., Ph.D., Washington University School of Medicine, St. LouisHartman, Boyd K., M.D., Washington University School of Medicine, St. Louis
Hand, Peter J., Ph.D., University of Pennsylvania, Philadelphia
ASSISTANTS
McClure, Bertha, Washington University School of Medicine, St. Louis
Steiner, Ron, B.A., Washington University School of Medicine, St. Louis
Kalmbach, Sandra, Washington University School of Medicine, St. Louis
This was primarily a laboratory course designed for research workers interested in learning basic
neuroanatomical techniques. Participants carried out an extensive set of laboratory exercisesinvolving most of the commonly used methods and there were lectures and discussions by theinstructors and visiting speakers.
Classical methods covered included: perfusion fixation; embedding in different media; frozen,paraffin, celloidin, and plastic sectioning; conventional cell staining methods; lesion making; silverimpregnation of normal and degenerating nerve fibers; brightfield, darkfield, and fluorescence
microscopy, photomicrography, and electron microscopy.
Newly developed methods included histochemical, radiochemical, and immunocytochemical
methods for tracing neuronal pathways in terms of axoplasmically transported material, neuro-transmitter-related compounds, or metabolic activity.
PARTICIPANTS
Amico, Lonnie L., M.D., University of Chicago, Illinois
Carr, Catherine E., M.A., University of California, San Diego
Harry, Gaylia J., M.S., NIEHS, National Institutes of Health, Research Triangle Park, NorthCarolina
HuppenbaCier, Robert, B.A., University of California, Berkeley
Juliano, Sharon L., B.A., University of Pennsylvania, Philadelphia
Lydic, Ralph B., Ph.D., Harvard Medical School, Cambridge, Massachusetts
Nahin, Richard L., B.A., University of California, Los Angeles
Schechter, Nisson, Ph.D., State University of New York, Stony Brook
Theriault, Elizabeth, B.A., McMaster University, Hamilton, Ontario, Canada
Wallace, N.M., B.S., University of Glasgow, England
SEMINARS
Pickel, V., Cornell Medical College. lmmunocytochemistry and the electron microscope.
Raviola, E., Harvard Medical School. Freeze fracture and related techniques.
Swanson, L., Salk Institute. Fluorescent dyes as retrograde tracers.
Peters, A., Boston University. The Golgi-EM technique.
Hendrickson, A., University of Washington. Autoradiographic techniques.
Principles of Neural Development, July 14-July 29
INSTRUCTORS
Purves, Dale, M.D., Washington University School of Medicine, St. Louis, Missouri
Patterson, Paul H., Ph.D., Harvard Medical School, Boston, Massachusetts
The aim of this intensive two-week course was to expose students to the classical literature on neural
development, with special emphasis on recent advances and controversies in this rapidly growing
field. The selection of students was based primarily on recommendations and potential rather than
background; thus this year's group of 21 students was composed of 7 postdoctoral fellows, 11
graduate students, and 3 fulltime faculty members involved in widely different research programs.
The common denominator was an interest in pursuing research related to neural development.
The format of the course was to have invited lecturers present a detailed review of particular
subjects in a three-hour morning session. The speaker then chose several important papers,
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generally ones not discussed in the morning, for the students to read during the afternoon. In the
late afternoon the speaker and instructors met with groups of 6-7 students to discuss the reading
and prepare one of the students in each group to present the papers at an evening meeting of the
whole class. The evening then consisted of several student presentations of aspects of the morning's
subject not covered by the invited lecturer, as well as a general discussion of the issues raised during
the day. Most evenings ended with one or two student research seminars in which an individual's
work in progress was described for discussion and criticism by fellow students and instructors. In
general, we attempted to have such presentations on an evening when the day's guest lecturer had a
special interest in the student's field. An occasional variant of this format was to end the evening
with a research seminar by an additional invited speaker whose material was deemed of special
interest, but not broad enough to devote an entire day to.
PARTICIPANTS
Bastiani, Michael, B.A., University of California, Davis
Chiu, Arlene Y., M.S., California Institute of Technology, Pasadena
Cospito, Joseph A., Ph.D., University of California, Los Angeles
Denis-Donini, Suzanne, Ph.D., Laboratory of Molecular Embryology, Naples, Italy
di Porzio, Umberto, M.D., College of France, Paris
Doupe, Allison J., B.S., Harvard Medical School, Cambridge, Massachusetts
Fentress, John C.,1 Ph.D., Dalhousie University, Halifax, Nova Scotia, Canada
hlooghe-Peters, Elisabeth L., Ph.D., University of Geneva, Switzerland
Loring, Jeanne F., Ph.D., University of California, San Diego
Mailhammer, Reinhard, Ph.D., Rockefeller University, New York, New York
Moody, Sally A., M.S., University of Florida, Gainesville
Naujoks, Kurt W., B.S., Max-Planck-Institut, Martinsried, Federal Republic of Germany
O'Donovan, Michael J., Ph.D., Yale University, New Haven, Connecticut
Reh, Thomas A., B.S., University of Wisconsin, Madison
Rubin, Eric, B.A., Washington University School of Medicine, Seattle
Seeley, John, Ph.D., New York University, New York
Suburo, Angela Maria, M.D., IMBICE, La Plata, Argentina
Tapscott, Stephen J., B.A., University of Pennsylvania, Philadelphia
Vulliamy, Thomas J., Ph.D., University College London, England
Whitelaw, Virginia A., B.A., University of Chicago, Illinois
Yao, Yung-mae, B.A., University of North Carolina, Chapel Hill
SEMINARS
Cowan, W.M., Washington University School of Medicine. Neural induction, neural prolifera-
tion, neural migration, and neural aggregation.
Patterson, P.H., Harvard Medical School. Epigenetic control of development: In vivo and in
vitro studies of neural crest.
Nerve growth factor: Its biological role and its biochemistry.
Brockes, J., California Institute of Technology. Immunological approaches to neural development.
Lawrence, P.A., Medical Research Council Laboratory of Molecular Biology. Pattern formation
and its genetic control.
Bentley, D., University of California, Berkeley. Invertebrate development.
Rakic, P., Yale University School of Medicine. Cell migration in the monkey CNS.
. Differentiation of neuronal geometry.
Mutant mice as a tool for studying CNS development.
Berg, D., University of California, San Diego. A trophic factor secreted by skeletal muscle or eye.
Fundamentals of synapse formation.
Landmesser, L.T., Yale University. Axon guidance.
Jaffe, L., Purdue University. Role of ionic currents in development.
Purves, D., Washington University School of Medicine. Synapse elimination.
. Sprouting of axons in maturity.
Sanes, J., Washington University School of Medicine. Denervation and reinnervation of muscle
cells.
Purves, D., Washington University School of Medicine. Target/neuron interactions in maturity.
.
Specificity in the peripheral nervous system.
Constantine-Paton, M., Princeton University. Retinotopic mapping.
Easter, S., University of Michigan. Retino-tectal connectivity.
Hubel, D.H., Harvard Medical School. The mammalian visual system.
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Electrophysiological Methods for Cellular Neurobiology
July 21-August 10
INSTRUCTORS
Kehoe, Jac Sue, Ph.D., Ecole Norma le Superieure, Paris, France
Chiarandini, Dante, M.D., New York University School of Medicine, New York
Stefani, Enrique, M.D., Instituto Politecnico Nacinal, Mexico City, Mexico
GUEST LECTURER
Kado, Ray, Ph.D., Centre National de la Recherche Scientifique, Gif-sur-Yvette, France
In this neurobiology course the neuromuscular junction of the frog and the central ganglia of the
mollusk Aplysia were used as experimental preparations for training students in basic electro-
physiological methods for cellular neurobiology. Examination of certain characteristics of the
resting, action and synaptic potentials of these two preparations served as a basis for introducing the
following techniques: microdissection, fabrication of single and multibarreled capillary micro-
electrodes; intracellular recording of membrane voltage changes (in so-called current clamp) and
membrane currents (using a slow voltage clamp); intracellular and extracellular application of ions
and drugs (by ionophoresis and pressure injections); and intracellular staining of Aplysia neurons.
The first 3 days of the course were devoted to lectures and exercises on electronics for cellular
neurobiologists given by Ray Kado. The last 2 days of the course were devoted to individual
experimental projects chosen by the students. These projects permitted them to try techniques not
taught in the course and to use biological preparations that they intended to study when they
returned to their own laboratories.
PARTICIPANTS
Chaillet, John, B.A., Yale University, New Haven, Connecticut
Crean, Geraldine, M.S., University of Connecticut, Farmington
Covarrubias, Manuel, M.S., National University of Mexico, Mexico City
Hernandez, Norma, B.S., IVIC, Caracas, Venezuela
Horton, Jonathan C., B.A., Harvard Medical School, Cambridge, Massachusetts
Lautt, Ruth, B.A., Hunter College, City University of New York, New York
Role, Lorna W., B.A., Harvard Medical School, Cambridge, Massachusetts
Schlichter, Lyanne, M.S., University of Toronto, Canada
Tapparelli, Carlo, B.S., University of Basel, Switzerland
Taylor, P., B.S., University of Bristol, England
Transformed Cells and Teratocarcinomas, July 23-August 12
INSTRUCTORS
Hynes, Richard 0., Ph.D., Massachusetts Institute of Technology, Cambridge
Martin, Gail R., Ph.D., University of California, San Francisco
ASSISTANTS
Destree, Antonia, B.S., Massachusetts Institute of Technology, Cambridge
Fujii, Joann, B.S., University of California, San Francisco
The course consisted of an integrated series of lectures, demonstrations, discussions, and laboratory
experiments designed to introduce students to the concepts and techniques involved in the study of
oncogenic transformation, teratocarcinomas, and mouse embryos. The lecture topics covered
initiation of transformation by tumor viruses and chemicals, the nature of the transformed
phenotype, establishment and properties of teratocarcinomas, and the study of early mouse
embryos.
Established cell lines and primary cultures were transformed by SV40, by SV40 DNA, by avian
sarcoma viruses, and by microinjection of 5V40 DNA. Growth properties of transformed cells were
analyzed and the transformed phenotype was studied by a variety of techniques: immuno-
fluorescence for T antigen, cell-surface fibronectin, laminin and type IV collagen and several
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cytoskeletal proteins; SDS-polyacrylamide gels; immunoprecipitation; plasminogen activator
assays; and nutrient transport. Teratocarcinoma cells were cultivated for differentiation and
analyzed by similar methods. Superovulated mice were used to prepare two-cell and blastocyst
embryos for culture and immunosurgery.
PARTICIPANTS
Bach, Richard G., B.S., New York University, New York
Backer, Joseph M., Ph.D., Columbia University, New York, New York
Blikstad, Ingrid, B.S., Uppsala University, Sweden
Boecker, Joerg F., Ph.D., University Freiburg, Federal Republic of Germany
Carlsson, Lars, Ph.D., Uppsala University, Sweden
Daya-Grossjean, Lee la, Ph.D., Institut de Recherches Scientifiques, Villejuif, France
Denny, John B., M.S., University of Florida, Gainesville
Kunz, Linda M., Ph.D., NCI, National Institutes of Health, Bethesda, Maryland
Kwan, Sau-Wah, Ph.D., University of Texas, Galveston
Lennox, Ronald W., Ph.D., Institute for Cancer Research, Fox Chase, Philadelphia, Pennsylvania
MacDonald, Raymond J., Ph.D., University of Texas, Dallas
Orida, Norman K., Ph.D., University of California, San Diego
Pourcel, Christine, B.S., Institut Pasteur, Paris, France
Reich, Nancy C., M.S., State University of New York, Stony Brook
Saborio, Jose L., Ph.D., CINVESTAV, Mexico City, Mexico
SEMINARS
Hynes, R., Massachusetts Institute of Technology. Introduction to transformation.
. Surface changes in transformation.
Martin, G., University of California, San Francisco. Introduction to teratocarcinoma.
Hopkins, N., Massachusetts Institute of Technology. Murine retroviruses.
Benjamin, T., Harvard Medical School. Small DNA tumor viruses.
Fidler, J., Frederick Cancer Research Center. Analysis of metastasis.
Todaro, G., NCI, National Institutes of Health. Growth factors and transformation.
Quigley, J., Downstate Medical Center, State University of New York, Brooklyn. Proteases in
transformation and malignancy.
Fisher, P., Columbia University. Initiating and promoting carcinogens.
Martin, S., University of California, Berkeley. Transformation by avian retroviruses.
Stevens, L., Jackson Laboratory. Establishment of teratocarcinomas.
Papaoiannou, G., University of Oxford. Embryos and teratocarcinomas.
Strickland, S., Rockefeller University. Induction of endoderm formation.
Stringer, J., Cold Spring Harbor Laboratory. Viral integration sites.
Zetter, B., Children's Hospital. Tumor angiogenesis.
Feramisco, J., Cold Spring Harbor Laboratory. Microinjection studies on the cytoskeleton.
Silver, L., Einstein University. Cell surfaces and teratocarcinomas.
The T locus of mice.
Willison, K., Cold Spring Harbor Laboratory. Cell surfaces and teratocarcinomas.
Molecular Biology and Genetics of Yeast, July 23-August 12
INSTRUCTORS
McLaughlin, Calvin S., Ph.D., University of California, Irvine
Cox, Brian S., Ph.D., University of Oxford, England
ASSISTANTS
Dobson, Melanie, Ph.D., University of Oxford, England
Tuite, Mick, Ph.D., University of California, Irvine
This program emphasized the major laboratory techniques used in the genetic analysis of yeast
tetrad analysis, mitotic recombination, five-structure mapping, cytoduction, tetraploid analysis,
complementation, and allelism. The isolation and characterization of both chromosomal and
cytoplasmic mutants was undertaken. Biochemical studies including two-dimensional gel electro-
phoresis were performed with a uxotrophic, radiation-sensitive, temperature-sensitive, and altered
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mating type mutants. Recombinant DNA techniques including yeast transformation filter hybridiza-
tion, gel electrophoresis mRNA isolation and in vitro protein synthesis were applied to cloning and
genetic analysis of yeast DNA.
PARTICIPANTS
Belfort, Marlene, Ph.D., New York State Dept. of Health, New York
Cleveland, Don W., Ph.D., University of California, San Francisco
Cumsky, Michael G., B.A., University of California, Berkeley
Freese, Elisabeth B., Ph.D., NLMB, National Institutes of Health, Bethesda, Maryland
Gibson, Raymond K., Ph.D., Public Health Laboratory, Salisbury, England
Gill, Gurnam S., Ph.D., Upjohn Company, Kalamazoo, Michigan
Hillman, Richard E., M.D., Washington University, Seattle
Huberman, Joel A., Ph.D., Roswell Park Memorial Institute, Buffalo, New York
Huffaker, Tim C., B.A., Massachusetts Institute of Technology, Cambridge
Knapp, Gayle, Ph.D., University of California, San Diego
Orlowska, Gabriela, M.S., University of Wroclaw, Poland
Romesser, James A., Ph.D., E.I. duPont de Nemours & Co., Wilmington, Delaware
Spierenburg, Henk S., M.S., Gist-Brocades, Delft, The Netherlands
Toselli, Mauro, California Institute of Technology, Pasadena
Walder, Roxanne Y., B.A., University of Iowa, Iowa City
Walsh, J.M., B.S., Oregon State University, Eugene
SEMINARS
Cox, B., University of Oxford. An introduction to yeast genetics.
. Natural plasmids and cytoplasmic inheritance.
Fogel, S., University of California, Berkeley. Genetic recombination and gene conversion in
yeast. I.
. Genetic recombination and gene conversion in yeast. II.
Coruzi, G., Columbia University. Mitochondria/ genetics.
Haynes, R., York University. Mutagenesis.
Tuite, M., Univeristy of California, Irvine. Translational suppression.
. In vitro protein synthesis.
Carbon, J., University of California, Santa Barbara. Cloning techniques and concepts.
. Cloning a centromere.
Warner, J., Albert Einstein College of Medicine. mRNA: Properties and translation.
. RNA synthesis.
Esposito, R., University of Chicago. Genetic analysis of meiosis.
McLaughlin, C., University of California, Irvine. Genetic analysis of protein synthesis.
. Analysis of the cell cycle.
The original Davenport Laboratory (now part of Delbruck Laboratory), site of ge-
netics courses since 1945
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Knapp, G., University of California, San Diego. tRNA: Processing of intervening regions.
Broach, J., State University of New York, Stony Brook. Properties of the 2/..4. plasmid.
Hicks, J., Cold Spring Harbor Laboratory. Cloning the mating type gene.
McKay, V., Rutgers University. Genetic analysis of mating in yeast.
Klar, A. and J. Strathern, Cold Spring Harbor Laboratory. Genetic and molecular analysis of
mating type switching.
Workshop on Tumor and Developmental Antigens
August 3-August 10
ORGANIZERS
Levine, A.J., Ph.D., State University of New York, Stony Brook
Lane, D.P., Ph.D., Imperial College, London, England
The advent of the monoclonal antibody technique has revolutionized our ability to examine the
antigenic changes that accompany normal cellular differentiation and also tumor formation. The
impact of the technique and the many new areas which it is opening up were discussed in this
Workshop, which brought together a small group of immunologists, virologists, and developmental
biologists.
The Workshop first considered cellular differentiation antigens, particularly with reference to the
immune system. In this context, elegant studies using monoclonal antibodies to isolate novel H-2
mutants were described, as well as the extensive and intriguing cross reactions between
histocompatibility antigens of different species. Markers for T cell and B cell lineages and the
development of these cell types was discussed. Here the monoclonal antibody system has made it
possible to subdivide the human and mouse T cell population and, in the human case, this is
providing an exciting new way of studying the cell population of leukemia patients. The direct use of
monoclonal antibodies in the therapy of leukemia was described in a mouse model system. The
results were striking and very encouraging.
Studies on developmental antigens were described and discussed: in particular the T locus
received a very fine and clear coverage. This session introduced the extensive description of tumor
antigens, which was a major theme of the Workshop. These antigens often represented normal
cellular components which in the tumor were rendered more abundant either by direct
transposition placing them under the control of a viral promoter or more obliquely by the action of
virus specific proteins or other transforming agents. The nature of the potential transforming genes
themselves was reviewed and their exciting association with differentiation markers became
apparent in the case of the defective leukemia viruses. The Workshop ended on a high notewith a
beautiful description of UV irradiation, tumorigenesis antigens and a review of the diagnostic use of
monoclonal antibodies in certain human tumors. The interdisciplinary nature of the group and the
skillful chairmanship led to an enormously exciting and productive meeting.
PRESENTATIONS
Mitchison, A., University College London, England. The mechanisms of tumor recognition and
rejection.
. The major histocompatability locus.
Rajan, T.V., Albert Einstein College of Medicine, Bronx, New York. Genetics.
Nathenson, S., Albert Einstein College of Medicine, Bronx, New York. Biochemistry.
McKearn, T., University of Pennsylvania, Pittsburgh. Monoclonal antibodies.
Cantor, H., Harvard Medical School, Boston, Massachusetts. T-cell antigens.
Schlossman, S., Harvard Medical School, Boston, Massachusetts. T-cell antigens.
Doherty, P., The Wistar Institute, Philadelphia, Pennsylvania. T-cell functions and lineages.
Ledbetter, J., Stanford University, California. T-cell functions and lineages.
Cooper, M., University of Alabama, Birmingham. B-cell development and molecular biology.
Seidman, J., National Institutes of Health, Bethesda, Maryland. B-cell development and
molecular biology.
Wiley, L., University of Virginia, Charlottesville. Development of the mouse.
Silver, L., Sloan-Kettering Cancer Research Center. The T-locus of mice.
Lilly, F., Albert Einstein College of Medicine, Bronx, New York. Genetic loci of the mouse
involved in tumorigenesis.
Nowinski, R., Fred Hutchinson Cancer Research Center, Seattle, Washington. Immunotherapy
of mouse leukemia with monoclonal antibodies.
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Risser, R., University of Wisconsin, Madison. Murine and acute leukemia virus antigens.
Hayman, M., Imperial Cancer Research Fund Laboratories, London, England. Murine and acute
leukemia virus antigens.
Scolnick, E., NCI, National Institutes of Health, Bethesda, Maryland. Murine and avian sarcoma
virus antigens.
Erikson, R., University of Colorado, Denver. Murine and avian sarcoma virus antigens.
Weinberg, R., Massachusetts Institute of Technology, Cambridge. Cellular and viral trans-
forming genes.




Jay, G., National Institutes of Health, Bethesda, Maryland. Chemically transformed cells.
Lane, D., Imperial College of Science and Technology, London, England. SV40-cellular tumor
antigens.
. Cellular tumor antigens.
Krepke, M., Frederick Cancer Reserach Center, Maryland. Irradiation tumorigenesis antigens.




An important aspect of the summer program at the Laboratory is the participation of college
undergraduate students in active research projects under the supervision of full-time laboratory
staff members. The program was initiated in 1959. Since that year, 216 students have completed the
course, and many have gone on to creative careers in biological science.
The objectives of the program are to provide (1) a greater understanding of the fundamental
principles of biology, (2) an increased awareness of major problem areas under investigation, (3)
better understanding of the physical and intellectual tools for modern research and the pertinence
of this information to future training, and (4) a personal acquaintance with research, research
workers, and centers for study.
The following students, selected from a large number of applicants, took part in the program,
which was supported by The Camille and Henry Dreyfus Foundation, Inc. They are listed below with
their laboratory sponsors and topics of research.
Alexander Baxter, Haverford College
Research Advisor: D. Kurtz
Chris Corless, University of California,
Berkeley
Research Advisor: R. Roberts
Andy Ellington, Michigan State University
Research Advisor: J. Lewis
Deborah S. Gibson, Rensselaer Polytechnic
Research Advisor: J. Garrels
Felicia M. Hendrickson, Harvard University
Research Advisors: L. K. Drickamer,
J. Garrels
Thomas M. Laton, Le Moyne College
Research Advisor: J. Smart
Elizabeth McFarland, Northwestern
University
Research Advisor: D. Zipser
Allen B. Oser, Brown University
Research Advisor: A. I. Bukhari
Barry S. Rosen, Wesleyan University
Research Advisor: T. Broker
Eric S. Schulze, University of California,
Berkeley
Research Advisor: S. Blose
Olney Fellow
Leona Ling, University of California,
Berkeley
Research Advisor: Y. Gluzman
Characterization of the rat cx,,, globulin gene.
Dideoxy sequencing of adenovirus-2 DNA using
Hindil restriction fragments as primers.
In vitro mutagenesis of Ad2 as a means of
examining the significance of poly(A) tailing
of mRNA.
Two-dimensional gel electrophoresis analysis of
human fibroblast proteins: In quest of the
genetic defect which causes cystic fibrosis.
Mitochondrial protein identification on
two-dimensional gels.
(1) Does SV40 large T antigen exist in a
multimeric complex? (2) Determination
of the monoclonal antibody binding
site of SV40 large T antigen.
Sequence analysis of deletion and insertion
mutations of the cloned HSV-1 thymidine
kinase gene.
Restriction enzyme mapping of bacteriophage
Mu DNA and use of various methods to make
plasmids (pSC101 and pBR322) containing Mu
wild-type repressor gene.
Nucleotide sequence evolution. Adenovirus: The
determination of the sequence of gene IV,
in Ad7 and comparison to Ad2 sequences.
Purification and characterization of the midbody
of dividing He La cells.




Cold Spring Harbor In-House Seminars were initiated to
provide a semiformal avenue for communication between
the various research groups at the laboratory. They are
particularly useful for research personnel who have joined
the laboratory during the summer. The seminars also afford a
necessary opportunity for the graduate students and post-
graduate staff to develop their skills in defending, organizing,
and presenting their research. In addition to those listed
below, seminars were given by many others involved in
research at this laboratory.
1979-1980
Kurt Drickamer conducting a seminar
in James Laboratory
August
Marc van Montagu, Rijks University, Gent, Belgium: The Ti plasmids of Agrobacterium
tumifaciens: Possible vectors for genetic engineering in plants.
December
Robert G. Roeder, Washington University, St. Louis, Missouri: Transcription of purified eukaryotic
genes in reconstituted systems.
Magdelene So, University of California Medical Center, San Francisco: The molecular biology of
the E. coli heat stable toxin.
Fred Heffron, University of California, San Francisco: Structural and functional analysis of the
bacterial transposon Tn3.
Francine Eden, National Institutes of Health, Bethesda, Maryland: Very large methylated repeated
elements in chickens.
Mitchell Smith, University of Edinburgh, Scotland: Histone gene organization in yeast.
January
James Manley, Massachusetts Institute of Technology, Cambridge: Studies of adenovirus
transcription in vitro.
K. Wohlfarth-Botterman, University of Bonn, Federal Republic of Germany: Motive force
generation by cytoplasmic actomyosin for protoplasmic streaming in Physarum.
Hans van Ormondt, University of Leiden, The Netherlands: The nucleotide sequence of early
region 1 of adenovirus DNAs.
February
Benjamin Walcott, State University of New York, Stony Brook: Magnetic field detection by
specialized cells in pidgeons.
John Condeelis, Albert Einstein College of Medicine, Bronx, New York: Reciprocal interactions
between the actin lattice and cell membrane.
Brad Ozanne, University of Texas, Dallas: Transforming factors produced by virally transformed
cells.
Arthur Levinson, University of California, San Francisco: Characterization of the protein encoded
by the transforming gene of avian sarcoma virus.
Martin Chalfie, Medical Research Council Laboratories, Cambridge, England: Microtubule cells
of C. elegans; Genetics and development of identified neurons.
George Vande Woude, NCI, National Institutes of Health, Bethesda, Maryland: Properties of two
regions of the leukemia virus genome that are required for transformation by src/sarc.
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March
Clark Tibbetts, University of Connecticut, Farmington: Site-directed mutagenesis-An efficient and
general approach.
Margarita Sa las, University of Madrid, Spain: Protein p3, covalently linked to 4,29 DNA, is involved
in initiation of replication.
April
Eric Gruenstein, University of Cincinnati Medical Center, Ohio: Identification of lysosomal
abnormalities in fibroblasts from individuals with Duchenne muscular dystrophy.
Moshe Yaniv, Pasteur Institute, Paris, France: Mutants of polyoma virus able to grow in
teratocarcinoma cells.
Fuyuhiko Tamanoi, Harvard University, Cambridge, Massachusetts: Initiation of replication of
bacteriophage T7 DNA.
Mike Fried, Imperial Cancer Research Fund Laboratories, London, England: Organization and
expression of polyoma viral DNA sequences in transformed cells.
Nancy Hogg, Imperial Cancer Research Fund Laboratories, London, England: Heterogeneity of
human macrophages detected by monoclonal antibodies.
Gunther Schutz, Max-Planck-Institut far Molekulare Genetik, Bonn, Federal Republic of
Germany: Structure and expression of the chicken lysozyme gene.
May
Cathy Laughlin, National Institutes of Health, Bethesda, Maryland: Involvement of adenovirus
early region genes in the AAV helper function.
David Schubert, Salk Institute, San Diego, California: Role of a 16S glycoprotein complex in
cellular adhesion.
Bill Welch, Salk Institute, San Diego, California: Synthesis and orientation of viral membrane
glycoproteins.





The Nature Study Program is designed for elementary and high school students who wish to achieve a
greater understanding of their environment. During Summer and Fall a total of 440 students
participated in these activities. Most classes were held outdoors, when weather permitted, or at
Uplands Farm Nature Preserve of the Nature Conservancy, where the Laboratory has equipped and
maintains classroom laboratories for the study of field specimens collected by the students.
In addition to courses, a series of one-day Marine Biology Workshops was offered, with special
workshops for adults. Studies were conducted on Long Island Sound aboard a 55-foot schooner
chartered from Schooner, Inc. of New Haven, Connecticut. This vessel is equipped with a variety of
instrumentation and is staffed by a captain, mate, and marine biologists. Students participated in
biological studies and in the actual sailing of the vessel.
This summer a new course, Adventure Education II, was conducted at Watch Hill on Fire Island.
Students studied the environment while camping on the barrier beach.
In the Fall a Long Island Field Geology course included trips to the Montauk Peninsula, North and
South Shores of Long Island, and the State University of New York at Stony Brook.
PROGRAM DIRECTOR
Sanford Kaufman, M.S., M.P.A., science teacher, Hewlett High School
INSTRUCTORS
Kathryn Bott, M.S., science teacher, Friends Academy
Judith Calloway, M.S., biology teacher, East Islip High School
Don Dunn, M.S., art and photography teacher, Hewlett High School
Steven Englebright, M.S., curator of geology, State University of New York, Stony Brook
Carolyn Hess, M.S., Museum of Long Island Natural Sciences, State University of New York,
Stony Brook
James Romansky, M.S., biology teacher, Bay Shore High School












Frogs, Flippers, and Fins
They Swim, Crawl, and Walk
Nature Photography I & II
Adventure Education I & II
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DIRECTOR ADMINISTRATIVE DIRECTOR ASSISTANT DIRECTOR DIRECTOR-BANBURY CENTER







































Staff as of December 1980
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ADMINISTRATIVE BUILDINGS AND GROUNDS PUBLICATIONS












































Robert Anderson Doris Calhoun
John Bach Michaela Cooney
Joseph Brodawchuk Nadine Dumser
Carol Caldarelli Nancy Ford
Vincent Carey Kathleen Horan
Barbara Cuff Annette Kirk
Peter Dunn Douglas Owen

















Charles Schneider Carol Aznakian
Lane Smith Audrey Bevington
Peter Stahl Ellen DeWeerdt
Owen Stewart Susan Gensel
Patrick Sullivan David Gibson
Hans Trede Laura Hyman















First row: E. Chow, G. Binns, J. Smart; T. Kelly, J. Leibold, J. Garrets
Second row: T. Gingeras; C. Morita; A. Nickel; R. Blumenthal
Third row: D. Barczik; G. Kist, B. Ward, M. Berejka; J. Bach
Fourth row: T. Broker on Blood Drive Day; Annual staff picnic
First row: P. Reichel, B. Parsons, K. Washington, J. Sabin; J. Terrence, P. Hickey, C. Schneider
Second row: J. Richards; Y. Gluzman, B. Ahrens, H. Reichl, J. Bier, R. Frisque; N. Ford
Third row: J. Wood; R. Sa lant, S. Jay, J. Drum; F. Otto, C. Mendez; S. Schultz
Fourth row: L. Hyman, E. DeWeerdt, S. Gensel, H. Parsons; D. Owen, A. Kirk, L. Ritcey, M. Cooney
FINANCIAL STATEMENT
BALANCE SHEET
year ended December 31, 1980








Due from restricted fund
Due from Banbury Center
Total unrestricted
Restricted
Grants and contracts receivable









Total Robertson Research Fund
1980 1979



















Due to plant fund

























Total Olney Memorial Fund 28,055 27,410
Total endowment funds $ 9,020,224 $ 8,212,458 Fund balance $ 9,020,224
$ 8,212,458
PLANT FUNDS PLANT FUNDS
Investments 245,665 230,725
Due from unrestricted fund 808,714 1,001,089
Land and improvements 966,110 960,530
Buildings 6,006,958 5,735,358
Furniture, fixtures and equipment 1,255,429 1,103,409
Books and periodicals 365,630 365,630
Construction in progress 371,787 88,630
10,020,293 9,485,371
Less allowance for depreciation
and amortization 2,388,005 1,951,625
Total plant funds $7,632,288 $7,533,746 Fund balance
$ 7,632,288 $ 7,533,746
BANBURY CENTER BANBURY CENTER
Current funds Current funds
Cash $ 600 600 Accounts payable
$ 57,733 $ -
Accounts receivable 26,293 95 Due to CSHL unrestricted fund
128,785 $ 87,939
Fund balance (159,625) (87,244)
Total current funds 26,893 695 Total current funds
26,893 695





$1,879,191; 1979-$1,726,973) 1,630,397 1,586,667
Total endowment funds 1,614,083 1,524,076 Endowment funds balance
1,614,083 1,524,076
Plant funds Plant funds
Land 772,500 772,500
Buildings 412,672 412,672
Furniture, fixtures and equipment 176,285 164,416
Construction in progress 368,149 49,510
1,729,606 1,399,098
Less allowance for depreciation 173,596 129,340
Total plant funds 1,556,010 1,269,758 Plant funds balance 1,556,010 1,269,758
Total Banbury Center $ 3,196,986 $ 2,794,529 Total Banbury Center $ 3,196,986 $ 2,794,529
Total-All funds $24,696,995 $22,516,082 Total-All funds $24,696,995 $22,516,082
CURRENT REVENUES, EXPENSES AND TRANSFERS
year ended December 31, 1980









Long Island Biological Association


















































































































m Capital building projects 875,673 430,607
Banbury Center 378,345 40,655
Total transfers 1,254,018 471,262
Total expenses and transfers 9,362,154 7,205,442
Excess (deficit) of revenues
over expenses and transfers $(803,220)** $ 612,303
.Reported exclusive of an allocation for operation and maintenance of plant,
general and administrative, library, and depreciation expenses.
**1980 deficit primarily caused by conversion of current funds and 1979 revenue
excess to plant funds for capital building projects.
Note: Copies of our complete, audited financial statements, certified by our independent auditors, Peat, Marwick, Mitchell & Co., are available upon
request from the Comptroller, Cold Spring Harbor Laboratory.
COLD SPRING HARBOR LABORATORY
SOURCES OF REVENUE
Year End December 31, 1980
Federal Grants and Contracts
61.2%












January 1-December 31, 1980
NEW GRANTS
Grantor
COLD SPRING HARBOR LABORATORY
Principal Investigator Duration
and Program Total Award of Grant
National Institutes of Health Dr. Bukhari-research $1,661,439 6/1/80-5/31/83
Dr. Burridge-research 131,039 4/1/80-3/31/81
Dr. Feramisco-research 214,758 7/1/80-6/30/83
Dr. Gingeras/
Dr. Roberts-research 408,085 3/1/80-2/28/83
Dr. Goldfarb-fellowship 59,244 9/1/80-8/31/83
Dr. Hicks-advanced bacterial
genetics course 97,081 4/1/80-3/31/83
Dr. Kurtz-research 179,542 4/1/80-3/31/83
Dr. Mathews-research 266,570 4/1/80-3/31/83
Dr. Topp-research 303,452 8/1/80-6/30/83
Dr. So-research 124,370 9/30/80-8/31/82
Mr. Udry-1980 protein phos-
phorylation meeting 10,000
National Science Foundation Dr. Garrels-research 140,000 9/1/80-8/31/82
Dr. Hicks-1980 plant workshop 7,373 2/15/80-1/31/81
Dr. Roberts-research 345,000 8/15/80-7/31/83
Mr. Udry-1980
symposium support 6,000 5/1/80-4/30/81
Dr. D. Zipser-research 157,000 5/15/80-4/30/83
Rita Allen Foundation Dr. Watson-1980 pain workshop 12,500
American Cancer Society Dr. Watson-1980
cell culture course 21,120 4/1/80-7/31/81
Dr. Mathews-research 13,841 1/1/80-3/31/80
Bethesda Research
Laboratory 1980 symposium 5,000
Cetus Corporation 1980 symposium 5,000
1980 mammalian vectors meeting 3,000
Collaborative
Research Corp. 1980 mammalian vectors meeting 1,000
COGENE Dr. Bukhari-COGENE-India
training course 10,000
Cystic Fibrosis Dr. Carrels- research 87,230 7/1/80-6/30/82
Department of Energy Mr. Udry-1980
symposium support 9,000
Dr. Hicks-1980 plant workshop 4,000
E. I. duPont
de Nemours & Co. 1981 pain workshop 1,000
1980 mammalian vectors meeting 1,500
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NEW GRANTS
COLD SPRING HARBOR LABORATORY
Grantor
Principal Investigator
and Program Total Award
Duration
of Grant
Genentech, Inc. 1980 mammalian vectors meeting 3,000
Grass Foundation Dr. B. Zipser-neurobiology
scholarships 14,000 1980-1981
Lilly Research Laboratories 1980 mammalian vectors meeting 3,000
Molecular Genetics, Inc. 1980 mammalian vectors meeting 1,500
Monsanto 1980 mammalian vectors meeting 1,000
Muscular Dystrophy Assoc. Dr. Blose-research 19,000 1/1/80-12/31/80
Dr. Garrels-research 20,000 1/1/80-12/31/80
Dr. Lin-research 29,750 1/1/81-12/31/81
Dr. B. Zipser-1980 synapse course 4,000
Dr. B. Zipser-1980 neural devel-
opment course 4,000
New England
Biolabs, Inc. Dr. Roberts-research 5,000
1980 mammalian vectors meeting 3,000
Upjohn 1980 pain workshop 500
Volkswagen Foundation Dr. Watson-neurobiology
scholarships 236,088 1980-1982
Whitehall Foundation Dr. B. Zipser-research 135,000 10/1/80-9/30/83
Helen Hay Whitney
Foundation Dr. Frisque-fellowship 29,000 9/1/80-8/31/82
Damon Runyon-Walter
Winchell Cancer Fund Dr. B. Anderson-fellowship 35,000 10/1/80-9/30/82
Dr. Goldfarb-fellowship 35,000 10/1/80-9/30/82
BANBURY CENTER
Principal Investigator Duration
Grantor and Program Total Award of Grant
National Institutes of Health purchase of Banbury reports $82,125 8/80




COLD SPRING HARBOR LABORATORY
Principal Investigator Duration
and Program Total Award of Grant
National Institutes of Health Dr. Watson-cancer research
center $13,500,000 1/1/77-12/31/81
Dr. Watson-general
research support 173,612 4/1/76-3/31/81
Dr. Watson-summer workshops 470,340 4/1/77-3/31/82
Dr. Watson-symposium support 187,433 4/1/79- 3/3W84
Dr. Watson-neurobiology
course support 258,500 6/1/79-3/31/82
Dr. Watson-herpesvirus meeting 42,280 8/1/79-6/30/81
Dr. Watson-viruses in naturally
occurring cancers
meeting 30,000 8/14/79-1/15/80
Mr. Udry-cancer research facility 1,411,011 9/15/77-indefinite
Dr. Albrecht-Buehler-research 73,612 9/1/78-8/31/80
Dr. Blose-research 167,702 12/1/78-11/30/81
Dr. Bukhari-career development 148,961 5/1/75-4/30/80
Dr. Bukhari-research 121,351 9/9/77-8/31/80
Dr. Chaconas-fellowship 19,040 8/1/79-7/31/81
4/1/77-3/31/80
Dr. Carrels- research 323,073 4/1/79-3/31/82
Dr. Hicks-research 384,703 7/1/78-6/30/81
Dr. Klar-research 253,000 7/1/78-6/30/81
Dr. Sciaky-fellowship 13,800 3/1/79-2/28/80
Dr. Stringer-fellowship 0,890 2/1/79-1/31/82
Dr. Topp-research 275,806 1/1/79-12/31/81
Dr. D. Zipser-fellowship training 852,578 7/1/78-6/30/83
National Science Foundation Dr. Bukhari-research 330,000 6/15/79-5/30/82
Dr. Carrels- research
and equipment 192,484 7/1/78-6/30/80
Dr. Hicks-equipment 24,000 8/15/78-1/31/80
Dr. Roberts-research 210,000 12/15/79-11/30/82
Dr. ain-research 65,000 8/15/77-1/31/80
Dr. B. Zipser-neurobiology
course support 60,000 7/1/79-12/31/82
Dr. B. Zipser-research 120,000 11/1/78-10/31/81
Dr. D. Zipser-research 136,000 2/15/78-1/31/81
Rita Allen Foundation Dr. Lewis-research 120,000 8/1/76-7/31/80
American Cancer Society Dr. Lewis-research 62,500 7/1/79-6/30/80
Dr. Stringer-fellowship 13,000 1/1/79-1/31/80
American Heart Association Dr. Blose-resarch 8,570 7/1/79-6/30/80
Dr. Carrels- research 8,570 7/1/79-6/30/80
Canadian Medical




COLD SPRING HARBOR LABORATORY
Principal Investigator Duration
and Program Total Award of Grant
The Camille and
Henry Dreyfus Foundation
Institute of Molecular Biology
Division of Bethesda
Dr. Watson-undergraduate re-
search participation 46,000 12/1/78-1/1/81
Research Laboratory Dr. Watson-research 7,500 2/1/79-1/31/80
Esther A. and Joseph Dr. Watson-neurobiology
Klingenstein Fund course support 60,000 5/1/79-4/30/82
Leukemia Society of America Dr. Engler-fellowship 25,000 11/1/78-10/31/80
Muscular Dystrophy
Association Dr. Burridge-research 25,142 7/1/79-6/30/80
Dr. Feramisco-fellowship 32,000 1/1/79-12/31/80
Dr. E. Lane-fellowship 25,000 1/1/79-7/1/80
Alfred P. Sloan Foundation Dr. D. Zipser-computer
workshops 31,000 6/1/79-12/31/81
Whitehall Foundation Dr. Roberts-research 34,500 4/1/79-3/31/80
Helen Hay Whitney
Foundation Dr. Drickamer-fellowship 24,125 9/1/79-5/31/81
Damon Runyon-Walter
Winchell Cancer Fund Dr. Hu-fellowship 26,070 7/1/78-6/30/80
Dr. Lin-fellowship 28,000 7/1/79-6/30/81
Dr. Stillman-fellowship 28,000 4/1/79-3/31/81
Dr. Stow-fellowship 30,000 10/1/78-9/30/80
BANBURY CENTER
Principal Investigator Duration
Grantor and Program Total Award of Grant
Esther A. and Joseph
Klingenstein Fund program support $100,000 3/1/78-2/29/80
Alfred P. Sloan Foundation program support 100,000 8/1/78-7/31/80
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SPONSORS
of the Cold Spring Harbor Laboratory
Abbot Laboratories




Smith Kline & French Laboratories
CONTRIBUTORS
to the Cold Spring Harbor Laboratory
Albert Einstein College of Medicine
Patrice Albert
Anne Klein & Company
Mrs. Richard Babcock
Dr. & Mrs. Paul Berg
Mr. & Mrs. S. T. Bourne, Jr.
Dr. Thomas Broker










Mr. Walter Frank, Jr.
Louis M. Fuccio
Mr. & Mrs. H. Bentley Glass
Dr. & Mrs. G. P. Griffin, Jr.
Conchita P. Gurgui
Robert A. Hack
Mr. Richard F. Hatzel
The Hearst Foundation
Dr. & Mrs. Alfred Hershey
Dr. Ira Herskowitz
Dr. A. W. Hsie
Estate of Lillian Keily
Maxwell Lester III
Dr. & Mrs. Monroe Levin
Mrs. Yvette Levin & Family
Mrs. Mary Lindsay
Robert V. Lindsay
Mrs. V. S. Littauer
Long Island Biological Association
Massachusetts Institute of Technology
Mr. & Mrs. John D. Maxwell
Leila Laughlin McKnight
Mr. Robert McLane
Memorial Sloan-Kettering Cancer Center
Mr. & Mrs. K. Middendorf
Morgan Guarantee Trust Company
Dr. Takashi Morimoto
Helen I. Morris
New York University Medical Center




Mr. & Mrs. M. G. Pfeifer
Henri Polak Diamond Corporation
H. W. Powers
Staff of Charles Pratt & Company
Princeton University






Dr. & Mrs. W. Shropshire, Jr.
Mr. & Mrs. Daniel Singer
Dr. P. F. Spahr
Steven W. Spencer
Ina Sporecke
State University of New York at Stony Brook
Gunther S. Stent
John Storck, Jr.
Dr. & Mrs. C. A. Thomas, Jr.
Dr. A. Tissieres
A. Tomlinson
Henry J. Topping, Jr.
Mr. & Mrs. Colton Wagner
Kazuhiko Wakabayashi
Dr. J. D. Watson
Frank C. Whittelsey III
Mr. & Mrs. Harold Williamson, Jr.
Mr. R. Thornton Wilson, Jr.
University of Wisconsin




The Cold Spring Harbor Laboratory is a publicly supported educational institution chartered by the
University of the State of New York and may receive contributions which are tax exempt under the
provisions of the Internal Revenue Code, particularly Section 501C. In addition, the Laboratory has
been formally designated a "public charity" by the Internal Revenue Service. Accordingly, it is an
acceptable recipient of funds which would result from the termination of "private" foundations.
The Laboratory depends upon the generous contributions of its sponsors, participating
institutions, and friends for central institutional needs and capital improvements. In addition, the
development of any new programs, such as year-round research in neurobiology or the marine
sciences, can be undertaken only with substantial support from private sources.
Methods of Contributing to Cold Spring Harbor Laboratory
Gifts of money can be made directly to Cold Spring Harbor Laboratory.
Securities
You can generally deduct the full amount of the gift on your income tax return, if the
appreciation would have been a long-term gain, to the extent of 50% of your adjusted gross
income and you need pay no capital gains tax on the stock's appreciation.
We recommend either of the following methods:
(1) Deliver the stock certificates to your broker with instructions to him to open an account for
Cold Spring Harbor Laboratory and hold the securities in that account pending instructions
from Cold Spring Harbor Laboratory.
(2) Send the unendorsed stock certificates directly to the Laboratory: Comptroller, Cold Spring
Harbor Laboratory, Box 100, Cold Spring Harbor, New York 11724. In a separate envelope
send an executed stock power.
Bequests
Probably most wills need to be updated. Designating Cold Spring Harbor Laboratory as
beneficiary ensures that a bequest will be utilized as specified for continuing good.
Appreciated real estate or personal property
Sizable tax benefits can result from such donations; the Laboratory can use some in its program
and can sell others.
Life insurance and charitable remainder trusts can be structured to suit the donor's specific desires
as to extent, timing, and tax needs.
Conversion of private foundation to "public" status on termination
This may be done by creating a separate fund within Cold Spring Harbor Laboratory whereby
the assets of the private foundation could be accounted for as a separate fund and used for the
purposes specified by the donor. Alternatively, the private foundation can be established as a
"supporting organization of Cold Spring Harbor Laboratory."
For additional information, please contact the Administrative Director, Cold Spring Harbor




THE LONG ISLAND BIOLOGICAL ASSOCIATION (LIBA)
and Its Relation to the Cold Spring Harbor Laboratory
Biological research at Cold Spring Harbor began in
1890 when the Brooklyn Institute of Arts and
Sciences was looking for a place to set up a
summer laboratory as the headquarters of its
Department of Zoology. Representatives of the
Institute were invited by Eugene S. Blackford, at
that time the First Commissioner of the State of
New York, to inspect a site on Bungtown Road
across Northern Boulevard (25A) from the Fish
Hatchery. The site was found to be ideal, and so
the original Laboratory was organized with Mr.
Blackford as president of the Board of Trustees.
The land was leased from Mr. John D. Jones,
whose family since 1819 had operated various
industries including shipbuilding, coopering, and
textile manufacture (later whaling, also) at the
head of Cold Spring Harbor. Bungtown Road,
which runs through the Lab property, got its name
from the factory that specialized in making
bungs-or stoppers-for barrels.
In 1892 the Laboratory's land was leased for a
dollar a year from the Wawepex Society, which
Mr. Jones had organized as a corporation for
holding real estate and for investing funds for the
propagation of fishes and for scientific research. In
1904 the Wawepex Society leased additional land
to the Carnegie Institution of Washington, which
wanted to locate a Department of Experimental
Evolution in the Cold Spring Harbor area. Charles
B. Davenport, who had been directing the Labora-
tory since 1896, assumed the additional duties of
director of the Carnegie Institution's experimental
station. It is interesting to note that Mr. Davenport
lived in what came to be known later as the
Carnegie Dormitory, the Victorian house on 25A
built by John D. Jones before the turn of the
century, and recently repainted in its original
colors.
The Long Island Biological Association was
established in 1924 when the Brooklyn Institute
decided to discontinue its research at Cold Spring
Harbor and offered its laboratory to two univer-
sities. Fortunately, a local group of interested
neighbors decided to assume responsibility for the
Lab, and thus LIBA came into being. For 38 years
LIBA actually operated the Laboratory in conjunc-
tion with the Carnegie Institution, but in 1962 it
seemed advisable for the Laboratory to be reor-
ganized as an independent unit. Therefore, the
property on which it now stands was conveyed to
it by LIBA, which, however, still retains rever-
sionary rights. Today LIBA is one of thirteen
institutions participating in the support of the
Laboratory, each institution being represented on
the Laboratory's Board of Trustees.
What has happened, in effect, is that LIBA has
become an expanding group of local "Friends of
the Laboratory" who help support it through
annual contributions. Also, from time to time, the
Association undertakes campaigns to finance
special important projects for which the Lab
cannot obtain funds from the Federal Govern-
ment or from other sources. For instance, in 1974,
LIBA made possible building the James Laboratory
Annex and the renovation of Blackford Hall; and
in 1976 the re-building of Williams House.
The affairs of LIBA are handled by a board of 28
directors who are elected to office by the mem-
bership at an annual meeting. At least twice a year
LIBA members are invited to bring their friends to
a lecture or an open house at the Lab.
Membership in LIBA requires a minimum
annual contribution (tax deductible) of $25 for a
husband and wife, $15 for a single adult, $5 for a
junior member (under 21). Further information
can be obtained from the Long Island Biological
Association, Box 100, Cold Spring Harbor, N.Y.
11724, or by telephoning the Laboratory's ad-
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REPORT OF THE CHAIRMAN FOR 1980
LIBA's most important activity in 1980 was com-
pleting the fund of $200,000 which its members
had undertaken to raise for the purchase of twenty
acres of land owned, but no longer needed, by the
Carnegie Institution of Washington. The owner-
ship of this land by the Lab is essential for rounding
out and preserving its property.
The custom of giving dinner parties for the
visiting scientists at the Lab's summer Symposium
was successfully continued and greatly appreci-
ated. On June 1st eighteen of our directors and
members gave parties for over a hundred guests.
This year's hosts and hostesses were:
Mr. & Mrs. Charles 0. Ames
Mr. & Mrs. Edmund Bartlett
Mrs. Jeannette S. Berman
Mr. & Mrs. Arik Brissenden
Mr. & Mrs. Miner D. Crary, Jr.
Mr. & Mrs. Roderick H. Cushman
Mr. & Mrs. Norris W. Darrell, Jr.
Mr. & Mrs. James A. Eisenman
Mr. & Mrs. Clarence E. Galston
Mr. & Mrs. Robert P. Koenig
Mr. & Mrs. George N. Lindsay, Jr.
Mr. & Mrs. Edward Everett Post
Mrs. H. Irving Pratt
Mr. & Mrs. Richardson Pratt
Mr. & Mrs. Franz Schneider
Mr. & Mrs. Richard J. Weghorn
Mrs. Alex M. White
Mr. & Mrs. Theodore Wickersham
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There were two LIBA meetings open to the
whole membership. At the first, the Dorcas
Cummings Memorial Lecture, on May 18th, the
speaker was Dr. Stephen Jay Gould, professor of
Geology and curator of Invertebrate Paleontology
at Harvard University. Dr. Gould's lecture was on
"The Meaning of the Darwin Revolution;" in it he
discussed his fascinating theories about the evo-
lutionary process in Nature. The annual meeting,
usually held in December, was postponed until
January 18th, 1981 as the speaker we eagerly
wanted, Dr. Lewis Thomas, head of Sloan-Kettering
Cancer Research Center, was not available at an
earlier date. Dr. Thomas spoke brilliantly on "The
Value of Basic Scientific Research," stressing its
need for wide support and explaining how vital it
is that it remain basic in spite of the current
tendency to commercialize its discoveries. A copy
of Dr. Thomas' lecture was distributed to all LIBA
members.
On October 26th, LIBA directors and their
guests were addressed by Dr. Birgit Zipser, one of
the young members of the Lab's scientific staff.
Her subject, which intrigued her audience greatly,
was "The Application of Hybridoma Technology to
a Study of the Molecular Mechanism of Neural
Connectivity Essential for the Functioning of the
Nervous System." She and her associate, Dr. Ron
McKay, have been creating hybridomas which
produce monoclonal antibodies that are very
specific in binding (or labeling) individual proteins
Stephen Jay Gould and James D. Watson
in nerve cells. A hybridoma is made by fusing a
cancer cell (myeloma) with a normal antibody-
producing cell. Since the presence or absence of
certain proteins indicates what's happening in a
nerve cell, by "reading" these labels they can tell,
for example, if a particular nerve cell is passing on a
message. So their main experiment has been to
take a leech, which has relatively few but large
nerve cells, and stain the cells with monoclonal
antibodies that they had developed for very
specific nerve proteins which would be present
when the nerve cell was excited, or transmitting.
Since they used a fluorescent dye, the cells and
their connections lit up most graphically. They are
now trying to answer the question: Do these
antibodies stain groups of cells that are related
functionally when the brain is working? In other
words, can they light up the whole circuit of
nerves that receive, transmit a stimulus to the brain
and back again for a response? A positive answer
would, of course, be an incredible tool for
studying (and treating) many nervous system
problems, including pain itself.
After the lecture a buffet dinner was served to
the directors and their guests and to the Lab's
scientists in Blackford Hall.
At the annual meeting of members all previous
directors were re-elected with the exception of
Mr. Richard Olney, 3rd, whose resignation was
regretfully accepted because of his moving to
Massachusetts. His place was filled by the election
of Mrs. Henry Upham Harris, Jr. At the subsequent
director's meeting all previous officers were
re-elected with the exception of Mr. Walter H.
Page, who felt it necessary to devote himself fully
to his new responsibilities as chairman of the
Laboratory's Board of Trustees. A resolution of
regret and appreciation for his long and valuable
service to LIBA was adopted. Then Mr. George J.
Hossfeld, Jr. was elected to take his place as Vice-
Chairman.
I am happy to report that the LIBA membership
continues to expand and that the interest of the
community in the Lab and its support of its vital
research are both increasing.
February 15, 1981 Edward Pulling, Chairman
Long Island Biological Association
Lewis Thomas Birgit Zipser
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Mr. & Mrs. W.O. Simpson
Mrs. James C. Skiff
Mr. & Mrs. Rowland G. Skinner
Mr. & Mrs. William S. Smoot
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Cold Spring Harbor Laboratory, partial view
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